id sid tid token lemma pos dpc-3474 1 1 dermatology dermatology NOUN dpc-3474 1 2 : : PUNCT dpc-3474 1 3 practical practical ADJ dpc-3474 1 4 and and CCONJ dpc-3474 1 5 conceptual conceptual ADJ dpc-3474 1 6 review review NOUN dpc-3474 1 7 | | ADV dpc-3474 1 8 dermatol dermatol ADJ dpc-3474 1 9 pract pract NOUN dpc-3474 1 10 concept concept NOUN dpc-3474 1 11 . . PUNCT dpc-3474 2 1 2023;13(4):e2023304 2023;13(4):e2023304 NUM dpc-3474 2 2 1 1 NUM dpc-3474 2 3 patterns pattern NOUN dpc-3474 2 4 of of ADP dpc-3474 2 5 recurrence recurrence NOUN dpc-3474 2 6 of of ADP dpc-3474 2 7 cutaneous cutaneous ADJ dpc-3474 2 8 melanoma melanoma NOUN dpc-3474 2 9 : : PUNCT dpc-3474 2 10 a a DET dpc-3474 2 11     SPACE dpc-3474 2 12 literature literature NOUN dpc-3474 2 13 review review NOUN dpc-3474 2 14 dominga dominga ADJ dpc-3474 2 15 peirano1 peirano1 NOUN dpc-3474 2 16 , , PUNCT dpc-3474 2 17 francisca francisca PROPN dpc-3474 2 18 donoso1 donoso1 PROPN dpc-3474 2 19 , , PUNCT dpc-3474 2 20 sebastián sebastián PROPN dpc-3474 2 21 vargas1 vargas1 PROPN dpc-3474 2 22 , , PUNCT dpc-3474 2 23 leonel leonel PROPN dpc-3474 2 24 hidalgo1 hidalgo1 PROPN dpc-3474 2 25 , , PUNCT dpc-3474 2 26 rosario rosario PROPN dpc-3474 2 27 agüero1 agüero1 PROPN dpc-3474 2 28 , , PUNCT dpc-3474 2 29 pablo pablo PROPN dpc-3474 2 30 uribe1,2 uribe1,2 PROPN dpc-3474 2 31 , , PUNCT dpc-3474 2 32 sebastían sebastían PROPN dpc-3474 2 33 mondaca2,3 mondaca2,3 PROPN dpc-3474 2 34 , , PUNCT dpc-3474 2 35 cristian cristian ADJ dpc-3474 2 36 navarrete navarrete PROPN dpc-3474 2 37 - - PUNCT dpc-3474 2 38 dechent1,2 dechent1,2 ADJ dpc-3474 2 39 1 1 NUM dpc-3474 2 40 department department NOUN dpc-3474 2 41 of of ADP dpc-3474 2 42 dermatology dermatology NOUN dpc-3474 2 43 , , PUNCT dpc-3474 2 44 escuela escuela PROPN dpc-3474 2 45 de de PROPN dpc-3474 2 46 medicina medicina PROPN dpc-3474 2 47 , , PUNCT dpc-3474 2 48 pontificia pontificia PROPN dpc-3474 2 49 universidad universidad PROPN dpc-3474 2 50 católica católica PROPN dpc-3474 2 51 de de PROPN dpc-3474 2 52 chile chile PROPN dpc-3474 2 53 , , PUNCT dpc-3474 2 54 santiago santiago PROPN dpc-3474 2 55 , , PUNCT dpc-3474 2 56 chile chile NOUN dpc-3474 2 57 2 2 NUM dpc-3474 2 58 melanoma melanoma NOUN dpc-3474 2 59 and and CCONJ dpc-3474 2 60 skin skin NOUN dpc-3474 2 61 cancer cancer NOUN dpc-3474 2 62 unit unit NOUN dpc-3474 2 63 , , PUNCT dpc-3474 2 64 escuela escuela PROPN dpc-3474 2 65 de de PROPN dpc-3474 2 66 medicina medicina PROPN dpc-3474 2 67 , , PUNCT dpc-3474 2 68 pontificia pontificia PROPN dpc-3474 2 69 universidad universidad PROPN dpc-3474 2 70 católica católica PROPN dpc-3474 2 71 de de PROPN dpc-3474 2 72 chile chile PROPN dpc-3474 2 73 , , PUNCT dpc-3474 2 74 santiago santiago PROPN dpc-3474 2 75 , , PUNCT dpc-3474 2 76 chile chile PROPN dpc-3474 2 77 3 3 NUM dpc-3474 2 78 department department PROPN dpc-3474 2 79 of of ADP dpc-3474 2 80 medical medical ADJ dpc-3474 2 81 oncology oncology NOUN dpc-3474 2 82 , , PUNCT dpc-3474 2 83 escuela escuela PROPN dpc-3474 2 84 de de PROPN dpc-3474 2 85 medicina medicina PROPN dpc-3474 2 86 , , PUNCT dpc-3474 2 87 pontificia pontificia PROPN dpc-3474 2 88 universidad universidad PROPN dpc-3474 2 89 católica católica PROPN dpc-3474 2 90 de de PROPN dpc-3474 2 91 chile chile PROPN dpc-3474 2 92 , , PUNCT dpc-3474 2 93 santiago santiago PROPN dpc-3474 2 94 , , PUNCT dpc-3474 2 95 chile chile VERB dpc-3474 2 96 key key ADJ dpc-3474 2 97 words word NOUN dpc-3474 2 98 : : PUNCT dpc-3474 2 99 melanoma melanoma NOUN dpc-3474 2 100 , , PUNCT dpc-3474 2 101 staging staging NOUN dpc-3474 2 102 , , PUNCT dpc-3474 2 103 metastasis metastasis NOUN dpc-3474 2 104 , , PUNCT dpc-3474 2 105 recurrence recurrence NOUN dpc-3474 2 106 , , PUNCT dpc-3474 2 107 skin skin NOUN dpc-3474 2 108 cancer cancer NOUN dpc-3474 2 109 , , PUNCT dpc-3474 2 110 immune immune ADJ dpc-3474 2 111 checkpoint checkpoint NOUN dpc-3474 2 112 inhibitors inhibitor NOUN dpc-3474 2 113 , , PUNCT dpc-3474 2 114 screening screen VERB dpc-3474 2 115 citation citation NOUN dpc-3474 2 116 : : PUNCT dpc-3474 2 117 peirano peirano NOUN dpc-3474 2 118 d d X dpc-3474 2 119 , , PUNCT dpc-3474 2 120 donoso donoso PROPN dpc-3474 2 121 f f PROPN dpc-3474 2 122 , , PUNCT dpc-3474 2 123 vargas vargas PROPN dpc-3474 2 124 s s PART dpc-3474 2 125 , , PUNCT dpc-3474 2 126 et et PROPN dpc-3474 2 127 al al PROPN dpc-3474 2 128 . . PUNCT dpc-3474 2 129 patterns pattern NOUN dpc-3474 2 130 of of ADP dpc-3474 2 131 recurrence recurrence NOUN dpc-3474 2 132 on on ADP dpc-3474 2 133 cutaneous cutaneous ADJ dpc-3474 2 134 melanoma melanoma NOUN dpc-3474 2 135 : : PUNCT dpc-3474 2 136 a a DET dpc-3474 2 137 literature literature NOUN dpc-3474 2 138 review review NOUN dpc-3474 2 139 . . PUNCT dpc-3474 3 1 dermatol dermatol NOUN dpc-3474 3 2 pract pract PROPN dpc-3474 3 3 concept concept NOUN dpc-3474 3 4 . . PUNCT dpc-3474 4 1 2023;13(4):e2023304 2023;13(4):e2023304 X dpc-3474 4 2 . . PUNCT dpc-3474 4 3 doi doi PROPN dpc-3474 4 4 : : PUNCT dpc-3474 5 1 https://doi.org/10.5826/dpc.1304a304 https://doi.org/10.5826/dpc.1304a304 PROPN dpc-3474 5 2 accepted accept VERB dpc-3474 5 3 : : PUNCT dpc-3474 5 4 october october PROPN dpc-3474 5 5 10 10 NUM dpc-3474 5 6 , , PUNCT dpc-3474 5 7 2023 2023 NUM dpc-3474 5 8 ; ; PUNCT dpc-3474 5 9 published publish VERB dpc-3474 5 10 : : PUNCT dpc-3474 6 1 october october PROPN dpc-3474 6 2 2023 2023 NUM dpc-3474 6 3 copyright copyright NOUN dpc-3474 6 4 : : PUNCT dpc-3474 6 5 © © PROPN dpc-3474 6 6 2023 2023 NUM dpc-3474 6 7 peirano peirano NOUN dpc-3474 6 8 et et PROPN dpc-3474 6 9 al al PROPN dpc-3474 6 10 . . PUNCT dpc-3474 7 1 this this PRON dpc-3474 7 2 is be AUX dpc-3474 7 3 an an DET dpc-3474 7 4 open open ADJ dpc-3474 7 5 - - PUNCT dpc-3474 7 6 access access NOUN dpc-3474 7 7 article article NOUN dpc-3474 7 8 distributed distribute VERB dpc-3474 7 9 under under ADP dpc-3474 7 10 the the DET dpc-3474 7 11 terms term NOUN dpc-3474 7 12 of of ADP dpc-3474 7 13 the the DET dpc-3474 7 14 creative creative ADJ dpc-3474 7 15 commons common NOUN dpc-3474 7 16 attributionnoncommercial attributionnoncommercial ADJ dpc-3474 7 17 license license NOUN dpc-3474 7 18 ( ( PUNCT dpc-3474 7 19 by by ADP dpc-3474 7 20 - - PUNCT dpc-3474 7 21 nc-4.0 nc-4.0 NOUN dpc-3474 7 22 ) ) PUNCT dpc-3474 7 23 , , PUNCT dpc-3474 7 24 https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/ PROPN dpc-3474 7 25 , , PUNCT dpc-3474 7 26 which which PRON dpc-3474 7 27 permits permit VERB dpc-3474 7 28 unrestricted unrestricted ADJ dpc-3474 7 29 noncommercial noncommercial ADJ dpc-3474 7 30 use use NOUN dpc-3474 7 31 , , PUNCT dpc-3474 7 32 distribution distribution NOUN dpc-3474 7 33 , , PUNCT dpc-3474 7 34 and and CCONJ dpc-3474 7 35 reproduction reproduction NOUN dpc-3474 7 36 in in ADP dpc-3474 7 37 any any DET dpc-3474 7 38 medium medium NOUN dpc-3474 7 39 , , PUNCT dpc-3474 7 40 provided provide VERB dpc-3474 7 41 the the DET dpc-3474 7 42 original original ADJ dpc-3474 7 43 authors author NOUN dpc-3474 7 44 and and CCONJ dpc-3474 7 45 source source NOUN dpc-3474 7 46 are be AUX dpc-3474 7 47 credited credit VERB dpc-3474 7 48 . . PUNCT dpc-3474 8 1 funding funding NOUN dpc-3474 8 2 : : PUNCT dpc-3474 8 3 partial partial ADJ dpc-3474 8 4 funding funding NOUN dpc-3474 8 5 was be AUX dpc-3474 8 6 obtained obtain VERB dpc-3474 8 7 from from ADP dpc-3474 8 8 la la PROPN dpc-3474 8 9 fondation fondation PROPN dpc-3474 8 10 la la PROPN dpc-3474 8 11 roche roche PROPN dpc-3474 8 12 possay possay VERB dpc-3474 8 13 research research NOUN dpc-3474 8 14 awards award NOUN dpc-3474 8 15 . . PUNCT dpc-3474 9 1 the the DET dpc-3474 9 2 funding funding NOUN dpc-3474 9 3 source source NOUN dpc-3474 9 4 had have VERB dpc-3474 9 5 no no DET dpc-3474 9 6 role role NOUN dpc-3474 9 7 in in ADP dpc-3474 9 8 the the DET dpc-3474 9 9 study study NOUN dpc-3474 9 10 . . PUNCT dpc-3474 10 1 competing compete VERB dpc-3474 10 2 interests interest NOUN dpc-3474 10 3 : : PUNCT dpc-3474 10 4 none none NOUN dpc-3474 10 5 . . PUNCT dpc-3474 11 1 authorship authorship NOUN dpc-3474 11 2 : : PUNCT dpc-3474 11 3 all all DET dpc-3474 11 4 authors author NOUN dpc-3474 11 5 have have AUX dpc-3474 11 6 contributed contribute VERB dpc-3474 11 7 significantly significantly ADV dpc-3474 11 8 to to ADP dpc-3474 11 9 this this DET dpc-3474 11 10 publication publication NOUN dpc-3474 11 11 . . PUNCT dpc-3474 12 1 corresponding correspond VERB dpc-3474 12 2 author author NOUN dpc-3474 12 3 : : PUNCT dpc-3474 12 4 cristian cristian ADJ dpc-3474 12 5 navarrete navarrete NOUN dpc-3474 12 6 - - PUNCT dpc-3474 12 7 dechent dechent ADJ dpc-3474 12 8 , , PUNCT dpc-3474 12 9 md md PROPN dpc-3474 12 10 , , PUNCT dpc-3474 12 11 department department PROPN dpc-3474 12 12 of of ADP dpc-3474 12 13 dermatology dermatology NOUN dpc-3474 12 14 , , PUNCT dpc-3474 12 15 escuela escuela PROPN dpc-3474 12 16 de de PROPN dpc-3474 12 17 medicina medicina PROPN dpc-3474 12 18 , , PUNCT dpc-3474 12 19 pontificia pontificia PROPN dpc-3474 12 20 universidad universidad PROPN dpc-3474 12 21 católica católica PROPN dpc-3474 12 22 de de PROPN dpc-3474 12 23 chile chile PROPN dpc-3474 12 24 , , PUNCT dpc-3474 12 25 diagonal diagonal ADJ dpc-3474 12 26 paraguay paraguay NOUN dpc-3474 12 27 362 362 NUM dpc-3474 12 28 , , PUNCT dpc-3474 12 29 6th 6th ADJ dpc-3474 12 30 floor floor NOUN dpc-3474 12 31 , , PUNCT dpc-3474 12 32 santiago santiago PROPN dpc-3474 12 33 , , PUNCT dpc-3474 12 34 chile chile PROPN dpc-3474 12 35 8330077 8330077 NUM dpc-3474 12 36 . . PUNCT dpc-3474 13 1 phone phone NOUN dpc-3474 13 2 : : PUNCT dpc-3474 14 1 +56 +56 NUM dpc-3474 14 2 - - PUNCT dpc-3474 14 3 2 2 NUM dpc-3474 14 4 - - PUNCT dpc-3474 14 5 2435 2435 NUM dpc-3474 14 6 3574 3574 NUM dpc-3474 14 7 e e NOUN dpc-3474 14 8 - - NOUN dpc-3474 14 9 mail mail NOUN dpc-3474 14 10 : : PUNCT dpc-3474 15 1 ctnavarr@gmail.com ctnavarr@gmail.com X dpc-3474 16 1 the the DET dpc-3474 16 2 incidence incidence NOUN dpc-3474 16 3 of of ADP dpc-3474 16 4 melanoma melanoma NOUN dpc-3474 16 5 has have AUX dpc-3474 16 6 been be AUX dpc-3474 16 7 dramatically dramatically ADV dpc-3474 16 8 increasing increase VERB dpc-3474 16 9 over over ADP dpc-3474 16 10 the the DET dpc-3474 16 11 last last ADJ dpc-3474 16 12 decades decade NOUN dpc-3474 16 13 . . PUNCT dpc-3474 17 1 melanoma melanoma NOUN dpc-3474 17 2 is be AUX dpc-3474 17 3 considered consider VERB dpc-3474 17 4 to to PART dpc-3474 17 5 have have VERB dpc-3474 17 6 a a DET dpc-3474 17 7 high high ADJ dpc-3474 17 8 metastatic metastatic ADJ dpc-3474 17 9 potential potential NOUN dpc-3474 17 10 and and CCONJ dpc-3474 17 11 it it PRON dpc-3474 17 12 can can AUX dpc-3474 17 13 progress progress VERB dpc-3474 17 14 via via ADP dpc-3474 17 15 lymphatic lymphatic ADJ dpc-3474 17 16 vessels vessel NOUN dpc-3474 17 17 or or CCONJ dpc-3474 17 18 through through ADP dpc-3474 17 19 hematogenous hematogenous ADJ dpc-3474 17 20 metastasis metastasis NOUN dpc-3474 17 21 . . PUNCT dpc-3474 18 1 different different ADJ dpc-3474 18 2 patterns pattern NOUN dpc-3474 18 3 of of ADP dpc-3474 18 4 recurrence recurrence NOUN dpc-3474 18 5 have have AUX dpc-3474 18 6 been be AUX dpc-3474 18 7 described describe VERB dpc-3474 18 8 , , PUNCT dpc-3474 18 9 namely namely ADV dpc-3474 18 10 , , PUNCT dpc-3474 18 11 local local ADJ dpc-3474 18 12 , , PUNCT dpc-3474 18 13 satellite satellite NOUN dpc-3474 18 14 , , PUNCT dpc-3474 18 15 and and CCONJ dpc-3474 18 16 in in ADP dpc-3474 18 17 transit transit NOUN dpc-3474 18 18 metastasis metastasis NOUN dpc-3474 18 19 ( ( PUNCT dpc-3474 18 20 lcit lcit NOUN dpc-3474 18 21 ) ) PUNCT dpc-3474 18 22 , , PUNCT dpc-3474 18 23 lymphatic lymphatic ADJ dpc-3474 18 24 metastasis metastasis NOUN dpc-3474 18 25 , , PUNCT dpc-3474 18 26 and and CCONJ dpc-3474 18 27 systemic systemic ADJ dpc-3474 18 28 metastasis metastasis NOUN dpc-3474 18 29 . . PUNCT dpc-3474 19 1 with with ADP dpc-3474 19 2 a a DET dpc-3474 19 3 more more ADV dpc-3474 19 4 advanced advanced ADJ dpc-3474 19 5 melanoma melanoma NOUN dpc-3474 19 6 stage stage NOUN dpc-3474 19 7 at at ADP dpc-3474 19 8 diagnosis diagnosis NOUN dpc-3474 19 9 , , PUNCT dpc-3474 19 10 there there PRON dpc-3474 19 11 is be VERB dpc-3474 19 12 a a DET dpc-3474 19 13 higher high ADJ dpc-3474 19 14 risk risk NOUN dpc-3474 19 15 for for ADP dpc-3474 19 16 systemic systemic ADJ dpc-3474 19 17 metastasis metastasis NOUN dpc-3474 19 18 in in ADP dpc-3474 19 19 comparison comparison NOUN dpc-3474 19 20 to to ADP dpc-3474 19 21 lcit lcit NOUN dpc-3474 19 22 ; ; PUNCT dpc-3474 19 23 in in ADP dpc-3474 19 24 contrast contrast NOUN dpc-3474 19 25 , , PUNCT dpc-3474 19 26 early early ADJ dpc-3474 19 27 - - PUNCT dpc-3474 19 28 stage stage NOUN dpc-3474 19 29 melanoma melanoma NOUN dpc-3474 19 30 tends tend VERB dpc-3474 19 31 to to PART dpc-3474 19 32 recur recur VERB dpc-3474 19 33 more more ADV dpc-3474 19 34 frequently frequently ADV dpc-3474 19 35 as as ADP dpc-3474 19 36 lcit lcit ADJ dpc-3474 19 37 and and CCONJ dpc-3474 19 38 less less ADV dpc-3474 19 39 commonly commonly ADV dpc-3474 19 40 as as ADP dpc-3474 19 41 systematic systematic ADJ dpc-3474 19 42 metastasis metastasis NOUN dpc-3474 19 43 . . PUNCT dpc-3474 20 1 the the DET dpc-3474 20 2 aim aim NOUN dpc-3474 20 3 of of ADP dpc-3474 20 4 this this DET dpc-3474 20 5 review review NOUN dpc-3474 20 6 was be AUX dpc-3474 20 7 to to PART dpc-3474 20 8 summarize summarize VERB dpc-3474 20 9 the the DET dpc-3474 20 10 patterns pattern NOUN dpc-3474 20 11 of of ADP dpc-3474 20 12 recurrence recurrence NOUN dpc-3474 20 13 of of ADP dpc-3474 20 14 cutaneous cutaneous ADJ dpc-3474 20 15 melanoma melanoma NOUN dpc-3474 20 16 , , PUNCT dpc-3474 20 17 giving give VERB dpc-3474 20 18 the the DET dpc-3474 20 19 clinician clinician NOUN dpc-3474 20 20 a a DET dpc-3474 20 21 practical practical ADJ dpc-3474 20 22 summary summary NOUN dpc-3474 20 23 for for ADP dpc-3474 20 24 diagnosis diagnosis NOUN dpc-3474 20 25 , , PUNCT dpc-3474 20 26 prognosis prognosis NOUN dpc-3474 20 27 , , PUNCT dpc-3474 20 28 and and CCONJ dpc-3474 20 29 surveillance surveillance NOUN dpc-3474 20 30 . . PUNCT dpc-3474 21 1 there there PRON dpc-3474 21 2 is be VERB dpc-3474 21 3 a a DET dpc-3474 21 4 knowledge knowledge NOUN dpc-3474 21 5 gap gap NOUN dpc-3474 21 6 of of ADP dpc-3474 21 7 the the DET dpc-3474 21 8 common common ADJ dpc-3474 21 9 patterns pattern NOUN dpc-3474 21 10 of of ADP dpc-3474 21 11 recurrence recurrence NOUN dpc-3474 21 12 that that PRON dpc-3474 21 13 needs need VERB dpc-3474 21 14 to to PART dpc-3474 21 15 be be AUX dpc-3474 21 16 addressed address VERB dpc-3474 21 17 to to PART dpc-3474 21 18 better well ADV dpc-3474 21 19 identify identify VERB dpc-3474 21 20 patients patient NOUN dpc-3474 21 21 at at ADP dpc-3474 21 22 high high ADJ dpc-3474 21 23 risk risk NOUN dpc-3474 21 24 of of ADP dpc-3474 21 25 disease disease NOUN dpc-3474 21 26 recurrence recurrence NOUN dpc-3474 21 27 and and CCONJ dpc-3474 21 28 personalize personalize VERB dpc-3474 21 29 surveillance surveillance NOUN dpc-3474 21 30 strategies strategy NOUN dpc-3474 21 31 as as ADV dpc-3474 21 32 well well ADV dpc-3474 21 33 as as ADP dpc-3474 21 34 patient patient ADJ dpc-3474 21 35 counseling counseling NOUN dpc-3474 21 36 . . PUNCT dpc-3474 22 1 abstract abstract ADJ dpc-3474 22 2 2 2 NUM dpc-3474 22 3 review review NOUN dpc-3474 22 4 | | ADV dpc-3474 22 5 dermatol dermatol ADJ dpc-3474 22 6 pract pract NOUN dpc-3474 22 7 concept concept NOUN dpc-3474 22 8 . . PUNCT dpc-3474 23 1 2023;13(4):e2023304 2023;13(4):e2023304 NUM dpc-3474 23 2 introduction introduction NOUN dpc-3474 23 3 the the DET dpc-3474 23 4 incidence incidence NOUN dpc-3474 23 5 of of ADP dpc-3474 23 6 melanoma melanoma NOUN dpc-3474 23 7 has have AUX dpc-3474 23 8 been be AUX dpc-3474 23 9 dramatically dramatically ADV dpc-3474 23 10 increasing increase VERB dpc-3474 23 11 worldwide worldwide ADV dpc-3474 23 12 over over ADP dpc-3474 23 13 the the DET dpc-3474 23 14 last last ADJ dpc-3474 23 15 two two NUM dpc-3474 23 16 decades decade NOUN dpc-3474 23 17 [ [ X dpc-3474 23 18 1,2 1,2 NUM dpc-3474 23 19 ] ] PUNCT dpc-3474 23 20 . . PUNCT dpc-3474 24 1 it it PRON dpc-3474 24 2 is be AUX dpc-3474 24 3 the the DET dpc-3474 24 4 fifth fifth ADJ dpc-3474 24 5 most most ADV dpc-3474 24 6 common common ADJ dpc-3474 24 7 cancer cancer NOUN dpc-3474 24 8 in in ADP dpc-3474 24 9 the the DET dpc-3474 24 10 u.s u.s PROPN dpc-3474 24 11 . . PROPN dpc-3474 24 12 and and CCONJ dpc-3474 24 13 the the DET dpc-3474 24 14 ninth ninth ADJ dpc-3474 24 15 in in ADP dpc-3474 24 16 europe[3 europe[3 PROPN dpc-3474 24 17 ] ] PUNCT dpc-3474 24 18 . . PUNCT dpc-3474 25 1 in in ADP dpc-3474 25 2 2023 2023 NUM dpc-3474 25 3 , , PUNCT dpc-3474 25 4 it it PRON dpc-3474 25 5 was be AUX dpc-3474 25 6 estimated estimate VERB dpc-3474 25 7 that that SCONJ dpc-3474 25 8 there there PRON dpc-3474 25 9 would would AUX dpc-3474 25 10 be be AUX dpc-3474 25 11 89,070 89,070 NUM dpc-3474 25 12 new new ADJ dpc-3474 25 13 melanoma melanoma NOUN dpc-3474 25 14 cases case NOUN dpc-3474 25 15 in in ADP dpc-3474 25 16 the the DET dpc-3474 25 17 united united PROPN dpc-3474 25 18 states states PROPN dpc-3474 25 19 ( ( PUNCT dpc-3474 25 20 us us PROPN dpc-3474 25 21 ) ) PUNCT dpc-3474 25 22 with with ADP dpc-3474 25 23 7,990 7,990 NUM dpc-3474 25 24 patients patient NOUN dpc-3474 25 25 dying die VERB dpc-3474 25 26 of of ADP dpc-3474 25 27 the the DET dpc-3474 25 28 disease disease NOUN dpc-3474 25 29 [ [ X dpc-3474 25 30 2 2 NUM dpc-3474 25 31 ] ] PUNCT dpc-3474 25 32 . . PUNCT dpc-3474 26 1 patients patient NOUN dpc-3474 26 2 with with ADP dpc-3474 26 3 early early ADJ dpc-3474 26 4 - - PUNCT dpc-3474 26 5 stage stage NOUN dpc-3474 26 6 cutaneous cutaneous ADJ dpc-3474 26 7 melanoma melanoma NOUN dpc-3474 26 8 ( ( PUNCT dpc-3474 26 9 i.e. i.e. X dpc-3474 26 10 stages stage NOUN dpc-3474 26 11 i i PRON dpc-3474 26 12 and and CCONJ dpc-3474 26 13 ii ii NOUN dpc-3474 26 14 ) ) PUNCT dpc-3474 26 15 are be AUX dpc-3474 26 16 generally generally ADV dpc-3474 26 17 considered consider VERB dpc-3474 26 18 to to PART dpc-3474 26 19 have have VERB dpc-3474 26 20 an an DET dpc-3474 26 21 excellent excellent ADJ dpc-3474 26 22 prognosis prognosis NOUN dpc-3474 26 23 . . PUNCT dpc-3474 27 1 data datum NOUN dpc-3474 27 2 from from ADP dpc-3474 27 3 the the DET dpc-3474 27 4 surveillance surveillance NOUN dpc-3474 27 5 , , PUNCT dpc-3474 27 6 epidemiology epidemiology NOUN dpc-3474 27 7 , , PUNCT dpc-3474 27 8 and and CCONJ dpc-3474 27 9 end end VERB dpc-3474 27 10 results result NOUN dpc-3474 27 11 ( ( PUNCT dpc-3474 27 12 seer seer NOUN dpc-3474 27 13 ) ) PUNCT dpc-3474 27 14 program program NOUN dpc-3474 27 15 suggests suggest VERB dpc-3474 27 16 that that SCONJ dpc-3474 27 17 99.5 99.5 NUM dpc-3474 27 18 % % NOUN dpc-3474 27 19 of of ADP dpc-3474 27 20 patients patient NOUN dpc-3474 27 21 with with ADP dpc-3474 27 22 localized localized ADJ dpc-3474 27 23 melanoma melanoma NOUN dpc-3474 27 24 , , PUNCT dpc-3474 27 25 70.6 70.6 NUM dpc-3474 27 26 % % NOUN dpc-3474 27 27 regional regional ADJ dpc-3474 27 28 melanoma melanoma NOUN dpc-3474 27 29 , , PUNCT dpc-3474 27 30 and and CCONJ dpc-3474 27 31 31.9 31.9 NUM dpc-3474 27 32 % % NOUN dpc-3474 27 33 of of ADP dpc-3474 27 34 those those PRON dpc-3474 27 35 with with ADP dpc-3474 27 36 distant distant ADJ dpc-3474 27 37 metastases metastasis NOUN dpc-3474 27 38 , , PUNCT dpc-3474 27 39 will will AUX dpc-3474 27 40 be be AUX dpc-3474 27 41 alive alive ADJ dpc-3474 27 42 at at ADP dpc-3474 27 43 5 5 NUM dpc-3474 27 44 years year NOUN dpc-3474 27 45 [ [ X dpc-3474 27 46 4 4 NUM dpc-3474 27 47 ] ] PUNCT dpc-3474 27 48 . . PUNCT dpc-3474 28 1 cutaneous cutaneous ADJ dpc-3474 28 2 melanoma melanoma NOUN dpc-3474 28 3 is be AUX dpc-3474 28 4 considered consider VERB dpc-3474 28 5 to to PART dpc-3474 28 6 have have VERB dpc-3474 28 7 a a DET dpc-3474 28 8 high high ADJ dpc-3474 28 9 metastatic metastatic ADJ dpc-3474 28 10 potential potential NOUN dpc-3474 28 11 and and CCONJ dpc-3474 28 12 it it PRON dpc-3474 28 13 can can AUX dpc-3474 28 14 have have VERB dpc-3474 28 15 lymphatic lymphatic ADJ dpc-3474 28 16 metastasis metastasis NOUN dpc-3474 28 17 or or CCONJ dpc-3474 28 18 hematogenous hematogenous ADJ dpc-3474 28 19 metastasis metastasis NOUN dpc-3474 28 20 [ [ X dpc-3474 28 21 5 5 NUM dpc-3474 28 22 ] ] PUNCT dpc-3474 28 23 . . PUNCT dpc-3474 29 1 specifically specifically ADV dpc-3474 29 2 , , PUNCT dpc-3474 29 3 it it PRON dpc-3474 29 4 can can AUX dpc-3474 29 5 metastasize metastasize VERB dpc-3474 29 6 as as ADP dpc-3474 29 7 local local ADJ dpc-3474 29 8 , , PUNCT dpc-3474 29 9 satellite satellite NOUN dpc-3474 29 10 , , PUNCT dpc-3474 29 11 and and CCONJ dpc-3474 29 12 in in ADP dpc-3474 29 13 transit transit NOUN dpc-3474 29 14 metastasis metastasis NOUN dpc-3474 29 15 ( ( PUNCT dpc-3474 29 16 lcit lcit NOUN dpc-3474 29 17 ) ) PUNCT dpc-3474 29 18 , , PUNCT dpc-3474 29 19 on on ADP dpc-3474 29 20 lymph lymph NOUN dpc-3474 29 21 nodes node NOUN dpc-3474 29 22 , , PUNCT dpc-3474 29 23 or or CCONJ dpc-3474 29 24 as as ADP dpc-3474 29 25 distant distant ADJ dpc-3474 29 26 metastasis metastasis NOUN dpc-3474 29 27 [ [ X dpc-3474 29 28 5–8 5–8 NOUN dpc-3474 29 29 ] ] PUNCT dpc-3474 29 30 . . PUNCT dpc-3474 30 1 the the DET dpc-3474 30 2 presence presence NOUN dpc-3474 30 3 of of ADP dpc-3474 30 4 regional regional ADJ dpc-3474 30 5 lymph lymph NOUN dpc-3474 30 6 node node ADJ dpc-3474 30 7 metastatic metastatic ADJ dpc-3474 30 8 disease disease NOUN dpc-3474 30 9 is be AUX dpc-3474 30 10 a a DET dpc-3474 30 11 significant significant ADJ dpc-3474 30 12 predictor predictor NOUN dpc-3474 30 13 of of ADP dpc-3474 30 14 outcome outcome NOUN dpc-3474 30 15 in in ADP dpc-3474 30 16 melanomas melanomas PROPN dpc-3474 30 17 as as SCONJ dpc-3474 30 18 it it PRON dpc-3474 30 19 is be AUX dpc-3474 30 20 associated associate VERB dpc-3474 30 21 with with ADP dpc-3474 30 22 a a DET dpc-3474 30 23 50 50 NUM dpc-3474 30 24 % % NOUN dpc-3474 30 25 reduction reduction NOUN dpc-3474 30 26 in in ADP dpc-3474 30 27 survival survival NOUN dpc-3474 30 28 compared compare VERB dpc-3474 30 29 to to ADP dpc-3474 30 30 patients patient NOUN dpc-3474 30 31 without without ADP dpc-3474 30 32 nodal nodal NOUN dpc-3474 30 33 involvement involvement NOUN dpc-3474 30 34 [ [ X dpc-3474 30 35 3,9 3,9 NUM dpc-3474 30 36 ] ] PUNCT dpc-3474 30 37 . . PUNCT dpc-3474 31 1 there there PRON dpc-3474 31 2 is be VERB dpc-3474 31 3 limited limited ADJ dpc-3474 31 4 research research NOUN dpc-3474 31 5 analyzing analyze VERB dpc-3474 31 6 the the DET dpc-3474 31 7 patterns pattern NOUN dpc-3474 31 8 of of ADP dpc-3474 31 9 recurrence recurrence NOUN dpc-3474 31 10 in in ADP dpc-3474 31 11 patients patient NOUN dpc-3474 31 12 with with ADP dpc-3474 31 13 primary primary ADJ dpc-3474 31 14 localized localized ADJ dpc-3474 31 15 cutaneous cutaneous ADJ dpc-3474 31 16 melanoma melanoma NOUN dpc-3474 31 17 . . PUNCT dpc-3474 32 1 meier meier PROPN dpc-3474 32 2 et et PROPN dpc-3474 32 3 al al PROPN dpc-3474 32 4 study study PROPN dpc-3474 32 5 in in ADP dpc-3474 32 6 2002 2002 NUM dpc-3474 32 7 traced trace VERB dpc-3474 32 8 the the DET dpc-3474 32 9 metastatic metastatic ADJ dpc-3474 32 10 pathways pathway NOUN dpc-3474 32 11 of of ADP dpc-3474 32 12 3,001 3,001 NUM dpc-3474 32 13 patients patient NOUN dpc-3474 32 14 with with ADP dpc-3474 32 15 primary primary ADJ dpc-3474 32 16 cutaneous cutaneous ADJ dpc-3474 32 17 melanoma melanoma NOUN dpc-3474 32 18 from from ADP dpc-3474 32 19 1976 1976 NUM dpc-3474 32 20 - - SYM dpc-3474 32 21 1996 1996 NUM dpc-3474 32 22 . . PUNCT dpc-3474 33 1 of of ADP dpc-3474 33 2 the the DET dpc-3474 33 3 patients patient NOUN dpc-3474 33 4 who who PRON dpc-3474 33 5 had have VERB dpc-3474 33 6 disease disease NOUN dpc-3474 33 7 confined confine VERB dpc-3474 33 8 to to ADP dpc-3474 33 9 the the DET dpc-3474 33 10 primary primary ADJ dpc-3474 33 11 tumor tumor NOUN dpc-3474 33 12 at at ADP dpc-3474 33 13 diagnosis diagnosis NOUN dpc-3474 33 14 ( ( PUNCT dpc-3474 33 15 i.e. i.e. X dpc-3474 33 16 stages stage NOUN dpc-3474 33 17 i i PRON dpc-3474 33 18 and and CCONJ dpc-3474 33 19 ii ii PROPN dpc-3474 33 20 ) ) PUNCT dpc-3474 33 21 , , PUNCT dpc-3474 33 22 15.5 15.5 NUM dpc-3474 33 23 % % NOUN dpc-3474 33 24 developed develop VERB dpc-3474 33 25 metastasis metastasis NOUN dpc-3474 33 26 during during ADP dpc-3474 33 27 the the DET dpc-3474 33 28 study study NOUN dpc-3474 33 29 period period NOUN dpc-3474 33 30 [ [ X dpc-3474 33 31 6 6 NUM dpc-3474 33 32 ] ] PUNCT dpc-3474 33 33 . . PUNCT dpc-3474 34 1 another another DET dpc-3474 34 2 study study NOUN dpc-3474 34 3 conducted conduct VERB dpc-3474 34 4 in in ADP dpc-3474 34 5 1999 1999 NUM dpc-3474 34 6 by by ADP dpc-3474 34 7 cohn cohn PROPN dpc-3474 34 8 et et PROPN dpc-3474 34 9 al al PROPN dpc-3474 34 10 . . PROPN dpc-3474 34 11 identified identify VERB dpc-3474 34 12 569 569 NUM dpc-3474 34 13 of of ADP dpc-3474 34 14 2493 2493 NUM dpc-3474 34 15 patients patient NOUN dpc-3474 34 16 with with ADP dpc-3474 34 17 recurrent recurrent ADJ dpc-3474 34 18 melanoma melanoma NOUN dpc-3474 34 19 and and CCONJ dpc-3474 34 20 demonstrated demonstrate VERB dpc-3474 34 21 a a DET dpc-3474 34 22 5 5 NUM dpc-3474 34 23 - - PUNCT dpc-3474 34 24 year year NOUN dpc-3474 34 25 survival survival NOUN dpc-3474 34 26 rate rate NOUN dpc-3474 34 27 of of ADP dpc-3474 34 28 82 82 NUM dpc-3474 34 29 % % NOUN dpc-3474 34 30 and and CCONJ dpc-3474 34 31 30 30 NUM dpc-3474 34 32 % % NOUN dpc-3474 34 33 among among ADP dpc-3474 34 34 those those PRON dpc-3474 34 35 with with ADP dpc-3474 34 36 a a DET dpc-3474 34 37 primary primary ADJ dpc-3474 34 38 local local ADJ dpc-3474 34 39 versus versus ADP dpc-3474 34 40 regional regional ADJ dpc-3474 34 41 recurrence recurrence NOUN dpc-3474 34 42 , , PUNCT dpc-3474 34 43 respectively respectively ADV dpc-3474 34 44 [ [ X dpc-3474 34 45 10 10 NUM dpc-3474 34 46 ] ] PUNCT dpc-3474 34 47 . . PUNCT dpc-3474 35 1 furthermore furthermore ADV dpc-3474 35 2 , , PUNCT dpc-3474 35 3 current current ADJ dpc-3474 35 4 guidelines guideline NOUN dpc-3474 35 5 are be AUX dpc-3474 35 6 fairly fairly ADV dpc-3474 35 7 vague vague ADJ dpc-3474 35 8 as as ADP dpc-3474 35 9 to to ADP dpc-3474 35 10 how how SCONJ dpc-3474 35 11 aggressively aggressively ADV dpc-3474 35 12 we we PRON dpc-3474 35 13 should should AUX dpc-3474 35 14 follow follow VERB dpc-3474 35 15 up up ADP dpc-3474 35 16 patients patient NOUN dpc-3474 35 17 with with ADP dpc-3474 35 18 localized localized ADJ dpc-3474 35 19 disease disease NOUN dpc-3474 35 20 ( ( PUNCT dpc-3474 35 21 i.e. i.e. X dpc-3474 35 22 stage stage NOUN dpc-3474 35 23 i i PRON dpc-3474 35 24 and and CCONJ dpc-3474 35 25 ii ii NUM dpc-3474 35 26 ) ) PUNCT dpc-3474 35 27 , , PUNCT dpc-3474 35 28 with with ADP dpc-3474 35 29 most most ADJ dpc-3474 35 30 advocating advocate VERB dpc-3474 35 31 only only ADV dpc-3474 35 32 routine routine ADJ dpc-3474 35 33 skin skin NOUN dpc-3474 35 34 examinations examination NOUN dpc-3474 35 35 at at ADP dpc-3474 35 36 various various ADJ dpc-3474 35 37 intervals interval NOUN dpc-3474 35 38 for for ADP dpc-3474 35 39 the the DET dpc-3474 35 40 first first ADJ dpc-3474 35 41 5 5 NUM dpc-3474 35 42 years year NOUN dpc-3474 35 43 . . PUNCT dpc-3474 36 1 surveillance surveillance NOUN dpc-3474 36 2 guidelines guideline NOUN dpc-3474 36 3 , , PUNCT dpc-3474 36 4 in in ADP dpc-3474 36 5 general general ADJ dpc-3474 36 6 , , PUNCT dpc-3474 36 7 and and CCONJ dpc-3474 36 8 melanoma melanoma NOUN dpc-3474 36 9 patients patient NOUN dpc-3474 36 10 specifically specifically ADV dpc-3474 36 11 , , PUNCT dpc-3474 36 12 are be AUX dpc-3474 36 13 often often ADV dpc-3474 36 14 follow follow VERB dpc-3474 36 15 - - PUNCT dpc-3474 36 16 up up NOUN dpc-3474 36 17 based base VERB dpc-3474 36 18 on on ADP dpc-3474 36 19 low low ADJ dpc-3474 36 20 - - PUNCT dpc-3474 36 21 level level NOUN dpc-3474 36 22 evidence evidence NOUN dpc-3474 36 23 . . PUNCT dpc-3474 37 1 additionally additionally ADV dpc-3474 37 2 , , PUNCT dpc-3474 37 3 despite despite SCONJ dpc-3474 37 4 clinical clinical ADJ dpc-3474 37 5 guidelines guideline NOUN dpc-3474 37 6 , , PUNCT dpc-3474 37 7 practice practice NOUN dpc-3474 37 8 patterns pattern NOUN dpc-3474 37 9 tend tend VERB dpc-3474 37 10 to to PART dpc-3474 37 11 vary vary VERB dpc-3474 37 12 across across ADP dpc-3474 37 13 different different ADJ dpc-3474 37 14 institutions institution NOUN dpc-3474 37 15 and and CCONJ dpc-3474 37 16 countries country NOUN dpc-3474 37 17 [ [ X dpc-3474 37 18 11–14 11–14 NUM dpc-3474 37 19 ] ] PUNCT dpc-3474 37 20 . . PUNCT dpc-3474 38 1 given give VERB dpc-3474 38 2 the the DET dpc-3474 38 3 increasing increase VERB dpc-3474 38 4 incidence incidence NOUN dpc-3474 38 5 of of ADP dpc-3474 38 6 cutaneous cutaneous ADJ dpc-3474 38 7 malignant malignant ADJ dpc-3474 38 8 melanoma melanoma NOUN dpc-3474 38 9 and and CCONJ dpc-3474 38 10 the the DET dpc-3474 38 11 recent recent ADJ dpc-3474 38 12 changes change NOUN dpc-3474 38 13 in in ADP dpc-3474 38 14 the the DET dpc-3474 38 15 treatment treatment NOUN dpc-3474 38 16 landscape landscape NOUN dpc-3474 38 17 , , PUNCT dpc-3474 38 18 it it PRON dpc-3474 38 19 is be AUX dpc-3474 38 20 important important ADJ dpc-3474 38 21 to to PART dpc-3474 38 22 understand understand VERB dpc-3474 38 23 stage stage NOUN dpc-3474 38 24 - - PUNCT dpc-3474 38 25 specific specific ADJ dpc-3474 38 26 recurrence recurrence NOUN dpc-3474 38 27 patterns pattern NOUN dpc-3474 38 28 [ [ X dpc-3474 38 29 15 15 NUM dpc-3474 38 30 ] ] PUNCT dpc-3474 38 31 . . PUNCT dpc-3474 39 1 in in ADP dpc-3474 39 2 the the DET dpc-3474 39 3 current current ADJ dpc-3474 39 4 era era NOUN dpc-3474 39 5 of of ADP dpc-3474 39 6 immune immune ADJ dpc-3474 39 7 checkpoint checkpoint NOUN dpc-3474 39 8 inhibitors inhibitor NOUN dpc-3474 39 9 and and CCONJ dpc-3474 39 10 targeted target VERB dpc-3474 39 11 therapies therapy NOUN dpc-3474 39 12 , , PUNCT dpc-3474 39 13 early early ADJ dpc-3474 39 14 detection detection NOUN dpc-3474 39 15 of of ADP dpc-3474 39 16 melanoma melanoma NOUN dpc-3474 39 17 recurrences recurrence NOUN dpc-3474 39 18 is be AUX dpc-3474 39 19 important important ADJ dpc-3474 39 20 , , PUNCT dpc-3474 39 21 as as SCONJ dpc-3474 39 22 it it PRON dpc-3474 39 23 can can AUX dpc-3474 39 24 lead lead VERB dpc-3474 39 25 to to ADP dpc-3474 39 26 more more ADV dpc-3474 39 27 effective effective ADJ dpc-3474 39 28 and and CCONJ dpc-3474 39 29 manageable manageable ADJ dpc-3474 39 30 treatment treatment NOUN dpc-3474 39 31 options option NOUN dpc-3474 39 32 . . PUNCT dpc-3474 40 1 objective objective ADJ dpc-3474 40 2 the the DET dpc-3474 40 3 aim aim NOUN dpc-3474 40 4 of of ADP dpc-3474 40 5 this this DET dpc-3474 40 6 review review NOUN dpc-3474 40 7 was be AUX dpc-3474 40 8 to to PART dpc-3474 40 9 evaluate evaluate VERB dpc-3474 40 10 the the DET dpc-3474 40 11 recurrence recurrence NOUN dpc-3474 40 12 patterns pattern NOUN dpc-3474 40 13 of of ADP dpc-3474 40 14 cutaneous cutaneous ADJ dpc-3474 40 15 melanoma melanoma NOUN dpc-3474 40 16 , , PUNCT dpc-3474 40 17 regarding regard VERB dpc-3474 40 18 the the DET dpc-3474 40 19 time time NOUN dpc-3474 40 20 of of ADP dpc-3474 40 21 follow follow NOUN dpc-3474 40 22 - - PUNCT dpc-3474 40 23 up up NOUN dpc-3474 40 24 , , PUNCT dpc-3474 40 25 time time NOUN dpc-3474 40 26 of of ADP dpc-3474 40 27 detection detection NOUN dpc-3474 40 28 of of ADP dpc-3474 40 29 the the DET dpc-3474 40 30 recurrence recurrence NOUN dpc-3474 40 31 , , PUNCT dpc-3474 40 32 and and CCONJ dpc-3474 40 33 the the DET dpc-3474 40 34 most most ADV dpc-3474 40 35 frequent frequent ADJ dpc-3474 40 36 site site NOUN dpc-3474 40 37 of of ADP dpc-3474 40 38 recurrence recurrence NOUN dpc-3474 40 39 , , PUNCT dpc-3474 40 40 giving give VERB dpc-3474 40 41 the the DET dpc-3474 40 42 clinician clinician NOUN dpc-3474 40 43 a a DET dpc-3474 40 44 practical practical ADJ dpc-3474 40 45 summary summary NOUN dpc-3474 40 46 for for ADP dpc-3474 40 47 diagnosis diagnosis NOUN dpc-3474 40 48 , , PUNCT dpc-3474 40 49 prognosis prognosis NOUN dpc-3474 40 50 , , PUNCT dpc-3474 40 51 and and CCONJ dpc-3474 40 52 surveillance surveillance NOUN dpc-3474 40 53 . . PUNCT dpc-3474 41 1 methods method NOUN dpc-3474 41 2 a a DET dpc-3474 41 3 literature literature NOUN dpc-3474 41 4 narrative narrative NOUN dpc-3474 41 5 review review NOUN dpc-3474 41 6 of of ADP dpc-3474 41 7 articles article NOUN dpc-3474 41 8 published publish VERB dpc-3474 41 9 in in ADP dpc-3474 41 10 pubmed pubmed PROPN dpc-3474 41 11 between between ADP dpc-3474 41 12 the the DET dpc-3474 41 13 years year NOUN dpc-3474 41 14 2000 2000 NUM dpc-3474 41 15 to to ADP dpc-3474 41 16 2022 2022 NUM dpc-3474 41 17 was be AUX dpc-3474 41 18 conducted conduct VERB dpc-3474 41 19 . . PUNCT dpc-3474 42 1 the the DET dpc-3474 42 2 keywords keyword NOUN dpc-3474 42 3 were be AUX dpc-3474 42 4 “ " PUNCT dpc-3474 42 5 melanoma melanoma NOUN dpc-3474 42 6 ” " PUNCT dpc-3474 42 7 or or CCONJ dpc-3474 42 8 “ " PUNCT dpc-3474 42 9 cutaneous cutaneous ADJ dpc-3474 42 10 melanoma melanoma NOUN dpc-3474 42 11 ” " PUNCT dpc-3474 42 12 and and CCONJ dpc-3474 42 13 “ " PUNCT dpc-3474 42 14 recurrence recurrence NOUN dpc-3474 42 15 ” " PUNCT dpc-3474 42 16 or or CCONJ dpc-3474 42 17 “ " PUNCT dpc-3474 42 18 relapse relapse NOUN dpc-3474 42 19 ” " PUNCT dpc-3474 42 20 and/or and/or CCONJ dpc-3474 42 21 “ " PUNCT dpc-3474 42 22 patterns pattern NOUN dpc-3474 42 23 ” " PUNCT dpc-3474 42 24 . . PUNCT dpc-3474 43 1 we we PRON dpc-3474 43 2 included include VERB dpc-3474 43 3 all all DET dpc-3474 43 4 studies study NOUN dpc-3474 43 5 in in ADP dpc-3474 43 6 english english PROPN dpc-3474 43 7 and/or and/or CCONJ dpc-3474 43 8 spanish spanish PROPN dpc-3474 43 9 . . PUNCT dpc-3474 44 1 exclusion exclusion NOUN dpc-3474 44 2 criteria criterion NOUN dpc-3474 44 3 were be AUX dpc-3474 44 4 non non ADJ dpc-3474 44 5 - - ADJ dpc-3474 44 6 skin skin ADJ dpc-3474 44 7 melanomas melanomas NOUN dpc-3474 44 8 , , PUNCT dpc-3474 44 9 stage stage NOUN dpc-3474 44 10 iv iv NUM dpc-3474 44 11 melanoma melanoma NOUN dpc-3474 44 12 only only ADV dpc-3474 44 13 , , PUNCT dpc-3474 44 14 studies study NOUN dpc-3474 44 15 published publish VERB dpc-3474 44 16 before before ADP dpc-3474 44 17 the the DET dpc-3474 44 18 year year NOUN dpc-3474 44 19 2000 2000 NUM dpc-3474 44 20 , , PUNCT dpc-3474 44 21 studies study NOUN dpc-3474 44 22 reporting report VERB dpc-3474 44 23 the the DET dpc-3474 44 24 local local ADJ dpc-3474 44 25 and and CCONJ dpc-3474 44 26 regional regional ADJ dpc-3474 44 27 recurrence recurrence NOUN dpc-3474 44 28 together together ADV dpc-3474 44 29 as as ADP dpc-3474 44 30 one one NUM dpc-3474 44 31 group group NOUN dpc-3474 44 32 , , PUNCT dpc-3474 44 33 and and CCONJ dpc-3474 44 34 case case NOUN dpc-3474 44 35 reports report NOUN dpc-3474 44 36 and and CCONJ dpc-3474 44 37 case case NOUN dpc-3474 44 38 series series NOUN dpc-3474 44 39 with with ADP dpc-3474 44 40 less less ADJ dpc-3474 44 41 than than ADP dpc-3474 44 42 10 10 NUM dpc-3474 44 43 patients patient NOUN dpc-3474 44 44 . . PUNCT dpc-3474 45 1 from from ADP dpc-3474 45 2 the the DET dpc-3474 45 3 remaining remain VERB dpc-3474 45 4 results result NOUN dpc-3474 45 5 , , PUNCT dpc-3474 45 6 study study NOUN dpc-3474 45 7 type type NOUN dpc-3474 45 8 , , PUNCT dpc-3474 45 9 number number NOUN dpc-3474 45 10 of of ADP dpc-3474 45 11 patients patient NOUN dpc-3474 45 12 , , PUNCT dpc-3474 45 13 stage stage NOUN dpc-3474 45 14 of of ADP dpc-3474 45 15 melanoma melanoma NOUN dpc-3474 45 16 at at ADP dpc-3474 45 17 diagnosis diagnosis NOUN dpc-3474 45 18 and and CCONJ dpc-3474 45 19 substage substage NOUN dpc-3474 45 20 if if SCONJ dpc-3474 45 21 they they PRON dpc-3474 45 22 reported report VERB dpc-3474 45 23 ( ( PUNCT dpc-3474 45 24 e.g e.g PROPN dpc-3474 45 25 ia ia PROPN dpc-3474 45 26 , , PUNCT dpc-3474 45 27 iib iib PROPN dpc-3474 45 28 , , PUNCT dpc-3474 45 29 iic iic PROPN dpc-3474 45 30 ) ) PUNCT dpc-3474 45 31 , , PUNCT dpc-3474 45 32 median median ADJ dpc-3474 45 33 follow follow NOUN dpc-3474 45 34 - - PUNCT dpc-3474 45 35 up up NOUN dpc-3474 45 36 , , PUNCT dpc-3474 45 37 mean mean VERB dpc-3474 45 38 recurrence recurrence NOUN dpc-3474 45 39 time time NOUN dpc-3474 45 40 ( ( PUNCT dpc-3474 45 41 in in ADP dpc-3474 45 42 months month NOUN dpc-3474 45 43 ) ) PUNCT dpc-3474 45 44 , , PUNCT dpc-3474 45 45 recurrence recurrence NOUN dpc-3474 45 46 site site NOUN dpc-3474 45 47 , , PUNCT dpc-3474 45 48 recurrence recurrence NOUN dpc-3474 45 49 predictors predictor NOUN dpc-3474 45 50 , , PUNCT dpc-3474 45 51 and and CCONJ dpc-3474 45 52 survival survival NOUN dpc-3474 45 53 rate rate NOUN dpc-3474 45 54 were be AUX dpc-3474 45 55 recorded record VERB dpc-3474 45 56 . . PUNCT dpc-3474 46 1 for for ADP dpc-3474 46 2 the the DET dpc-3474 46 3 study study NOUN dpc-3474 46 4 purposes purpose NOUN dpc-3474 46 5 , , PUNCT dpc-3474 46 6 ‘ ' PUNCT dpc-3474 46 7 recurrence recurrence NOUN dpc-3474 46 8 ’ ' PUNCT dpc-3474 46 9 was be AUX dpc-3474 46 10 defined define VERB dpc-3474 46 11 as as ADP dpc-3474 46 12 the the DET dpc-3474 46 13 return return NOUN dpc-3474 46 14 of of ADP dpc-3474 46 15 the the DET dpc-3474 46 16 melanoma melanoma NOUN dpc-3474 46 17 after after ADP dpc-3474 46 18 initial initial ADJ dpc-3474 46 19 treatment treatment NOUN dpc-3474 46 20 and and CCONJ dpc-3474 46 21 after after ADP dpc-3474 46 22 a a DET dpc-3474 46 23 period period NOUN dpc-3474 46 24 of of ADP dpc-3474 46 25 time time NOUN dpc-3474 46 26 during during ADP dpc-3474 46 27 which which PRON dpc-3474 46 28 the the DET dpc-3474 46 29 cancer cancer NOUN dpc-3474 46 30 was be AUX dpc-3474 46 31 not not PART dpc-3474 46 32 detected detect VERB dpc-3474 46 33 . . PUNCT dpc-3474 47 1 ‘ ' PUNCT dpc-3474 47 2 progression progression NOUN dpc-3474 47 3 ’ ' PUNCT dpc-3474 47 4 was be AUX dpc-3474 47 5 defined define VERB dpc-3474 47 6 as as ADP dpc-3474 47 7 melanoma melanoma NOUN dpc-3474 47 8 growing grow VERB dpc-3474 47 9 or or CCONJ dpc-3474 47 10 spreading spread VERB dpc-3474 47 11 without without ADP dpc-3474 47 12 ever ever ADV dpc-3474 47 13 having having AUX dpc-3474 47 14 gone go VERB dpc-3474 47 15 away away ADV dpc-3474 47 16 completely completely ADV dpc-3474 47 17 . . PUNCT dpc-3474 48 1 the the DET dpc-3474 48 2 recurrence recurrence NOUN dpc-3474 48 3 sites site NOUN dpc-3474 48 4 were be AUX dpc-3474 48 5 divided divide VERB dpc-3474 48 6 into into ADP dpc-3474 48 7 local local ADJ dpc-3474 48 8 , , PUNCT dpc-3474 48 9 satellite satellite NOUN dpc-3474 48 10 , , PUNCT dpc-3474 48 11 and and CCONJ dpc-3474 48 12 in in ADP dpc-3474 48 13 transit transit NOUN dpc-3474 48 14 metastasis metastasis NOUN dpc-3474 48 15 ( ( PUNCT dpc-3474 48 16 lcit lcit NOUN dpc-3474 48 17 ) ) PUNCT dpc-3474 48 18 , , PUNCT dpc-3474 48 19 lymph lymph NOUN dpc-3474 48 20 nodes node NOUN dpc-3474 48 21 / / SYM dpc-3474 48 22 nodal nodal NOUN dpc-3474 48 23 , , PUNCT dpc-3474 48 24 and and CCONJ dpc-3474 48 25 systemic systemic ADJ dpc-3474 48 26 metastasis metastasis NOUN dpc-3474 48 27 . . PUNCT dpc-3474 49 1 we we PRON dpc-3474 49 2 also also ADV dpc-3474 49 3 described describe VERB dpc-3474 49 4 the the DET dpc-3474 49 5 sites site NOUN dpc-3474 49 6 of of ADP dpc-3474 49 7 systemic systemic ADJ dpc-3474 49 8 metastasis metastasis NOUN dpc-3474 49 9 , , PUNCT dpc-3474 49 10 if if SCONJ dpc-3474 49 11 reported report VERB dpc-3474 49 12 . . PUNCT dpc-3474 50 1 the the DET dpc-3474 50 2 recurrence recurrence NOUN dpc-3474 50 3 detection detection NOUN dpc-3474 50 4 method method NOUN dpc-3474 50 5 was be AUX dpc-3474 50 6 classified classify VERB dpc-3474 50 7 into into ADP dpc-3474 50 8 patient patient ADJ dpc-3474 50 9 symptoms symptom NOUN dpc-3474 50 10 ( ( PUNCT dpc-3474 50 11 i.e. i.e. X dpc-3474 50 12 detected detect VERB dpc-3474 50 13 by by ADP dpc-3474 50 14 the the DET dpc-3474 50 15 patient patient NOUN dpc-3474 50 16 ) ) PUNCT dpc-3474 50 17 , , PUNCT dpc-3474 50 18 physical physical ADJ dpc-3474 50 19 examination examination NOUN dpc-3474 50 20 ( ( PUNCT dpc-3474 50 21 e.g. e.g. ADV dpc-3474 50 22 palpation palpation NOUN dpc-3474 50 23 , , PUNCT dpc-3474 50 24 visual visual ADJ dpc-3474 50 25 examination examination NOUN dpc-3474 50 26 ) ) PUNCT dpc-3474 50 27 , , PUNCT dpc-3474 50 28 and and CCONJ dpc-3474 50 29 images image NOUN dpc-3474 50 30 ( ( PUNCT dpc-3474 50 31 e.g. e.g. ADV dpc-3474 50 32 pet pet NOUN dpc-3474 50 33 - - PUNCT dpc-3474 50 34 ct ct NOUN dpc-3474 50 35 ) ) PUNCT dpc-3474 50 36 . . PUNCT dpc-3474 51 1 overall overall ADJ dpc-3474 51 2 survival survival NOUN dpc-3474 51 3 ( ( PUNCT dpc-3474 51 4 os os NOUN dpc-3474 51 5 ) ) PUNCT dpc-3474 51 6 was be AUX dpc-3474 51 7 presented present VERB dpc-3474 51 8 as as ADP dpc-3474 51 9 a a DET dpc-3474 51 10 percentage percentage NOUN dpc-3474 51 11 rate rate NOUN dpc-3474 51 12 at at ADP dpc-3474 51 13 3 3 NUM dpc-3474 51 14 or or CCONJ dpc-3474 51 15 5 5 NUM dpc-3474 51 16 years year NOUN dpc-3474 51 17 . . PUNCT dpc-3474 52 1 results result VERB dpc-3474 52 2 the the DET dpc-3474 52 3 overall overall ADJ dpc-3474 52 4 information information NOUN dpc-3474 52 5 is be AUX dpc-3474 52 6 summarized summarize VERB dpc-3474 52 7 in in ADP dpc-3474 52 8 tables table NOUN dpc-3474 52 9 1 1 NUM dpc-3474 52 10 - - SYM dpc-3474 52 11 4 4 NUM dpc-3474 52 12 . . PUNCT dpc-3474 53 1 follow follow VERB dpc-3474 53 2 - - PUNCT dpc-3474 53 3 up up NOUN dpc-3474 53 4 and and CCONJ dpc-3474 53 5 recurrence recurrence NOUN dpc-3474 53 6 type type VERB dpc-3474 53 7 the the DET dpc-3474 53 8 rate rate NOUN dpc-3474 53 9 of of ADP dpc-3474 53 10 melanoma melanoma NOUN dpc-3474 53 11 recurrence recurrence NOUN dpc-3474 53 12 was be AUX dpc-3474 53 13 determined determine VERB dpc-3474 53 14 by by ADP dpc-3474 53 15 the the DET dpc-3474 53 16 median median ADJ dpc-3474 53 17 follow follow VERB dpc-3474 53 18 - - PUNCT dpc-3474 53 19 up up ADP dpc-3474 53 20 time time NOUN dpc-3474 53 21 reported report VERB dpc-3474 53 22 in in ADP dpc-3474 53 23 different different ADJ dpc-3474 53 24 studies study NOUN dpc-3474 53 25 . . PUNCT dpc-3474 54 1 most most ADJ dpc-3474 54 2 studies study NOUN dpc-3474 54 3 have have AUX dpc-3474 54 4 shown show VERB dpc-3474 54 5 similar similar ADJ dpc-3474 54 6 recurrence recurrence NOUN dpc-3474 54 7 timing time VERB dpc-3474 54 8 patterns pattern NOUN dpc-3474 54 9 . . PUNCT dpc-3474 55 1 across across ADP dpc-3474 55 2 all all DET dpc-3474 55 3 stages stage NOUN dpc-3474 55 4 , , PUNCT dpc-3474 55 5 meyers meyer NOUN dpc-3474 55 6 et et NOUN dpc-3474 55 7 al al PROPN dpc-3474 55 8 reported report VERB dpc-3474 55 9 a a DET dpc-3474 55 10 recurrence recurrence NOUN dpc-3474 55 11 rate rate NOUN dpc-3474 55 12 of of ADP dpc-3474 55 13 36 36 NUM dpc-3474 55 14 % % NOUN dpc-3474 55 15 , , PUNCT dpc-3474 55 16 with with ADP dpc-3474 55 17 a a DET dpc-3474 55 18 median median ADJ dpc-3474 55 19 time time NOUN dpc-3474 55 20 of of ADP dpc-3474 55 21 recurrence recurrence NOUN dpc-3474 55 22 of of ADP dpc-3474 55 23 14 14 NUM dpc-3474 55 24 months month NOUN dpc-3474 56 1 [ [ X dpc-3474 56 2 16 16 NUM dpc-3474 56 3 ] ] PUNCT dpc-3474 56 4 . . PUNCT dpc-3474 57 1 o o X dpc-3474 57 2 ‘ ' PUNCT dpc-3474 57 3 connell connell PROPN dpc-3474 57 4 et et PROPN dpc-3474 57 5 al al PROPN dpc-3474 57 6 and and CCONJ dpc-3474 57 7 berger berger PROPN dpc-3474 57 8 et et PROPN dpc-3474 57 9 al al PROPN dpc-3474 57 10 reported report VERB dpc-3474 57 11 lower low ADJ dpc-3474 57 12 recurrence recurrence NOUN dpc-3474 57 13 rates rate NOUN dpc-3474 57 14 of of ADP dpc-3474 57 15 24 24 NUM dpc-3474 57 16 % % NOUN dpc-3474 57 17 and and CCONJ dpc-3474 57 18 29.5 29.5 NUM dpc-3474 57 19 % % NOUN dpc-3474 57 20 , , PUNCT dpc-3474 57 21 respectively respectively ADV dpc-3474 57 22 [ [ X dpc-3474 57 23 1,3 1,3 NUM dpc-3474 57 24 ] ] PUNCT dpc-3474 57 25 . . PUNCT dpc-3474 58 1 barbour barbour PROPN dpc-3474 58 2 et et PROPN dpc-3474 58 3 al al PROPN dpc-3474 58 4 reported report VERB dpc-3474 58 5 the the DET dpc-3474 58 6 highest high ADJ dpc-3474 58 7 rate rate NOUN dpc-3474 58 8 of of ADP dpc-3474 58 9 recurrence recurrence NOUN dpc-3474 58 10 of of ADP dpc-3474 58 11 45 45 NUM dpc-3474 58 12 % % NOUN dpc-3474 58 13 in in ADP dpc-3474 58 14 their their PRON dpc-3474 58 15 series series NOUN dpc-3474 58 16 [ [ X dpc-3474 58 17 17 17 NUM dpc-3474 58 18 ] ] PUNCT dpc-3474 58 19 . . PUNCT dpc-3474 59 1 review review VERB dpc-3474 59 2 | | ADV dpc-3474 59 3 dermatol dermatol ADJ dpc-3474 59 4 pract pract NOUN dpc-3474 59 5 concept concept NOUN dpc-3474 59 6 . . PUNCT dpc-3474 60 1 2023;13(4):e2023304 2023;13(4):e2023304 NUM dpc-3474 60 2 3 3 NUM dpc-3474 60 3 ta ta PART dpc-3474 60 4 b b PROPN dpc-3474 60 5 le le ADP dpc-3474 60 6 1 1 NUM dpc-3474 60 7 . . PUNCT dpc-3474 61 1 p p NOUN dpc-3474 61 2 at at ADP dpc-3474 61 3 ie ie PROPN dpc-3474 61 4 nt nt PROPN dpc-3474 61 5 s s PART dpc-3474 61 6 ’ ' PUNCT dpc-3474 61 7 d d NOUN dpc-3474 61 8 em em PRON dpc-3474 62 1 og og INTJ dpc-3474 62 2 ra ra PROPN dpc-3474 62 3 ph ph PROPN dpc-3474 63 1 ic ic PROPN dpc-3474 63 2 s s VERB dpc-3474 63 3 an an DET dpc-3474 63 4 d d PROPN dpc-3474 63 5 m m PROPN dpc-3474 63 6 el el PROPN dpc-3474 63 7 an an PROPN dpc-3474 63 8 om om PROPN dpc-3474 63 9 a a DET dpc-3474 63 10 di di X dpc-3474 63 11 ag ag PROPN dpc-3474 63 12 no no DET dpc-3474 63 13 si si PROPN dpc-3474 63 14 s s X dpc-3474 63 15 de de X dpc-3474 63 16 ta ta X dpc-3474 63 17 ils ils PROPN dpc-3474 63 18 . . PUNCT dpc-3474 64 1 st st PROPN dpc-3474 64 2 u u PROPN dpc-3474 64 3 d d PROPN dpc-3474 64 4 y y PROPN dpc-3474 64 5 ye ye PROPN dpc-3474 64 6 ar ar PROPN dpc-3474 64 7 o o PROPN dpc-3474 65 1 f f X dpc-3474 65 2 p p X dpc-3474 65 3 u u PROPN dpc-3474 65 4 b b PROPN dpc-3474 65 5 lic lic PROPN dpc-3474 65 6 at at ADP dpc-3474 65 7 io io PROPN dpc-3474 65 8 n n PROPN dpc-3474 65 9 su su PROPN dpc-3474 65 10 m m PROPN dpc-3474 65 11 m m PROPN dpc-3474 65 12 ar ar PROPN dpc-3474 65 13 y y PROPN dpc-3474 65 14 o o PROPN dpc-3474 66 1 f f X dpc-3474 66 2     SPACE dpc-3474 66 3 th th X dpc-3474 66 4 e e NOUN dpc-3474 66 5     SPACE dpc-3474 66 6 st st PROPN dpc-3474 66 7 u u PROPN dpc-3474 66 8 d d PROPN dpc-3474 66 9 y y PROPN dpc-3474 66 10 c c NOUN dpc-3474 66 11 o o X dpc-3474 66 12 u u NOUN dpc-3474 66 13 n n PRON dpc-3474 66 14 tr tr PROPN dpc-3474 66 15 y y PROPN dpc-3474 66 16 n n NUM dpc-3474 66 17 u u NOUN dpc-3474 66 18 m m PROPN dpc-3474 66 19 b b NOUN dpc-3474 66 20 er er INTJ dpc-3474 66 21 o o X dpc-3474 66 22 f f X dpc-3474 66 23 p p NOUN dpc-3474 66 24 at at ADP dpc-3474 66 25 ie ie X dpc-3474 66 26 n n NOUN dpc-3474 66 27 ts ts ADP dpc-3474 66 28 o o PROPN dpc-3474 66 29 f f X dpc-3474 66 30 th th X dpc-3474 66 31 e e PROPN dpc-3474 66 32 st st PROPN dpc-3474 66 33 u u PROPN dpc-3474 66 34 d d PROPN dpc-3474 66 35 y y PROPN dpc-3474 66 36 ( ( PUNCT dpc-3474 66 37 n n NOUN dpc-3474 66 38 ) ) PUNCT dpc-3474 66 39 m m VERB dpc-3474 66 40 ea ea NOUN dpc-3474 66 41 n n ADP dpc-3474 66 42 a a DET dpc-3474 66 43 g g NOUN dpc-3474 66 44 e e X dpc-3474 66 45 ( ( PUNCT dpc-3474 66 46 y y PROPN dpc-3474 66 47 , , PUNCT dpc-3474 66 48 r r VERB dpc-3474 66 49 an an DET dpc-3474 66 50 g g NOUN dpc-3474 66 51 e e NOUN dpc-3474 66 52 o o NOUN dpc-3474 66 53 r r NOUN dpc-3474 66 54 sd sd NOUN dpc-3474 66 55 ) ) PUNCT dpc-3474 66 56 g g PROPN dpc-3474 66 57 en en PROPN dpc-3474 66 58 d d X dpc-3474 66 59 er er INTJ dpc-3474 66 60 ( ( PUNCT dpc-3474 66 61 m m VERB dpc-3474 66 62 al al PROPN dpc-3474 66 63 e/ e/ PROPN dpc-3474 66 64 f f PROPN dpc-3474 67 1 em em PROPN dpc-3474 67 2 al al PROPN dpc-3474 67 3 e e PROPN dpc-3474 67 4 ) ) PUNCT dpc-3474 67 5 st st PROPN dpc-3474 67 6 ag ag PROPN dpc-3474 67 7 e e PROPN dpc-3474 67 8 m m PROPN dpc-3474 67 9 ea ea PROPN dpc-3474 68 1 n n NUM dpc-3474 68 2 f f NOUN dpc-3474 69 1 o o INTJ dpc-3474 69 2 llo llo INTJ dpc-3474 69 3 w w PROPN dpc-3474 69 4 u u PROPN dpc-3474 69 5 p p X dpc-3474 69 6 ( ( PUNCT dpc-3474 69 7 m m VERB dpc-3474 69 8 o o NOUN dpc-3474 69 9 n n X dpc-3474 69 10 th th NUM dpc-3474 69 11 s s NOUN dpc-3474 69 12 ) ) PUNCT dpc-3474 69 13 m m VERB dpc-3474 69 14 ei ei NOUN dpc-3474 69 15 er er INTJ dpc-3474 69 16 f f X dpc-3474 69 17 , , PUNCT dpc-3474 69 18 e e PROPN dpc-3474 69 19 t t PROPN dpc-3474 69 20 al al PROPN dpc-3474 69 21 . . PUNCT dpc-3474 70 1 20 20 NUM dpc-3474 70 2 02 02 NUM dpc-3474 70 3 r r NOUN dpc-3474 70 4 et et NOUN dpc-3474 70 5 ro ro NOUN dpc-3474 70 6 sp sp ADP dpc-3474 70 7 ec ec PROPN dpc-3474 70 8 ti ti PROPN dpc-3474 70 9 ve ve VERB dpc-3474 70 10 g g PROPN dpc-3474 70 11 er er INTJ dpc-3474 70 12 m m VERB dpc-3474 70 13 an an DET dpc-3474 70 14 y y PROPN dpc-3474 70 15 30 30 NUM dpc-3474 70 16 01 01 NUM dpc-3474 70 17 iii iii NUM dpc-3474 70 18 12 12 NUM dpc-3474 70 19 0 0 NUM dpc-3474 70 20 m m VERB dpc-3474 70 21 ey ey INTJ dpc-3474 70 22 er er INTJ dpc-3474 70 23 s s X dpc-3474 70 24 o o NOUN dpc-3474 70 25 , , PUNCT dpc-3474 70 26 e e PROPN dpc-3474 70 27 t t PROPN dpc-3474 70 28 al al PROPN dpc-3474 70 29 . . PUNCT dpc-3474 71 1 20 20 NUM dpc-3474 71 2 08 08 NUM dpc-3474 71 3 r r NOUN dpc-3474 71 4 et et NOUN dpc-3474 71 5 ro ro NOUN dpc-3474 71 6 sp sp ADP dpc-3474 71 7 ec ec PROPN dpc-3474 71 8 ti ti PROPN dpc-3474 71 9 ve ve VERB dpc-3474 71 10 u u X dpc-3474 71 11 sa sa PROPN dpc-3474 71 12 11 11 NUM dpc-3474 71 13 8 8 NUM dpc-3474 71 14 63 63 NUM dpc-3474 71 15 , , PUNCT dpc-3474 71 16 5 5 NUM dpc-3474 71 17 41 41 NUM dpc-3474 71 18 ( ( PUNCT dpc-3474 71 19 35 35 NUM dpc-3474 71 20 % % NOUN dpc-3474 71 21 ) ) PUNCT dpc-3474 71 22 fe fe X dpc-3474 71 23 m m PROPN dpc-3474 71 24 al al PROPN dpc-3474 71 25 e e PROPN dpc-3474 71 26 77 77 NUM dpc-3474 71 27 ( ( PUNCT dpc-3474 71 28 65 65 NUM dpc-3474 71 29 % % NOUN dpc-3474 71 30 ) ) PUNCT dpc-3474 71 31 m m VERB dpc-3474 71 32 al al PROPN dpc-3474 71 33 e e PROPN dpc-3474 71 34 ii ii PROPN dpc-3474 71 35 -i -i PROPN dpc-3474 71 36 ii ii PROPN dpc-3474 71 37 44 44 NUM dpc-3474 71 38 b b NOUN dpc-3474 71 39 ar ar NOUN dpc-3474 71 40 bo bo PROPN dpc-3474 71 41 ur ur PROPN dpc-3474 71 42 s s PROPN dpc-3474 71 43 , , PUNCT dpc-3474 71 44 e e PROPN dpc-3474 71 45 t t PROPN dpc-3474 71 46 al al PROPN dpc-3474 71 47 . . PUNCT dpc-3474 72 1 20 20 NUM dpc-3474 72 2 15 15 NUM dpc-3474 72 3 pr pr NOUN dpc-3474 72 4 os os INTJ dpc-3474 73 1 pe pe INTJ dpc-3474 73 2 ct ct NUM dpc-3474 73 3 iv iv NUM dpc-3474 74 1 e e X dpc-3474 74 2 a a DET dpc-3474 74 3 us us PROPN dpc-3474 74 4 tr tr PROPN dpc-3474 74 5 al al PROPN dpc-3474 74 6 ia ia PROPN dpc-3474 74 7 17 17 NUM dpc-3474 74 8 3 3 NUM dpc-3474 74 9 g g NOUN dpc-3474 74 10 ro ro NOUN dpc-3474 74 11 up up ADP dpc-3474 74 12 1 1 NUM dpc-3474 74 13 : : SYM dpc-3474 74 14 6 6 NUM dpc-3474 74 15 1 1 NUM dpc-3474 74 16 ( ( PUNCT dpc-3474 74 17 1 1 NUM dpc-3474 74 18 5 5 NUM dpc-3474 74 19 – – PUNCT dpc-3474 74 20 92 92 NUM dpc-3474 74 21 ) ) PUNCT dpc-3474 74 22 g g NOUN dpc-3474 74 23 ro ro NOUN dpc-3474 74 24 up up ADP dpc-3474 74 25 2 2 NUM dpc-3474 74 26 : : SYM dpc-3474 74 27 6 6 NUM dpc-3474 74 28 1 1 NUM dpc-3474 74 29 ( ( PUNCT dpc-3474 74 30 2 2 NUM dpc-3474 74 31 0 0 NUM dpc-3474 74 32 – – PUNCT dpc-3474 74 33 88 88 NUM dpc-3474 74 34 ) ) SYM dpc-3474 74 35 19 19 NUM dpc-3474 74 36 ( ( PUNCT dpc-3474 74 37 18 18 NUM dpc-3474 74 38 % % NOUN dpc-3474 74 39 ) ) PUNCT dpc-3474 74 40 fe fe X dpc-3474 74 41 m m PROPN dpc-3474 74 42 al al PROPN dpc-3474 74 43 e e PROPN dpc-3474 74 44 88 88 NUM dpc-3474 74 45 ( ( PUNCT dpc-3474 74 46 82 82 NUM dpc-3474 74 47 % % NOUN dpc-3474 74 48 ) ) PUNCT dpc-3474 74 49 m m VERB dpc-3474 74 50 al al PROPN dpc-3474 74 51 e e PROPN dpc-3474 74 52 ii ii PROPN dpc-3474 74 53 ib ib PROPN dpc-3474 74 54 -i -i PROPN dpc-3474 74 55 ii ii PROPN dpc-3474 74 56 c c NOUN dpc-3474 74 57 32 32 NUM dpc-3474 74 58 o o NOUN dpc-3474 74 59 c c NOUN dpc-3474 74 60 on on ADP dpc-3474 74 61 ne ne X dpc-3474 74 62 ll ll PROPN dpc-3474 74 63 e e X dpc-3474 74 64 , , PUNCT dpc-3474 74 65 e e PROPN dpc-3474 74 66 t t PROPN dpc-3474 74 67 al al PROPN dpc-3474 74 68 . . PUNCT dpc-3474 75 1 20 20 NUM dpc-3474 75 2 15 15 NUM dpc-3474 75 3 r r NOUN dpc-3474 75 4 et et NOUN dpc-3474 75 5 ro ro NOUN dpc-3474 75 6 sp sp ADP dpc-3474 75 7 ec ec PROPN dpc-3474 75 8 ti ti PROPN dpc-3474 75 9 ve ve VERB dpc-3474 75 10 ir ir PROPN dpc-3474 75 11 el el PROPN dpc-3474 75 12 an an PROPN dpc-3474 76 1 d d PROPN dpc-3474 76 2 16 16 NUM dpc-3474 76 3 4 4 NUM dpc-3474 76 4 51 51 NUM dpc-3474 76 5 .2 .2 NUM dpc-3474 76 6 ( ( PUNCT dpc-3474 76 7 ±1 ±1 VERB dpc-3474 76 8 4 4 NUM dpc-3474 76 9 . . NOUN dpc-3474 76 10 1 1 NUM dpc-3474 76 11 ) ) PUNCT dpc-3474 76 12 88 88 NUM dpc-3474 76 13 ( ( PUNCT dpc-3474 76 14 53 53 NUM dpc-3474 76 15 .7 .7 NUM dpc-3474 76 16 % % NOUN dpc-3474 76 17 ) ) PUNCT dpc-3474 77 1 fe fe X dpc-3474 77 2 m m PROPN dpc-3474 77 3 al al PROPN dpc-3474 77 4 e e PROPN dpc-3474 77 5 76 76 NUM dpc-3474 77 6     SPACE dpc-3474 77 7 ( ( PUNCT dpc-3474 77 8 46 46 NUM dpc-3474 77 9 .3 .3 NUM dpc-3474 77 10 % % NOUN dpc-3474 77 11 ) ) PUNCT dpc-3474 78 1 m m VERB dpc-3474 78 2 al al PROPN dpc-3474 78 3 e e PROPN dpc-3474 78 4 iii iii PROPN dpc-3474 78 5 75 75 NUM dpc-3474 78 6 sv sv INTJ dpc-3474 78 7 ed ed PROPN dpc-3474 78 8 m m PROPN dpc-3474 78 9 an an DET dpc-3474 78 10 f f PROPN dpc-3474 78 11 , , PUNCT dpc-3474 78 12 et et PROPN dpc-3474 78 13 a a DET dpc-3474 78 14 l. l. PROPN dpc-3474 78 15 20 20 NUM dpc-3474 78 16 16 16 NUM dpc-3474 78 17 sy sy PROPN dpc-3474 78 18 st st PROPN dpc-3474 78 19 em em PRON dpc-3474 78 20 at at ADP dpc-3474 78 21 ic ic PROPN dpc-3474 78 22 r r NOUN dpc-3474 78 23 ev ev X dpc-3474 78 24 ie ie X dpc-3474 78 25 w w PROPN dpc-3474 78 26 . . PUNCT dpc-3474 79 1 m m VERB dpc-3474 79 2 ul ul INTJ dpc-3474 79 3 ti ti X dpc-3474 79 4 ce ce PROPN dpc-3474 79 5 nt not PART dpc-3474 79 6 er er INTJ dpc-3474 79 7 15 15 NUM dpc-3474 79 8 2 2 NUM dpc-3474 79 9 . . NUM dpc-3474 79 10 42 42 NUM dpc-3474 79 11 2 2 NUM dpc-3474 79 12 iii iii X dpc-3474 79 13 i i PRON dpc-3474 79 14 sp sp ADP dpc-3474 79 15 ar ar NOUN dpc-3474 79 16 ks ks PROPN dpc-3474 79 17 d d PROPN dpc-3474 79 18 s s PROPN dpc-3474 79 19 , , PUNCT dpc-3474 79 20 e e PROPN dpc-3474 79 21 t t PROPN dpc-3474 79 22 al al PROPN dpc-3474 79 23 . . PUNCT dpc-3474 80 1 20 20 NUM dpc-3474 80 2 16 16 NUM dpc-3474 80 3 r r NOUN dpc-3474 80 4 et et NOUN dpc-3474 80 5 ro ro NOUN dpc-3474 80 6 sp sp ADP dpc-3474 80 7 ec ec PROPN dpc-3474 80 8 ti ti PROPN dpc-3474 80 9 ve ve PROPN dpc-3474 80 10 a a DET dpc-3474 80 11 us us PROPN dpc-3474 80 12 tr tr PROPN dpc-3474 80 13 al al PROPN dpc-3474 80 14 ia ia PROPN dpc-3474 80 15 10 10 NUM dpc-3474 80 16 7 7 NUM dpc-3474 80 17 72 72 NUM dpc-3474 80 18 .1 .1 NUM dpc-3474 80 19 ( ( PUNCT dpc-3474 80 20 58 58 NUM dpc-3474 80 21 – – SYM dpc-3474 80 22 8 8 NUM dpc-3474 80 23 0 0 NUM dpc-3474 80 24 ) ) PUNCT dpc-3474 80 25 25 25 NUM dpc-3474 80 26 ( ( PUNCT dpc-3474 80 27 23 23 NUM dpc-3474 80 28 .4 .4 NUM dpc-3474 80 29 % % NOUN dpc-3474 80 30 ) ) PUNCT dpc-3474 81 1 fe fe X dpc-3474 81 2 m m PROPN dpc-3474 81 3 al al PROPN dpc-3474 81 4 e e PROPN dpc-3474 81 5 82 82 NUM dpc-3474 81 6 ( ( PUNCT dpc-3474 81 7 76 76 NUM dpc-3474 81 8 .6 .6 NUM dpc-3474 81 9 % % NOUN dpc-3474 81 10 ) ) PUNCT dpc-3474 81 11 m m VERB dpc-3474 81 12 al al PROPN dpc-3474 81 13 e e PROPN dpc-3474 81 14 iii iii PROPN dpc-3474 81 15 i i PRON dpc-3474 81 16 30 30 NUM dpc-3474 81 17 , , PUNCT dpc-3474 81 18 5 5 NUM dpc-3474 81 19 b b X dpc-3474 81 20 er er INTJ dpc-3474 81 21 ge ge PROPN dpc-3474 81 22 r r PROPN dpc-3474 81 23 a a DET dpc-3474 81 24 c c NOUN dpc-3474 81 25 , , PUNCT dpc-3474 81 26 e e PROPN dpc-3474 81 27 t t PROPN dpc-3474 81 28 al al PROPN dpc-3474 81 29 . . PUNCT dpc-3474 82 1 20 20 NUM dpc-3474 82 2 17 17 NUM dpc-3474 82 3 r r NOUN dpc-3474 82 4 et et NOUN dpc-3474 82 5 ro ro NOUN dpc-3474 82 6 sp sp ADP dpc-3474 82 7 ec ec PROPN dpc-3474 82 8 ti ti PROPN dpc-3474 82 9 ve ve VERB dpc-3474 82 10 u u PROPN dpc-3474 82 11 sa sa PROPN dpc-3474 82 12 58 58 NUM dpc-3474 82 13 1 1 NUM dpc-3474 82 14 63 63 NUM dpc-3474 82 15 .5 .5 NUM dpc-3474 82 16 ( ( PUNCT dpc-3474 82 17 11 11 NUM dpc-3474 82 18 – – SYM dpc-3474 82 19 9 9 NUM dpc-3474 82 20 1 1 NUM dpc-3474 82 21 ) ) PUNCT dpc-3474 82 22 22 22 NUM dpc-3474 82 23 1 1 NUM dpc-3474 82 24 ( ( PUNCT dpc-3474 82 25 3 3 NUM dpc-3474 82 26 8 8 NUM dpc-3474 82 27 % % NOUN dpc-3474 82 28 ) ) PUNCT dpc-3474 82 29 fe fe X dpc-3474 82 30 m m PROPN dpc-3474 82 31 al al PROPN dpc-3474 82 32 e e PROPN dpc-3474 82 33 36 36 NUM dpc-3474 82 34 0 0 NUM dpc-3474 82 35 ( ( PUNCT dpc-3474 82 36 6 6 NUM dpc-3474 82 37 2 2 NUM dpc-3474 82 38 % % NOUN dpc-3474 82 39 ) ) PUNCT dpc-3474 82 40 m m VERB dpc-3474 82 41 al al PROPN dpc-3474 82 42 e e PROPN dpc-3474 82 43 ii ii PROPN dpc-3474 82 44 l l NOUN dpc-3474 82 45 ee ee VERB dpc-3474 82 46 a a DET dpc-3474 82 47 y y PROPN dpc-3474 82 48 , , PUNCT dpc-3474 82 49 e e PROPN dpc-3474 82 50 t t PROPN dpc-3474 82 51 al al PROPN dpc-3474 82 52 . . PUNCT dpc-3474 83 1 20 20 NUM dpc-3474 83 2 17 17 NUM dpc-3474 83 3 r r NOUN dpc-3474 83 4 et et NOUN dpc-3474 83 5 ro ro NOUN dpc-3474 83 6 sp sp ADP dpc-3474 83 7 ec ec PROPN dpc-3474 83 8 ti ti PROPN dpc-3474 83 9 ve ve VERB dpc-3474 83 10 u u X dpc-3474 83 11 sa sa PROPN dpc-3474 83 12 73 73 NUM dpc-3474 83 13 8 8 NUM dpc-3474 83 14 62 62 NUM dpc-3474 83 15 ( ( PUNCT dpc-3474 83 16 17 17 NUM dpc-3474 83 17 – – SYM dpc-3474 83 18 9 9 NUM dpc-3474 83 19 1 1 NUM dpc-3474 83 20 ) ) PUNCT dpc-3474 83 21 28 28 NUM dpc-3474 83 22 4 4 NUM dpc-3474 83 23 ( ( PUNCT dpc-3474 83 24 3 3 NUM dpc-3474 83 25 8 8 NUM dpc-3474 83 26 . . PUNCT dpc-3474 83 27 5 5 NUM dpc-3474 83 28 % % NOUN dpc-3474 83 29 ) ) PUNCT dpc-3474 83 30 fe fe X dpc-3474 83 31 m m PROPN dpc-3474 83 32 al al PROPN dpc-3474 83 33 e e PROPN dpc-3474 83 34 45 45 NUM dpc-3474 83 35 4 4 NUM dpc-3474 83 36 ( ( PUNCT dpc-3474 83 37 6 6 NUM dpc-3474 83 38 1 1 NUM dpc-3474 83 39 . . NOUN dpc-3474 83 40 5 5 NUM dpc-3474 83 41 % % NOUN dpc-3474 83 42 ) ) PUNCT dpc-3474 84 1 m m VERB dpc-3474 84 2 al al PROPN dpc-3474 84 3 e e PROPN dpc-3474 84 4 ii ii PROPN dpc-3474 84 5 52 52 NUM dpc-3474 84 6 n n PRON dpc-3474 84 7 am be AUX dpc-3474 84 8 in in ADP dpc-3474 84 9 a a DET dpc-3474 84 10 w w NOUN dpc-3474 84 11 , , PUNCT dpc-3474 84 12 e e PROPN dpc-3474 84 13 t t PROPN dpc-3474 84 14 al al PROPN dpc-3474 84 15 . . PUNCT dpc-3474 85 1 20 20 NUM dpc-3474 85 2 18 18 NUM dpc-3474 85 3 r r NOUN dpc-3474 85 4 et et NOUN dpc-3474 85 5 ro ro NOUN dpc-3474 85 6 sp sp ADP dpc-3474 85 7 ec ec PROPN dpc-3474 85 8 ti ti PROPN dpc-3474 85 9 ve ve VERB dpc-3474 85 10 u u X dpc-3474 85 11 sa sa PROPN dpc-3474 85 12 16 16 NUM dpc-3474 85 13 8 8 NUM dpc-3474 85 14 62 62 NUM dpc-3474 85 15 42 42 NUM dpc-3474 85 16 ( ( PUNCT dpc-3474 85 17 25 25 NUM dpc-3474 85 18 % % NOUN dpc-3474 85 19 ) ) PUNCT dpc-3474 85 20 fe fe X dpc-3474 85 21 m m PROPN dpc-3474 85 22 al al PROPN dpc-3474 85 23 e e PROPN dpc-3474 85 24 12 12 NUM dpc-3474 85 25 6 6 NUM dpc-3474 85 26 ( ( PUNCT dpc-3474 85 27 7 7 NUM dpc-3474 85 28 5 5 NUM dpc-3474 85 29 % % NOUN dpc-3474 85 30 ) ) PUNCT dpc-3474 85 31 m m VERB dpc-3474 85 32 al al PROPN dpc-3474 85 33 e e PROPN dpc-3474 85 34 iii iii PROPN dpc-3474 85 35 l l X dpc-3474 85 36 ee ee X dpc-3474 85 37 ne ne PROPN dpc-3474 85 38 m m PROPN dpc-3474 85 39 an an DET dpc-3474 85 40 b b NOUN dpc-3474 85 41 , , PUNCT dpc-3474 85 42 e e PROPN dpc-3474 85 43 t t PROPN dpc-3474 85 44 al al PROPN dpc-3474 85 45 . . PUNCT dpc-3474 86 1 20 20 NUM dpc-3474 86 2 19 19 NUM dpc-3474 86 3 r r NOUN dpc-3474 86 4 et et NOUN dpc-3474 86 5 ro ro NOUN dpc-3474 86 6 sp sp ADP dpc-3474 86 7 ec ec PROPN dpc-3474 86 8 ti ti PROPN dpc-3474 86 9 ve ve VERB dpc-3474 86 10 n n ADP dpc-3474 86 11 et et NOUN dpc-3474 87 1 he he PRON dpc-3474 87 2 rl rl VERB dpc-3474 87 3 an an DET dpc-3474 87 4 ds ds ADJ dpc-3474 87 5 13 13 NUM dpc-3474 87 6 97 97 NUM dpc-3474 87 7 st st PROPN dpc-3474 87 8 ag ag PROPN dpc-3474 87 9 e e PROPN dpc-3474 87 10 i i PRON dpc-3474 87 11 54 54 NUM dpc-3474 87 12 ( ( PUNCT dpc-3474 87 13 43 43 NUM dpc-3474 87 14 – – SYM dpc-3474 87 15 6 6 NUM dpc-3474 87 16 4 4 NUM dpc-3474 87 17 ) ) PUNCT dpc-3474 87 18 st st PROPN dpc-3474 87 19 ag ag PROPN dpc-3474 87 20 e e PROPN dpc-3474 87 21 ii ii PROPN dpc-3474 87 22 6 6 NUM dpc-3474 87 23 3 3 NUM dpc-3474 87 24 ( ( PUNCT dpc-3474 87 25 5 5 NUM dpc-3474 87 26 0 0 NUM dpc-3474 87 27 – – PUNCT dpc-3474 87 28 74 74 NUM dpc-3474 87 29 ) ) PUNCT dpc-3474 87 30 st st PROPN dpc-3474 87 31 ag ag PROPN dpc-3474 87 32 e e PROPN dpc-3474 87 33 ii ii PROPN dpc-3474 88 1 i i PRON dpc-3474 88 2 58 58 NUM dpc-3474 88 3 ( ( PUNCT dpc-3474 88 4 45 45 NUM dpc-3474 88 5 – – SYM dpc-3474 88 6 6 6 NUM dpc-3474 88 7 9 9 NUM dpc-3474 88 8 ) ) PUNCT dpc-3474 88 9 17 17 NUM dpc-3474 88 10 54 54 NUM dpc-3474 88 11 ( ( PUNCT dpc-3474 88 12 56 56 NUM dpc-3474 88 13 .7 .7 NUM dpc-3474 88 14 % % NOUN dpc-3474 88 15 ) ) PUNCT dpc-3474 88 16 fe fe X dpc-3474 88 17 m m PROPN dpc-3474 88 18 al al PROPN dpc-3474 88 19 e e PROPN dpc-3474 88 20 13 13 NUM dpc-3474 88 21 39 39 NUM dpc-3474 88 22     SPACE dpc-3474 88 23 ( ( PUNCT dpc-3474 88 24 43 43 NUM dpc-3474 88 25 .2 .2 NUM dpc-3474 88 26 % % NOUN dpc-3474 88 27 ) ) PUNCT dpc-3474 88 28 m m VERB dpc-3474 88 29 al al PROPN dpc-3474 88 30 e e PROPN dpc-3474 88 31 iii iii PROPN dpc-3474 88 32 i i PRON dpc-3474 88 33 65 65 NUM dpc-3474 88 34 t t PROPN dpc-3474 88 35 ho ho PROPN dpc-3474 88 36 m m PROPN dpc-3474 88 37 as as ADP dpc-3474 88 38 d d PROPN dpc-3474 88 39 c c NOUN dpc-3474 88 40 , , PUNCT dpc-3474 88 41 e e PROPN dpc-3474 88 42 t t PROPN dpc-3474 88 43 al al PROPN dpc-3474 88 44 . . PUNCT dpc-3474 89 1 20 20 NUM dpc-3474 89 2 19 19 NUM dpc-3474 89 3 r r NOUN dpc-3474 89 4 et et NOUN dpc-3474 89 5 ro ro NOUN dpc-3474 89 6 sp sp ADP dpc-3474 89 7 ec ec PROPN dpc-3474 89 8 ti ti PROPN dpc-3474 89 9 ve ve VERB dpc-3474 89 10 m m ADP dpc-3474 89 11 ul ul INTJ dpc-3474 89 12 ti ti X dpc-3474 89 13 ce ce PROPN dpc-3474 89 14 nt not PART dpc-3474 89 15 er er INTJ dpc-3474 89 16 63 63 NUM dpc-3474 89 17 05 05 NUM dpc-3474 89 18 ( ( PUNCT dpc-3474 89 19 53 53 NUM dpc-3474 89 20 51 51 NUM dpc-3474 89 21 s s NOUN dpc-3474 89 22 l l NOUN dpc-3474 89 23 n n ADP dpc-3474 89 24 n n ADV dpc-3474 89 25 eg eg NOUN dpc-3474 89 26 at at ADP dpc-3474 89 27 iv iv NUM dpc-3474 89 28 e e NOUN dpc-3474 89 29 ) ) PUNCT dpc-3474 89 30 23 23 NUM dpc-3474 89 31 10 10 NUM dpc-3474 89 32 ( ( PUNCT dpc-3474 89 33 4 4 NUM dpc-3474 89 34 3 3 NUM dpc-3474 89 35 % % NOUN dpc-3474 89 36 ) ) PUNCT dpc-3474 90 1 fe fe NOUN dpc-3474 90 2 m m PROPN dpc-3474 90 3 al al PROPN dpc-3474 90 4 e. e. PROPN dpc-3474 90 5 30 30 NUM dpc-3474 90 6 41 41 NUM dpc-3474 90 7 ( ( PUNCT dpc-3474 90 8 57 57 NUM dpc-3474 90 9 % % NOUN dpc-3474 90 10 ) ) PUNCT dpc-3474 91 1 m m VERB dpc-3474 91 2 al al PROPN dpc-3474 91 3 e e PROPN dpc-3474 91 4 iii iii PROPN dpc-3474 91 5 32 32 NUM dpc-3474 91 6 , , PUNCT dpc-3474 92 1 1 1 NUM dpc-3474 92 2 b b X dpc-3474 92 3 ar ar NOUN dpc-3474 92 4 tl tl PROPN dpc-3474 92 5 et et NOUN dpc-3474 92 6 t t PROPN dpc-3474 92 7 e e PROPN dpc-3474 92 8 k k PROPN dpc-3474 92 9 , , PUNCT dpc-3474 92 10 e e PROPN dpc-3474 92 11 t t PROPN dpc-3474 92 12 al al PROPN dpc-3474 92 13 . . PUNCT dpc-3474 93 1 20 20 NUM dpc-3474 93 2 20 20 NUM dpc-3474 93 3 pr pr NOUN dpc-3474 93 4 os os INTJ dpc-3474 94 1 pe pe INTJ dpc-3474 94 2 ct ct NUM dpc-3474 94 3 iv iv NUM dpc-3474 94 4 e e X dpc-3474 94 5 u u NOUN dpc-3474 94 6 sa sa PROPN dpc-3474 94 7 37 37 NUM dpc-3474 94 8 0 0 NUM dpc-3474 94 9 61 61 NUM dpc-3474 94 10 ( ( PUNCT dpc-3474 94 11 5 5 NUM dpc-3474 94 12 – – SYM dpc-3474 94 13 95 95 NUM dpc-3474 94 14 ) ) PUNCT dpc-3474 94 15 14 14 NUM dpc-3474 94 16 5 5 NUM dpc-3474 94 17 ( ( PUNCT dpc-3474 94 18 3 3 NUM dpc-3474 94 19 9 9 NUM dpc-3474 94 20 % % NOUN dpc-3474 94 21 ) ) PUNCT dpc-3474 94 22 fe fe X dpc-3474 94 23 m m PROPN dpc-3474 94 24 al al PROPN dpc-3474 94 25 e e PROPN dpc-3474 94 26 22 22 NUM dpc-3474 94 27 5 5 NUM dpc-3474 94 28 ( ( PUNCT dpc-3474 94 29 6 6 NUM dpc-3474 94 30 1 1 NUM dpc-3474 94 31 % % NOUN dpc-3474 94 32 ) ) PUNCT dpc-3474 95 1 m m VERB dpc-3474 95 2 al al PROPN dpc-3474 95 3 e e PROPN dpc-3474 95 4 ii ii PROPN dpc-3474 96 1 i i PRON dpc-3474 96 2 33 33 NUM dpc-3474 96 3 b b X dpc-3474 96 4 le le X dpc-3474 97 1 ic ic INTJ dpc-3474 98 1 he he PRON dpc-3474 98 2 r r PROPN dpc-3474 98 3 j j PROPN dpc-3474 98 4 , , PUNCT dpc-3474 98 5 e e PROPN dpc-3474 98 6 t t PROPN dpc-3474 98 7 al al PROPN dpc-3474 98 8 . . PUNCT dpc-3474 99 1 20 20 NUM dpc-3474 99 2 20 20 NUM dpc-3474 99 3 r r NOUN dpc-3474 99 4 et et NOUN dpc-3474 99 5 ro ro NOUN dpc-3474 99 6 sp sp ADP dpc-3474 99 7 ec ec PROPN dpc-3474 99 8 ti ti PROPN dpc-3474 99 9 ve ve VERB dpc-3474 99 10 u u PROPN dpc-3474 99 11 sa sa PROPN dpc-3474 99 12 58 58 NUM dpc-3474 99 13 0 0 NUM dpc-3474 99 14 62 62 NUM dpc-3474 99 15 ( ( PUNCT dpc-3474 99 16 48 48 NUM dpc-3474 99 17 – – SYM dpc-3474 99 18 7 7 NUM dpc-3474 99 19 4 4 NUM dpc-3474 99 20 ) ) PUNCT dpc-3474 99 21 22 22 NUM dpc-3474 99 22 8 8 NUM dpc-3474 99 23 ( ( PUNCT dpc-3474 99 24 3 3 NUM dpc-3474 99 25 9 9 NUM dpc-3474 99 26 . . NOUN dpc-3474 99 27 3 3 NUM dpc-3474 99 28 % % NOUN dpc-3474 99 29 ) ) PUNCT dpc-3474 99 30 fe fe X dpc-3474 99 31 m m PROPN dpc-3474 99 32 al al PROPN dpc-3474 99 33 e e PROPN dpc-3474 99 34 35 35 NUM dpc-3474 99 35 2 2 NUM dpc-3474 99 36 ( ( PUNCT dpc-3474 99 37 6 6 NUM dpc-3474 99 38 0 0 NUM dpc-3474 99 39 . . PUNCT dpc-3474 99 40 7 7 NUM dpc-3474 99 41 % % NOUN dpc-3474 99 42 ) ) PUNCT dpc-3474 100 1 m m VERB dpc-3474 100 2 al al PROPN dpc-3474 100 3 e e PROPN dpc-3474 100 4 ii ii PROPN dpc-3474 100 5 59 59 NUM dpc-3474 100 6 o o NOUN dpc-3474 100 7 h h NOUN dpc-3474 100 8 y y PROPN dpc-3474 100 9 , , PUNCT dpc-3474 100 10 e e PROPN dpc-3474 100 11 t t PROPN dpc-3474 100 12 al al PROPN dpc-3474 100 13 . . PUNCT dpc-3474 101 1 20 20 NUM dpc-3474 101 2 20 20 NUM dpc-3474 101 3 r r NOUN dpc-3474 101 4 et et NOUN dpc-3474 101 5 ro ro NOUN dpc-3474 101 6 sp sp ADP dpc-3474 101 7 ec ec PROPN dpc-3474 101 8 ti ti PROPN dpc-3474 101 9 ve ve NOUN dpc-3474 101 10 c c NOUN dpc-3474 101 11 or or CCONJ dpc-3474 101 12 ea ea NUM dpc-3474 101 13 34 34 NUM dpc-3474 101 14 0 0 NUM dpc-3474 101 15 57 57 NUM dpc-3474 101 16 , , PUNCT dpc-3474 101 17 9 9 NUM dpc-3474 101 18 4 4 NUM dpc-3474 101 19 19 19 NUM dpc-3474 101 20 5 5 NUM dpc-3474 101 21 ( ( PUNCT dpc-3474 101 22 5 5 NUM dpc-3474 101 23 7 7 NUM dpc-3474 101 24 . . NOUN dpc-3474 101 25 4 4 NUM dpc-3474 101 26 % % NOUN dpc-3474 101 27 ) ) PUNCT dpc-3474 101 28 fe fe X dpc-3474 101 29 m m PROPN dpc-3474 101 30 al al PROPN dpc-3474 101 31 e e PROPN dpc-3474 101 32 14 14 NUM dpc-3474 101 33 2 2 NUM dpc-3474 101 34     SPACE dpc-3474 101 35 ( ( PUNCT dpc-3474 101 36 4 4 NUM dpc-3474 101 37 2 2 NUM dpc-3474 101 38 . . NOUN dpc-3474 101 39 6 6 NUM dpc-3474 101 40 % % NOUN dpc-3474 101 41 ) ) PUNCT dpc-3474 102 1 m m VERB dpc-3474 102 2 al al PROPN dpc-3474 102 3 e e PROPN dpc-3474 102 4 iii iii PROPN dpc-3474 102 5 46 46 NUM dpc-3474 102 6 , , PUNCT dpc-3474 102 7 2 2 NUM dpc-3474 102 8 e e NOUN dpc-3474 102 9 gg gg NOUN dpc-3474 102 10 er er INTJ dpc-3474 102 11 m m VERB dpc-3474 102 12 on on ADP dpc-3474 102 13 t t PROPN dpc-3474 102 14 m m PROPN dpc-3474 102 15 , , PUNCT dpc-3474 102 16 e e PROPN dpc-3474 102 17 t t PROPN dpc-3474 102 18 al al PROPN dpc-3474 102 19 . . PUNCT dpc-3474 103 1 20 20 NUM dpc-3474 103 2 21 21 NUM dpc-3474 103 3 c c NOUN dpc-3474 103 4 lin lin PROPN dpc-3474 103 5 ic ic PROPN dpc-3474 103 6 al al PROPN dpc-3474 103 7 t t PROPN dpc-3474 103 8 ri ri PROPN dpc-3474 104 1 al al PROPN dpc-3474 104 2 m m PROPN dpc-3474 104 3 ul ul INTJ dpc-3474 104 4 ti ti X dpc-3474 104 5 ce ce PROPN dpc-3474 104 6 nt not PART dpc-3474 104 7 er er INTJ dpc-3474 104 8 10 10 NUM dpc-3474 104 9 19 19 NUM dpc-3474 104 10 ( ( PUNCT dpc-3474 104 11 5 5 NUM dpc-3474 104 12 14 14 NUM dpc-3474 104 13 p p NOUN dpc-3474 104 14 em em PRON dpc-3474 104 15 br br VERB dpc-3474 104 16 ol ol PROPN dpc-3474 105 1 iz iz INTJ dpc-3474 105 2 um um INTJ dpc-3474 105 3 ab ab INTJ dpc-3474 105 4 , , PUNCT dpc-3474 105 5 50 50 NUM dpc-3474 105 6 5 5 NUM dpc-3474 105 7 pl pl X dpc-3474 105 8 ac ac PROPN dpc-3474 105 9 eb eb PROPN dpc-3474 105 10 o o PROPN dpc-3474 105 11 ) ) PUNCT dpc-3474 105 12 25 25 NUM dpc-3474 105 13 1 1 NUM dpc-3474 105 14 ( ( PUNCT dpc-3474 105 15 2 2 NUM dpc-3474 105 16 5 5 NUM dpc-3474 105 17 % % NOUN dpc-3474 105 18 ) ) PUNCT dpc-3474 105 19 > > X dpc-3474 106 1 65 65 NUM dpc-3474 106 2 y y SYM dpc-3474 106 3 ea ea PROPN dpc-3474 106 4 rs rs X dpc-3474 106 5 fe fe INTJ dpc-3474 106 6 m m PROPN dpc-3474 106 7 al al PROPN dpc-3474 106 8 e e PROPN dpc-3474 106 9 39 39 NUM dpc-3474 106 10 1 1 NUM dpc-3474 106 11 ( ( PUNCT dpc-3474 106 12 38 38 NUM dpc-3474 106 13 % % NOUN dpc-3474 106 14 ) ) PUNCT dpc-3474 107 1 m m VERB dpc-3474 107 2 al al PROPN dpc-3474 107 3 e e NOUN dpc-3474 107 4     SPACE dpc-3474 107 5 62 62 NUM dpc-3474 107 6 8 8 NUM dpc-3474 107 7 ( ( PUNCT dpc-3474 107 8 6 6 NUM dpc-3474 107 9 2 2 NUM dpc-3474 107 10 % % NOUN dpc-3474 107 11 ) ) PUNCT dpc-3474 107 12 ii ii PROPN dpc-3474 108 1 i i PRON dpc-3474 108 2 42 42 NUM dpc-3474 108 3 , , PUNCT dpc-3474 108 4 3 3 NUM dpc-3474 108 5 e e NOUN dpc-3474 108 6 rt rt PROPN dpc-3474 108 7 ek ek VERB dpc-3474 108 8 in in ADP dpc-3474 108 9 s s PRON dpc-3474 108 10 , , PUNCT dpc-3474 108 11 e e PROPN dpc-3474 108 12 t t PROPN dpc-3474 108 13 al al PROPN dpc-3474 108 14 . . PUNCT dpc-3474 109 1 20 20 NUM dpc-3474 109 2 21 21 NUM dpc-3474 109 3 r r NOUN dpc-3474 109 4 et et NOUN dpc-3474 109 5 ro ro NOUN dpc-3474 109 6 sp sp ADP dpc-3474 109 7 ec ec PROPN dpc-3474 109 8 ti ti PROPN dpc-3474 109 9 ve ve VERB dpc-3474 109 10 sp sp ADP dpc-3474 109 11 ai ai NOUN dpc-3474 109 12 n n ADV dpc-3474 109 13 37 37 NUM dpc-3474 109 14 86 86 NUM dpc-3474 109 15 58 58 NUM dpc-3474 109 16 .2 .2 NUM dpc-3474 109 17 7 7 NUM dpc-3474 109 18 ( ( PUNCT dpc-3474 109 19 ± ± NOUN dpc-3474 109 20 1 1 NUM dpc-3474 109 21 6 6 NUM dpc-3474 109 22 . . NOUN dpc-3474 109 23 75 75 NUM dpc-3474 109 24 ) ) PUNCT dpc-3474 109 25 33 33 NUM dpc-3474 109 26 0 0 NUM dpc-3474 109 27 ( ( PUNCT dpc-3474 109 28 4 4 NUM dpc-3474 109 29 2 2 NUM dpc-3474 109 30 . . NOUN dpc-3474 109 31 1 1 NUM dpc-3474 109 32 % % NOUN dpc-3474 109 33 ) ) PUNCT dpc-3474 109 34 fe fe NOUN dpc-3474 109 35 m m PROPN dpc-3474 109 36 al al PROPN dpc-3474 109 37 e e PROPN dpc-3474 109 38 45 45 NUM dpc-3474 109 39 4 4 NUM dpc-3474 109 40     SPACE dpc-3474 109 41 ( ( PUNCT dpc-3474 109 42 5 5 NUM dpc-3474 109 43 7 7 NUM dpc-3474 109 44 . . NOUN dpc-3474 109 45 9 9 NUM dpc-3474 109 46 % % NOUN dpc-3474 109 47 ) ) PUNCT dpc-3474 110 1 m m VERB dpc-3474 110 2 al al PROPN dpc-3474 110 3 e e PROPN dpc-3474 110 4 iii iii PROPN dpc-3474 111 1 i i VERB dpc-3474 111 2 l l NOUN dpc-3474 111 3 uk uk PROPN dpc-3474 111 4 e e PROPN dpc-3474 111 5 j j PROPN dpc-3474 111 6 , , PUNCT dpc-3474 111 7 e e PROPN dpc-3474 111 8 t t PROPN dpc-3474 111 9 al al PROPN dpc-3474 111 10 . . PUNCT dpc-3474 112 1 20 20 NUM dpc-3474 112 2 22 22 NUM dpc-3474 112 3 c c NOUN dpc-3474 112 4 lin lin PROPN dpc-3474 112 5 ic ic PROPN dpc-3474 112 6 al al PROPN dpc-3474 112 7 t t PROPN dpc-3474 112 8 ri ri PROPN dpc-3474 113 1 al al PROPN dpc-3474 113 2 m m PROPN dpc-3474 113 3 ul ul INTJ dpc-3474 113 4 ti ti X dpc-3474 113 5 ce ce PROPN dpc-3474 113 6 nt not PART dpc-3474 113 7 er er INTJ dpc-3474 113 8 97 97 NUM dpc-3474 113 9 6 6 NUM dpc-3474 113 10 ( ( PUNCT dpc-3474 113 11 4 4 NUM dpc-3474 113 12 87 87 NUM dpc-3474 113 13 g g NOUN dpc-3474 113 14 ro ro X dpc-3474 113 15 up up ADP dpc-3474 113 16 1 1 NUM dpc-3474 113 17 , , PUNCT dpc-3474 113 18 48 48 NUM dpc-3474 113 19 9 9 NUM dpc-3474 113 20     SPACE dpc-3474 113 21 gr gr NOUN dpc-3474 113 22 ou ou ADP dpc-3474 113 23 p p PROPN dpc-3474 113 24 2 2 NUM dpc-3474 113 25 ) ) PUNCT dpc-3474 113 26 61 61 NUM dpc-3474 113 27 fe fe X dpc-3474 113 28 m m NOUN dpc-3474 113 29 al al PROPN dpc-3474 113 30 e e PROPN dpc-3474 113 31 38 38 NUM dpc-3474 113 32 7 7 NUM dpc-3474 113 33 ( ( PUNCT dpc-3474 113 34 4 4 NUM dpc-3474 113 35 0 0 NUM dpc-3474 113 36 % % NOUN dpc-3474 113 37 ) ) PUNCT dpc-3474 114 1 m m VERB dpc-3474 114 2 al al NOUN dpc-3474 114 3 e e PROPN dpc-3474 114 4 58 58 NUM dpc-3474 114 5 9 9 NUM dpc-3474 114 6 ( ( PUNCT dpc-3474 114 7 6 6 NUM dpc-3474 114 8 0 0 NUM dpc-3474 114 9 % % NOUN dpc-3474 114 10 ) ) PUNCT dpc-3474 114 11 ii ii PROPN dpc-3474 115 1 b b X dpc-3474 115 2 -i -i PROPN dpc-3474 115 3 ic ic PROPN dpc-3474 115 4 20 20 NUM dpc-3474 115 5 , , PUNCT dpc-3474 115 6 9 9 NUM dpc-3474 115 7 4 4 NUM dpc-3474 115 8 review review NOUN dpc-3474 115 9 | | ADV dpc-3474 115 10 dermatol dermatol ADJ dpc-3474 115 11 pract pract NOUN dpc-3474 115 12 concept concept NOUN dpc-3474 115 13 . . PUNCT dpc-3474 116 1 2023;13(4):e2023304 2023;13(4):e2023304 NUM dpc-3474 116 2 ta ta X dpc-3474 116 3 b b PROPN dpc-3474 116 4 le le ADP dpc-3474 116 5 2 2 NUM dpc-3474 116 6 . . PUNCT dpc-3474 117 1 m m VERB dpc-3474 118 1 el el PROPN dpc-3474 118 2 an an DET dpc-3474 118 3 om om PROPN dpc-3474 118 4 a a DET dpc-3474 118 5 re re X dpc-3474 118 6 cu cu PROPN dpc-3474 118 7 rr rr PROPN dpc-3474 118 8 en en PROPN dpc-3474 118 9 ce ce PROPN dpc-3474 119 1 d d X dpc-3474 119 2 et et NOUN dpc-3474 119 3 ai ai VERB dpc-3474 119 4 ls ls ADP dpc-3474 119 5 a a DET dpc-3474 119 6 nd nd NOUN dpc-3474 119 7 m m NOUN dpc-3474 119 8 et et NOUN dpc-3474 119 9 ho ho PROPN dpc-3474 119 10 d d PROPN dpc-3474 119 11 of of ADP dpc-3474 119 12 d d PROPN dpc-3474 119 13 et et NOUN dpc-3474 119 14 ec ec PROPN dpc-3474 119 15 ti ti PROPN dpc-3474 119 16 on on ADP dpc-3474 119 17 . . PUNCT dpc-3474 120 1 st st PROPN dpc-3474 120 2 u u PROPN dpc-3474 120 3 d d X dpc-3474 120 4 y y PROPN dpc-3474 120 5 r r NOUN dpc-3474 120 6 ec ec PROPN dpc-3474 120 7 u u PROPN dpc-3474 120 8 rr rr PROPN dpc-3474 120 9 en en PROPN dpc-3474 120 10 ce ce PROPN dpc-3474 120 11 o o PROPN dpc-3474 121 1 f f X dpc-3474 121 2     SPACE dpc-3474 121 3 m m VERB dpc-3474 121 4 el el PROPN dpc-3474 121 5 an an DET dpc-3474 121 6 o o X dpc-3474 121 7 m m VERB dpc-3474 121 8 a a DET dpc-3474 121 9 n n NOUN dpc-3474 121 10 ( ( PUNCT dpc-3474 121 11 % % NOUN dpc-3474 121 12 ) ) PUNCT dpc-3474 121 13 m m VERB dpc-3474 121 14 ea ea NOUN dpc-3474 121 15 n n NUM dpc-3474 121 16 t t NOUN dpc-3474 122 1 i i PRON dpc-3474 122 2 m m VERB dpc-3474 122 3 e e NOUN dpc-3474 122 4 o o X dpc-3474 122 5 f f X dpc-3474 122 6 re re VERB dpc-3474 122 7 cu cu PROPN dpc-3474 122 8 rr rr PROPN dpc-3474 122 9 en en PROPN dpc-3474 122 10 ce ce PROPN dpc-3474 122 11 ( ( PUNCT dpc-3474 122 12 m m VERB dpc-3474 122 13 o o NOUN dpc-3474 122 14 n n X dpc-3474 122 15 th th NUM dpc-3474 122 16 s s NOUN dpc-3474 122 17 ) ) PUNCT dpc-3474 122 18 m m VERB dpc-3474 122 19 ea ea NOUN dpc-3474 122 20 n n NUM dpc-3474 122 21 t t NOUN dpc-3474 123 1 i i PRON dpc-3474 123 2 m m VERB dpc-3474 123 3 e e NOUN dpc-3474 123 4 o o NOUN dpc-3474 123 5 f f X dpc-3474 123 6 lc lc PROPN dpc-3474 124 1 it it PRON dpc-3474 124 2 re re VERB dpc-3474 124 3 cu cu PROPN dpc-3474 124 4 rr rr PROPN dpc-3474 124 5 en en PROPN dpc-3474 124 6 ce ce PROPN dpc-3474 125 1 ( ( PUNCT dpc-3474 125 2 m m VERB dpc-3474 125 3 o o NOUN dpc-3474 125 4 n n X dpc-3474 125 5 th th NUM dpc-3474 125 6 s s NOUN dpc-3474 125 7 ) ) PUNCT dpc-3474 125 8 m m VERB dpc-3474 125 9 ea ea NOUN dpc-3474 125 10 n n NUM dpc-3474 125 11 t t NOUN dpc-3474 126 1 i i PRON dpc-3474 126 2 m m VERB dpc-3474 126 3 e e NOUN dpc-3474 126 4 o o X dpc-3474 126 5 f f X dpc-3474 126 6 ln ln NOUN dpc-3474 126 7 re re PROPN dpc-3474 126 8 cu cu PROPN dpc-3474 126 9 rr rr PROPN dpc-3474 126 10 en en PROPN dpc-3474 126 11 ce ce PROPN dpc-3474 126 12 ( ( PUNCT dpc-3474 126 13 m m VERB dpc-3474 126 14 o o NOUN dpc-3474 126 15 n n X dpc-3474 126 16 th th NUM dpc-3474 126 17 s s NOUN dpc-3474 126 18 ) ) PUNCT dpc-3474 126 19 m m VERB dpc-3474 126 20 ea ea NOUN dpc-3474 126 21 n n NUM dpc-3474 126 22 t t NOUN dpc-3474 127 1 i i PRON dpc-3474 127 2 m m VERB dpc-3474 127 3 e e NOUN dpc-3474 127 4 o o NOUN dpc-3474 127 5 f f X dpc-3474 127 6 sy sy PROPN dpc-3474 127 7 st st PROPN dpc-3474 127 8 em em PRON dpc-3474 127 9 ic ic PROPN dpc-3474 127 10 re re PROPN dpc-3474 127 11 cu cu PROPN dpc-3474 127 12 rr rr PROPN dpc-3474 127 13 en en PROPN dpc-3474 127 14 ce ce PROPN dpc-3474 127 15 ( ( PUNCT dpc-3474 127 16 m m VERB dpc-3474 127 17 o o NOUN dpc-3474 127 18 n n X dpc-3474 127 19 th th NUM dpc-3474 127 20 s s NOUN dpc-3474 127 21 ) ) PUNCT dpc-3474 127 22 d d X dpc-3474 127 23 et et NOUN dpc-3474 127 24 ec ec PROPN dpc-3474 128 1 ti ti NOUN dpc-3474 128 2 o o NOUN dpc-3474 128 3 n n X dpc-3474 128 4 o o X dpc-3474 128 5 f f X dpc-3474 128 6 re re PROPN dpc-3474 128 7 cu cu PROPN dpc-3474 128 8 rr rr PROPN dpc-3474 128 9 en en PROPN dpc-3474 128 10 ce ce PROPN dpc-3474 128 11 m m PROPN dpc-3474 128 12 ei ei PROPN dpc-3474 128 13 er er INTJ dpc-3474 128 14 f f X dpc-3474 128 15 , , PUNCT dpc-3474 128 16 e e PROPN dpc-3474 128 17 t t PROPN dpc-3474 128 18 al al PROPN dpc-3474 128 19 . . PUNCT dpc-3474 129 1 46 46 NUM dpc-3474 129 2 6/ 6/ NUM dpc-3474 129 3 30 30 NUM dpc-3474 129 4 01 01 NUM dpc-3474 129 5 ( ( PUNCT dpc-3474 129 6 15 15 NUM dpc-3474 129 7 % % NOUN dpc-3474 129 8 ) ) PUNCT dpc-3474 129 9 17 17 NUM dpc-3474 129 10 16 16 NUM dpc-3474 129 11 25 25 NUM dpc-3474 129 12 m m NOUN dpc-3474 129 13 ey ey INTJ dpc-3474 129 14 er er INTJ dpc-3474 129 15 s s X dpc-3474 129 16 o o NOUN dpc-3474 129 17 , , PUNCT dpc-3474 129 18 e e PROPN dpc-3474 129 19 t t PROPN dpc-3474 129 20 al al PROPN dpc-3474 129 21 . . PUNCT dpc-3474 130 1 43 43 NUM dpc-3474 130 2 /1 /1 NOUN dpc-3474 130 3 18 18 NUM dpc-3474 130 4 ( ( PUNCT dpc-3474 130 5 36 36 NUM dpc-3474 130 6 % % NOUN dpc-3474 130 7 ) ) PUNCT dpc-3474 130 8 14 14 NUM dpc-3474 130 9 pa pa NOUN dpc-3474 130 10 ti ti PROPN dpc-3474 130 11 en en PROPN dpc-3474 130 12 t t PROPN dpc-3474 130 13 se se X dpc-3474 130 14 lf lf ADP dpc-3474 130 15 -r -r PROPN dpc-3474 130 16 ep ep PROPN dpc-3474 130 17 or or CCONJ dpc-3474 130 18 t t PROPN dpc-3474 130 19 ( ( PUNCT dpc-3474 130 20 6 6 NUM dpc-3474 130 21 7 7 NUM dpc-3474 130 22 % % NOUN dpc-3474 130 23 ) ) PUNCT dpc-3474 130 24 ph ph PROPN dpc-3474 130 25 ys ys INTJ dpc-3474 131 1 ic ic PROPN dpc-3474 131 2 al al PROPN dpc-3474 131 3 e e PROPN dpc-3474 131 4 xa xa PROPN dpc-3474 131 5 m m VERB dpc-3474 131 6 in in ADP dpc-3474 131 7 at at ADP dpc-3474 131 8 io io X dpc-3474 131 9 n n X dpc-3474 131 10 ( ( PUNCT dpc-3474 131 11 2 2 NUM dpc-3474 131 12 6 6 NUM dpc-3474 131 13 % % NOUN dpc-3474 131 14 ) ) PUNCT dpc-3474 132 1 i i PRON dpc-3474 132 2 m m VERB dpc-3474 132 3 ag ag PROPN dpc-3474 132 4 es es X dpc-3474 132 5 ( ( PUNCT dpc-3474 132 6 7 7 NUM dpc-3474 132 7 % % NOUN dpc-3474 132 8 ) ) PUNCT dpc-3474 132 9 b b PROPN dpc-3474 132 10 ar ar NOUN dpc-3474 132 11 bo bo PROPN dpc-3474 132 12 ur ur PROPN dpc-3474 132 13 s s PROPN dpc-3474 132 14 , , PUNCT dpc-3474 132 15 e e PROPN dpc-3474 132 16 t t PROPN dpc-3474 132 17 al al PROPN dpc-3474 132 18 . . PUNCT dpc-3474 133 1 78 78 NUM dpc-3474 133 2 /1 /1 NOUN dpc-3474 133 3 73 73 NUM dpc-3474 133 4 ( ( PUNCT dpc-3474 133 5 45 45 NUM dpc-3474 133 6 % % NOUN dpc-3474 133 7 ) ) PUNCT dpc-3474 134 1 o o NOUN dpc-3474 134 2 c c NOUN dpc-3474 134 3 on on ADP dpc-3474 134 4 ne ne X dpc-3474 134 5 ll ll PROPN dpc-3474 134 6 e e X dpc-3474 134 7 , , PUNCT dpc-3474 134 8 e e PROPN dpc-3474 134 9 t t PROPN dpc-3474 134 10 al al PROPN dpc-3474 134 11 . . PUNCT dpc-3474 135 1 40 40 NUM dpc-3474 135 2 /1 /1 NOUN dpc-3474 135 3 64 64 NUM dpc-3474 135 4 ( ( PUNCT dpc-3474 135 5 24 24 NUM dpc-3474 135 6 % % NOUN dpc-3474 135 7 ) ) PUNCT dpc-3474 135 8 39 39 NUM dpc-3474 135 9 , , PUNCT dpc-3474 135 10 5 5 NUM dpc-3474 135 11 sv sv NOUN dpc-3474 135 12 ed ed PROPN dpc-3474 135 13 m m VERB dpc-3474 135 14 an an DET dpc-3474 135 15 f f PROPN dpc-3474 135 16 , , PUNCT dpc-3474 135 17 et et PROPN dpc-3474 135 18 a a DET dpc-3474 135 19 l. l. PROPN dpc-3474 135 20 sp sp ADP dpc-3474 135 21 ar ar PROPN dpc-3474 135 22 ks ks PROPN dpc-3474 135 23 d d PROPN dpc-3474 135 24 s s PROPN dpc-3474 135 25 , , PUNCT dpc-3474 135 26 e e PROPN dpc-3474 135 27 t t PROPN dpc-3474 135 28 al al PROPN dpc-3474 135 29 . . PUNCT dpc-3474 136 1 38 38 NUM dpc-3474 136 2 /1 /1 NOUN dpc-3474 136 3 07 07 NUM dpc-3474 136 4 ( ( PUNCT dpc-3474 136 5 35 35 NUM dpc-3474 136 6 .5 .5 NUM dpc-3474 136 7 % % NOUN dpc-3474 136 8 ) ) PUNCT dpc-3474 136 9 11 11 NUM dpc-3474 136 10 , , PUNCT dpc-3474 136 11 8 8 NUM dpc-3474 136 12 b b X dpc-3474 136 13 er er INTJ dpc-3474 136 14 ge ge PROPN dpc-3474 136 15 r r PROPN dpc-3474 136 16 a a DET dpc-3474 136 17 c c NOUN dpc-3474 136 18 , , PUNCT dpc-3474 136 19 e e PROPN dpc-3474 136 20 t t PROPN dpc-3474 136 21 al al PROPN dpc-3474 136 22 . . PUNCT dpc-3474 137 1 17 17 NUM dpc-3474 137 2 1/ 1/ NUM dpc-3474 137 3 58 58 NUM dpc-3474 137 4 1 1 NUM dpc-3474 137 5 ( ( PUNCT dpc-3474 137 6 2 2 NUM dpc-3474 137 7 9 9 NUM dpc-3474 137 8 . . NOUN dpc-3474 137 9 4 4 NUM dpc-3474 137 10 % % NOUN dpc-3474 137 11 ) ) PUNCT dpc-3474 138 1 pa pa PROPN dpc-3474 138 2 ti ti PROPN dpc-3474 138 3 en en PROPN dpc-3474 138 4 t t PROPN dpc-3474 138 5 se se X dpc-3474 138 6 lf lf ADP dpc-3474 138 7 -r -r PROPN dpc-3474 138 8 ep ep PROPN dpc-3474 138 9 or or CCONJ dpc-3474 138 10 t t PROPN dpc-3474 138 11 ( ( PUNCT dpc-3474 138 12 3 3 NUM dpc-3474 138 13 9 9 NUM dpc-3474 138 14 % % NOUN dpc-3474 138 15 ) ) PUNCT dpc-3474 139 1 ph ph PROPN dpc-3474 139 2 ys ys INTJ dpc-3474 139 3 ic ic PROPN dpc-3474 139 4 al al PROPN dpc-3474 139 5 e e PROPN dpc-3474 139 6 xa xa PROPN dpc-3474 139 7 m m VERB dpc-3474 139 8 in in ADP dpc-3474 139 9 at at ADP dpc-3474 139 10 io io X dpc-3474 139 11 n n X dpc-3474 139 12 ( ( PUNCT dpc-3474 139 13 3 3 NUM dpc-3474 139 14 2 2 NUM dpc-3474 139 15 % % NOUN dpc-3474 139 16 ) ) PUNCT dpc-3474 140 1 i i PRON dpc-3474 140 2 m m VERB dpc-3474 140 3 ag ag PROPN dpc-3474 140 4 es es X dpc-3474 140 5 ( ( PUNCT dpc-3474 140 6 21 21 NUM dpc-3474 140 7 % % NOUN dpc-3474 140 8 ) ) PUNCT dpc-3474 140 9 l l NOUN dpc-3474 140 10 ee ee ADP dpc-3474 140 11 a a DET dpc-3474 140 12 y y PROPN dpc-3474 140 13 , , PUNCT dpc-3474 140 14 e e PROPN dpc-3474 140 15 t t PROPN dpc-3474 140 16 al al PROPN dpc-3474 140 17 . . PUNCT dpc-3474 141 1 21 21 NUM dpc-3474 141 2 9/ 9/ NUM dpc-3474 141 3 73 73 NUM dpc-3474 141 4 8 8 NUM dpc-3474 141 5 ( ( PUNCT dpc-3474 141 6 2 2 NUM dpc-3474 141 7 9 9 NUM dpc-3474 141 8 . . NOUN dpc-3474 141 9 6 6 NUM dpc-3474 141 10 % % NOUN dpc-3474 141 11 ) ) PUNCT dpc-3474 141 12 ii ii PROPN dpc-3474 142 1 a a DET dpc-3474 142 2 ( ( PUNCT dpc-3474 142 3 19 19 NUM dpc-3474 142 4 5 5 NUM dpc-3474 142 5 . . NOUN dpc-3474 142 6 1 1 NUM dpc-3474 142 7 ) ) PUNCT dpc-3474 143 1 i i PRON dpc-3474 143 2 ib ib INTJ dpc-3474 143 3 ( ( PUNCT dpc-3474 143 4 u u NOUN dpc-3474 143 5 nk nk PROPN dpc-3474 143 6 no no PROPN dpc-3474 143 7 w w PROPN dpc-3474 143 8 n n CCONJ dpc-3474 143 9 ) ) PUNCT dpc-3474 144 1 i i PRON dpc-3474 144 2 ic ic INTJ dpc-3474 144 3 ( ( PUNCT dpc-3474 144 4 85 85 NUM dpc-3474 144 5 .9 .9 NUM dpc-3474 144 6 ) ) PUNCT dpc-3474 145 1 pa pa PROPN dpc-3474 145 2 ti ti PROPN dpc-3474 145 3 en en PROPN dpc-3474 145 4 t t PROPN dpc-3474 145 5 se se X dpc-3474 145 6 lf lf ADP dpc-3474 145 7 -r -r PROPN dpc-3474 145 8 ep ep PROPN dpc-3474 145 9 or or CCONJ dpc-3474 145 10 t t PROPN dpc-3474 145 11 ( ( PUNCT dpc-3474 145 12 5 5 NUM dpc-3474 145 13 9 9 NUM dpc-3474 145 14 % % NOUN dpc-3474 145 15 ) ) PUNCT dpc-3474 146 1 n n CCONJ dpc-3474 146 2 am be AUX dpc-3474 146 3 in in ADP dpc-3474 146 4 a a DET dpc-3474 146 5 w w NOUN dpc-3474 146 6 , , PUNCT dpc-3474 146 7 e e PROPN dpc-3474 146 8 t t PROPN dpc-3474 146 9 al al PROPN dpc-3474 146 10 . . PUNCT dpc-3474 147 1 33 33 NUM dpc-3474 147 2 /1 /1 NOUN dpc-3474 147 3 68 68 NUM dpc-3474 147 4 ( ( PUNCT dpc-3474 147 5 20 20 NUM dpc-3474 147 6 % % NOUN dpc-3474 147 7 ) ) PUNCT dpc-3474 147 8 17 17 NUM dpc-3474 147 9 8 8 NUM dpc-3474 147 10 13 13 NUM dpc-3474 147 11 , , PUNCT dpc-3474 147 12 5 5 NUM dpc-3474 147 13 18 18 NUM dpc-3474 147 14 , , PUNCT dpc-3474 147 15 3 3 NUM dpc-3474 147 16 l l NOUN dpc-3474 147 17 ee ee X dpc-3474 147 18 ne ne PROPN dpc-3474 147 19 m m PROPN dpc-3474 147 20 an an DET dpc-3474 147 21 b b NOUN dpc-3474 147 22 , , PUNCT dpc-3474 147 23 e e PROPN dpc-3474 147 24 t t PROPN dpc-3474 147 25 al al PROPN dpc-3474 147 26 . . PUNCT dpc-3474 148 1 27 27 NUM dpc-3474 148 2 5/ 5/ NUM dpc-3474 148 3 13 13 NUM dpc-3474 148 4 97 97 NUM dpc-3474 148 5 ( ( PUNCT dpc-3474 148 6 20 20 NUM dpc-3474 148 7 % % NOUN dpc-3474 148 8 ) ) PUNCT dpc-3474 149 1 ib ib NOUN dpc-3474 149 2 ( ( PUNCT dpc-3474 149 3 34 34 NUM dpc-3474 149 4 ) ) PUNCT dpc-3474 149 5 ii ii PROPN dpc-3474 149 6 ( ( PUNCT dpc-3474 149 7 18 18 NUM dpc-3474 149 8 ) ) PUNCT dpc-3474 149 9 ii ii NOUN dpc-3474 150 1 i i PRON dpc-3474 150 2 ( ( PUNCT dpc-3474 150 3 1 1 NUM dpc-3474 150 4 2 2 NUM dpc-3474 150 5 ) ) PUNCT dpc-3474 150 6 ib ib NOUN dpc-3474 150 7 3 3 NUM dpc-3474 150 8 6 6 NUM dpc-3474 150 9 ) ) PUNCT dpc-3474 151 1 i i PRON dpc-3474 151 2 i i PRON dpc-3474 151 3 ( ( PUNCT dpc-3474 151 4 9 9 NUM dpc-3474 151 5 .6 .6 NUM dpc-3474 151 6 ) ) PUNCT dpc-3474 151 7 ii ii PROPN dpc-3474 152 1 i i PRON dpc-3474 152 2 ( ( PUNCT dpc-3474 152 3 6 6 NUM dpc-3474 152 4 ) ) PUNCT dpc-3474 152 5 ib ib NOUN dpc-3474 152 6 ( ( PUNCT dpc-3474 152 7 37 37 NUM dpc-3474 152 8 ) ) PUNCT dpc-3474 152 9 ii ii PROPN dpc-3474 152 10 ( ( PUNCT dpc-3474 152 11 26 26 NUM dpc-3474 152 12 ) ) PUNCT dpc-3474 152 13 ii ii NOUN dpc-3474 152 14 i i PRON dpc-3474 152 15 ( ( PUNCT dpc-3474 152 16 1 1 NUM dpc-3474 152 17 3 3 NUM dpc-3474 152 18 ) ) PUNCT dpc-3474 152 19 t t PROPN dpc-3474 152 20 ho ho PROPN dpc-3474 152 21 m m PROPN dpc-3474 152 22 as as ADP dpc-3474 152 23 d d PROPN dpc-3474 152 24 c c NOUN dpc-3474 152 25 , , PUNCT dpc-3474 152 26 e e PROPN dpc-3474 152 27 t t PROPN dpc-3474 152 28 al al PROPN dpc-3474 152 29 . . PUNCT dpc-3474 153 1 55 55 NUM dpc-3474 153 2 8/ 8/ NUM dpc-3474 153 3 53 53 NUM dpc-3474 153 4 51 51 NUM dpc-3474 153 5 ( ( PUNCT dpc-3474 153 6 10 10 NUM dpc-3474 153 7 .4 .4 NUM dpc-3474 153 8 % % NOUN dpc-3474 153 9 ) ) PUNCT dpc-3474 153 10 16 16 NUM dpc-3474 153 11 , , PUNCT dpc-3474 153 12 7 7 NUM dpc-3474 153 13 18 18 NUM dpc-3474 153 14 , , PUNCT dpc-3474 153 15 6 6 NUM dpc-3474 153 16 31 31 NUM dpc-3474 153 17 , , PUNCT dpc-3474 153 18 2 2 NUM dpc-3474 153 19 b b X dpc-3474 153 20 ar ar NOUN dpc-3474 153 21 tl tl PROPN dpc-3474 153 22 et et NOUN dpc-3474 153 23 t t PROPN dpc-3474 153 24 e e PROPN dpc-3474 153 25 k k PROPN dpc-3474 153 26 , , PUNCT dpc-3474 153 27 e e PROPN dpc-3474 153 28 t t PROPN dpc-3474 153 29 al al PROPN dpc-3474 153 30 . . PUNCT dpc-3474 154 1 15 15 NUM dpc-3474 154 2 8/ 8/ NUM dpc-3474 154 3 37 37 NUM dpc-3474 154 4 0 0 NUM dpc-3474 154 5 ( ( PUNCT dpc-3474 154 6 4 4 NUM dpc-3474 154 7 2 2 NUM dpc-3474 154 8 . . NOUN dpc-3474 154 9 7 7 NUM dpc-3474 154 10 % % NOUN dpc-3474 154 11 ) ) PUNCT dpc-3474 154 12 12 12 NUM dpc-3474 154 13 pa pa PROPN dpc-3474 154 14 ti ti PROPN dpc-3474 154 15 en en PROPN dpc-3474 154 16 t t PROPN dpc-3474 154 17 se se X dpc-3474 154 18 lf lf ADP dpc-3474 154 19 -r -r PROPN dpc-3474 154 20 ep ep PROPN dpc-3474 154 21 or or CCONJ dpc-3474 154 22 t t PROPN dpc-3474 154 23 ( ( PUNCT dpc-3474 154 24 2 2 NUM dpc-3474 154 25 9 9 NUM dpc-3474 154 26 % % NOUN dpc-3474 154 27 ) ) PUNCT dpc-3474 154 28 , , PUNCT dpc-3474 154 29 ph ph PROPN dpc-3474 154 30 ys ys PROPN dpc-3474 154 31 ic ic PROPN dpc-3474 154 32 al al PROPN dpc-3474 154 33 e e PROPN dpc-3474 154 34 xa xa PROPN dpc-3474 154 35 m m VERB dpc-3474 154 36 in in ADP dpc-3474 154 37 at at ADP dpc-3474 154 38 io io X dpc-3474 154 39 n n X dpc-3474 154 40 ( ( PUNCT dpc-3474 154 41 2 2 NUM dpc-3474 154 42 0 0 NUM dpc-3474 154 43 . . PUNCT dpc-3474 155 1 3 3 NUM dpc-3474 155 2 % % NOUN dpc-3474 155 3 ) ) PUNCT dpc-3474 155 4 , , PUNCT dpc-3474 155 5 i i PRON dpc-3474 155 6 m m VERB dpc-3474 155 7 ag ag PROPN dpc-3474 155 8 es es X dpc-3474 155 9 ( ( PUNCT dpc-3474 155 10 39 39 NUM dpc-3474 155 11 .9 .9 NUM dpc-3474 155 12 % % NOUN dpc-3474 155 13 ) ) PUNCT dpc-3474 155 14 . . PUNCT dpc-3474 156 1 b b X dpc-3474 156 2 le le PUNCT dpc-3474 156 3 ic ic INTJ dpc-3474 156 4 he he PRON dpc-3474 156 5 r r PROPN dpc-3474 156 6 j j PROPN dpc-3474 156 7 , , PUNCT dpc-3474 156 8 e e PROPN dpc-3474 156 9 t t PROPN dpc-3474 156 10 al al PROPN dpc-3474 156 11 . . PUNCT dpc-3474 157 1 15 15 NUM dpc-3474 157 2 8/ 8/ NUM dpc-3474 157 3 58 58 NUM dpc-3474 157 4 0 0 NUM dpc-3474 157 5 ( ( PUNCT dpc-3474 157 6 2 2 NUM dpc-3474 157 7 7 7 NUM dpc-3474 157 8 . . SYM dpc-3474 157 9 2 2 NUM dpc-3474 157 10 % % NOUN dpc-3474 157 11 ) ) PUNCT dpc-3474 157 12 pa pa PROPN dpc-3474 157 13 ti ti PROPN dpc-3474 157 14 en en PROPN dpc-3474 157 15 t t PROPN dpc-3474 157 16 se se X dpc-3474 157 17 lf lf ADP dpc-3474 157 18 -r -r PROPN dpc-3474 157 19 ep ep PROPN dpc-3474 157 20 or or CCONJ dpc-3474 157 21 t t PROPN dpc-3474 157 22 ( ( PUNCT dpc-3474 157 23 6 6 NUM dpc-3474 157 24 0 0 NUM dpc-3474 157 25 . . NOUN dpc-3474 157 26 1 1 NUM dpc-3474 157 27 % % NOUN dpc-3474 157 28 ) ) PUNCT dpc-3474 157 29 ph ph PROPN dpc-3474 157 30 ys ys INTJ dpc-3474 158 1 ic ic PROPN dpc-3474 158 2 al al PROPN dpc-3474 158 3 e e PROPN dpc-3474 158 4 xa xa PROPN dpc-3474 158 5 m m VERB dpc-3474 158 6 in in ADP dpc-3474 158 7 at at ADP dpc-3474 158 8 io io X dpc-3474 158 9 n n X dpc-3474 158 10 ( ( PUNCT dpc-3474 158 11 1 1 NUM dpc-3474 158 12 2 2 NUM dpc-3474 158 13 . . NOUN dpc-3474 158 14 0 0 NUM dpc-3474 158 15 % % NOUN dpc-3474 158 16 ) ) PUNCT dpc-3474 159 1 i i PRON dpc-3474 159 2 m m VERB dpc-3474 159 3 ag ag PROPN dpc-3474 159 4 es es X dpc-3474 159 5 ( ( PUNCT dpc-3474 159 6 27 27 NUM dpc-3474 159 7 .3 .3 NUM dpc-3474 159 8 % % NOUN dpc-3474 159 9 ) ) PUNCT dpc-3474 160 1 o o NOUN dpc-3474 161 1 h h NOUN dpc-3474 162 1 y y PROPN dpc-3474 162 2 , , PUNCT dpc-3474 162 3 e e PROPN dpc-3474 162 4 t t PROPN dpc-3474 162 5 al al PROPN dpc-3474 162 6 . . PUNCT dpc-3474 163 1 92 92 NUM dpc-3474 163 2 /3 /3 NUM dpc-3474 163 3 40 40 NUM dpc-3474 163 4 ( ( PUNCT dpc-3474 163 5 2 2 NUM dpc-3474 163 6 7 7 NUM dpc-3474 163 7 . . NOUN dpc-3474 163 8 1 1 NUM dpc-3474 163 9 % % NOUN dpc-3474 163 10 ) ) PUNCT dpc-3474 163 11 16 16 NUM dpc-3474 163 12 , , PUNCT dpc-3474 163 13 3 3 NUM dpc-3474 163 14 e e NOUN dpc-3474 163 15 gg gg NOUN dpc-3474 163 16 er er INTJ dpc-3474 163 17 m m VERB dpc-3474 163 18 on on ADP dpc-3474 163 19 t t PROPN dpc-3474 163 20 m m PROPN dpc-3474 163 21 , , PUNCT dpc-3474 163 22 e e PROPN dpc-3474 163 23 t t PROPN dpc-3474 163 24 al al PROPN dpc-3474 163 25 . . PUNCT dpc-3474 164 1 19 19 NUM dpc-3474 164 2 9/ 9/ NUM dpc-3474 164 3 51 51 NUM dpc-3474 164 4 4 4 NUM dpc-3474 164 5 ( ( PUNCT dpc-3474 164 6 3 3 NUM dpc-3474 164 7 9 9 NUM dpc-3474 164 8 % % NOUN dpc-3474 164 9 ) ) PUNCT dpc-3474 164 10 g g NOUN dpc-3474 164 11 ro ro X dpc-3474 164 12 up up ADV dpc-3474 164 13 1 1 NUM dpc-3474 164 14 28 28 NUM dpc-3474 164 15 7/ 7/ NUM dpc-3474 164 16 50 50 NUM dpc-3474 164 17 5 5 NUM dpc-3474 164 18 ( ( PUNCT dpc-3474 164 19 5 5 NUM dpc-3474 164 20 3 3 NUM dpc-3474 164 21 % % NOUN dpc-3474 164 22 ) ) PUNCT dpc-3474 164 23 g g NOUN dpc-3474 164 24 ro ro X dpc-3474 164 25 up up ADP dpc-3474 164 26 2 2 NUM dpc-3474 164 27 . . PUNCT dpc-3474 165 1 to to ADP dpc-3474 165 2 ta ta ADP dpc-3474 165 3 l l NOUN dpc-3474 165 4 4 4 NUM dpc-3474 165 5 7 7 NUM dpc-3474 165 6 . . NOUN dpc-3474 165 7 6 6 NUM dpc-3474 165 8 % % NOUN dpc-3474 165 9 e e NOUN dpc-3474 165 10 rt rt PROPN dpc-3474 165 11 ek ek VERB dpc-3474 165 12 in in ADP dpc-3474 165 13 s s PRON dpc-3474 165 14 , , PUNCT dpc-3474 165 15 e e PROPN dpc-3474 165 16 t t PROPN dpc-3474 165 17 al al PROPN dpc-3474 165 18 . . PUNCT dpc-3474 166 1 to to ADP dpc-3474 166 2 ta ta PROPN dpc-3474 166 3 l l NOUN dpc-3474 166 4 : : PUNCT dpc-3474 166 5 78 78 NUM dpc-3474 166 6 4/ 4/ NUM dpc-3474 166 7 37 37 NUM dpc-3474 166 8 86 86 NUM dpc-3474 166 9 ( ( PUNCT dpc-3474 166 10 20 20 NUM dpc-3474 166 11 .7 .7 NUM dpc-3474 166 12 % % NOUN dpc-3474 166 13 ) ) PUNCT dpc-3474 166 14 st st PROPN dpc-3474 166 15 ag ag PROPN dpc-3474 166 16 e e PROPN dpc-3474 166 17 i i PROPN dpc-3474 166 18 ( ( PUNCT dpc-3474 166 19 2 2 NUM dpc-3474 166 20 1 1 NUM dpc-3474 166 21 % % NOUN dpc-3474 166 22 ) ) PUNCT dpc-3474 166 23 st st PROPN dpc-3474 166 24 ag ag PROPN dpc-3474 166 25 e e PROPN dpc-3474 166 26 ii ii PROPN dpc-3474 166 27 ( ( PUNCT dpc-3474 166 28 33 33 NUM dpc-3474 166 29 % % NOUN dpc-3474 166 30 ) ) PUNCT dpc-3474 166 31 st st PROPN dpc-3474 166 32 ag ag PROPN dpc-3474 166 33 e e PROPN dpc-3474 166 34     SPACE dpc-3474 166 35 ii ii PROPN dpc-3474 166 36 i i PRON dpc-3474 166 37     SPACE dpc-3474 166 38 ( ( PUNCT dpc-3474 166 39 4 4 NUM dpc-3474 166 40 5 5 NUM dpc-3474 166 41 % % NOUN dpc-3474 166 42 ) ) PUNCT dpc-3474 166 43 to to ADP dpc-3474 166 44 ta ta ADP dpc-3474 166 45 l l NOUN dpc-3474 166 46 : : PUNCT dpc-3474 166 47 21 21 NUM dpc-3474 166 48 s s NOUN dpc-3474 166 49 ta ta X dpc-3474 166 50 ge ge PROPN dpc-3474 167 1 i i PRON dpc-3474 167 2 ( ( PUNCT dpc-3474 167 3 40 40 NUM dpc-3474 167 4 ) ) PUNCT dpc-3474 167 5 st st PROPN dpc-3474 167 6 ag ag PROPN dpc-3474 167 7 e e PROPN dpc-3474 167 8 ii ii PROPN dpc-3474 167 9 ( ( PUNCT dpc-3474 167 10 22 22 NUM dpc-3474 167 11 ) ) PUNCT dpc-3474 167 12 st st PROPN dpc-3474 167 13 ag ag PROPN dpc-3474 167 14 e e PROPN dpc-3474 167 15     SPACE dpc-3474 167 16 ii ii PROPN dpc-3474 168 1 i i PRON dpc-3474 168 2     SPACE dpc-3474 168 3 ( ( PUNCT dpc-3474 168 4 1 1 NUM dpc-3474 168 5 4 4 NUM dpc-3474 168 6 ) ) PUNCT dpc-3474 168 7 17 17 NUM dpc-3474 168 8 , , PUNCT dpc-3474 168 9 5 5 NUM dpc-3474 168 10 25 25 NUM dpc-3474 168 11 , , PUNCT dpc-3474 168 12 5 5 NUM dpc-3474 168 13 25 25 NUM dpc-3474 168 14 l l NOUN dpc-3474 168 15 uk uk PROPN dpc-3474 168 16 e e PROPN dpc-3474 168 17 j j PROPN dpc-3474 168 18 , , PUNCT dpc-3474 168 19 e e PROPN dpc-3474 168 20 t t PROPN dpc-3474 168 21 al al PROPN dpc-3474 168 22 . . PUNCT dpc-3474 169 1 18 18 NUM dpc-3474 169 2 7/ 7/ NUM dpc-3474 169 3 97 97 NUM dpc-3474 169 4 6 6 NUM dpc-3474 169 5 ( ( PUNCT dpc-3474 169 6 1 1 NUM dpc-3474 169 7 9 9 NUM dpc-3474 169 8 % % NOUN dpc-3474 169 9 ) ) PUNCT dpc-3474 169 10 review review NOUN dpc-3474 169 11 | | ADV dpc-3474 169 12 dermatol dermatol ADJ dpc-3474 169 13 pract pract NOUN dpc-3474 169 14 concept concept NOUN dpc-3474 169 15 . . PUNCT dpc-3474 170 1 2023;13(4):e2023304 2023;13(4):e2023304 NUM dpc-3474 170 2 5 5 NUM dpc-3474 170 3 ta ta PART dpc-3474 170 4 b b PROPN dpc-3474 170 5 le le ADP dpc-3474 170 6 3 3 NUM dpc-3474 170 7 . . PUNCT dpc-3474 171 1 m m PROPN dpc-3474 171 2 el el PROPN dpc-3474 171 3 an an DET dpc-3474 171 4 om om PROPN dpc-3474 171 5 a a DET dpc-3474 171 6 re re X dpc-3474 171 7 cu cu PROPN dpc-3474 171 8 rr rr PROPN dpc-3474 171 9 en en PROPN dpc-3474 171 10 ce ce PROPN dpc-3474 172 1 lo lo PROPN dpc-3474 172 2 ca can AUX dpc-3474 172 3 ti ti PROPN dpc-3474 172 4 on on ADP dpc-3474 172 5 d d ADP dpc-3474 172 6 et et NOUN dpc-3474 172 7 ai ai VERB dpc-3474 172 8 ls ls ADP dpc-3474 172 9 a a DET dpc-3474 172 10 nd nd NOUN dpc-3474 172 11 p p X dpc-3474 172 12 re re ADJ dpc-3474 172 13 di di X dpc-3474 172 14 ct ct PROPN dpc-3474 172 15 or or CCONJ dpc-3474 172 16 s s PROPN dpc-3474 172 17 of of ADP dpc-3474 172 18 r r NOUN dpc-3474 172 19 ec ec PROPN dpc-3474 172 20 ur ur INTJ dpc-3474 172 21 re re PROPN dpc-3474 172 22 nc nc PROPN dpc-3474 172 23 e. e. PROPN dpc-3474 172 24 st st PROPN dpc-3474 173 1 u u PROPN dpc-3474 173 2 d d PROPN dpc-3474 173 3 y y PROPN dpc-3474 173 4 lo lo PROPN dpc-3474 173 5 ca can AUX dpc-3474 173 6 ti ti X dpc-3474 173 7 o o NOUN dpc-3474 173 8 n n ADP dpc-3474 173 9 o o X dpc-3474 173 10 f f X dpc-3474 173 11 re re PROPN dpc-3474 173 12 cu cu PROPN dpc-3474 173 13 rr rr PROPN dpc-3474 173 14 en en PROPN dpc-3474 173 15 ce ce PROPN dpc-3474 173 16 r r PROPN dpc-3474 173 17 ec ec PROPN dpc-3474 173 18 u u PROPN dpc-3474 173 19 rr rr PROPN dpc-3474 173 20 en en PROPN dpc-3474 173 21 ce ce PROPN dpc-3474 173 22 lc lc PROPN dpc-3474 174 1 it it PRON dpc-3474 174 2 ( ( PUNCT dpc-3474 174 3 n n X dpc-3474 174 4 ) ) PUNCT dpc-3474 174 5 r r NOUN dpc-3474 174 6 ec ec PROPN dpc-3474 174 7 u u PROPN dpc-3474 174 8 rr rr PROPN dpc-3474 174 9 en en PROPN dpc-3474 174 10 ce ce PROPN dpc-3474 174 11 ln ln PROPN dpc-3474 174 12 ( ( PUNCT dpc-3474 174 13 n n NOUN dpc-3474 174 14 ) ) PUNCT dpc-3474 174 15 r r NOUN dpc-3474 174 16 ec ec PROPN dpc-3474 174 17 u u PROPN dpc-3474 174 18 rr rr PROPN dpc-3474 174 19 en en PROPN dpc-3474 174 20 ce ce PROPN dpc-3474 174 21 sy sy PROPN dpc-3474 174 22 st st PROPN dpc-3474 174 23 em em PRON dpc-3474 174 24 ic ic PROPN dpc-3474 174 25 ( ( PUNCT dpc-3474 174 26 n n NOUN dpc-3474 174 27 ) ) PUNCT dpc-3474 174 28 pr pr NOUN dpc-3474 174 29 ed ed NOUN dpc-3474 174 30 ic ic PROPN dpc-3474 174 31 to to PART dpc-3474 174 32 rs rs VERB dpc-3474 174 33 o o X dpc-3474 174 34 f f X dpc-3474 174 35 re re PROPN dpc-3474 174 36 cu cu PROPN dpc-3474 174 37 rr rr PROPN dpc-3474 174 38 en en PROPN dpc-3474 174 39 ce ce PROPN dpc-3474 174 40 m m PROPN dpc-3474 174 41 ei ei PROPN dpc-3474 174 42 er er INTJ dpc-3474 174 43 f f X dpc-3474 174 44 , , PUNCT dpc-3474 174 45 e e PROPN dpc-3474 174 46 t t PROPN dpc-3474 174 47 al al PROPN dpc-3474 174 48 . . PUNCT dpc-3474 175 1 l l PROPN dpc-3474 176 1 c c X dpc-3474 177 1 it it PRON dpc-3474 177 2 ( ( PUNCT dpc-3474 177 3 21 21 NUM dpc-3474 177 4 .7 .7 NUM dpc-3474 177 5 % % NOUN dpc-3474 177 6 ) ) PUNCT dpc-3474 177 7 l l NOUN dpc-3474 177 8 n n X dpc-3474 177 9 ( ( PUNCT dpc-3474 177 10 50 50 NUM dpc-3474 177 11 .2 .2 NUM dpc-3474 177 12 % % NOUN dpc-3474 177 13 ) ) PUNCT dpc-3474 177 14 sy sy INTJ dpc-3474 177 15 st st PROPN dpc-3474 177 16 em em PRON dpc-3474 177 17 ic ic PROPN dpc-3474 177 18 ( ( PUNCT dpc-3474 177 19 28 28 NUM dpc-3474 177 20 .1 .1 NUM dpc-3474 177 21 % % NOUN dpc-3474 177 22 ) ) PUNCT dpc-3474 177 23 10 10 NUM dpc-3474 177 24 1 1 NUM dpc-3474 177 25 23 23 NUM dpc-3474 177 26 4 4 NUM dpc-3474 177 27 13 13 NUM dpc-3474 177 28 1 1 NUM dpc-3474 177 29 l l NOUN dpc-3474 177 30 oc oc NOUN dpc-3474 177 31 at at ADP dpc-3474 177 32 io io PROPN dpc-3474 177 33 n n ADP dpc-3474 177 34 of of ADV dpc-3474 177 35 in in ADP dpc-3474 177 36 it it PRON dpc-3474 177 37 ia ia PROPN dpc-3474 177 38 l l PROPN dpc-3474 177 39 t t PROPN dpc-3474 177 40 um um INTJ dpc-3474 177 41 or or CCONJ dpc-3474 177 42 ( ( PUNCT dpc-3474 177 43 p p X dpc-3474 177 44 < < X dpc-3474 177 45 0 0 NUM dpc-3474 177 46 . . NOUN dpc-3474 177 47 00 00 NUM dpc-3474 178 1 1 1 NUM dpc-3474 178 2 ) ) PUNCT dpc-3474 178 3 t t NOUN dpc-3474 178 4 um um INTJ dpc-3474 178 5 or or CCONJ dpc-3474 178 6 t t X dpc-3474 178 7 hi hi INTJ dpc-3474 178 8 ck ck PROPN dpc-3474 178 9 ne ne PROPN dpc-3474 178 10 ss ss PROPN dpc-3474 178 11 ( ( PUNCT dpc-3474 178 12 p= p= NOUN dpc-3474 178 13 0 0 NUM dpc-3474 178 14 . . PUNCT dpc-3474 178 15 02 02 NUM dpc-3474 178 16 8) 8) NUM dpc-3474 178 17 m m NOUN dpc-3474 178 18 ey ey PRON dpc-3474 178 19 er er INTJ dpc-3474 178 20 s s X dpc-3474 178 21 o o NOUN dpc-3474 178 22 , , PUNCT dpc-3474 178 23 e e PROPN dpc-3474 178 24 t t PROPN dpc-3474 178 25 al al PROPN dpc-3474 178 26 . . PUNCT dpc-3474 179 1 l l PROPN dpc-3474 180 1 c c X dpc-3474 180 2 it it PRON dpc-3474 180 3 ( ( PUNCT dpc-3474 180 4 49 49 NUM dpc-3474 180 5 % % NOUN dpc-3474 180 6 ) ) PUNCT dpc-3474 181 1 l l NOUN dpc-3474 181 2 n n CCONJ dpc-3474 181 3 ( ( PUNCT dpc-3474 181 4 16 16 NUM dpc-3474 181 5 % % NOUN dpc-3474 181 6 ) ) PUNCT dpc-3474 182 1 sy sy INTJ dpc-3474 182 2 st st PROPN dpc-3474 182 3 em em PRON dpc-3474 182 4 ic ic INTJ dpc-3474 182 5 : : PUNCT dpc-3474 182 6 ( ( PUNCT dpc-3474 182 7 35 35 NUM dpc-3474 182 8 % % NOUN dpc-3474 182 9 ) ) PUNCT dpc-3474 182 10 21 21 NUM dpc-3474 182 11 7 7 NUM dpc-3474 182 12 15 15 NUM dpc-3474 182 13 b b NOUN dpc-3474 182 14 ar ar NOUN dpc-3474 182 15 bo bo PROPN dpc-3474 182 16 ur ur PROPN dpc-3474 182 17 s s PROPN dpc-3474 182 18 , , PUNCT dpc-3474 182 19 e e PROPN dpc-3474 182 20 t t PROPN dpc-3474 182 21 al al PROPN dpc-3474 182 22 . . PUNCT dpc-3474 183 1 l l PROPN dpc-3474 184 1 c c X dpc-3474 185 1 it it PRON dpc-3474 185 2 ( ( PUNCT dpc-3474 185 3 14 14 NUM dpc-3474 185 4 % % NOUN dpc-3474 185 5 ) ) PUNCT dpc-3474 185 6 l l NOUN dpc-3474 185 7 n n CCONJ dpc-3474 185 8 ( ( PUNCT dpc-3474 185 9 8 8 NUM dpc-3474 185 10 % % NOUN dpc-3474 185 11 ) ) PUNCT dpc-3474 185 12 sy sy INTJ dpc-3474 185 13 st st PROPN dpc-3474 185 14 em em PRON dpc-3474 185 15 ic ic PROPN dpc-3474 185 16 ( ( PUNCT dpc-3474 185 17 78 78 NUM dpc-3474 185 18 % % NOUN dpc-3474 185 19 ) ) PUNCT dpc-3474 186 1 g g NOUN dpc-3474 186 2 ro ro X dpc-3474 186 3 up up ADP dpc-3474 186 4 1 1 NUM dpc-3474 186 5 : : SYM dpc-3474 186 6 5 5 NUM dpc-3474 186 7 g g NOUN dpc-3474 186 8 ro ro X dpc-3474 186 9 up up ADP dpc-3474 186 10 2 2 NUM dpc-3474 186 11 : : SYM dpc-3474 186 12 6 6 NUM dpc-3474 186 13 g g NOUN dpc-3474 186 14 ro ro X dpc-3474 186 15 up up ADP dpc-3474 186 16 1 1 NUM dpc-3474 186 17 : : SYM dpc-3474 186 18 5 5 NUM dpc-3474 186 19 g g NOUN dpc-3474 186 20 ro ro X dpc-3474 186 21 up up ADP dpc-3474 186 22 2 2 NUM dpc-3474 186 23 : : SYM dpc-3474 186 24 1 1 NUM dpc-3474 186 25 g g NOUN dpc-3474 186 26 ro ro X dpc-3474 186 27 up up ADP dpc-3474 186 28 1 1 NUM dpc-3474 186 29 : : SYM dpc-3474 186 30 3 3 NUM dpc-3474 186 31 3 3 NUM dpc-3474 186 32 g g NOUN dpc-3474 186 33 ro ro NOUN dpc-3474 186 34 up up ADP dpc-3474 186 35 2 2 NUM dpc-3474 186 36 : : SYM dpc-3474 186 37 2 2 NUM dpc-3474 186 38 8 8 NUM dpc-3474 186 39 o o NOUN dpc-3474 186 40 c c NOUN dpc-3474 186 41 on on ADP dpc-3474 186 42 ne ne X dpc-3474 186 43 ll ll PROPN dpc-3474 186 44 e e X dpc-3474 186 45 , , PUNCT dpc-3474 186 46 e e PROPN dpc-3474 186 47 t t PROPN dpc-3474 186 48 al al PROPN dpc-3474 186 49 . . PUNCT dpc-3474 187 1 l l PROPN dpc-3474 188 1 c c X dpc-3474 189 1 it it PRON dpc-3474 189 2 ( ( PUNCT dpc-3474 189 3 30 30 NUM dpc-3474 189 4 % % NOUN dpc-3474 189 5 ) ) PUNCT dpc-3474 189 6 l l NOUN dpc-3474 189 7 n n CCONJ dpc-3474 189 8 ( ( PUNCT dpc-3474 189 9 30 30 NUM dpc-3474 189 10 % % NOUN dpc-3474 189 11 ) ) PUNCT dpc-3474 190 1 sy sy INTJ dpc-3474 190 2 st st PROPN dpc-3474 190 3 em em PRON dpc-3474 190 4 ic ic INTJ dpc-3474 190 5 : : PUNCT dpc-3474 190 6 ( ( PUNCT dpc-3474 190 7 40 40 NUM dpc-3474 190 8 % % NOUN dpc-3474 190 9 ) ) PUNCT dpc-3474 190 10 12 12 NUM dpc-3474 190 11 12 12 NUM dpc-3474 190 12 16 16 NUM dpc-3474 190 13 n n PROPN dpc-3474 190 14 od od PROPN dpc-3474 190 15 ul ul PROPN dpc-3474 190 16 ar ar PROPN dpc-3474 190 17 s s PROPN dpc-3474 190 18 ub ub INTJ dpc-3474 190 19 ty ty INTJ dpc-3474 190 20 pe pe INTJ dpc-3474 191 1 ( ( PUNCT dpc-3474 191 2 p p X dpc-3474 191 3 < < X dpc-3474 191 4 0 0 NUM dpc-3474 191 5 . . NUM dpc-3474 191 6 05 05 NUM dpc-3474 191 7 ) ) PUNCT dpc-3474 192 1 t t NOUN dpc-3474 192 2 um um INTJ dpc-3474 192 3 or or CCONJ dpc-3474 192 4 t t X dpc-3474 192 5 hi hi INTJ dpc-3474 192 6 ck ck PROPN dpc-3474 192 7 ne ne INTJ dpc-3474 192 8 ss ss PROPN dpc-3474 193 1 ( ( PUNCT dpc-3474 193 2 p p X dpc-3474 193 3 < < X dpc-3474 193 4 0 0 NUM dpc-3474 193 5 . . NOUN dpc-3474 193 6 00 00 NUM dpc-3474 194 1 1 1 NUM dpc-3474 194 2 ) ) PUNCT dpc-3474 194 3 sv sv INTJ dpc-3474 195 1 ed ed NOUN dpc-3474 195 2 m m VERB dpc-3474 195 3 an an DET dpc-3474 195 4 f f X dpc-3474 195 5 , , PUNCT dpc-3474 195 6 e e PROPN dpc-3474 195 7 t t PROPN dpc-3474 195 8 al al PROPN dpc-3474 195 9 . . PUNCT dpc-3474 196 1 sp sp ADP dpc-3474 196 2 ar ar PROPN dpc-3474 196 3 ks ks PROPN dpc-3474 196 4 d d PROPN dpc-3474 196 5 s s PROPN dpc-3474 196 6 , , PUNCT dpc-3474 196 7 e e PROPN dpc-3474 196 8 t t PROPN dpc-3474 196 9 al al PROPN dpc-3474 196 10 . . PUNCT dpc-3474 197 1 l l PROPN dpc-3474 198 1 c c X dpc-3474 199 1 it it PRON dpc-3474 199 2 ( ( PUNCT dpc-3474 199 3 16 16 NUM dpc-3474 199 4 % % NOUN dpc-3474 199 5 ) ) PUNCT dpc-3474 199 6 l l NOUN dpc-3474 199 7 n n CCONJ dpc-3474 199 8 ( ( PUNCT dpc-3474 199 9 12 12 NUM dpc-3474 199 10 % % NOUN dpc-3474 199 11 ) ) PUNCT dpc-3474 200 1 sy sy INTJ dpc-3474 200 2 st st PROPN dpc-3474 200 3 em em PRON dpc-3474 200 4 ic ic PROPN dpc-3474 200 5 ( ( PUNCT dpc-3474 200 6 15 15 NUM dpc-3474 200 7 % % NOUN dpc-3474 200 8 ) ) PUNCT dpc-3474 200 9 17 17 NUM dpc-3474 200 10 13 13 NUM dpc-3474 200 11 16 16 NUM dpc-3474 200 12 b b NOUN dpc-3474 200 13 er er INTJ dpc-3474 200 14 ge ge PROPN dpc-3474 200 15 r r PROPN dpc-3474 200 16 a a DET dpc-3474 200 17 c c NOUN dpc-3474 200 18 , , PUNCT dpc-3474 200 19 e e PROPN dpc-3474 200 20 t t PROPN dpc-3474 200 21 al al PROPN dpc-3474 200 22 . . PUNCT dpc-3474 201 1 56 56 NUM dpc-3474 201 2 52 52 NUM dpc-3474 201 3 63 63 NUM dpc-3474 201 4 m m NOUN dpc-3474 201 5 al al PROPN dpc-3474 201 6 e e PROPN dpc-3474 201 7 se se X dpc-3474 201 8 x x X dpc-3474 202 1 ( ( PUNCT dpc-3474 202 2 p p NOUN dpc-3474 202 3 = = NOUN dpc-3474 202 4 0 0 SYM dpc-3474 202 5 .0 .0 NUM dpc-3474 202 6 01 01 NUM dpc-3474 202 7 8) 8) NUM dpc-3474 202 8 t t NOUN dpc-3474 202 9 c c PROPN dpc-3474 202 10 la la PROPN dpc-3474 202 11 ss ss PROPN dpc-3474 202 12 ifi ifi PROPN dpc-3474 202 13 ca can AUX dpc-3474 202 14 ti ti PROPN dpc-3474 202 15 on on ADP dpc-3474 202 16 ( ( PUNCT dpc-3474 202 17 p= p= NOUN dpc-3474 202 18 0 0 NUM dpc-3474 202 19 . . PROPN dpc-3474 202 20 00 00 NUM dpc-3474 203 1 49 49 NUM dpc-3474 203 2 ) ) PUNCT dpc-3474 203 3 u u NOUN dpc-3474 203 4 lc lc PROPN dpc-3474 203 5 er er INTJ dpc-3474 203 6 at at ADP dpc-3474 203 7 io io X dpc-3474 203 8 n n PRON dpc-3474 203 9 ( ( PUNCT dpc-3474 203 10 p p NOUN dpc-3474 203 11 = = PROPN dpc-3474 203 12 0 0 SYM dpc-3474 203 13 .0 .0 NUM dpc-3474 203 14 01 01 NUM dpc-3474 203 15 6 6 NUM dpc-3474 203 16 ) ) PUNCT dpc-3474 203 17 l l NOUN dpc-3474 203 18 ee ee ADP dpc-3474 203 19 a a DET dpc-3474 203 20 y y PROPN dpc-3474 203 21 , , PUNCT dpc-3474 203 22 e e PROPN dpc-3474 203 23 t t PROPN dpc-3474 203 24 al al PROPN dpc-3474 203 25 . . PUNCT dpc-3474 204 1 80 80 NUM dpc-3474 204 2 50 50 NUM dpc-3474 204 3 81 81 NUM dpc-3474 204 4 n n NUM dpc-3474 204 5 am be AUX dpc-3474 204 6 in in ADP dpc-3474 204 7 a a DET dpc-3474 204 8 w w NOUN dpc-3474 204 9 , , PUNCT dpc-3474 204 10 e e PROPN dpc-3474 204 11 t t PROPN dpc-3474 204 12 al al PROPN dpc-3474 204 13 . . PUNCT dpc-3474 205 1 l l PROPN dpc-3474 206 1 c c X dpc-3474 207 1 it it PRON dpc-3474 207 2 ( ( PUNCT dpc-3474 207 3 18 18 NUM dpc-3474 207 4 % % NOUN dpc-3474 207 5 ) ) PUNCT dpc-3474 207 6 l l NOUN dpc-3474 207 7 n n CCONJ dpc-3474 207 8 ( ( PUNCT dpc-3474 207 9 18 18 NUM dpc-3474 207 10 % % NOUN dpc-3474 207 11 ) ) PUNCT dpc-3474 207 12 sy sy PROPN dpc-3474 207 13 st st PROPN dpc-3474 207 14 em em PRON dpc-3474 207 15 ic ic PROPN dpc-3474 207 16 ( ( PUNCT dpc-3474 207 17 49 49 NUM dpc-3474 207 18 % % NOUN dpc-3474 207 19 ) ) PUNCT dpc-3474 207 20 6 6 NUM dpc-3474 207 21 6 6 NUM dpc-3474 207 22 21 21 NUM dpc-3474 207 23 l l NOUN dpc-3474 207 24 ee ee X dpc-3474 207 25 ne ne PROPN dpc-3474 207 26 m m PROPN dpc-3474 207 27 an an DET dpc-3474 207 28 b b NOUN dpc-3474 207 29 , , PUNCT dpc-3474 207 30 e e PROPN dpc-3474 207 31 t t PROPN dpc-3474 207 32 al al PROPN dpc-3474 207 33 . . PUNCT dpc-3474 208 1 59 59 NUM dpc-3474 208 2 10 10 NUM dpc-3474 208 3 0 0 NUM dpc-3474 208 4 11 11 NUM dpc-3474 208 5 6 6 NUM dpc-3474 208 6 t t NOUN dpc-3474 208 7 ho ho PROPN dpc-3474 208 8 m m PROPN dpc-3474 208 9 as as ADP dpc-3474 208 10 d d PROPN dpc-3474 208 11 c c NOUN dpc-3474 208 12 , , PUNCT dpc-3474 208 13 e e PROPN dpc-3474 208 14 t t PROPN dpc-3474 208 15 al al PROPN dpc-3474 208 16 . . PUNCT dpc-3474 209 1 22 22 NUM dpc-3474 209 2 1 1 NUM dpc-3474 209 3 10 10 NUM dpc-3474 209 4 9 9 NUM dpc-3474 209 5 22 22 NUM dpc-3474 209 6 0 0 NUM dpc-3474 210 1 fo fo ADP dpc-3474 210 2 r r NOUN dpc-3474 210 3 l l NOUN dpc-3474 210 4 c c NOUN dpc-3474 211 1 it it PRON dpc-3474 211 2 r r NOUN dpc-3474 211 3 ec ec X dpc-3474 211 4 ur ur INTJ dpc-3474 211 5 re re VERB dpc-3474 211 6 nc nc PROPN dpc-3474 211 7 e e PROPN dpc-3474 211 8 : : PUNCT dpc-3474 211 9 a a DET dpc-3474 211 10 ge ge PROPN dpc-3474 211 11 , , PUNCT dpc-3474 211 12 a a DET dpc-3474 211 13 na na NOUN dpc-3474 211 14 to to ADP dpc-3474 211 15 m m PROPN dpc-3474 211 16 ic ic INTJ dpc-3474 211 17 lo lo NOUN dpc-3474 211 18 ca can AUX dpc-3474 211 19 ti ti X dpc-3474 211 20 on on ADP dpc-3474 211 21 , , PUNCT dpc-3474 211 22 t t PROPN dpc-3474 211 23 hi hi INTJ dpc-3474 211 24 ck ck PROPN dpc-3474 211 25 ne ne PROPN dpc-3474 211 26 ss ss PROPN dpc-3474 211 27 ( ( PUNCT dpc-3474 211 28 a a DET dpc-3474 211 29 ll ll NOUN dpc-3474 211 30 p p X dpc-3474 211 31 < < X dpc-3474 211 32 0 0 NUM dpc-3474 211 33 . . NUM dpc-3474 211 34 05 05 NUM dpc-3474 211 35 ) ) PUNCT dpc-3474 212 1 fo fo ADP dpc-3474 212 2 r r NOUN dpc-3474 212 3 l l NOUN dpc-3474 212 4 n n ADP dpc-3474 212 5 r r NOUN dpc-3474 212 6 ec ec X dpc-3474 212 7 ur ur INTJ dpc-3474 212 8 re re VERB dpc-3474 212 9 nc nc PROPN dpc-3474 212 10 e e PROPN dpc-3474 212 11 : : PUNCT dpc-3474 212 12 a a DET dpc-3474 212 13 ge ge PROPN dpc-3474 212 14 a a PRON dpc-3474 212 15 nd nd NOUN dpc-3474 212 16 t t NOUN dpc-3474 212 17 hi hi INTJ dpc-3474 212 18 ck ck PROPN dpc-3474 212 19 ne ne PROPN dpc-3474 212 20 ss ss PROPN dpc-3474 212 21 ( ( PUNCT dpc-3474 212 22 al al PROPN dpc-3474 212 23 l l PROPN dpc-3474 212 24 p p X dpc-3474 213 1 < < X dpc-3474 213 2 0 0 NUM dpc-3474 213 3 .0 .0 NUM dpc-3474 213 4 5 5 NUM dpc-3474 213 5 ) ) PUNCT dpc-3474 214 1 fo fo ADP dpc-3474 214 2 r r NOUN dpc-3474 214 3 sy sy PROPN dpc-3474 214 4 st st PROPN dpc-3474 214 5 em em PRON dpc-3474 214 6 ic ic PROPN dpc-3474 214 7 r r NOUN dpc-3474 214 8 ec ec PROPN dpc-3474 214 9 ur ur INTJ dpc-3474 214 10 re re VERB dpc-3474 214 11 nc nc PROPN dpc-3474 214 12 e e PROPN dpc-3474 214 13 : : PUNCT dpc-3474 214 14 a a DET dpc-3474 214 15 na na NOUN dpc-3474 214 16 to to ADP dpc-3474 214 17 m m PROPN dpc-3474 214 18 ic ic INTJ dpc-3474 214 19 lo lo NOUN dpc-3474 214 20 ca can AUX dpc-3474 214 21 ti ti PROPN dpc-3474 214 22 on on ADP dpc-3474 214 23 s s PROPN dpc-3474 214 24 , , PUNCT dpc-3474 214 25 t t PROPN dpc-3474 214 26 hi hi INTJ dpc-3474 214 27 ck ck PROPN dpc-3474 214 28 ne ne PROPN dpc-3474 214 29 ss ss PROPN dpc-3474 214 30 , , PUNCT dpc-3474 214 31 ul ul PROPN dpc-3474 214 32 ce ce PROPN dpc-3474 214 33 ra ra PROPN dpc-3474 214 34 ti ti PROPN dpc-3474 214 35 on on ADP dpc-3474 214 36 , , PUNCT dpc-3474 214 37 a a DET dpc-3474 214 38 nd nd INTJ dpc-3474 214 39 ly ly ADP dpc-3474 214 40 m m VERB dpc-3474 214 41 ph ph ADJ dpc-3474 214 42 ov ov PROPN dpc-3474 214 43 as as ADP dpc-3474 214 44 cu cu PROPN dpc-3474 214 45 la la PROPN dpc-3474 214 46 r r PROPN dpc-3474 214 47 in in ADP dpc-3474 214 48 va va PROPN dpc-3474 214 49 si si X dpc-3474 215 1 on on ADP dpc-3474 215 2 ( ( PUNCT dpc-3474 215 3 al al PROPN dpc-3474 215 4 l l PROPN dpc-3474 215 5 p p X dpc-3474 215 6 < < X dpc-3474 215 7 0 0 NUM dpc-3474 215 8 .0 .0 NUM dpc-3474 215 9 5 5 NUM dpc-3474 215 10 ) ) PUNCT dpc-3474 215 11 b b PROPN dpc-3474 215 12 ar ar NOUN dpc-3474 215 13 tl tl PROPN dpc-3474 215 14 et et NOUN dpc-3474 215 15 t t PROPN dpc-3474 215 16 e e PROPN dpc-3474 215 17 k k PROPN dpc-3474 215 18 , , PUNCT dpc-3474 215 19 e e PROPN dpc-3474 215 20 t t PROPN dpc-3474 215 21 al al PROPN dpc-3474 215 22 . . PUNCT dpc-3474 216 1 45 45 NUM dpc-3474 216 2 62 62 NUM dpc-3474 216 3 51 51 NUM dpc-3474 216 4 b b NOUN dpc-3474 216 5 le le X dpc-3474 216 6 ic ic INTJ dpc-3474 217 1 he he PRON dpc-3474 217 2 r r PROPN dpc-3474 217 3 j j PROPN dpc-3474 217 4 , , PUNCT dpc-3474 217 5 e e PROPN dpc-3474 217 6 t t PROPN dpc-3474 217 7 al al PROPN dpc-3474 217 8 . . PUNCT dpc-3474 218 1 l l PROPN dpc-3474 219 1 c c X dpc-3474 220 1 it it PRON dpc-3474 220 2 ( ( PUNCT dpc-3474 220 3 19 19 NUM dpc-3474 220 4 .6 .6 NUM dpc-3474 220 5 % % NOUN dpc-3474 220 6 ) ) PUNCT dpc-3474 220 7 l l NOUN dpc-3474 220 8 n n CCONJ dpc-3474 220 9 ( ( PUNCT dpc-3474 220 10 29 29 NUM dpc-3474 220 11 .8 .8 NUM dpc-3474 220 12 % % NOUN dpc-3474 220 13 ) ) PUNCT dpc-3474 221 1 sy sy INTJ dpc-3474 221 2 st st PROPN dpc-3474 221 3 em em PRON dpc-3474 221 4 ic ic PROPN dpc-3474 221 5 ( ( PUNCT dpc-3474 221 6 50 50 NUM dpc-3474 221 7 .6 .6 NUM dpc-3474 221 8 % % NOUN dpc-3474 221 9 ) ) PUNCT dpc-3474 221 10 31 31 NUM dpc-3474 221 11 47 47 NUM dpc-3474 221 12 80 80 NUM dpc-3474 221 13 a a DET dpc-3474 221 14 ge ge NOUN dpc-3474 221 15 ( ( PUNCT dpc-3474 221 16 p p X dpc-3474 221 17 < < X dpc-3474 221 18 0 0 NUM dpc-3474 221 19 .0 .0 NUM dpc-3474 221 20 5 5 NUM dpc-3474 221 21 ) ) PUNCT dpc-3474 221 22 s s PART dpc-3474 221 23 ta ta X dpc-3474 221 24 ge ge PROPN dpc-3474 221 25 ( ( PUNCT dpc-3474 221 26 p p X dpc-3474 221 27 < < X dpc-3474 221 28 0 0 NUM dpc-3474 221 29 . . NUM dpc-3474 221 30 05 05 NUM dpc-3474 221 31 ) ) PUNCT dpc-3474 221 32 b b NOUN dpc-3474 221 33 re re ADP dpc-3474 221 34 sl sl INTJ dpc-3474 221 35 ow ow INTJ dpc-3474 221 36 ( ( PUNCT dpc-3474 221 37 p p X dpc-3474 221 38 < < X dpc-3474 221 39 0 0 NUM dpc-3474 221 40 .0 .0 NUM dpc-3474 221 41 1 1 NUM dpc-3474 221 42 ) ) PUNCT dpc-3474 222 1 o o NOUN dpc-3474 223 1 h h NOUN dpc-3474 224 1 y y PROPN dpc-3474 224 2 , , PUNCT dpc-3474 224 3 e e PROPN dpc-3474 224 4 t t PROPN dpc-3474 224 5 al al PROPN dpc-3474 224 6 . . PUNCT dpc-3474 225 1 29 29 NUM dpc-3474 225 2 49 49 NUM dpc-3474 225 3 28 28 NUM dpc-3474 225 4 m m NOUN dpc-3474 225 5 al al PROPN dpc-3474 225 6 e e PROPN dpc-3474 225 7 se se X dpc-3474 225 8 x x X dpc-3474 225 9 ( ( PUNCT dpc-3474 225 10 p p NOUN dpc-3474 225 11 = = NOUN dpc-3474 225 12 0 0 NUM dpc-3474 225 13 .0 .0 NUM dpc-3474 225 14 30 30 NUM dpc-3474 225 15 ) ) PUNCT dpc-3474 225 16 b b NOUN dpc-3474 225 17 re re ADP dpc-3474 225 18 sl sl INTJ dpc-3474 225 19 ow ow INTJ dpc-3474 225 20 > > X dpc-3474 225 21 1 1 NUM dpc-3474 225 22 m m VERB dpc-3474 225 23 m m VERB dpc-3474 225 24 ( ( PUNCT dpc-3474 225 25 p= p= NOUN dpc-3474 225 26 0 0 NUM dpc-3474 225 27 . . PUNCT dpc-3474 225 28 00 00 NUM dpc-3474 225 29 8) 8) NUM dpc-3474 225 30 e e NOUN dpc-3474 225 31 gg gg NOUN dpc-3474 225 32 er er INTJ dpc-3474 225 33 m m VERB dpc-3474 225 34 on on ADP dpc-3474 225 35 t t PROPN dpc-3474 225 36 m m PROPN dpc-3474 225 37 , , PUNCT dpc-3474 225 38 e e PROPN dpc-3474 225 39 t t PROPN dpc-3474 225 40 al al PROPN dpc-3474 225 41 . . PUNCT dpc-3474 226 1 g g PROPN dpc-3474 226 2 ro ro PROPN dpc-3474 226 3 up up ADV dpc-3474 226 4 1 1 NUM dpc-3474 226 5 1 1 NUM dpc-3474 226 6 26 26 NUM dpc-3474 226 7 ( ( PUNCT dpc-3474 226 8 2 2 NUM dpc-3474 226 9 5 5 NUM dpc-3474 226 10 % % NOUN dpc-3474 226 11 ) ) PUNCT dpc-3474 226 12 g g PROPN dpc-3474 226 13 ro ro X dpc-3474 226 14 up up ADP dpc-3474 226 15 2 2 NUM dpc-3474 226 16     SPACE dpc-3474 226 17 19 19 NUM dpc-3474 226 18 4 4 NUM dpc-3474 226 19 ( ( PUNCT dpc-3474 226 20 3 3 NUM dpc-3474 226 21 8 8 NUM dpc-3474 226 22 % % NOUN dpc-3474 226 23 ) ) PUNCT dpc-3474 227 1 e e PROPN dpc-3474 227 2 rt rt PROPN dpc-3474 227 3 ek ek VERB dpc-3474 227 4 in in ADP dpc-3474 227 5 s s PRON dpc-3474 227 6 , , PUNCT dpc-3474 227 7 e e PROPN dpc-3474 227 8 t t PROPN dpc-3474 227 9 al al PROPN dpc-3474 227 10 . . PUNCT dpc-3474 228 1 l l PROPN dpc-3474 229 1 c c X dpc-3474 229 2 it it PRON dpc-3474 229 3 . . PUNCT dpc-3474 230 1 ( ( PUNCT dpc-3474 230 2 50 50 NUM dpc-3474 230 3 .1 .1 NUM dpc-3474 230 4 % % NOUN dpc-3474 230 5 ) ) PUNCT dpc-3474 231 1 l l NOUN dpc-3474 231 2 n n PRON dpc-3474 231 3 s s X dpc-3474 231 4 ys ys NOUN dpc-3474 231 5 te te PROPN dpc-3474 231 6 m m PROPN dpc-3474 231 7 ic ic PROPN dpc-3474 232 1 ( ( PUNCT dpc-3474 232 2 49 49 NUM dpc-3474 232 3 .9 .9 NUM dpc-3474 232 4 % % NOUN dpc-3474 232 5 ) ) PUNCT dpc-3474 232 6 39 39 NUM dpc-3474 232 7 3 3 NUM dpc-3474 232 8 98 98 NUM dpc-3474 232 9 29 29 NUM dpc-3474 232 10 3 3 NUM dpc-3474 232 11 l l NOUN dpc-3474 232 12 uk uk PROPN dpc-3474 232 13 e e PROPN dpc-3474 232 14 j j PROPN dpc-3474 232 15 , , PUNCT dpc-3474 232 16 e e PROPN dpc-3474 232 17 t t PROPN dpc-3474 232 18 al al PROPN dpc-3474 232 19 . . PUNCT dpc-3474 233 1 g g PROPN dpc-3474 233 2 ro ro PROPN dpc-3474 233 3 up up ADV dpc-3474 233 4 1 1 NUM dpc-3474 233 5 :3 :3 SYM dpc-3474 233 6 1 1 NUM dpc-3474 233 7 g g NOUN dpc-3474 233 8 ro ro X dpc-3474 233 9 up up ADP dpc-3474 233 10 2 2 NUM dpc-3474 233 11 : : SYM dpc-3474 233 12 60 60 NUM dpc-3474 233 13 6 6 NUM dpc-3474 233 14 review review NOUN dpc-3474 233 15 | | ADV dpc-3474 233 16 dermatol dermatol ADJ dpc-3474 233 17 pract pract NOUN dpc-3474 233 18 concept concept NOUN dpc-3474 233 19 . . PUNCT dpc-3474 234 1 2023;13(4):e2023304 2023;13(4):e2023304 NUM dpc-3474 234 2 ta ta X dpc-3474 234 3 b b PROPN dpc-3474 234 4 le le ADP dpc-3474 234 5 4 4 NUM dpc-3474 234 6 . . PUNCT dpc-3474 235 1 m m VERB dpc-3474 236 1 el el PROPN dpc-3474 236 2 an an DET dpc-3474 236 3 om om PROPN dpc-3474 236 4 a a PRON dpc-3474 236 5 su su PROPN dpc-3474 236 6 rv rv PROPN dpc-3474 237 1 iv iv NUM dpc-3474 238 1 al al PROPN dpc-3474 238 2 a a PRON dpc-3474 238 3 nd nd INTJ dpc-3474 238 4 a a DET dpc-3474 238 5 dd dd NOUN dpc-3474 238 6 it it PRON dpc-3474 238 7 io io INTJ dpc-3474 238 8 na na NOUN dpc-3474 238 9 l l NOUN dpc-3474 238 10 d d X dpc-3474 238 11 et et NOUN dpc-3474 238 12 ai ai VERB dpc-3474 238 13 ls ls INTJ dpc-3474 238 14 . . PUNCT dpc-3474 239 1 st st PROPN dpc-3474 239 2 u u PROPN dpc-3474 239 3 d d PROPN dpc-3474 239 4 y y PROPN dpc-3474 239 5 su su PROPN dpc-3474 239 6 rv rv PROPN dpc-3474 239 7 iv iv NUM dpc-3474 240 1 al al PROPN dpc-3474 240 2 o o PROPN dpc-3474 240 3 ve ve VERB dpc-3474 240 4 ra ra INTJ dpc-3474 241 1 ll ll INTJ dpc-3474 241 2 su su PROPN dpc-3474 241 3 rv rv PROPN dpc-3474 241 4 iv iv PROPN dpc-3474 241 5 al al PROPN dpc-3474 241 6 ( ( PUNCT dpc-3474 241 7 m m VERB dpc-3474 241 8 o o NOUN dpc-3474 241 9 n n X dpc-3474 242 1 th th X dpc-3474 242 2 s s VERB dpc-3474 242 3 at at ADP dpc-3474 242 4 5 5 NUM dpc-3474 242 5     SPACE dpc-3474 242 6 y y PROPN dpc-3474 242 7 ea ea PROPN dpc-3474 242 8 rs rs PROPN dpc-3474 243 1 ) ) PUNCT dpc-3474 244 1 o o INTJ dpc-3474 244 2 ve ve VERB dpc-3474 244 3 ra ra INTJ dpc-3474 244 4 ll ll INTJ dpc-3474 244 5 su su PROPN dpc-3474 244 6 rv rv PROPN dpc-3474 245 1 iv iv NUM dpc-3474 245 2 al al PROPN dpc-3474 245 3 % % PROPN dpc-3474 246 1 a a DET dpc-3474 246 2 t t PROPN dpc-3474 246 3 5 5 NUM dpc-3474 246 4 ye ye PROPN dpc-3474 246 5 ar ar PROPN dpc-3474 246 6 s s PROPN dpc-3474 246 7 d d NOUN dpc-3474 246 8 is be AUX dpc-3474 246 9 ea ea X dpc-3474 246 10 se se X dpc-3474 246 11 f f X dpc-3474 246 12 re re X dpc-3474 246 13 e e PROPN dpc-3474 246 14 su su PROPN dpc-3474 246 15 rv rv PROPN dpc-3474 246 16 iv iv PROPN dpc-3474 246 17 al al PROPN dpc-3474 246 18 ( ( PUNCT dpc-3474 246 19 n n PROPN dpc-3474 246 20 ) ) PUNCT dpc-3474 246 21 at at ADP dpc-3474 246 22 5 5 NUM dpc-3474 246 23 y y PROPN dpc-3474 246 24 ea ea NOUN dpc-3474 247 1 rs rs PROPN dpc-3474 247 2 d d NOUN dpc-3474 247 3 is be AUX dpc-3474 247 4 ea ea X dpc-3474 247 5 se se X dpc-3474 247 6 f f X dpc-3474 247 7 re re X dpc-3474 247 8 e e PROPN dpc-3474 247 9 su su PROPN dpc-3474 247 10 rv rv PROPN dpc-3474 247 11 iv iv PROPN dpc-3474 247 12 al al PROPN dpc-3474 247 13 ( ( PUNCT dpc-3474 247 14 % % NOUN dpc-3474 247 15 ) ) PUNCT dpc-3474 247 16 at at ADP dpc-3474 247 17 5 5 NUM dpc-3474 247 18 y y SYM dpc-3474 247 19 ea ea NOUN dpc-3474 248 1 rs rs NOUN dpc-3474 249 1 a a DET dpc-3474 249 2 d d X dpc-3474 249 3 d d VERB dpc-3474 249 4 it it PRON dpc-3474 249 5 io io PROPN dpc-3474 249 6 n n PROPN dpc-3474 249 7 al al PROPN dpc-3474 249 8 d d NOUN dpc-3474 249 9 et et NOUN dpc-3474 249 10 ai ai VERB dpc-3474 249 11 ls ls PROPN dpc-3474 249 12 m m PROPN dpc-3474 249 13 ei ei NOUN dpc-3474 249 14 er er INTJ dpc-3474 249 15 f f X dpc-3474 249 16 , , PUNCT dpc-3474 249 17 e e PROPN dpc-3474 249 18 t t PROPN dpc-3474 249 19 al al PROPN dpc-3474 249 20 . . PUNCT dpc-3474 250 1 m m VERB dpc-3474 250 2 ey ey INTJ dpc-3474 250 3 er er INTJ dpc-3474 250 4 s s X dpc-3474 250 5 o o NOUN dpc-3474 250 6 , , PUNCT dpc-3474 250 7 e e PROPN dpc-3474 250 8 t t PROPN dpc-3474 250 9 al al PROPN dpc-3474 250 10 . . PUNCT dpc-3474 251 1 22 22 NUM dpc-3474 252 1 ( ( PUNCT dpc-3474 252 2 l l NOUN dpc-3474 252 3 n n ADP dpc-3474 252 4 a a DET dpc-3474 252 5 nd nd NOUN dpc-3474 252 6 l l NOUN dpc-3474 252 7 c c NOUN dpc-3474 252 8 it it PRON dpc-3474 252 9 ) ) PUNCT dpc-3474 252 10 7 7 NUM dpc-3474 252 11     SPACE dpc-3474 252 12 ( ( PUNCT dpc-3474 252 13 s s VERB dpc-3474 252 14 ys ys NOUN dpc-3474 252 15 te te PROPN dpc-3474 252 16 m m PROPN dpc-3474 252 17 ic ic PROPN dpc-3474 252 18 ) ) PUNCT dpc-3474 252 19 b b PROPN dpc-3474 252 20 ar ar NOUN dpc-3474 252 21 bo bo PROPN dpc-3474 252 22 ur ur PROPN dpc-3474 252 23 s s PROPN dpc-3474 252 24 , , PUNCT dpc-3474 252 25 e e PROPN dpc-3474 252 26 t t PROPN dpc-3474 252 27 al al PROPN dpc-3474 252 28 . . PUNCT dpc-3474 253 1 53 53 NUM dpc-3474 253 2 80 80 NUM dpc-3474 253 3 46 46 NUM dpc-3474 253 4 % % NOUN dpc-3474 253 5 o o X dpc-3474 253 6 c c NOUN dpc-3474 253 7 on on ADP dpc-3474 253 8 ne ne X dpc-3474 253 9 ll ll PROPN dpc-3474 253 10 e e X dpc-3474 253 11 , , PUNCT dpc-3474 253 12 e e PROPN dpc-3474 253 13 t t PROPN dpc-3474 253 14 al al PROPN dpc-3474 253 15 . . PUNCT dpc-3474 254 1 23 23 NUM dpc-3474 255 1 .5 .5 NUM dpc-3474 255 2 % % NOUN dpc-3474 255 3 f f PROPN dpc-3474 256 1 ro ro INTJ dpc-3474 256 2 m m PROPN dpc-3474 256 3 t t NOUN dpc-3474 256 4 he he PRON dpc-3474 256 5 di di PROPN dpc-3474 256 6 ag ag PROPN dpc-3474 256 7 no no DET dpc-3474 256 8 si si PROPN dpc-3474 256 9 s s PROPN dpc-3474 256 10 6 6 NUM dpc-3474 256 11 sv sv NOUN dpc-3474 256 12 ed ed PROPN dpc-3474 256 13 m m PROPN dpc-3474 256 14 an an DET dpc-3474 256 15 f f PROPN dpc-3474 256 16 , , PUNCT dpc-3474 256 17 et et PROPN dpc-3474 256 18 a a DET dpc-3474 256 19 l. l. PROPN dpc-3474 256 20 st st PROPN dpc-3474 256 21 ag ag PROPN dpc-3474 256 22 e e PROPN dpc-3474 256 23 i i PROPN dpc-3474 256 24 ( ( PUNCT dpc-3474 256 25 9 9 NUM dpc-3474 256 26 5 5 NUM dpc-3474 256 27 % % NOUN dpc-3474 256 28 – – PUNCT dpc-3474 256 29 1 1 NUM dpc-3474 256 30 00 00 NUM dpc-3474 256 31 % % NOUN dpc-3474 256 32 ) ) PUNCT dpc-3474 256 33 st st PROPN dpc-3474 256 34 ag ag PROPN dpc-3474 256 35 e e PROPN dpc-3474 256 36 ii ii PROPN dpc-3474 256 37 ( ( PUNCT dpc-3474 256 38 65 65 NUM dpc-3474 256 39 % % NOUN dpc-3474 256 40 – – PUNCT dpc-3474 256 41 9 9 NUM dpc-3474 256 42 2 2 NUM dpc-3474 256 43 . . NOUN dpc-3474 256 44 8 8 NUM dpc-3474 256 45 % % NOUN dpc-3474 256 46 ) ) PUNCT dpc-3474 256 47 st st PROPN dpc-3474 256 48 ag ag PROPN dpc-3474 256 49 e e PROPN dpc-3474 256 50 ii ii PROPN dpc-3474 257 1 i i PRON dpc-3474 257 2 ( ( PUNCT dpc-3474 257 3 4 4 NUM dpc-3474 257 4 1 1 NUM dpc-3474 257 5 % % NOUN dpc-3474 257 6 – – PUNCT dpc-3474 257 7 7 7 NUM dpc-3474 257 8 1 1 NUM dpc-3474 257 9 % % NOUN dpc-3474 257 10 ) ) PUNCT dpc-3474 257 11 st st PROPN dpc-3474 257 12 ag ag PROPN dpc-3474 257 13 e e PROPN dpc-3474 257 14 iv iv X dpc-3474 257 15 ( ( PUNCT dpc-3474 257 16 9 9 NUM dpc-3474 257 17 % % NOUN dpc-3474 257 18 – – PUNCT dpc-3474 257 19 2 2 NUM dpc-3474 257 20 8 8 NUM dpc-3474 257 21 % % NOUN dpc-3474 257 22 ) ) PUNCT dpc-3474 257 23 sp sp ADP dpc-3474 257 24 ar ar NOUN dpc-3474 257 25 ks ks PROPN dpc-3474 257 26 d d PROPN dpc-3474 257 27 s s PROPN dpc-3474 257 28 , , PUNCT dpc-3474 257 29 e e PROPN dpc-3474 257 30 t t PROPN dpc-3474 257 31 al al PROPN dpc-3474 257 32 . . PUNCT dpc-3474 258 1 47 47 NUM dpc-3474 258 2 47 47 NUM dpc-3474 258 3 fi fi NOUN dpc-3474 258 4 rs rs NOUN dpc-3474 258 5 t t PROPN dpc-3474 258 6 si si X dpc-3474 259 1 te te PROPN dpc-3474 259 2 b b PROPN dpc-3474 259 3 ei ei INTJ dpc-3474 259 4 ng ng PROPN dpc-3474 259 5 lu lu PROPN dpc-3474 259 6 ng ng PROPN dpc-3474 259 7 s s X dpc-3474 259 8 ( ( PUNCT dpc-3474 259 9 4 4 NUM dpc-3474 259 10 ) ) PUNCT dpc-3474 259 11 , , PUNCT dpc-3474 259 12 br br PROPN dpc-3474 259 13 ai ai VERB dpc-3474 259 14 n n PROPN dpc-3474 259 15 ( ( PUNCT dpc-3474 259 16 3 3 NUM dpc-3474 259 17 ) ) PUNCT dpc-3474 259 18 , , PUNCT dpc-3474 259 19 liv liv PROPN dpc-3474 259 20 er er INTJ dpc-3474 259 21 ( ( PUNCT dpc-3474 259 22 2 2 NUM dpc-3474 259 23 ) ) PUNCT dpc-3474 259 24 , , PUNCT dpc-3474 259 25 s s VERB dpc-3474 259 26 ub ub INTJ dpc-3474 259 27 cu cu PROPN dpc-3474 259 28 ta ta PROPN dpc-3474 259 29 ne ne PROPN dpc-3474 259 30 ou ou X dpc-3474 259 31 s s PROPN dpc-3474 259 32 ( ( PUNCT dpc-3474 259 33 1 1 NUM dpc-3474 259 34 ) ) PUNCT dpc-3474 259 35 , , PUNCT dpc-3474 259 36 bo bo PROPN dpc-3474 259 37 ne ne PROPN dpc-3474 259 38 ( ( PUNCT dpc-3474 259 39 1 1 NUM dpc-3474 259 40 ) ) PUNCT dpc-3474 259 41 , , PUNCT dpc-3474 259 42 an an DET dpc-3474 259 43 d d X dpc-3474 259 44 sy sy PROPN dpc-3474 259 45 nc nc PROPN dpc-3474 259 46 hr hr PROPN dpc-3474 259 47 on on ADP dpc-3474 259 48 ou ou PROPN dpc-3474 259 49 s s PART dpc-3474 259 50 m m VERB dpc-3474 259 51 et et NOUN dpc-3474 259 52 as as ADP dpc-3474 259 53 ta ta PROPN dpc-3474 259 54 se se PROPN dpc-3474 259 55 s s VERB dpc-3474 259 56 to to PART dpc-3474 259 57 m m PROPN dpc-3474 259 58 ul ul INTJ dpc-3474 259 59 ti ti X dpc-3474 259 60 pl pl X dpc-3474 259 61 e e X dpc-3474 259 62 si si X dpc-3474 259 63 te te PROPN dpc-3474 259 64 s s X dpc-3474 259 65 ( ( PUNCT dpc-3474 259 66 6 6 NUM dpc-3474 259 67 ) ) PUNCT dpc-3474 259 68 b b NOUN dpc-3474 259 69 er er INTJ dpc-3474 259 70 ge ge PROPN dpc-3474 259 71 r r PROPN dpc-3474 259 72 a a DET dpc-3474 259 73 c c NOUN dpc-3474 259 74 , , PUNCT dpc-3474 259 75 e e PROPN dpc-3474 259 76 t t PROPN dpc-3474 259 77 al al PROPN dpc-3474 259 78 . . PUNCT dpc-3474 260 1 ii ii PROPN dpc-3474 261 1 a a DET dpc-3474 261 2 ( ( PUNCT dpc-3474 261 3 57 57 NUM dpc-3474 261 4 % % NOUN dpc-3474 261 5 ) ) PUNCT dpc-3474 261 6 ii ii PROPN dpc-3474 261 7 b b PROPN dpc-3474 261 8 ( ( PUNCT dpc-3474 261 9 57 57 NUM dpc-3474 261 10 % % NOUN dpc-3474 261 11 ) ) PUNCT dpc-3474 261 12 ii ii PROPN dpc-3474 261 13 c c NOUN dpc-3474 261 14 ( ( PUNCT dpc-3474 261 15 40 40 NUM dpc-3474 261 16 % % NOUN dpc-3474 261 17 ) ) PUNCT dpc-3474 261 18 at at ADP dpc-3474 261 19 5 5 NUM dpc-3474 261 20 y y SYM dpc-3474 261 21 ea ea NOUN dpc-3474 261 22 rs rs X dpc-3474 261 23 l l NOUN dpc-3474 261 24 ee ee ADP dpc-3474 261 25 a a DET dpc-3474 261 26 y y PROPN dpc-3474 261 27 , , PUNCT dpc-3474 261 28 e e PROPN dpc-3474 261 29 t t PROPN dpc-3474 261 30 al al PROPN dpc-3474 261 31 . . PUNCT dpc-3474 261 32 st st PROPN dpc-3474 261 33 ag ag PROPN dpc-3474 261 34 e e PROPN dpc-3474 261 35 ii ii PROPN dpc-3474 261 36 a a PRON dpc-3474 261 37 ( ( PUNCT dpc-3474 261 38 87 87 NUM dpc-3474 261 39 % % NOUN dpc-3474 261 40 ) ) PUNCT dpc-3474 261 41 st st PROPN dpc-3474 261 42 ag ag PROPN dpc-3474 261 43 e e PROPN dpc-3474 261 44 ii ii PROPN dpc-3474 261 45 b b PROPN dpc-3474 261 46 ( ( PUNCT dpc-3474 261 47 78 78 NUM dpc-3474 261 48 % % NOUN dpc-3474 261 49 ) ) PUNCT dpc-3474 261 50 st st PROPN dpc-3474 261 51 ag ag PROPN dpc-3474 261 52 e e PROPN dpc-3474 261 53 ii ii PROPN dpc-3474 261 54 c c PROPN dpc-3474 261 55 ( ( PUNCT dpc-3474 261 56 69 69 NUM dpc-3474 261 57 % % NOUN dpc-3474 261 58 ) ) PUNCT dpc-3474 262 1 l l NOUN dpc-3474 262 2 un un PROPN dpc-3474 262 3 g g PROPN dpc-3474 262 4 w w PROPN dpc-3474 262 5 as as ADP dpc-3474 262 6 t t PROPN dpc-3474 262 7 he he PRON dpc-3474 262 8 m m VERB dpc-3474 262 9 os os VERB dpc-3474 263 1 t t INTJ dpc-3474 263 2 fr fr INTJ dpc-3474 264 1 eq eq PROPN dpc-3474 264 2 ue ue PROPN dpc-3474 265 1 nt not PART dpc-3474 265 2 s s VERB dpc-3474 265 3 it it PRON dpc-3474 265 4 e e PROPN dpc-3474 265 5 of of ADP dpc-3474 265 6 s s PRON dpc-3474 265 7 ys ys NOUN dpc-3474 265 8 te te PROPN dpc-3474 265 9 m m NOUN dpc-3474 266 1 ic ic PROPN dpc-3474 267 1 r r PROPN dpc-3474 267 2 el el PROPN dpc-3474 267 3 ap ap PROPN dpc-3474 267 4 se se PROPN dpc-3474 267 5 in in ADP dpc-3474 267 6 a a DET dpc-3474 267 7 ll ll NOUN dpc-3474 267 8 su su NOUN dpc-3474 267 9 bs bs NOUN dpc-3474 267 10 ta ta ADP dpc-3474 267 11 ge ge PROPN dpc-3474 267 12 s s PROPN dpc-3474 267 13 ( ( PUNCT dpc-3474 267 14 n n NOUN dpc-3474 267 15 = = SYM dpc-3474 267 16 1 1 NUM dpc-3474 267 17 1 1 NUM dpc-3474 267 18 , , PUNCT dpc-3474 267 19 1 1 NUM dpc-3474 267 20 1 1 NUM dpc-3474 267 21 , , PUNCT dpc-3474 267 22 a a DET dpc-3474 267 23 nd nd NOUN dpc-3474 267 24 1 1 NUM dpc-3474 267 25 3 3 NUM dpc-3474 267 26 fo fo ADP dpc-3474 267 27 r r PROPN dpc-3474 267 28 st st PROPN dpc-3474 267 29 ag ag PROPN dpc-3474 267 30 e e PROPN dpc-3474 267 31 ii ii PROPN dpc-3474 267 32 a a PRON dpc-3474 267 33 , , PUNCT dpc-3474 267 34 i i PRON dpc-3474 267 35 ib ib VERB dpc-3474 267 36 , , PUNCT dpc-3474 267 37 an an DET dpc-3474 267 38 d d X dpc-3474 267 39 ii ii NOUN dpc-3474 267 40 c c NOUN dpc-3474 267 41 , , PUNCT dpc-3474 268 1 r r NOUN dpc-3474 268 2 es es X dpc-3474 268 3 pe pe INTJ dpc-3474 268 4 ct ct NUM dpc-3474 268 5 iv iv NUM dpc-3474 268 6 el el PROPN dpc-3474 268 7 y y PROPN dpc-3474 268 8 ) ) PUNCT dpc-3474 268 9 . . PUNCT dpc-3474 269 1 t t PROPN dpc-3474 269 2 he he PRON dpc-3474 269 3 s s VERB dpc-3474 269 4 ec ec PROPN dpc-3474 269 5 on on ADP dpc-3474 269 6 d d PROPN dpc-3474 269 7 m m VERB dpc-3474 269 8 os os NOUN dpc-3474 270 1 t t INTJ dpc-3474 271 1 fr fr INTJ dpc-3474 271 2 eq eq PROPN dpc-3474 271 3 ue ue PROPN dpc-3474 272 1 nt not PART dpc-3474 272 2 s s VERB dpc-3474 272 3 it it PRON dpc-3474 272 4 e e NOUN dpc-3474 272 5 w w NOUN dpc-3474 272 6 as as ADP dpc-3474 272 7 b b PROPN dpc-3474 272 8 ra ra PROPN dpc-3474 272 9 in in ADP dpc-3474 272 10 f f PROPN dpc-3474 272 11 or or CCONJ dpc-3474 272 12 i i PRON dpc-3474 272 13 ia ia PROPN dpc-3474 272 14 ( ( PUNCT dpc-3474 272 15 n n NOUN dpc-3474 272 16 = = SYM dpc-3474 272 17 9 9 NUM dpc-3474 272 18 ) ) PUNCT dpc-3474 272 19 an an DET dpc-3474 272 20 d d X dpc-3474 272 21 ii ii PROPN dpc-3474 272 22 c c NOUN dpc-3474 272 23 ( ( PUNCT dpc-3474 272 24 n n NOUN dpc-3474 272 25 = = SYM dpc-3474 272 26 5 5 NUM dpc-3474 272 27 ) ) PUNCT dpc-3474 272 28 , , PUNCT dpc-3474 272 29 a a DET dpc-3474 272 30 nd nd NOUN dpc-3474 272 31 li li PROPN dpc-3474 272 32 ve ve PROPN dpc-3474 272 33 r r NOUN dpc-3474 272 34 fo fo ADP dpc-3474 272 35 r r NOUN dpc-3474 272 36 ii ii PROPN dpc-3474 272 37 b b PROPN dpc-3474 272 38 ( ( PUNCT dpc-3474 272 39 n n NOUN dpc-3474 272 40 = = NUM dpc-3474 272 41 4 4 NUM dpc-3474 272 42 ) ) PUNCT dpc-3474 272 43 . . PUNCT dpc-3474 273 1 t t PROPN dpc-3474 273 2 hr hr NOUN dpc-3474 273 3 ee ee INTJ dpc-3474 274 1 i i PROPN dpc-3474 274 2 ia ia VERB dpc-3474 274 3 p p NOUN dpc-3474 274 4 at at ADP dpc-3474 274 5 ie ie PROPN dpc-3474 274 6 nt not PART dpc-3474 274 7 s s X dpc-3474 275 1 ha ha INTJ dpc-3474 275 2 d d X dpc-3474 275 3 a a DET dpc-3474 275 4 ra ra PROPN dpc-3474 275 5 re re ADP dpc-3474 275 6 s s NOUN dpc-3474 275 7 it it PRON dpc-3474 275 8 e e PROPN dpc-3474 275 9 of of ADP dpc-3474 275 10 d d PROPN dpc-3474 275 11 is be AUX dpc-3474 275 12 ta ta ADP dpc-3474 275 13 nt not PART dpc-3474 275 14 m m ADV dpc-3474 275 15 et et NOUN dpc-3474 275 16 as as ADP dpc-3474 275 17 ta ta ADP dpc-3474 275 18 si si PROPN dpc-3474 275 19 s s PROPN dpc-3474 275 20 — — PUNCT dpc-3474 275 21 t t PROPN dpc-3474 275 22 w w NOUN dpc-3474 275 23 o o NOUN dpc-3474 275 24 to to ADP dpc-3474 275 25 t t NOUN dpc-3474 276 1 he he PRON dpc-3474 276 2 la la PROPN dpc-3474 276 3 ry ry PROPN dpc-3474 276 4 nx nx PROPN dpc-3474 276 5 , , PUNCT dpc-3474 276 6 a a DET dpc-3474 276 7 nd nd NOUN dpc-3474 276 8 o o PROPN dpc-3474 276 9 ne ne PROPN dpc-3474 276 10 t t PROPN dpc-3474 276 11 o o X dpc-3474 276 12 th th X dpc-3474 276 13 e e X dpc-3474 276 14 he he PRON dpc-3474 276 15 ar ar VERB dpc-3474 276 16 t. t. PROPN dpc-3474 276 17 n n PART dpc-3474 276 18 am be AUX dpc-3474 276 19 in in ADP dpc-3474 276 20 a a DET dpc-3474 276 21 w w NOUN dpc-3474 276 22 , , PUNCT dpc-3474 276 23 e e PROPN dpc-3474 276 24 t t PROPN dpc-3474 276 25 al al PROPN dpc-3474 276 26 . . PUNCT dpc-3474 277 1 92 92 NUM dpc-3474 277 2 % % NOUN dpc-3474 277 3 . . PUNCT dpc-3474 278 1 13 13 NUM dpc-3474 278 2 5 5 NUM dpc-3474 278 3 85 85 NUM dpc-3474 278 4 l l NOUN dpc-3474 278 5 ee ee X dpc-3474 278 6 ne ne PROPN dpc-3474 278 7 m m PROPN dpc-3474 278 8 an an DET dpc-3474 278 9 b b NOUN dpc-3474 278 10 , , PUNCT dpc-3474 278 11 e e PROPN dpc-3474 278 12 t t PROPN dpc-3474 278 13 al al PROPN dpc-3474 278 14 . . PUNCT dpc-3474 279 1 st st PROPN dpc-3474 279 2 ag ag PROPN dpc-3474 279 3 e e PROPN dpc-3474 279 4 ib ib NOUN dpc-3474 279 5 1 1 NUM dpc-3474 279 6 .9 .9 NUM dpc-3474 279 7 y y PROPN dpc-3474 279 8 ea ea PROPN dpc-3474 279 9 rs rs X dpc-3474 279 10 ( ( PUNCT dpc-3474 279 11 9 9 NUM dpc-3474 279 12 5 5 NUM dpc-3474 279 13 % % NOUN dpc-3474 279 14 c c NOUN dpc-3474 280 1 i i PRON dpc-3474 280 2 : : PUNCT dpc-3474 280 3 0 0 NUM dpc-3474 280 4 .8 .8 NUM dpc-3474 280 5 -3 -3 PUNCT dpc-3474 280 6 .2 .2 NUM dpc-3474 280 7 ) ) PUNCT dpc-3474 280 8 st st PROPN dpc-3474 280 9 ag ag PROPN dpc-3474 280 10 e e PROPN dpc-3474 280 11 ii ii PROPN dpc-3474 280 12 1 1 NUM dpc-3474 280 13 .5 .5 NUM dpc-3474 280 14 y y PROPN dpc-3474 280 15 ea ea PROPN dpc-3474 280 16 rs rs X dpc-3474 280 17 ( ( PUNCT dpc-3474 280 18 9 9 NUM dpc-3474 280 19 5 5 NUM dpc-3474 280 20 % % NOUN dpc-3474 280 21 c c NOUN dpc-3474 281 1 i i PRON dpc-3474 281 2 : : PUNCT dpc-3474 281 3 1 1 NUM dpc-3474 281 4 .1 .1 NUM dpc-3474 281 5 -2 -2 INTJ dpc-3474 281 6 .1 .1 NUM dpc-3474 281 7 ) ) PUNCT dpc-3474 281 8 st st PROPN dpc-3474 281 9 ag ag PROPN dpc-3474 281 10 e e PROPN dpc-3474 281 11 ii ii PROPN dpc-3474 281 12 i i PRON dpc-3474 281 13 1 1 NUM dpc-3474 281 14 . . NOUN dpc-3474 281 15 1 1 NUM dpc-3474 281 16 ye ye NUM dpc-3474 281 17 ar ar PROPN dpc-3474 281 18 s s PART dpc-3474 281 19 ( ( PUNCT dpc-3474 281 20 9 9 NUM dpc-3474 281 21 5 5 NUM dpc-3474 281 22 % % NOUN dpc-3474 281 23 c c NOUN dpc-3474 282 1 i i PRON dpc-3474 282 2 : : PUNCT dpc-3474 282 3 0 0 NUM dpc-3474 283 1 .6 .6 NUM dpc-3474 283 2 -2 -2 NOUN dpc-3474 283 3 .2 .2 NUM dpc-3474 283 4 ) ) PUNCT dpc-3474 283 5 . . PUNCT dpc-3474 284 1 st st PROPN dpc-3474 284 2 ag ag PROPN dpc-3474 284 3 e e PROPN dpc-3474 284 4 ib ib X dpc-3474 284 5 ( ( PUNCT dpc-3474 284 6 41 41 NUM dpc-3474 284 7 % % NOUN dpc-3474 284 8 ) ) PUNCT dpc-3474 284 9 st st PROPN dpc-3474 284 10 ag ag PROPN dpc-3474 284 11 e e PROPN dpc-3474 284 12 ii ii PROPN dpc-3474 284 13 ( ( PUNCT dpc-3474 284 14 4 4 NUM dpc-3474 284 15 2 2 NUM dpc-3474 284 16 % % NOUN dpc-3474 284 17 ) ) PUNCT dpc-3474 284 18 st st PROPN dpc-3474 284 19 ag ag PROPN dpc-3474 284 20 e e PROPN dpc-3474 284 21 ii ii PROPN dpc-3474 284 22 i i PRON dpc-3474 284 23 ( ( PUNCT dpc-3474 284 24 4 4 NUM dpc-3474 284 25 3 3 NUM dpc-3474 284 26 % % NOUN dpc-3474 284 27 ) ) PUNCT dpc-3474 284 28 at at ADP dpc-3474 284 29 2 2 NUM dpc-3474 284 30 y y PROPN dpc-3474 284 31 ea ea X dpc-3474 284 32 rs rs NOUN dpc-3474 284 33 review review NOUN dpc-3474 284 34 | | ADV dpc-3474 284 35 dermatol dermatol ADJ dpc-3474 284 36 pract pract NOUN dpc-3474 284 37 concept concept NOUN dpc-3474 284 38 . . PUNCT dpc-3474 285 1 2023;13(4):e2023304 2023;13(4):e2023304 NUM dpc-3474 285 2 7 7 NUM dpc-3474 285 3 t t NOUN dpc-3474 285 4 ho ho PROPN dpc-3474 285 5 m m PROPN dpc-3474 285 6 as as ADP dpc-3474 285 7 d d PROPN dpc-3474 285 8 c c NOUN dpc-3474 285 9 , , PUNCT dpc-3474 285 10 e e PROPN dpc-3474 285 11 t t PROPN dpc-3474 285 12 al al PROPN dpc-3474 285 13 . . PUNCT dpc-3474 286 1 86 86 NUM dpc-3474 286 2 .9 .9 NUM dpc-3474 286 3 % % NOUN dpc-3474 286 4 . . PUNCT dpc-3474 287 1 b b X dpc-3474 287 2 ar ar PROPN dpc-3474 287 3 tl tl PROPN dpc-3474 287 4 et et NOUN dpc-3474 287 5 t t PROPN dpc-3474 287 6 e e PROPN dpc-3474 287 7 k k PROPN dpc-3474 287 8 , , PUNCT dpc-3474 287 9 e e PROPN dpc-3474 287 10 t t PROPN dpc-3474 287 11 al al PROPN dpc-3474 287 12 . . PUNCT dpc-3474 288 1 b b X dpc-3474 288 2 le le PUNCT dpc-3474 288 3 ic ic INTJ dpc-3474 288 4 he he PRON dpc-3474 288 5 r r PROPN dpc-3474 288 6 j j PROPN dpc-3474 288 7 , , PUNCT dpc-3474 288 8 e e PROPN dpc-3474 288 9 t t PROPN dpc-3474 288 10 al al PROPN dpc-3474 288 11 . . PUNCT dpc-3474 289 1 st st PROPN dpc-3474 289 2 ag ag PROPN dpc-3474 289 3 e e PROPN dpc-3474 289 4 ii ii PROPN dpc-3474 289 5 a a PRON dpc-3474 289 6 ( ( PUNCT dpc-3474 289 7 82 82 NUM dpc-3474 289 8 .6 .6 NUM dpc-3474 289 9 % % NOUN dpc-3474 289 10 ) ) PUNCT dpc-3474 289 11 st st PROPN dpc-3474 289 12 ag ag PROPN dpc-3474 289 13 e e PROPN dpc-3474 289 14 ii ii PROPN dpc-3474 289 15 b b PROPN dpc-3474 289 16 ( ( PUNCT dpc-3474 289 17 71 71 NUM dpc-3474 289 18 .5 .5 NUM dpc-3474 289 19 ) ) PUNCT dpc-3474 289 20 st st PROPN dpc-3474 289 21 ag ag PROPN dpc-3474 289 22 e e PROPN dpc-3474 289 23 ii ii PROPN dpc-3474 289 24 c c X dpc-3474 289 25 ( ( PUNCT dpc-3474 289 26 6 6 NUM dpc-3474 289 27 0 0 NUM dpc-3474 289 28 . . PUNCT dpc-3474 289 29 3 3 NUM dpc-3474 289 30 % % NOUN dpc-3474 289 31 ) ) PUNCT dpc-3474 290 1 d d NOUN dpc-3474 290 2 is be AUX dpc-3474 290 3 ta ta PART dpc-3474 290 4 nt not PART dpc-3474 290 5 r r PROPN dpc-3474 290 6 ec ec PROPN dpc-3474 290 7 ur ur INTJ dpc-3474 290 8 re re VERB dpc-3474 290 9 nc nc PROPN dpc-3474 290 10 e e PROPN dpc-3474 290 11 , , PUNCT dpc-3474 290 12 2 2 NUM dpc-3474 290 13 9 9 NUM dpc-3474 290 14 ( ( PUNCT dpc-3474 290 15 3 3 NUM dpc-3474 290 16 6 6 NUM dpc-3474 290 17 . . PUNCT dpc-3474 290 18 3 3 NUM dpc-3474 290 19 % % NOUN dpc-3474 290 20 ) ) PUNCT dpc-3474 291 1 pa pa PROPN dpc-3474 291 2 ti ti PROPN dpc-3474 291 3 en en X dpc-3474 291 4 ts ts ADP dpc-3474 291 5 h h PROPN dpc-3474 291 6 ad ad NOUN dpc-3474 291 7 p p X dpc-3474 291 8 ul ul INTJ dpc-3474 291 9 m m VERB dpc-3474 291 10 on on ADP dpc-3474 291 11 ar ar PROPN dpc-3474 291 12 y y PROPN dpc-3474 291 13 m m PROPN dpc-3474 291 14 et et NOUN dpc-3474 291 15 as as ADP dpc-3474 291 16 ta ta PROPN dpc-3474 291 17 se se PROPN dpc-3474 291 18 s s PROPN dpc-3474 291 19 , , PUNCT dpc-3474 291 20 17 17 NUM dpc-3474 291 21 ( ( PUNCT dpc-3474 291 22 21 21 NUM dpc-3474 291 23 .3 .3 NUM dpc-3474 291 24 % % NOUN dpc-3474 291 25 ) ) PUNCT dpc-3474 292 1 ha ha INTJ dpc-3474 293 1 d d X dpc-3474 293 2 br br INTJ dpc-3474 293 3 ai ai VERB dpc-3474 293 4 n n ADV dpc-3474 293 5 m m VERB dpc-3474 293 6 et et NOUN dpc-3474 293 7 as as ADP dpc-3474 293 8 ta ta PROPN dpc-3474 293 9 se se PROPN dpc-3474 293 10 s s PROPN dpc-3474 293 11 , , PUNCT dpc-3474 293 12 9 9 NUM dpc-3474 293 13 ( ( PUNCT dpc-3474 293 14 11 11 NUM dpc-3474 293 15 .3 .3 NUM dpc-3474 293 16 % % NOUN dpc-3474 293 17 ) ) PUNCT dpc-3474 294 1 ha ha INTJ dpc-3474 295 1 d d X dpc-3474 295 2 in in ADP dpc-3474 295 3 tr tr NOUN dpc-3474 295 4 aa aa NOUN dpc-3474 295 5 bd bd PROPN dpc-3474 295 6 om om PROPN dpc-3474 295 7 in in ADP dpc-3474 295 8 al al PROPN dpc-3474 295 9 m m PROPN dpc-3474 295 10 et et NOUN dpc-3474 295 11 as as ADP dpc-3474 295 12 ta ta PROPN dpc-3474 295 13 se se PROPN dpc-3474 295 14 s s PROPN dpc-3474 295 15 , , PUNCT dpc-3474 295 16 6 6 NUM dpc-3474 295 17 ( ( PUNCT dpc-3474 295 18 7 7 NUM dpc-3474 295 19 . . NOUN dpc-3474 295 20 5 5 NUM dpc-3474 295 21 % % NOUN dpc-3474 295 22 ) ) PUNCT dpc-3474 295 23 ha ha INTJ dpc-3474 296 1 d d X dpc-3474 296 2 bo bo PROPN dpc-3474 296 3 ne ne PROPN dpc-3474 296 4 m m PROPN dpc-3474 296 5 et et NOUN dpc-3474 296 6 as as ADP dpc-3474 296 7 ta ta PROPN dpc-3474 296 8 se se PROPN dpc-3474 296 9 s s PROPN dpc-3474 296 10 , , PUNCT dpc-3474 296 11 7 7 NUM dpc-3474 296 12 ( ( PUNCT dpc-3474 296 13 8 8 NUM dpc-3474 296 14 . . NOUN dpc-3474 296 15 8 8 NUM dpc-3474 296 16 % % NOUN dpc-3474 296 17 ) ) PUNCT dpc-3474 297 1 ha ha INTJ dpc-3474 298 1 d d X dpc-3474 298 2 m m VERB dpc-3474 298 3 ul ul INTJ dpc-3474 298 4 ti ti X dpc-3474 298 5 pl pl X dpc-3474 298 6 e e X dpc-3474 298 7 si si X dpc-3474 298 8 te te PROPN dpc-3474 298 9 s s X dpc-3474 298 10 of of ADP dpc-3474 298 11 p p PROPN dpc-3474 298 12 ri ri PROPN dpc-3474 298 13 m m PROPN dpc-3474 298 14 ar ar PROPN dpc-3474 298 15 y y PROPN dpc-3474 298 16 re re PROPN dpc-3474 298 17 cu cu PROPN dpc-3474 298 18 rr rr PROPN dpc-3474 298 19 en en PROPN dpc-3474 298 20 ce ce PROPN dpc-3474 298 21 , , PUNCT dpc-3474 298 22 an an DET dpc-3474 298 23 d d NOUN dpc-3474 298 24 12 12 NUM dpc-3474 298 25 ( ( PUNCT dpc-3474 298 26 15 15 NUM dpc-3474 298 27 .0 .0 NUM dpc-3474 298 28 % % NOUN dpc-3474 298 29 ) ) PUNCT dpc-3474 299 1 ha ha INTJ dpc-3474 299 2 d d X dpc-3474 299 3 di di PROPN dpc-3474 299 4 st st PROPN dpc-3474 300 1 an an DET dpc-3474 300 2 t t PROPN dpc-3474 300 3 m m NOUN dpc-3474 300 4 et et NOUN dpc-3474 300 5 as as ADP dpc-3474 300 6 ta ta AUX dpc-3474 300 7 si si PROPN dpc-3474 300 8 s s X dpc-3474 300 9 at at ADP dpc-3474 300 10 a a DET dpc-3474 300 11 no no INTJ dpc-3474 300 12 th th INTJ dpc-3474 300 13 er er INTJ dpc-3474 300 14 lo lo NOUN dpc-3474 300 15 ca ca AUX dpc-3474 300 16 ti ti VERB dpc-3474 300 17 on on ADP dpc-3474 300 18 . . PUNCT dpc-3474 301 1 o o INTJ dpc-3474 301 2 h h NOUN dpc-3474 301 3 y y PROPN dpc-3474 301 4 , , PUNCT dpc-3474 301 5 e e PROPN dpc-3474 301 6 t t PROPN dpc-3474 301 7 al al PROPN dpc-3474 301 8 . . PUNCT dpc-3474 302 1 t t PROPN dpc-3474 302 2 he he PRON dpc-3474 302 3 m m VERB dpc-3474 302 4 os os PROPN dpc-3474 302 5 t t X dpc-3474 302 6 co co NOUN dpc-3474 302 7 m m VERB dpc-3474 302 8 m m VERB dpc-3474 302 9 on on ADP dpc-3474 302 10 s s PRON dpc-3474 302 11 it it PRON dpc-3474 302 12 e e PROPN dpc-3474 302 13 of of ADP dpc-3474 302 14 d d PROPN dpc-3474 302 15 is be AUX dpc-3474 302 16 ta ta ADP dpc-3474 302 17 nt not PART dpc-3474 302 18 m m ADV dpc-3474 302 19 et et NOUN dpc-3474 302 20 as as ADP dpc-3474 302 21 ta ta X dpc-3474 302 22 si si PROPN dpc-3474 302 23 s s PROPN dpc-3474 302 24 w w PROPN dpc-3474 302 25 as as ADP dpc-3474 302 26 t t PROPN dpc-3474 302 27 he he PRON dpc-3474 303 1 lu lu PROPN dpc-3474 303 2 ng ng PROPN dpc-3474 303 3 , , PUNCT dpc-3474 303 4 a a DET dpc-3474 303 5 nd nd NOUN dpc-3474 303 6 t t NOUN dpc-3474 304 1 he he PRON dpc-3474 304 2 m m VERB dpc-3474 304 3 ed ed PROPN dpc-3474 304 4 ia ia PROPN dpc-3474 304 5 n n PROPN dpc-3474 304 6 la la X dpc-3474 304 7 te te PROPN dpc-3474 304 8 nc nc PROPN dpc-3474 304 9 y y PROPN dpc-3474 304 10 of of ADP dpc-3474 304 11 lu lu PROPN dpc-3474 304 12 ng ng PROPN dpc-3474 304 13 m m VERB dpc-3474 304 14 et et NOUN dpc-3474 304 15 as as ADP dpc-3474 304 16 ta ta X dpc-3474 304 17 si si PROPN dpc-3474 304 18 s s PROPN dpc-3474 304 19 w w NOUN dpc-3474 304 20 as as ADP dpc-3474 304 21 1 1 NUM dpc-3474 304 22 9 9 NUM dpc-3474 304 23 . . NOUN dpc-3474 304 24 7 7 NUM dpc-3474 304 25 m m NOUN dpc-3474 304 26 on on ADP dpc-3474 304 27 th th NUM dpc-3474 304 28 s. s. PROPN dpc-3474 304 29 e e PROPN dpc-3474 304 30 gg gg PROPN dpc-3474 304 31 er er INTJ dpc-3474 304 32 m m VERB dpc-3474 304 33 on on ADP dpc-3474 304 34 t t PROPN dpc-3474 304 35 m m PROPN dpc-3474 304 36 , , PUNCT dpc-3474 304 37 et et PROPN dpc-3474 304 38 a a DET dpc-3474 304 39 l. l. PROPN dpc-3474 304 40 st st PROPN dpc-3474 304 41 ag ag PROPN dpc-3474 304 42 e e PROPN dpc-3474 304 43 ii ii PROPN dpc-3474 305 1 i i PRON dpc-3474 305 2 a a DET dpc-3474 305 3 6 6 NUM dpc-3474 305 4 2 2 NUM dpc-3474 305 5 ( ( PUNCT dpc-3474 305 6 g g PROPN dpc-3474 305 7 ro ro X dpc-3474 305 8 up up ADV dpc-3474 305 9     SPACE dpc-3474 305 10 1 1 NUM dpc-3474 305 11 ) ) PUNCT dpc-3474 305 12 54 54 NUM dpc-3474 305 13 ( ( PUNCT dpc-3474 305 14 g g NOUN dpc-3474 305 15 ro ro X dpc-3474 305 16 up up ADP dpc-3474 305 17 2 2 NUM dpc-3474 305 18 ) ) PUNCT dpc-3474 305 19 . . PUNCT dpc-3474 306 1 st st PROPN dpc-3474 306 2 ag ag PROPN dpc-3474 306 3 e e PROPN dpc-3474 306 4 ii ii PROPN dpc-3474 307 1 i i NOUN dpc-3474 307 2 b b PROPN dpc-3474 307 3 1 1 NUM dpc-3474 307 4 64 64 NUM dpc-3474 307 5 ( ( PUNCT dpc-3474 307 6 gr gr ADP dpc-3474 307 7 ou ou ADP dpc-3474 307 8 p p NOUN dpc-3474 307 9 1 1 NUM dpc-3474 307 10 ) ) PUNCT dpc-3474 307 11 12 12 NUM dpc-3474 307 12 3 3 NUM dpc-3474 307 13     SPACE dpc-3474 307 14 ( ( PUNCT dpc-3474 307 15 g g PROPN dpc-3474 307 16 ro ro X dpc-3474 307 17 up up ADP dpc-3474 307 18 2 2 NUM dpc-3474 307 19 ) ) PUNCT dpc-3474 307 20 st st PROPN dpc-3474 307 21 ag ag PROPN dpc-3474 307 22 e e PROPN dpc-3474 307 23 ii ii PROPN dpc-3474 308 1 i i PRON dpc-3474 308 2 c c NOUN dpc-3474 308 3 1 1 NUM dpc-3474 308 4 15 15 NUM dpc-3474 308 5 ( ( PUNCT dpc-3474 308 6 gr gr ADV dpc-3474 308 7 ou ou ADP dpc-3474 308 8 p p NOUN dpc-3474 308 9 1 1 NUM dpc-3474 308 10 ) ) PUNCT dpc-3474 308 11 83 83 NUM dpc-3474 308 12     SPACE dpc-3474 308 13 ( ( PUNCT dpc-3474 308 14 gr gr ADV dpc-3474 308 15 ou ou ADP dpc-3474 308 16 p p ADJ dpc-3474 308 17 2 2 NUM dpc-3474 308 18 ) ) PUNCT dpc-3474 308 19 st st PROPN dpc-3474 308 20 ag ag PROPN dpc-3474 308 21 e e PROPN dpc-3474 308 22 ii ii PROPN dpc-3474 308 23 ia ia PROPN dpc-3474 308 24 : : PUNCT dpc-3474 308 25 8 8 NUM dpc-3474 308 26 0 0 NUM dpc-3474 308 27 . . NOUN dpc-3474 308 28 8 8 NUM dpc-3474 308 29 % % NOUN dpc-3474 308 30 ( ( PUNCT dpc-3474 308 31 9 9 NUM dpc-3474 308 32 5 5 NUM dpc-3474 308 33 % % NOUN dpc-3474 308 34 c c NOUN dpc-3474 309 1 i i PRON dpc-3474 309 2 69 69 NUM dpc-3474 309 3 .7 .7 NUM dpc-3474 309 4 – – PUNCT dpc-3474 309 5 8 8 NUM dpc-3474 309 6 8 8 NUM dpc-3474 309 7 . . NOUN dpc-3474 309 8 2 2 NUM dpc-3474 309 9 ) ) PUNCT dpc-3474 309 10 in in ADP dpc-3474 309 11 g g PROPN dpc-3474 309 12 ro ro NOUN dpc-3474 309 13 up up ADP dpc-3474 309 14 1 1 NUM dpc-3474 309 15 a a DET dpc-3474 309 16 nd nd NOUN dpc-3474 309 17 7 7 NUM dpc-3474 309 18 0 0 NUM dpc-3474 309 19 . . NOUN dpc-3474 309 20 8 8 NUM dpc-3474 309 21 % % NOUN dpc-3474 309 22 ( ( PUNCT dpc-3474 309 23 5 5 NUM dpc-3474 309 24 8 8 NUM dpc-3474 309 25 . . PUNCT dpc-3474 309 26 7 7 NUM dpc-3474 309 27 – – PUNCT dpc-3474 309 28 79 79 NUM dpc-3474 309 29 .9 .9 NUM dpc-3474 309 30 ) ) PUNCT dpc-3474 309 31 in in ADP dpc-3474 309 32 g g PROPN dpc-3474 309 33 ro ro PROPN dpc-3474 309 34 up up ADP dpc-3474 309 35 2 2 NUM dpc-3474 309 36 st st PROPN dpc-3474 309 37 ag ag PROPN dpc-3474 309 38 e e PROPN dpc-3474 309 39 ii ii PROPN dpc-3474 309 40 ib ib PROPN dpc-3474 310 1 d d NOUN dpc-3474 310 2 is be AUX dpc-3474 310 3 ea ea X dpc-3474 310 4 se se X dpc-3474 310 5 , , PUNCT dpc-3474 311 1 68 68 NUM dpc-3474 311 2 .1 .1 NUM dpc-3474 311 3 % % NOUN dpc-3474 311 4 ( ( PUNCT dpc-3474 311 5 61 61 NUM dpc-3474 311 6 .6 .6 NUM dpc-3474 311 7 – – PUNCT dpc-3474 311 8 7 7 NUM dpc-3474 311 9 3 3 NUM dpc-3474 311 10 . . NOUN dpc-3474 311 11 8) 8) NUM dpc-3474 311 12 in in ADP dpc-3474 311 13     SPACE dpc-3474 311 14 g g PROPN dpc-3474 311 15 ro ro X dpc-3474 311 16 up up ADV dpc-3474 311 17 1 1 NUM dpc-3474 311 18     SPACE dpc-3474 311 19 a a DET dpc-3474 311 20 nd nd NOUN dpc-3474 311 21 5 5 NUM dpc-3474 311 22 1 1 NUM dpc-3474 311 23 . . NOUN dpc-3474 311 24 0 0 NUM dpc-3474 311 25 % % NOUN dpc-3474 311 26 ( ( PUNCT dpc-3474 311 27 4 4 NUM dpc-3474 311 28 4 4 NUM dpc-3474 311 29 · · SYM dpc-3474 311 30 2 2 NUM dpc-3474 311 31 – – PUNCT dpc-3474 311 32 57 57 NUM dpc-3474 311 33 · · SYM dpc-3474 311 34 4 4 NUM dpc-3474 311 35 ) ) PUNCT dpc-3474 311 36 in in ADP dpc-3474 311 37 g g PROPN dpc-3474 311 38 ro ro NOUN dpc-3474 311 39 up up ADP dpc-3474 311 40 2 2 NUM dpc-3474 311 41 . . PUNCT dpc-3474 311 42 st st PROPN dpc-3474 311 43 ag ag PROPN dpc-3474 311 44 e e PROPN dpc-3474 311 45 ii ii PROPN dpc-3474 311 46 ic ic PROPN dpc-3474 312 1 d d PROPN dpc-3474 312 2 is be AUX dpc-3474 312 3 ea ea X dpc-3474 312 4 se se X dpc-3474 312 5 5 5 NUM dpc-3474 312 6 5 5 NUM dpc-3474 312 7 , , PUNCT dpc-3474 312 8 8 8 NUM dpc-3474 312 9 % % NOUN dpc-3474 312 10 ( ( PUNCT dpc-3474 312 11 4 4 NUM dpc-3474 312 12 8 8 NUM dpc-3474 312 13 . . NOUN dpc-3474 312 14 1 1 NUM dpc-3474 312 15 – – PUNCT dpc-3474 312 16 62 62 NUM dpc-3474 312 17 .8 .8 NUM dpc-3474 312 18 ) ) PUNCT dpc-3474 312 19 in in ADP dpc-3474 312 20 g g PROPN dpc-3474 312 21 ro ro PROPN dpc-3474 312 22 up up ADP dpc-3474 312 23 1 1 NUM dpc-3474 312 24     SPACE dpc-3474 312 25 an an DET dpc-3474 312 26 d d NOUN dpc-3474 312 27 39 39 NUM dpc-3474 312 28 .2 .2 NUM dpc-3474 312 29 % % NOUN dpc-3474 312 30 ( ( PUNCT dpc-3474 312 31 32 32 NUM dpc-3474 312 32 .2 .2 NUM dpc-3474 312 33 – – PUNCT dpc-3474 312 34 46 46 NUM dpc-3474 312 35 .1 .1 NUM dpc-3474 312 36 ) ) PUNCT dpc-3474 312 37 in in ADP dpc-3474 312 38 t t PROPN dpc-3474 312 39 he he PRON dpc-3474 312 40 g g PROPN dpc-3474 312 41 ro ro X dpc-3474 312 42 up up ADP dpc-3474 312 43 2 2 NUM dpc-3474 312 44 . . PUNCT dpc-3474 313 1 e e X dpc-3474 313 2 rt rt PROPN dpc-3474 313 3 ek ek VERB dpc-3474 313 4 in in ADP dpc-3474 313 5 s s PRON dpc-3474 313 6 , , PUNCT dpc-3474 313 7 e e PROPN dpc-3474 313 8 t t PROPN dpc-3474 313 9 al al PROPN dpc-3474 313 10 . . PUNCT dpc-3474 314 1 l l PROPN dpc-3474 314 2 uk uk PROPN dpc-3474 314 3 e e PROPN dpc-3474 314 4 j j PROPN dpc-3474 314 5 , , PUNCT dpc-3474 314 6 e e PROPN dpc-3474 314 7 t t PROPN dpc-3474 314 8 al al PROPN dpc-3474 314 9 . . PUNCT dpc-3474 315 1 8 8 NUM dpc-3474 315 2 review review NOUN dpc-3474 315 3 | | ADV dpc-3474 315 4 dermatol dermatol ADJ dpc-3474 315 5 pract pract NOUN dpc-3474 315 6 concept concept NOUN dpc-3474 315 7 . . PUNCT dpc-3474 316 1 2023;13(4):e2023304 2023;13(4):e2023304 NUM dpc-3474 316 2 group group NOUN dpc-3474 317 1 [ [ X dpc-3474 317 2 6 6 NUM dpc-3474 317 3 ] ] PUNCT dpc-3474 317 4 . . PUNCT dpc-3474 318 1 also also ADV dpc-3474 318 2 , , PUNCT dpc-3474 318 3 namin namin PROPN dpc-3474 318 4 et et PROPN dpc-3474 318 5 al al PROPN dpc-3474 318 6 study study PROPN dpc-3474 318 7 showed show VERB dpc-3474 318 8 a a DET dpc-3474 318 9 mean mean ADJ dpc-3474 318 10 time time NOUN dpc-3474 318 11 to to PART dpc-3474 318 12 recurrence recurrence NOUN dpc-3474 318 13 of of ADP dpc-3474 318 14 8 8 NUM dpc-3474 318 15 months month NOUN dpc-3474 318 16 in in ADP dpc-3474 318 17 the the DET dpc-3474 318 18 lcit lcit PROPN dpc-3474 318 19 group group NOUN dpc-3474 318 20 , , PUNCT dpc-3474 318 21 13.5 13.5 NUM dpc-3474 318 22 months month NOUN dpc-3474 318 23 in in ADP dpc-3474 318 24 the the DET dpc-3474 318 25 ln ln ADJ dpc-3474 318 26 group group NOUN dpc-3474 318 27 , , PUNCT dpc-3474 318 28 and and CCONJ dpc-3474 318 29 18.3 18.3 NUM dpc-3474 318 30 in in ADP dpc-3474 318 31 the the DET dpc-3474 318 32 systemic systemic ADJ dpc-3474 318 33 recurrence recurrence NOUN dpc-3474 318 34 group group NOUN dpc-3474 318 35 [ [ X dpc-3474 318 36 31 31 NUM dpc-3474 318 37 ] ] PUNCT dpc-3474 318 38 . . PUNCT dpc-3474 319 1 type type NOUN dpc-3474 319 2 and and CCONJ dpc-3474 319 3 site site NOUN dpc-3474 319 4 of of ADP dpc-3474 319 5 recurrence recurrence NOUN dpc-3474 319 6 in in ADP dpc-3474 319 7 all all PRON dpc-3474 319 8 ( ( PUNCT dpc-3474 319 9 without without ADP dpc-3474 319 10 accounting account VERB dpc-3474 319 11 for for ADP dpc-3474 319 12 melanoma melanoma NOUN dpc-3474 319 13 stage stage NOUN dpc-3474 319 14 at at ADP dpc-3474 319 15 diagnosis diagnosis NOUN dpc-3474 319 16 ) ) PUNCT dpc-3474 320 1 , , PUNCT dpc-3474 320 2 the the DET dpc-3474 320 3 most most ADV dpc-3474 320 4 common common ADJ dpc-3474 320 5 melanoma melanoma NOUN dpc-3474 320 6 recurrence recurrence NOUN dpc-3474 320 7 type type NOUN dpc-3474 320 8 was be AUX dpc-3474 320 9 systemic systemic ADJ dpc-3474 320 10 recurrence recurrence NOUN dpc-3474 320 11 in in ADP dpc-3474 320 12 all all DET dpc-3474 320 13 studies study NOUN dpc-3474 320 14 [ [ X dpc-3474 320 15 1,3,17,22,24,29–31 1,3,17,22,24,29–31 NUM dpc-3474 320 16 ] ] PUNCT dpc-3474 320 17 . . PUNCT dpc-3474 321 1 o’connell o’connell INTJ dpc-3474 321 2 et et PROPN dpc-3474 321 3 al al PROPN dpc-3474 321 4 reported report VERB dpc-3474 321 5 that that SCONJ dpc-3474 321 6 40 40 NUM dpc-3474 321 7 % % NOUN dpc-3474 321 8 of of ADP dpc-3474 321 9 melanoma melanoma NOUN dpc-3474 321 10 recurrences recurrence NOUN dpc-3474 321 11 were be AUX dpc-3474 321 12 systemic systemic ADJ dpc-3474 321 13 [ [ X dpc-3474 321 14 3 3 NUM dpc-3474 321 15 ] ] PUNCT dpc-3474 321 16 ; ; PUNCT dpc-3474 321 17 for for ADP dpc-3474 321 18 namin namin PROPN dpc-3474 321 19 et et PROPN dpc-3474 321 20 al al PROPN dpc-3474 321 21 and and CCONJ dpc-3474 321 22 bleicher bleicher PROPN dpc-3474 321 23 et et PROPN dpc-3474 321 24 al al PROPN dpc-3474 321 25 , , PUNCT dpc-3474 321 26 recurrences recurrence NOUN dpc-3474 321 27 were be AUX dpc-3474 321 28 systemic systemic ADJ dpc-3474 321 29 in in ADP dpc-3474 321 30 49 49 NUM dpc-3474 321 31 % % NOUN dpc-3474 321 32 and and CCONJ dpc-3474 321 33 50.6 50.6 NUM dpc-3474 321 34 % % NOUN dpc-3474 321 35 , , PUNCT dpc-3474 321 36 respectively respectively ADV dpc-3474 321 37 . . PUNCT dpc-3474 322 1 in in ADP dpc-3474 322 2 prospective prospective ADJ dpc-3474 322 3 randomized randomized ADJ dpc-3474 322 4 studies study NOUN dpc-3474 322 5 evaluating evaluate VERB dpc-3474 322 6 melanoma melanoma ADJ dpc-3474 322 7 surgical surgical ADJ dpc-3474 322 8 margins margin NOUN dpc-3474 322 9 , , PUNCT dpc-3474 322 10 lcit lcit ADJ dpc-3474 322 11 recurrence recurrence NOUN dpc-3474 322 12 rates rate NOUN dpc-3474 322 13 ( ( PUNCT dpc-3474 322 14 or or CCONJ dpc-3474 322 15 surgical surgical ADJ dpc-3474 322 16 site site NOUN dpc-3474 322 17 recurrence recurrence NOUN dpc-3474 322 18 ) ) PUNCT dpc-3474 322 19 were be AUX dpc-3474 322 20 as as ADV dpc-3474 322 21 low low ADJ dpc-3474 322 22 as as ADP dpc-3474 322 23 2 2 NUM dpc-3474 322 24 - - SYM dpc-3474 322 25 5 5 NUM dpc-3474 322 26 % % NOUN dpc-3474 322 27 , , PUNCT dpc-3474 322 28 despite despite SCONJ dpc-3474 322 29 wide wide ADJ dpc-3474 322 30 or or CCONJ dpc-3474 322 31 narrow narrow ADJ dpc-3474 322 32 surgical surgical ADJ dpc-3474 322 33 margins margin NOUN dpc-3474 322 34 used use VERB dpc-3474 322 35 [ [ PUNCT dpc-3474 322 36 36 36 NUM dpc-3474 322 37 ] ] PUNCT dpc-3474 322 38 . . PUNCT dpc-3474 323 1 overall overall ADJ dpc-3474 323 2 , , PUNCT dpc-3474 323 3 lcit lcit ADJ dpc-3474 323 4 recurrences recurrence NOUN dpc-3474 323 5 are be AUX dpc-3474 323 6 low low ADJ dpc-3474 323 7 compared compare VERB dpc-3474 323 8 to to ADP dpc-3474 323 9 systemic systemic ADJ dpc-3474 323 10 or or CCONJ dpc-3474 323 11 nodal nodal ADJ dpc-3474 323 12 recurrences recurrence NOUN dpc-3474 323 13 . . PUNCT dpc-3474 324 1 when when SCONJ dpc-3474 324 2 systemic systemic ADJ dpc-3474 324 3 recurrence recurrence NOUN dpc-3474 324 4 occurs occur VERB dpc-3474 324 5 , , PUNCT dpc-3474 324 6 the the DET dpc-3474 324 7 most most ADV dpc-3474 324 8 common common ADJ dpc-3474 324 9 site site NOUN dpc-3474 324 10 of of ADP dpc-3474 324 11 distant distant ADJ dpc-3474 324 12 metastasis metastasis NOUN dpc-3474 324 13 was be AUX dpc-3474 324 14 the the DET dpc-3474 324 15 lung lung NOUN dpc-3474 324 16 followed follow VERB dpc-3474 324 17 by by ADP dpc-3474 324 18 the the DET dpc-3474 324 19 brain brain NOUN dpc-3474 324 20 , , PUNCT dpc-3474 324 21 liver liver NOUN dpc-3474 324 22 , , PUNCT dpc-3474 324 23 and and CCONJ dpc-3474 324 24 bone bone NOUN dpc-3474 324 25 [ [ X dpc-3474 324 26 22,24,27,28,31 22,24,27,28,31 NOUN dpc-3474 324 27 ] ] X dpc-3474 324 28 . . PUNCT dpc-3474 325 1 the the DET dpc-3474 325 2 second second ADJ dpc-3474 325 3 most most ADV dpc-3474 325 4 frequent frequent ADJ dpc-3474 325 5 recurrence recurrence NOUN dpc-3474 325 6 site site NOUN dpc-3474 325 7 was be AUX dpc-3474 325 8 lcit lcit ADJ dpc-3474 325 9 [ [ X dpc-3474 325 10 6,32 6,32 NUM dpc-3474 325 11 ] ] X dpc-3474 325 12 . . PUNCT dpc-3474 326 1 this this PRON dpc-3474 326 2 is be AUX dpc-3474 326 3 also also ADV dpc-3474 326 4 in in ADP dpc-3474 326 5 line line NOUN dpc-3474 326 6 with with ADP dpc-3474 326 7 studies study NOUN dpc-3474 326 8 evaluating evaluate VERB dpc-3474 326 9 systemic systemic ADJ dpc-3474 326 10 therapies therapy NOUN dpc-3474 326 11 where where SCONJ dpc-3474 326 12 systemic systemic ADJ dpc-3474 326 13 recurrences recurrence NOUN dpc-3474 326 14 were be AUX dpc-3474 326 15 the the DET dpc-3474 326 16 most most ADV dpc-3474 326 17 frequent frequent ADJ dpc-3474 326 18 [ [ X dpc-3474 326 19 37 37 NUM dpc-3474 326 20 ] ] PUNCT dpc-3474 326 21 . . PUNCT dpc-3474 327 1 in in ADP dpc-3474 327 2 2020 2020 NUM dpc-3474 327 3 , , PUNCT dpc-3474 327 4 the the DET dpc-3474 327 5 checkmate checkmate NOUN dpc-3474 327 6 238 238 NUM dpc-3474 327 7 trial trial NOUN dpc-3474 327 8 concluded conclude VERB dpc-3474 327 9 that that SCONJ dpc-3474 327 10 the the DET dpc-3474 327 11 lung lung NOUN dpc-3474 327 12 , , PUNCT dpc-3474 327 13 liver liver NOUN dpc-3474 327 14 , , PUNCT dpc-3474 327 15 and and CCONJ dpc-3474 327 16 brain brain NOUN dpc-3474 327 17 were be AUX dpc-3474 327 18 the the DET dpc-3474 327 19 most most ADV dpc-3474 327 20 common common ADJ dpc-3474 327 21 sites site NOUN dpc-3474 327 22 of of ADP dpc-3474 327 23 first first ADJ dpc-3474 327 24 distant distant ADJ dpc-3474 327 25 metastasis metastasis NOUN dpc-3474 327 26 ( ( PUNCT dpc-3474 327 27 seen see VERB dpc-3474 327 28 in in ADP dpc-3474 327 29 24 24 NUM dpc-3474 327 30 % % NOUN dpc-3474 327 31 , , PUNCT dpc-3474 327 32 13 13 NUM dpc-3474 327 33 % % NOUN dpc-3474 327 34 , , PUNCT dpc-3474 327 35 and and CCONJ dpc-3474 327 36 10 10 NUM dpc-3474 327 37 % % NOUN dpc-3474 327 38 of of ADP dpc-3474 327 39 patients patient NOUN dpc-3474 327 40 , , PUNCT dpc-3474 327 41 respectively respectively ADV dpc-3474 327 42 ) ) PUNCT dpc-3474 327 43 for for ADP dpc-3474 327 44 patients patient NOUN dpc-3474 327 45 with with ADP dpc-3474 327 46 resected resect VERB dpc-3474 327 47 stage stage NOUN dpc-3474 327 48 iiib iiib NOUN dpc-3474 327 49 - - PUNCT dpc-3474 327 50 c c NOUN dpc-3474 327 51 disease disease NOUN dpc-3474 327 52 [ [ X dpc-3474 327 53 38 38 NUM dpc-3474 327 54 ] ] PUNCT dpc-3474 327 55 . . PUNCT dpc-3474 328 1 when when SCONJ dpc-3474 328 2 evaluating evaluate VERB dpc-3474 328 3 recurrence recurrence NOUN dpc-3474 328 4 based base VERB dpc-3474 328 5 on on ADP dpc-3474 328 6 melanoma melanoma NOUN dpc-3474 328 7 stage stage NOUN dpc-3474 328 8 , , PUNCT dpc-3474 328 9 recurrences recurrence NOUN dpc-3474 328 10 were be AUX dpc-3474 328 11 more more ADV dpc-3474 328 12 likely likely ADJ dpc-3474 328 13 to to PART dpc-3474 328 14 be be AUX dpc-3474 328 15 systemic systemic ADJ dpc-3474 328 16 and and CCONJ dpc-3474 328 17 less less ADV dpc-3474 328 18 likely likely ADJ dpc-3474 328 19 to to PART dpc-3474 328 20 be be AUX dpc-3474 328 21 nodal nodal NOUN dpc-3474 328 22 or or CCONJ dpc-3474 328 23 lcit lcit ADJ dpc-3474 328 24 , , PUNCT dpc-3474 328 25 as as SCONJ dpc-3474 328 26 the the DET dpc-3474 328 27 ajcc ajcc PROPN dpc-3474 328 28 stage stage NOUN dpc-3474 328 29 increases increase VERB dpc-3474 328 30 [ [ X dpc-3474 328 31 39 39 NUM dpc-3474 328 32 ] ] PUNCT dpc-3474 328 33 . . PUNCT dpc-3474 329 1 a a DET dpc-3474 329 2 retrospective retrospective ADJ dpc-3474 329 3 study study NOUN dpc-3474 329 4 of of ADP dpc-3474 329 5 466 466 NUM dpc-3474 329 6 patients patient NOUN dpc-3474 329 7 , , PUNCT dpc-3474 329 8 detected detect VERB dpc-3474 329 9 the the DET dpc-3474 329 10 proportion proportion NOUN dpc-3474 329 11 of of ADP dpc-3474 329 12 recurrences recurrence NOUN dpc-3474 329 13 to to PART dpc-3474 329 14 be be AUX dpc-3474 329 15 systemic systemic ADJ dpc-3474 329 16 in in ADP dpc-3474 329 17 48 48 NUM dpc-3474 329 18 % % NOUN dpc-3474 329 19 of of ADP dpc-3474 329 20 stage stage PROPN dpc-3474 329 21 ii ii PROPN dpc-3474 329 22 , , PUNCT dpc-3474 329 23 68 68 NUM dpc-3474 329 24 % % NOUN dpc-3474 329 25 of of ADP dpc-3474 329 26 stage stage NOUN dpc-3474 329 27 iii iii NOUN dpc-3474 329 28 , , PUNCT dpc-3474 329 29 and and CCONJ dpc-3474 329 30 77 77 NUM dpc-3474 329 31 % % NOUN dpc-3474 329 32 of of ADP dpc-3474 329 33 resected resect VERB dpc-3474 329 34 stage stage NOUN dpc-3474 329 35 iv iv NUM dpc-3474 329 36 patients patient NOUN dpc-3474 329 37 [ [ X dpc-3474 329 38 40 40 NUM dpc-3474 329 39 ] ] PUNCT dpc-3474 329 40 . . PUNCT dpc-3474 330 1 this this DET dpc-3474 330 2 trend trend NOUN dpc-3474 330 3 was be AUX dpc-3474 330 4 also also ADV dpc-3474 330 5 related relate VERB dpc-3474 330 6 to to PART dpc-3474 330 7 substage substage NOUN dpc-3474 330 8 as as SCONJ dpc-3474 330 9 patients patient NOUN dpc-3474 330 10 with with ADP dpc-3474 330 11 stage stage NOUN dpc-3474 330 12 iia iia NOUN dpc-3474 330 13 and and CCONJ dpc-3474 330 14 iic iic PROPN dpc-3474 330 15 had have VERB dpc-3474 330 16 a a DET dpc-3474 330 17 systemic systemic ADJ dpc-3474 330 18 recurrence recurrence NOUN dpc-3474 330 19 rate rate NOUN dpc-3474 330 20 of of ADP dpc-3474 330 21 34 34 NUM dpc-3474 330 22 % % NOUN dpc-3474 330 23 and and CCONJ dpc-3474 330 24 52 52 NUM dpc-3474 330 25 % % NOUN dpc-3474 330 26 , , PUNCT dpc-3474 330 27 respectively respectively ADV dpc-3474 330 28 [ [ X dpc-3474 330 29 40,41 40,41 NOUN dpc-3474 330 30 ] ] X dpc-3474 330 31 . . PUNCT dpc-3474 331 1 a a DET dpc-3474 331 2 study study NOUN dpc-3474 331 3 by by ADP dpc-3474 331 4 romano romano NOUN dpc-3474 331 5 et et PROPN dpc-3474 331 6 al al PROPN dpc-3474 331 7 concluded conclude VERB dpc-3474 331 8 that that SCONJ dpc-3474 331 9 as as SCONJ dpc-3474 331 10 substages substage NOUN dpc-3474 331 11 increased increase VERB dpc-3474 331 12 from from ADP dpc-3474 331 13 iiia iiia NOUN dpc-3474 331 14 to to PART dpc-3474 331 15 iiib iiib VERB dpc-3474 331 16 to to ADP dpc-3474 331 17 iiic iiic PROPN dpc-3474 331 18 , , PUNCT dpc-3474 331 19 the the DET dpc-3474 331 20 proportion proportion NOUN dpc-3474 331 21 of of ADP dpc-3474 331 22 lcit lcit ADJ dpc-3474 331 23 recurrence recurrence NOUN dpc-3474 331 24 as as ADP dpc-3474 331 25 the the DET dpc-3474 331 26 site site NOUN dpc-3474 331 27 of of ADP dpc-3474 331 28 first first ADJ dpc-3474 331 29 relapse relapse NOUN dpc-3474 331 30 progressively progressively ADV dpc-3474 331 31 decreased decrease VERB dpc-3474 331 32 from from ADP dpc-3474 331 33 32 32 NUM dpc-3474 331 34 % % NOUN dpc-3474 331 35 , , PUNCT dpc-3474 331 36 30 30 NUM dpc-3474 331 37 % % NOUN dpc-3474 331 38 , , PUNCT dpc-3474 331 39 and and CCONJ dpc-3474 331 40 22 22 NUM dpc-3474 331 41 % % NOUN dpc-3474 331 42 , , PUNCT dpc-3474 331 43 respectively respectively ADV dpc-3474 331 44 [ [ X dpc-3474 331 45 20 20 NUM dpc-3474 331 46 ] ] PUNCT dpc-3474 331 47 . . PUNCT dpc-3474 332 1 similarly similarly ADV dpc-3474 332 2 , , PUNCT dpc-3474 332 3 the the DET dpc-3474 332 4 proportion proportion NOUN dpc-3474 332 5 of of ADP dpc-3474 332 6 initial initial ADJ dpc-3474 332 7 relapse relapse NOUN dpc-3474 332 8 in in ADP dpc-3474 332 9 lymph lymph NOUN dpc-3474 332 10 nodes node NOUN dpc-3474 332 11 decreased decrease VERB dpc-3474 332 12 ( ( PUNCT dpc-3474 332 13 28 28 NUM dpc-3474 332 14 % % NOUN dpc-3474 332 15 , , PUNCT dpc-3474 332 16 19 19 NUM dpc-3474 332 17 % % NOUN dpc-3474 332 18 , , PUNCT dpc-3474 332 19 and and CCONJ dpc-3474 332 20 17 17 NUM dpc-3474 332 21 % % NOUN dpc-3474 332 22 ) ) PUNCT dpc-3474 332 23 and and CCONJ dpc-3474 332 24 the the DET dpc-3474 332 25 proportion proportion NOUN dpc-3474 332 26 of of ADP dpc-3474 332 27 initial initial ADJ dpc-3474 332 28 relapse relapse NOUN dpc-3474 332 29 as as ADP dpc-3474 332 30 a a DET dpc-3474 332 31 systemic systemic ADJ dpc-3474 332 32 recurrence recurrence NOUN dpc-3474 332 33 increased increase VERB dpc-3474 332 34 as as SCONJ dpc-3474 332 35 substage substage NOUN dpc-3474 332 36 progressed progress VERB dpc-3474 332 37 ( ( PUNCT dpc-3474 332 38 40 40 NUM dpc-3474 332 39 % % NOUN dpc-3474 332 40 , , PUNCT dpc-3474 332 41 51 51 NUM dpc-3474 332 42 % % NOUN dpc-3474 332 43 , , PUNCT dpc-3474 332 44 and and CCONJ dpc-3474 332 45 61 61 NUM dpc-3474 332 46 % % NOUN dpc-3474 332 47 ) ) PUNCT dpc-3474 333 1 [ [ X dpc-3474 333 2 20 20 NUM dpc-3474 333 3 ] ] PUNCT dpc-3474 333 4 . . PUNCT dpc-3474 334 1 leeneman leeneman PROPN dpc-3474 334 2 et et PROPN dpc-3474 334 3 al al PROPN dpc-3474 334 4 , , PUNCT dpc-3474 334 5 however however ADV dpc-3474 334 6 , , PUNCT dpc-3474 334 7 showed show VERB dpc-3474 334 8 that that SCONJ dpc-3474 334 9 lymph lymph NOUN dpc-3474 334 10 nodes node NOUN dpc-3474 334 11 were be AUX dpc-3474 334 12 the the DET dpc-3474 334 13 most most ADV dpc-3474 334 14 frequent frequent ADJ dpc-3474 334 15 site site NOUN dpc-3474 334 16 of of ADP dpc-3474 334 17 recurrence recurrence NOUN dpc-3474 334 18 [ [ X dpc-3474 334 19 29 29 NUM dpc-3474 334 20 ] ] PUNCT dpc-3474 334 21 and and CCONJ dpc-3474 334 22 in in ADP dpc-3474 334 23 lee lee PROPN dpc-3474 334 24 et et PROPN dpc-3474 334 25 al al PROPN dpc-3474 334 26 study study PROPN dpc-3474 334 27 , , PUNCT dpc-3474 334 28 lcit lcit PROPN dpc-3474 334 29 was be AUX dpc-3474 334 30 the the DET dpc-3474 334 31 most most ADV dpc-3474 334 32 common common ADJ dpc-3474 334 33 recurrence recurrence NOUN dpc-3474 334 34 site site NOUN dpc-3474 334 35 ( ( PUNCT dpc-3474 334 36 12 12 NUM dpc-3474 334 37 % % NOUN dpc-3474 334 38 ) ) PUNCT dpc-3474 335 1 [ [ X dpc-3474 335 2 24 24 NUM dpc-3474 335 3 ] ] PUNCT dpc-3474 335 4 . . PUNCT dpc-3474 336 1 these these DET dpc-3474 336 2 differences difference NOUN dpc-3474 336 3 might might AUX dpc-3474 336 4 be be AUX dpc-3474 336 5 explained explain VERB dpc-3474 336 6 by by ADP dpc-3474 336 7 different different ADJ dpc-3474 336 8 inclusion inclusion NOUN dpc-3474 336 9 criteria criterion NOUN dpc-3474 336 10 and and CCONJ dpc-3474 336 11 different different ADJ dpc-3474 336 12 representation representation NOUN dpc-3474 336 13 of of ADP dpc-3474 336 14 melanoma melanoma NOUN dpc-3474 336 15 stages stage NOUN dpc-3474 336 16 as as ADV dpc-3474 336 17 well well ADV dpc-3474 336 18 as as ADP dpc-3474 336 19 specific specific ADJ dpc-3474 336 20 clinical clinical ADJ dpc-3474 336 21 and and CCONJ dpc-3474 336 22 histopathological histopathological ADJ dpc-3474 336 23 details detail NOUN dpc-3474 336 24 . . PUNCT dpc-3474 337 1 recurrence recurrence NOUN dpc-3474 337 2 detection detection NOUN dpc-3474 337 3 method method NOUN dpc-3474 337 4 there there PRON dpc-3474 337 5 is be VERB dpc-3474 337 6 relevance relevance NOUN dpc-3474 337 7 to to ADP dpc-3474 337 8 the the DET dpc-3474 337 9 modalities modality NOUN dpc-3474 337 10 for for ADP dpc-3474 337 11 melanoma melanoma NOUN dpc-3474 337 12 recurrence recurrence NOUN dpc-3474 337 13 detection detection NOUN dpc-3474 337 14 ( ( PUNCT dpc-3474 337 15 i.e. i.e. X dpc-3474 337 16 clinical clinical ADJ dpc-3474 337 17 examination examination NOUN dpc-3474 337 18 vs vs ADP dpc-3474 337 19 imaging imaging NOUN dpc-3474 337 20 ) ) PUNCT dpc-3474 337 21 . . PUNCT dpc-3474 338 1 some some DET dpc-3474 338 2 frequency frequency NOUN dpc-3474 338 3 and and CCONJ dpc-3474 338 4 patterns pattern NOUN dpc-3474 338 5 of of ADP dpc-3474 338 6 melanoma melanoma NOUN dpc-3474 338 7 recurrence recurrence NOUN dpc-3474 338 8 were be AUX dpc-3474 338 9 highly highly ADV dpc-3474 338 10 stage stage NOUN dpc-3474 338 11 dependent dependent ADJ dpc-3474 338 12 . . PUNCT dpc-3474 339 1 studies study NOUN dpc-3474 339 2 grouping group VERB dpc-3474 339 3 stage stage NOUN dpc-3474 339 4 i i PRON dpc-3474 339 5 and and CCONJ dpc-3474 339 6 ii ii PROPN dpc-3474 339 7 melanoma melanoma NOUN dpc-3474 339 8 patients patient NOUN dpc-3474 339 9 have have AUX dpc-3474 339 10 estimated estimate VERB dpc-3474 339 11 1 1 NUM dpc-3474 339 12 and and CCONJ dpc-3474 339 13 10‐year 10‐year NUM dpc-3474 339 14 recurrence recurrence NOUN dpc-3474 339 15 rates rate NOUN dpc-3474 339 16 at at ADP dpc-3474 339 17 approximately approximately ADV dpc-3474 339 18 9 9 NUM dpc-3474 339 19 % % NOUN dpc-3474 339 20 and and CCONJ dpc-3474 339 21 23 23 NUM dpc-3474 339 22 % % NOUN dpc-3474 339 23 respectively respectively ADV dpc-3474 339 24 , , PUNCT dpc-3474 339 25 with with ADP dpc-3474 339 26 increasing increase VERB dpc-3474 339 27 risk risk NOUN dpc-3474 339 28 dependent dependent ADJ dpc-3474 339 29 on on ADP dpc-3474 339 30 stage stage NOUN dpc-3474 339 31 [ [ X dpc-3474 339 32 8,18,19 8,18,19 NUM dpc-3474 339 33 ] ] PUNCT dpc-3474 339 34 . . PUNCT dpc-3474 340 1 when when SCONJ dpc-3474 340 2 stratified stratify VERB dpc-3474 340 3 by by ADP dpc-3474 340 4 ajcc ajcc NOUN dpc-3474 340 5 7th 7th ADJ dpc-3474 340 6 substage substage NOUN dpc-3474 340 7 , , PUNCT dpc-3474 340 8 a a DET dpc-3474 340 9 large large ADJ dpc-3474 340 10 retrospective retrospective ADJ dpc-3474 340 11 study study NOUN dpc-3474 340 12 conducted conduct VERB dpc-3474 340 13 at at ADP dpc-3474 340 14 memorial memorial ADJ dpc-3474 340 15 sloan sloan PROPN dpc-3474 340 16 kettering kettering PROPN dpc-3474 340 17 cancer cancer PROPN dpc-3474 340 18 center center PROPN dpc-3474 340 19 found find VERB dpc-3474 340 20 the the DET dpc-3474 340 21 5‐year 5‐year ADJ dpc-3474 340 22 risk risk NOUN dpc-3474 340 23 of of ADP dpc-3474 340 24 recurrence recurrence NOUN dpc-3474 340 25 for for ADP dpc-3474 340 26 stage stage NOUN dpc-3474 340 27 iia iia PROPN dpc-3474 340 28 , , PUNCT dpc-3474 340 29 iib iib NOUN dpc-3474 340 30 , , PUNCT dpc-3474 340 31 and and CCONJ dpc-3474 340 32 iic iic PROPN dpc-3474 340 33 to to PART dpc-3474 340 34 be be AUX dpc-3474 340 35 21.6 21.6 NUM dpc-3474 340 36 % % NOUN dpc-3474 340 37 , , PUNCT dpc-3474 340 38 35.1 35.1 NUM dpc-3474 340 39 % % NOUN dpc-3474 340 40 , , PUNCT dpc-3474 340 41 and and CCONJ dpc-3474 340 42 45.3 45.3 NUM dpc-3474 340 43 % % NOUN dpc-3474 340 44 , , PUNCT dpc-3474 340 45 respectively respectively ADV dpc-3474 340 46 . . PUNCT dpc-3474 341 1 substratification substratification NOUN dpc-3474 341 2 of of ADP dpc-3474 341 3 stage stage NOUN dpc-3474 341 4 iii iii NUM dpc-3474 341 5 patients patient NOUN dpc-3474 341 6 in in ADP dpc-3474 341 7 a a DET dpc-3474 341 8 large large ADJ dpc-3474 341 9 retrospective retrospective ADJ dpc-3474 341 10 analysis analysis NOUN dpc-3474 341 11 reported report VERB dpc-3474 341 12 an an DET dpc-3474 341 13 overall overall ADJ dpc-3474 341 14 5‐year 5‐year ADJ dpc-3474 341 15 risk risk NOUN dpc-3474 341 16 of of ADP dpc-3474 341 17 recurrence recurrence NOUN dpc-3474 341 18 for for ADP dpc-3474 341 19 stages stage NOUN dpc-3474 341 20 iiia iiia NOUN dpc-3474 341 21 , , PUNCT dpc-3474 341 22 iiib iiib NOUN dpc-3474 341 23 , , PUNCT dpc-3474 341 24 and and CCONJ dpc-3474 341 25 iiic iiic PROPN dpc-3474 341 26 to to PART dpc-3474 341 27 be be AUX dpc-3474 341 28 approximately approximately ADV dpc-3474 341 29 48 48 NUM dpc-3474 341 30 % % NOUN dpc-3474 341 31 , , PUNCT dpc-3474 341 32 71 71 NUM dpc-3474 341 33 % % NOUN dpc-3474 341 34 , , PUNCT dpc-3474 341 35 and and CCONJ dpc-3474 341 36 85 85 NUM dpc-3474 341 37 % % NOUN dpc-3474 341 38 , , PUNCT dpc-3474 341 39 respectively respectively ADV dpc-3474 341 40 [ [ X dpc-3474 341 41 8,20 8,20 NOUN dpc-3474 341 42 ] ] X dpc-3474 341 43 . . PUNCT dpc-3474 342 1 a a DET dpc-3474 342 2 recent recent ADJ dpc-3474 342 3 study study NOUN dpc-3474 342 4 from from ADP dpc-3474 342 5 finland finland PROPN dpc-3474 342 6 examined examine VERB dpc-3474 342 7 the the DET dpc-3474 342 8 pet pet NOUN dpc-3474 342 9 / / SYM dpc-3474 342 10 ct ct NOUN dpc-3474 342 11 follow follow NOUN dpc-3474 342 12 - - PUNCT dpc-3474 342 13 up up ADP dpc-3474 342 14 utility utility NOUN dpc-3474 342 15 , , PUNCT dpc-3474 342 16 the the DET dpc-3474 342 17 recurrence recurrence NOUN dpc-3474 342 18 rate rate NOUN dpc-3474 342 19 was be AUX dpc-3474 342 20 49 49 NUM dpc-3474 342 21 % % NOUN dpc-3474 342 22 in in ADP dpc-3474 342 23 stage stage NOUN dpc-3474 342 24 iib iib PROPN dpc-3474 342 25 and and CCONJ dpc-3474 342 26 iic iic PROPN dpc-3474 342 27 patients patient NOUN dpc-3474 342 28 . . PUNCT dpc-3474 343 1 a a DET dpc-3474 343 2 total total NOUN dpc-3474 343 3 of of ADP dpc-3474 343 4 38 38 NUM dpc-3474 343 5 % % NOUN dpc-3474 343 6 of of ADP dpc-3474 343 7 the the DET dpc-3474 343 8 melanoma melanoma NOUN dpc-3474 343 9 recurrences recurrence NOUN dpc-3474 343 10 were be AUX dpc-3474 343 11 loco loco NOUN dpc-3474 343 12 - - PUNCT dpc-3474 343 13 regional regional ADJ dpc-3474 343 14 recurrences recurrence NOUN dpc-3474 343 15 ( ( PUNCT dpc-3474 343 16 9 9 NUM dpc-3474 343 17 % % NOUN dpc-3474 343 18 lcit lcit NOUN dpc-3474 343 19 and and CCONJ dpc-3474 343 20 29 29 NUM dpc-3474 343 21 % % NOUN dpc-3474 343 22 in in ADP dpc-3474 343 23 lymph lymph NOUN dpc-3474 343 24 nodes node NOUN dpc-3474 343 25 ) ) PUNCT dpc-3474 343 26 and and CCONJ dpc-3474 343 27 61 61 NUM dpc-3474 343 28 % % NOUN dpc-3474 343 29 were be AUX dpc-3474 343 30 systemic systemic ADJ dpc-3474 343 31 recurrences recurrence NOUN dpc-3474 343 32 [ [ X dpc-3474 343 33 1,21 1,21 X dpc-3474 343 34 ] ] PUNCT dpc-3474 343 35 . . PUNCT dpc-3474 344 1 stage stage PROPN dpc-3474 344 2 iic iic PROPN dpc-3474 344 3 disease disease NOUN dpc-3474 344 4 behaved behave VERB dpc-3474 344 5 similarly similarly ADV dpc-3474 344 6 to to PART dpc-3474 344 7 stage stage NOUN dpc-3474 344 8 iiib iiib NOUN dpc-3474 344 9 and and CCONJ dpc-3474 344 10 iiic iiic PROPN dpc-3474 344 11 melanoma melanoma PROPN dpc-3474 344 12 with with ADP dpc-3474 344 13 the the DET dpc-3474 344 14 highest high ADJ dpc-3474 344 15 risk risk NOUN dpc-3474 344 16 of of ADP dpc-3474 344 17 recurrence recurrence NOUN dpc-3474 344 18 in in ADP dpc-3474 344 19 the the DET dpc-3474 344 20 first first ADJ dpc-3474 344 21 2–3 2–3 NUM dpc-3474 344 22 years year NOUN dpc-3474 344 23 following follow VERB dpc-3474 344 24 diagnosis diagnosis NOUN dpc-3474 344 25 [ [ X dpc-3474 344 26 8,22,23 8,22,23 NUM dpc-3474 344 27 ] ] PUNCT dpc-3474 344 28 . . PUNCT dpc-3474 345 1 time time NOUN dpc-3474 345 2 for for ADP dpc-3474 345 3 recurrence recurrence NOUN dpc-3474 345 4 the the DET dpc-3474 345 5 timing timing NOUN dpc-3474 345 6 for for ADP dpc-3474 345 7 metastasis metastasis NOUN dpc-3474 345 8 development development NOUN dpc-3474 345 9 in in ADP dpc-3474 345 10 patients patient NOUN dpc-3474 345 11 with with ADP dpc-3474 345 12 primary primary ADJ dpc-3474 345 13 cutaneous cutaneous ADJ dpc-3474 345 14 melanoma melanoma NOUN dpc-3474 345 15 must must AUX dpc-3474 345 16 be be AUX dpc-3474 345 17 considered consider VERB dpc-3474 345 18 within within ADP dpc-3474 345 19 the the DET dpc-3474 345 20 context context NOUN dpc-3474 345 21 of of ADP dpc-3474 345 22 the the DET dpc-3474 345 23 above above ADV dpc-3474 345 24 - - PUNCT dpc-3474 345 25 mentioned mention VERB dpc-3474 345 26 melanoma melanoma NOUN dpc-3474 345 27 tnm tnm NUM dpc-3474 345 28 stages stage NOUN dpc-3474 345 29 . . PUNCT dpc-3474 346 1 most most ADJ dpc-3474 346 2 of of ADP dpc-3474 346 3 the the DET dpc-3474 346 4 studies study NOUN dpc-3474 346 5 did do AUX dpc-3474 346 6 not not PART dpc-3474 346 7 report report VERB dpc-3474 346 8 the the DET dpc-3474 346 9 onset onset NOUN dpc-3474 346 10 or or CCONJ dpc-3474 346 11 timing timing NOUN dpc-3474 346 12 of of ADP dpc-3474 346 13 the the DET dpc-3474 346 14 recurrence recurrence NOUN dpc-3474 346 15 from from ADP dpc-3474 346 16 diagnosis diagnosis NOUN dpc-3474 346 17 . . PUNCT dpc-3474 347 1 for for ADP dpc-3474 347 2 those those DET dpc-3474 347 3 studies study NOUN dpc-3474 347 4 that that PRON dpc-3474 347 5 mention mention VERB dpc-3474 347 6 it it PRON dpc-3474 347 7 , , PUNCT dpc-3474 347 8 the the DET dpc-3474 347 9 majority majority NOUN dpc-3474 347 10 of of ADP dpc-3474 347 11 metastasis metastasis NOUN dpc-3474 347 12 occurs occur VERB dpc-3474 347 13 within within ADP dpc-3474 347 14 3 3 NUM dpc-3474 347 15 years year NOUN dpc-3474 347 16 of of ADP dpc-3474 347 17 diagnosis diagnosis NOUN dpc-3474 347 18 [ [ X dpc-3474 347 19 8,20,22,24 8,20,22,24 NUM dpc-3474 347 20 - - SYM dpc-3474 347 21 26 26 NUM dpc-3474 347 22 ] ] PUNCT dpc-3474 347 23 and and CCONJ dpc-3474 347 24 recurrence recurrence NOUN dpc-3474 347 25 rates rate NOUN dpc-3474 347 26 were be AUX dpc-3474 347 27 earlier early ADJ dpc-3474 347 28 with with ADP dpc-3474 347 29 more more ADV dpc-3474 347 30 advanced advanced ADJ dpc-3474 347 31 stages stage NOUN dpc-3474 347 32 [ [ X dpc-3474 347 33 3,6,16,21,28 3,6,16,21,28 NUM dpc-3474 347 34 - - SYM dpc-3474 347 35 32 32 NUM dpc-3474 347 36 ] ] PUNCT dpc-3474 347 37 . . PUNCT dpc-3474 348 1 fusi fusi PROPN dpc-3474 348 2 et et PROPN dpc-3474 348 3 al al PROPN dpc-3474 348 4 in in ADP dpc-3474 348 5 their their PRON dpc-3474 348 6 study study NOUN dpc-3474 348 7 of of ADP dpc-3474 348 8 250 250 NUM dpc-3474 348 9 patients patient NOUN dpc-3474 348 10 with with ADP dpc-3474 348 11 stage stage NOUN dpc-3474 348 12 i i PROPN dpc-3474 348 13 - - PUNCT dpc-3474 348 14 ii ii PROPN dpc-3474 348 15 melanoma melanoma NOUN dpc-3474 348 16 , , PUNCT dpc-3474 348 17 reported report VERB dpc-3474 348 18 that that SCONJ dpc-3474 348 19 67 67 NUM dpc-3474 348 20 % % NOUN dpc-3474 348 21 of of ADP dpc-3474 348 22 recurrences recurrence NOUN dpc-3474 348 23 arose arise VERB dpc-3474 348 24 within within ADP dpc-3474 348 25 2 2 NUM dpc-3474 348 26 years year NOUN dpc-3474 348 27 and and CCONJ dpc-3474 348 28 81 81 NUM dpc-3474 348 29 % % NOUN dpc-3474 348 30 within within ADP dpc-3474 348 31 3 3 NUM dpc-3474 348 32 years year NOUN dpc-3474 348 33 of of ADP dpc-3474 348 34 disease disease NOUN dpc-3474 348 35 [ [ X dpc-3474 348 36 33 33 NUM dpc-3474 348 37 ] ] PUNCT dpc-3474 348 38 . . PUNCT dpc-3474 349 1 dicker dicker PROPN dpc-3474 349 2 et et PROPN dpc-3474 349 3 al al PROPN dpc-3474 349 4 in in ADP dpc-3474 349 5 their their PRON dpc-3474 349 6 study study NOUN dpc-3474 349 7 of of ADP dpc-3474 349 8 1,568 1,568 NUM dpc-3474 349 9 patients patient NOUN dpc-3474 349 10 with with ADP dpc-3474 349 11 stage stage NOUN dpc-3474 349 12 i i PRON dpc-3474 349 13 melanoma melanoma VERB dpc-3474 349 14 reported report VERB dpc-3474 349 15 that that SCONJ dpc-3474 349 16 80 80 NUM dpc-3474 349 17 % % NOUN dpc-3474 349 18 of of ADP dpc-3474 349 19 recurrences recurrence NOUN dpc-3474 349 20 occurred occur VERB dpc-3474 349 21 in in ADP dpc-3474 349 22 the the DET dpc-3474 349 23 first first ADJ dpc-3474 349 24 3 3 NUM dpc-3474 349 25 years year NOUN dpc-3474 349 26 [ [ X dpc-3474 349 27 26 26 NUM dpc-3474 349 28 ] ] PUNCT dpc-3474 349 29 . . PUNCT dpc-3474 350 1 behave behave AUX dpc-3474 350 2 et et PROPN dpc-3474 350 3 al al PROPN dpc-3474 350 4 in in ADP dpc-3474 350 5 their their PRON dpc-3474 350 6 study study NOUN dpc-3474 350 7 reported report VERB dpc-3474 350 8 that that DET dpc-3474 350 9 time time NOUN dpc-3474 350 10 to to ADP dpc-3474 350 11 first first ADJ dpc-3474 350 12 recurrence recurrence NOUN dpc-3474 350 13 occurred occur VERB dpc-3474 350 14 at at ADP dpc-3474 350 15 a a DET dpc-3474 350 16 median median ADJ dpc-3474 350 17 time time NOUN dpc-3474 350 18 of of ADP dpc-3474 350 19 17.7 17.7 NUM dpc-3474 350 20 months month NOUN dpc-3474 350 21 ( ( PUNCT dpc-3474 350 22 range range NOUN dpc-3474 350 23 1.7–53.6 1.7–53.6 NUM dpc-3474 350 24 ) ) PUNCT dpc-3474 351 1 [ [ X dpc-3474 351 2 34 34 NUM dpc-3474 351 3 ] ] PUNCT dpc-3474 351 4 . . PUNCT dpc-3474 352 1 however however ADV dpc-3474 352 2 , , PUNCT dpc-3474 352 3 a a DET dpc-3474 352 4 recent recent ADJ dpc-3474 352 5 study study NOUN dpc-3474 352 6 with with ADP dpc-3474 352 7 long long ADJ dpc-3474 352 8 - - PUNCT dpc-3474 352 9 term term NOUN dpc-3474 352 10 follow follow NOUN dpc-3474 352 11 - - PUNCT dpc-3474 352 12 up up NOUN dpc-3474 352 13 showed show VERB dpc-3474 352 14 that that SCONJ dpc-3474 352 15 only only ADV dpc-3474 352 16 82 82 NUM dpc-3474 352 17 % % NOUN dpc-3474 352 18 of of ADP dpc-3474 352 19 recurrences recurrence NOUN dpc-3474 352 20 occurred occur VERB dpc-3474 352 21 in in ADP dpc-3474 352 22 the the DET dpc-3474 352 23 first first ADJ dpc-3474 352 24 5 5 NUM dpc-3474 352 25 years year NOUN dpc-3474 352 26 , , PUNCT dpc-3474 352 27 91 91 NUM dpc-3474 352 28 % % NOUN dpc-3474 352 29 in in ADP dpc-3474 352 30 the the DET dpc-3474 352 31 first first ADJ dpc-3474 352 32 7 7 NUM dpc-3474 352 33 years year NOUN dpc-3474 352 34 , , PUNCT dpc-3474 352 35 and and CCONJ dpc-3474 352 36 some some PRON dpc-3474 352 37 occurring occur VERB dpc-3474 352 38 even even ADV dpc-3474 352 39 after after ADP dpc-3474 352 40 10 10 NUM dpc-3474 352 41 years year NOUN dpc-3474 352 42 from from ADP dpc-3474 352 43 melanoma melanoma ADJ dpc-3474 352 44 diagnosis diagnosis NOUN dpc-3474 352 45 [ [ X dpc-3474 352 46 35 35 NUM dpc-3474 352 47 ] ] PUNCT dpc-3474 352 48 . . PUNCT dpc-3474 353 1 similarly similarly ADV dpc-3474 353 2 , , PUNCT dpc-3474 353 3 the the DET dpc-3474 353 4 mean mean ADJ dpc-3474 353 5 time time NOUN dpc-3474 353 6 for for ADP dpc-3474 353 7 recurrence recurrence NOUN dpc-3474 353 8 in in ADP dpc-3474 353 9 lee lee PROPN dpc-3474 353 10 et et PROPN dpc-3474 353 11 al al PROPN dpc-3474 353 12 series series PROPN dpc-3474 353 13 was be AUX dpc-3474 353 14 shorter short ADJ dpc-3474 353 15 in in ADP dpc-3474 353 16 later later ADJ dpc-3474 353 17 stages stage NOUN dpc-3474 353 18 when when SCONJ dpc-3474 353 19 compared compare VERB dpc-3474 353 20 to to ADP dpc-3474 353 21 early early ADJ dpc-3474 353 22 stages stage NOUN dpc-3474 353 23 ( ( PUNCT dpc-3474 353 24 34 34 NUM dpc-3474 353 25     SPACE dpc-3474 353 26 months month NOUN dpc-3474 353 27 in in ADP dpc-3474 353 28 stage stage NOUN dpc-3474 353 29 ib ib NOUN dpc-3474 353 30 vs. vs. ADP dpc-3474 353 31 12 12 NUM dpc-3474 353 32 months month NOUN dpc-3474 353 33 in in ADP dpc-3474 353 34 stage stage NOUN dpc-3474 353 35 iii iii NOUN dpc-3474 353 36 ) ) PUNCT dpc-3474 353 37     SPACE dpc-3474 354 1 [ [ X dpc-3474 354 2 24 24 NUM dpc-3474 354 3 ] ] PUNCT dpc-3474 354 4 . . PUNCT dpc-3474 355 1 ertekin ertekin PROPN dpc-3474 355 2 et et PROPN dpc-3474 355 3     SPACE dpc-3474 355 4 al al PROPN dpc-3474 355 5 reported report VERB dpc-3474 355 6 a a DET dpc-3474 355 7 mean mean ADJ dpc-3474 355 8 time time NOUN dpc-3474 355 9 of of ADP dpc-3474 355 10 recurrence recurrence NOUN dpc-3474 355 11 of of ADP dpc-3474 355 12 40 40 NUM dpc-3474 355 13     SPACE dpc-3474 355 14 months month NOUN dpc-3474 355 15 in in ADP dpc-3474 355 16 stage stage NOUN dpc-3474 355 17 i i PRON dpc-3474 355 18 melanoma melanoma VERB dpc-3474 355 19 , , PUNCT dpc-3474 355 20 22 22 NUM dpc-3474 355 21 months month NOUN dpc-3474 355 22 in in ADP dpc-3474 355 23 stage stage NOUN dpc-3474 355 24 ii ii NOUN dpc-3474 355 25 melanoma melanoma NOUN dpc-3474 355 26 , , PUNCT dpc-3474 355 27 and and CCONJ dpc-3474 355 28 14 14 NUM dpc-3474 355 29     SPACE dpc-3474 355 30 months month NOUN dpc-3474 355 31 in in ADP dpc-3474 355 32 stage stage NOUN dpc-3474 355 33 iii iii NUM dpc-3474 355 34 melanoma melanoma NOUN dpc-3474 355 35 [ [ X dpc-3474 355 36 32 32 NUM dpc-3474 355 37 ] ] PUNCT dpc-3474 355 38 . . PUNCT dpc-3474 356 1 even even ADV dpc-3474 356 2 more more ADJ dpc-3474 356 3 , , PUNCT dpc-3474 356 4 some some DET dpc-3474 356 5 studies study NOUN dpc-3474 356 6 reported report VERB dpc-3474 356 7 the the DET dpc-3474 356 8 time time NOUN dpc-3474 356 9 to to ADP dpc-3474 356 10 recurrence recurrence VERB dpc-3474 356 11 according accord VERB dpc-3474 356 12 to to ADP dpc-3474 356 13 the the DET dpc-3474 356 14 initial initial ADJ dpc-3474 356 15 type type NOUN dpc-3474 356 16 of of ADP dpc-3474 356 17 recurrence recurrence NOUN dpc-3474 356 18 ( ( PUNCT dpc-3474 356 19 e.g. e.g. ADV dpc-3474 356 20 lcit lcit ADJ dpc-3474 356 21 vs. vs. ADP dpc-3474 356 22 lymph lymph NOUN dpc-3474 356 23 nodes node NOUN dpc-3474 356 24 vs. vs. X dpc-3474 356 25 systemic systemic ADJ dpc-3474 356 26 ) ) PUNCT dpc-3474 356 27 . . PUNCT dpc-3474 357 1 systemic systemic ADJ dpc-3474 357 2 recurrences recurrence NOUN dpc-3474 357 3 tend tend VERB dpc-3474 357 4 to to PART dpc-3474 357 5 appear appear VERB dpc-3474 357 6 later later ADV dpc-3474 357 7 when when SCONJ dpc-3474 357 8 compared compare VERB dpc-3474 357 9 to to ADP dpc-3474 357 10 local local ADJ dpc-3474 357 11 recurrences recurrence NOUN dpc-3474 357 12 . . PUNCT dpc-3474 358 1 the the DET dpc-3474 358 2 mean mean ADJ dpc-3474 358 3 time time NOUN dpc-3474 358 4 to to PART dpc-3474 358 5 recurrence recurrence VERB dpc-3474 358 6 in in ADP dpc-3474 358 7 meier meier PROPN dpc-3474 358 8 et et PROPN dpc-3474 358 9 al al PROPN dpc-3474 358 10 study study PROPN dpc-3474 358 11 was be AUX dpc-3474 358 12 17 17 NUM dpc-3474 358 13 months month NOUN dpc-3474 358 14 for for ADP dpc-3474 358 15 the the DET dpc-3474 358 16 lcit lcit PROPN dpc-3474 358 17 group group NOUN dpc-3474 358 18 , , PUNCT dpc-3474 358 19 16 16 NUM dpc-3474 358 20 months month NOUN dpc-3474 358 21 for for ADP dpc-3474 358 22 the the DET dpc-3474 358 23 lymph lymph NOUN dpc-3474 358 24 node node NOUN dpc-3474 358 25 group group NOUN dpc-3474 358 26 , , PUNCT dpc-3474 358 27 and and CCONJ dpc-3474 358 28 25 25 NUM dpc-3474 358 29 months month NOUN dpc-3474 358 30 for for ADP dpc-3474 358 31 the the DET dpc-3474 358 32 systemic systemic ADJ dpc-3474 358 33 recurrence recurrence NOUN dpc-3474 358 34 review review NOUN dpc-3474 358 35 | | ADV dpc-3474 358 36 dermatol dermatol ADJ dpc-3474 358 37 pract pract NOUN dpc-3474 358 38 concept concept NOUN dpc-3474 358 39 . . PUNCT dpc-3474 359 1 2023;13(4):e2023304 2023;13(4):e2023304 NUM dpc-3474 359 2 9 9 NUM dpc-3474 359 3 1.1 1.1 NUM dpc-3474 359 4     SPACE dpc-3474 359 5 years year NOUN dpc-3474 359 6 ( ( PUNCT dpc-3474 359 7 95 95 NUM dpc-3474 359 8 % % NOUN dpc-3474 359 9 ci:0.6 ci:0.6 NOUN dpc-3474 359 10 - - PUNCT dpc-3474 359 11 2.2 2.2 NUM dpc-3474 359 12 ) ) PUNCT dpc-3474 359 13 for for ADP dpc-3474 359 14 patients patient NOUN dpc-3474 359 15 initially initially ADV dpc-3474 359 16 diagnosed diagnose VERB dpc-3474 359 17 with with ADP dpc-3474 359 18 stage stage NOUN dpc-3474 359 19 iii iii NUM dpc-3474 359 20 that that PRON dpc-3474 359 21 recurred recur VERB dpc-3474 359 22 [ [ X dpc-3474 359 23 29 29 NUM dpc-3474 359 24 ] ] PUNCT dpc-3474 359 25 . . PUNCT dpc-3474 360 1 sparks spark VERB dpc-3474 360 2 et et PROPN dpc-3474 360 3 al al PROPN dpc-3474 360 4 reported report VERB dpc-3474 360 5 an an DET dpc-3474 360 6 os os NOUN dpc-3474 360 7 of of ADP dpc-3474 360 8 47 47 NUM dpc-3474 360 9 % % NOUN dpc-3474 360 10 at at ADP dpc-3474 360 11 5 5 NUM dpc-3474 360 12 years year NOUN dpc-3474 360 13 and and CCONJ dpc-3474 360 14 thomas thomas PROPN dpc-3474 360 15 et et PROPN dpc-3474 360 16     SPACE dpc-3474 360 17 al al PROPN dpc-3474 360 18 an an DET dpc-3474 360 19 os os NOUN dpc-3474 360 20 of of ADP dpc-3474 360 21 86.9 86.9 NUM dpc-3474 360 22 % % NOUN dpc-3474 360 23 at at ADP dpc-3474 360 24 5 5 NUM dpc-3474 360 25 years year NOUN dpc-3474 360 26 after after ADP dpc-3474 360 27 recurrence recurrence NOUN dpc-3474 360 28 [ [ X dpc-3474 360 29 27,42 27,42 NOUN dpc-3474 360 30 ] ] PUNCT dpc-3474 360 31 . . PUNCT dpc-3474 361 1 o’connell o’connell INTJ dpc-3474 361 2 et et NOUN dpc-3474 361 3 al al PROPN dpc-3474 361 4 reported report VERB dpc-3474 361 5 an an DET dpc-3474 361 6 os os NOUN dpc-3474 361 7 of of ADP dpc-3474 361 8 6 6 NUM dpc-3474 361 9 months month NOUN dpc-3474 361 10 ( ( PUNCT dpc-3474 361 11 range range NOUN dpc-3474 361 12 of of ADP dpc-3474 361 13 1 1 NUM dpc-3474 361 14 - - SYM dpc-3474 361 15 126 126 NUM dpc-3474 361 16 months month NOUN dpc-3474 361 17 ) ) PUNCT dpc-3474 361 18 at at ADP dpc-3474 361 19 5 5 NUM dpc-3474 361 20 years year NOUN dpc-3474 361 21 in in ADP dpc-3474 361 22 the the DET dpc-3474 361 23 recurrent recurrent ADJ dpc-3474 361 24 melanoma melanoma NOUN dpc-3474 361 25 group group NOUN dpc-3474 361 26 when when SCONJ dpc-3474 361 27 compared compare VERB dpc-3474 361 28 to to ADP dpc-3474 361 29 the the DET dpc-3474 361 30 non non ADJ dpc-3474 361 31 - - ADJ dpc-3474 361 32 recurrent recurrent ADJ dpc-3474 361 33 group group NOUN dpc-3474 361 34 [ [ X dpc-3474 361 35 3 3 NUM dpc-3474 361 36 ] ] PUNCT dpc-3474 361 37 . . PUNCT dpc-3474 362 1 leeneman leeneman PROPN dpc-3474 362 2 et et PROPN dpc-3474 362 3 al al PROPN dpc-3474 362 4 also also ADV dpc-3474 362 5 found find VERB dpc-3474 362 6 a a DET dpc-3474 362 7 two two NUM dpc-3474 362 8 - - PUNCT dpc-3474 362 9 year year NOUN dpc-3474 362 10 post post ADJ dpc-3474 362 11 - - ADJ dpc-3474 362 12 recurrence recurrence ADJ dpc-3474 362 13 survival survival NOUN dpc-3474 362 14 rate rate NOUN dpc-3474 362 15 of of ADP dpc-3474 362 16 41 41 NUM dpc-3474 362 17 % % NOUN dpc-3474 362 18 , , PUNCT dpc-3474 362 19 42 42 NUM dpc-3474 362 20 % % NOUN dpc-3474 362 21 , , PUNCT dpc-3474 362 22 and and CCONJ dpc-3474 362 23 43 43 NUM dpc-3474 362 24 % % NOUN dpc-3474 362 25 for for ADP dpc-3474 362 26 patients patient NOUN dpc-3474 362 27 initially initially ADV dpc-3474 362 28 diagnosed diagnose VERB dpc-3474 362 29 with with ADP dpc-3474 362 30 stages stage NOUN dpc-3474 362 31 ib ib PROPN dpc-3474 362 32 , , PUNCT dpc-3474 362 33 ii ii PROPN dpc-3474 362 34 , , PUNCT dpc-3474 362 35 and and CCONJ dpc-3474 362 36 iii iii NOUN dpc-3474 362 37 , , PUNCT dpc-3474 362 38 respectively respectively ADV dpc-3474 362 39 . . PUNCT dpc-3474 363 1 by by ADP dpc-3474 363 2 the the DET dpc-3474 363 3 type type NOUN dpc-3474 363 4 of of ADP dpc-3474 363 5 first first ADJ dpc-3474 363 6 recurrence recurrence NOUN dpc-3474 363 7 , , PUNCT dpc-3474 363 8 median median ADJ dpc-3474 363 9 post post NOUN dpc-3474 363 10 - - NOUN dpc-3474 363 11 recurrence recurrence ADJ dpc-3474 363 12 os os NOUN dpc-3474 363 13 was be AUX dpc-3474 363 14 longer long ADJ dpc-3474 363 15 for for ADP dpc-3474 363 16 patients patient NOUN dpc-3474 363 17 with with ADP dpc-3474 363 18 lymph lymph NOUN dpc-3474 363 19 node node ADJ dpc-3474 363 20 metastasis metastasis NOUN dpc-3474 363 21 ( ( PUNCT dpc-3474 363 22 3.9 3.9 NUM dpc-3474 363 23 years year NOUN dpc-3474 363 24 ; ; PUNCT dpc-3474 363 25 95 95 NUM dpc-3474 363 26 % % NOUN dpc-3474 363 27 ci ci NOUN dpc-3474 363 28 : : PUNCT dpc-3474 363 29 2.5 2.5 NUM dpc-3474 363 30 - - PUNCT dpc-3474 363 31 not not PART dpc-3474 363 32 reached reach VERB dpc-3474 363 33 ) ) PUNCT dpc-3474 363 34 than than ADP dpc-3474 363 35 for for ADP dpc-3474 363 36 patients patient NOUN dpc-3474 363 37 with with ADP dpc-3474 363 38 lcit lcit ADJ dpc-3474 363 39 ( ( PUNCT dpc-3474 363 40 2.8 2.8 NUM dpc-3474 363 41 years year NOUN dpc-3474 363 42 ; ; PUNCT dpc-3474 363 43 95 95 NUM dpc-3474 363 44 % % NOUN dpc-3474 363 45 ci ci NOUN dpc-3474 363 46 : : PUNCT dpc-3474 363 47 1.9 1.9 NUM dpc-3474 363 48 - - SYM dpc-3474 363 49 4.6 4.6 NUM dpc-3474 363 50 ) ) PUNCT dpc-3474 363 51 and and CCONJ dpc-3474 363 52 distant distant ADJ dpc-3474 363 53 metastasis metastasis NOUN dpc-3474 363 54 ( ( PUNCT dpc-3474 363 55 0.5 0.5 NUM dpc-3474 363 56 years year NOUN dpc-3474 363 57 ; ; PUNCT dpc-3474 363 58 95 95 NUM dpc-3474 363 59 % % NOUN dpc-3474 363 60 ci ci NOUN dpc-3474 363 61 : : PUNCT dpc-3474 363 62 0.3 0.3 NUM dpc-3474 363 63 - - PUNCT dpc-3474 363 64 0.6)[29 0.6)[29 NUM dpc-3474 363 65 ] ] PUNCT dpc-3474 363 66 . . PUNCT dpc-3474 364 1 conclusions conclusion NOUN dpc-3474 364 2 in in ADP dpc-3474 364 3 this this DET dpc-3474 364 4 review review NOUN dpc-3474 364 5 , , PUNCT dpc-3474 364 6 we we PRON dpc-3474 364 7 have have AUX dpc-3474 364 8 summarized summarize VERB dpc-3474 364 9 the the DET dpc-3474 364 10 patterns pattern NOUN dpc-3474 364 11 of of ADP dpc-3474 364 12 recurrence recurrence NOUN dpc-3474 364 13 of of ADP dpc-3474 364 14 primary primary ADJ dpc-3474 364 15 cutaneous cutaneous ADJ dpc-3474 364 16 melanoma melanoma NOUN dpc-3474 364 17 in in ADP dpc-3474 364 18 various various ADJ dpc-3474 364 19 studies study NOUN dpc-3474 364 20 and and CCONJ dpc-3474 364 21 populations population NOUN dpc-3474 364 22 . . PUNCT dpc-3474 365 1 the the DET dpc-3474 365 2 overall overall ADJ dpc-3474 365 3 recurrence recurrence NOUN dpc-3474 365 4 rate rate NOUN dpc-3474 365 5 ranged range VERB dpc-3474 365 6 from from ADP dpc-3474 365 7 approximately approximately ADV dpc-3474 365 8 20 20 NUM dpc-3474 365 9 % % NOUN dpc-3474 365 10 to to PART dpc-3474 365 11 40 40 NUM dpc-3474 365 12 % % NOUN dpc-3474 365 13 , , PUNCT dpc-3474 365 14 with with ADP dpc-3474 365 15 systemic systemic ADJ dpc-3474 365 16 recurrence recurrence NOUN dpc-3474 365 17 , , PUNCT dpc-3474 365 18 particularly particularly ADV dpc-3474 365 19 to to ADP dpc-3474 365 20 the the DET dpc-3474 365 21 lungs lung NOUN dpc-3474 365 22 , , PUNCT dpc-3474 365 23 being be AUX dpc-3474 365 24 the the DET dpc-3474 365 25 most most ADV dpc-3474 365 26 frequent frequent ADJ dpc-3474 365 27 pattern pattern NOUN dpc-3474 365 28 . . PUNCT dpc-3474 366 1 the the DET dpc-3474 366 2 primary primary ADJ dpc-3474 366 3 predictors predictor NOUN dpc-3474 366 4 of of ADP dpc-3474 366 5 recurrence recurrence NOUN dpc-3474 366 6 were be AUX dpc-3474 366 7 breslow breslow ADJ dpc-3474 366 8 thickness thickness NOUN dpc-3474 366 9 and and CCONJ dpc-3474 366 10 male male ADJ dpc-3474 366 11 sex sex NOUN dpc-3474 366 12 . . PUNCT dpc-3474 367 1 notably notably ADV dpc-3474 367 2 , , PUNCT dpc-3474 367 3 patient patient ADJ dpc-3474 367 4 self self NOUN dpc-3474 367 5 - - PUNCT dpc-3474 367 6 report report NOUN dpc-3474 367 7 , , PUNCT dpc-3474 367 8 primarily primarily ADV dpc-3474 367 9 based base VERB dpc-3474 367 10 on on ADP dpc-3474 367 11 symptoms symptom NOUN dpc-3474 367 12 , , PUNCT dpc-3474 367 13 was be AUX dpc-3474 367 14 the the DET dpc-3474 367 15 most most ADV dpc-3474 367 16 frequent frequent ADJ dpc-3474 367 17 method method NOUN dpc-3474 367 18 of of ADP dpc-3474 367 19 recurrence recurrence NOUN dpc-3474 367 20 detection detection NOUN dpc-3474 367 21 . . PUNCT dpc-3474 368 1 this this DET dpc-3474 368 2 particular particular ADJ dpc-3474 368 3 finding finding NOUN dpc-3474 368 4 underscores underscore VERB dpc-3474 368 5 the the DET dpc-3474 368 6 importance importance NOUN dpc-3474 368 7 of of ADP dpc-3474 368 8 patient patient ADJ dpc-3474 368 9 education education NOUN dpc-3474 368 10 regarding regard VERB dpc-3474 368 11 signs sign NOUN dpc-3474 368 12 and and CCONJ dpc-3474 368 13 symptoms symptom NOUN dpc-3474 368 14 for for ADP dpc-3474 368 15 the the DET dpc-3474 368 16 early early ADJ dpc-3474 368 17 detection detection NOUN dpc-3474 368 18 of of ADP dpc-3474 368 19 melanoma melanoma NOUN dpc-3474 368 20 recurrence recurrence NOUN dpc-3474 368 21 or or CCONJ dpc-3474 368 22 progression progression NOUN dpc-3474 368 23 . . PUNCT dpc-3474 369 1 directly directly ADV dpc-3474 369 2 questioning question VERB dpc-3474 369 3 about about ADP dpc-3474 369 4 specific specific ADJ dpc-3474 369 5 signs sign NOUN dpc-3474 369 6 and and CCONJ dpc-3474 369 7 symptoms symptom NOUN dpc-3474 369 8 during during ADP dpc-3474 369 9 each each DET dpc-3474 369 10 visit visit NOUN dpc-3474 369 11 is be AUX dpc-3474 369 12 highly highly ADV dpc-3474 369 13 relevant relevant ADJ dpc-3474 369 14 . . PUNCT dpc-3474 370 1 this this DET dpc-3474 370 2 simple simple ADJ dpc-3474 370 3 strategy strategy NOUN dpc-3474 370 4 should should AUX dpc-3474 370 5 not not PART dpc-3474 370 6 be be AUX dpc-3474 370 7 underestimated underestimate VERB dpc-3474 370 8 . . PUNCT dpc-3474 371 1 current current ADJ dpc-3474 371 2 melanoma melanoma NOUN dpc-3474 371 3 guidelines guideline NOUN dpc-3474 371 4 lack lack VERB dpc-3474 371 5 precision precision NOUN dpc-3474 371 6 regarding regard VERB dpc-3474 371 7 optimal optimal ADJ dpc-3474 371 8 follow follow VERB dpc-3474 371 9 - - PUNCT dpc-3474 371 10 up up ADP dpc-3474 371 11 modalities modality NOUN dpc-3474 371 12 and and CCONJ dpc-3474 371 13 when when SCONJ dpc-3474 371 14 to to PART dpc-3474 371 15 order order VERB dpc-3474 371 16 specific specific ADJ dpc-3474 371 17 cross cross ADJ dpc-3474 371 18 - - ADJ dpc-3474 371 19 sectional sectional ADJ dpc-3474 371 20 imaging imaging NOUN dpc-3474 371 21 studies study NOUN dpc-3474 371 22 ( ( PUNCT dpc-3474 371 23 e.g. e.g. ADV dpc-3474 371 24 computed compute VERB dpc-3474 371 25 tomography tomography NOUN dpc-3474 371 26 , , PUNCT dpc-3474 371 27 pet pet NOUN dpc-3474 371 28 - - PUNCT dpc-3474 371 29 ct ct NOUN dpc-3474 371 30 ) ) PUNCT dpc-3474 371 31 . . PUNCT dpc-3474 372 1 moreover moreover ADV dpc-3474 372 2 , , PUNCT dpc-3474 372 3 there there PRON dpc-3474 372 4 is be VERB dpc-3474 372 5 also also ADV dpc-3474 372 6 a a DET dpc-3474 372 7 wide wide ADJ dpc-3474 372 8 variation variation NOUN dpc-3474 372 9 in in ADP dpc-3474 372 10 recommendations recommendation NOUN dpc-3474 372 11 among among ADP dpc-3474 372 12 different different ADJ dpc-3474 372 13 melanoma melanoma NOUN dpc-3474 372 14 guidelines guideline NOUN dpc-3474 372 15 [ [ X dpc-3474 372 16 12,13,43,44 12,13,43,44 NUM dpc-3474 372 17 ] ] PUNCT dpc-3474 372 18 . . PUNCT dpc-3474 373 1 for for ADP dpc-3474 373 2 example example NOUN dpc-3474 373 3 , , PUNCT dpc-3474 373 4 the the DET dpc-3474 373 5 national national ADJ dpc-3474 373 6 comprehensive comprehensive ADJ dpc-3474 373 7 cancer cancer NOUN dpc-3474 373 8 network network NOUN dpc-3474 373 9 ( ( PUNCT dpc-3474 373 10 nccn nccn ADJ dpc-3474 373 11 ) ) PUNCT dpc-3474 373 12 does do AUX dpc-3474 373 13 not not PART dpc-3474 373 14 recommend recommend VERB dpc-3474 373 15 imaging imaging NOUN dpc-3474 373 16 in in ADP dpc-3474 373 17 stages stage NOUN dpc-3474 373 18 i i PRON dpc-3474 373 19 and and CCONJ dpc-3474 373 20 ii ii PROPN dpc-3474 373 21 in in ADP dpc-3474 373 22 the the DET dpc-3474 373 23 absence absence NOUN dpc-3474 373 24 of of ADP dpc-3474 373 25 symptoms symptom NOUN dpc-3474 373 26 . . PUNCT dpc-3474 374 1 for for ADP dpc-3474 374 2 asymptomatic asymptomatic ADJ dpc-3474 374 3 patients patient NOUN dpc-3474 374 4 with with ADP dpc-3474 374 5 stages stage NOUN dpc-3474 374 6 iib iib PROPN dpc-3474 374 7 and and CCONJ dpc-3474 374 8 iic iic PROPN dpc-3474 374 9 , , PUNCT dpc-3474 374 10 nccn nccn PROPN dpc-3474 374 11 guidelines guideline NOUN dpc-3474 374 12 do do AUX dpc-3474 374 13 not not PART dpc-3474 374 14 strongly strongly ADV dpc-3474 374 15 recommend recommend VERB dpc-3474 374 16 cross cross ADJ dpc-3474 374 17 - - ADJ dpc-3474 374 18 sectional sectional ADJ dpc-3474 374 19 imaging imaging NOUN dpc-3474 374 20 . . PUNCT dpc-3474 375 1 in in ADP dpc-3474 375 2 contrast contrast NOUN dpc-3474 375 3 , , PUNCT dpc-3474 375 4 european european ADJ dpc-3474 375 5 guidelines guideline NOUN dpc-3474 375 6 recommend recommend VERB dpc-3474 375 7 cross cross ADJ dpc-3474 375 8 - - ADJ dpc-3474 375 9 sectional sectional ADJ dpc-3474 375 10 imaging imaging NOUN dpc-3474 375 11 from from ADP dpc-3474 375 12 stage stage NOUN dpc-3474 375 13 iic iic PROPN dpc-3474 375 14 onwards onwards ADV dpc-3474 375 15 but but CCONJ dpc-3474 375 16 recommend recommend VERB dpc-3474 375 17 nodal nodal NOUN dpc-3474 375 18 ultrasound ultrasound NOUN dpc-3474 375 19 from from ADP dpc-3474 375 20 stage stage NOUN dpc-3474 375 21 ib ib NOUN dpc-3474 375 22 and and CCONJ dpc-3474 375 23 above above ADP dpc-3474 375 24 [ [ X dpc-3474 375 25 43 43 NUM dpc-3474 375 26 ] ] PUNCT dpc-3474 375 27 . . PUNCT dpc-3474 376 1 given give VERB dpc-3474 376 2 these these DET dpc-3474 376 3 variations variation NOUN dpc-3474 376 4 in in ADP dpc-3474 376 5 the the DET dpc-3474 376 6 specific specific ADJ dpc-3474 376 7 recommendations recommendation NOUN dpc-3474 376 8 , , PUNCT dpc-3474 376 9 a a DET dpc-3474 376 10 comprehensive comprehensive ADJ dpc-3474 376 11 understanding understanding NOUN dpc-3474 376 12 of of ADP dpc-3474 376 13 recurrence recurrence NOUN dpc-3474 376 14 patterns pattern NOUN dpc-3474 376 15 is be AUX dpc-3474 376 16 paramount paramount ADJ dpc-3474 376 17 when when SCONJ dpc-3474 376 18 deciding decide VERB dpc-3474 376 19 a a DET dpc-3474 376 20 detailed detailed ADJ dpc-3474 376 21 and and CCONJ dpc-3474 376 22 individualized individualized ADJ dpc-3474 376 23 follow follow NOUN dpc-3474 376 24 - - PUNCT dpc-3474 376 25 up up ADP dpc-3474 376 26 plan plan NOUN dpc-3474 376 27 for for ADP dpc-3474 376 28 specific specific ADJ dpc-3474 376 29 patients patient NOUN dpc-3474 376 30 [ [ X dpc-3474 376 31 1 1 NUM dpc-3474 376 32 ] ] PUNCT dpc-3474 376 33 . . PUNCT dpc-3474 377 1 additionally additionally ADV dpc-3474 377 2 , , PUNCT dpc-3474 377 3 a a DET dpc-3474 377 4 detailed detailed ADJ dpc-3474 377 5 understanding understanding NOUN dpc-3474 377 6 of of ADP dpc-3474 377 7 melanoma melanoma NOUN dpc-3474 377 8 recurrence recurrence NOUN dpc-3474 377 9 patterns pattern NOUN dpc-3474 377 10 might might AUX dpc-3474 377 11 have have VERB dpc-3474 377 12 a a DET dpc-3474 377 13 role role NOUN dpc-3474 377 14 in in ADP dpc-3474 377 15 adjuvant adjuvant ADJ dpc-3474 377 16 treatment treatment NOUN dpc-3474 377 17 selection selection NOUN dpc-3474 377 18 . . PUNCT dpc-3474 378 1 recently recently ADV dpc-3474 378 2 , , PUNCT dpc-3474 378 3 the the DET dpc-3474 378 4 approval approval NOUN dpc-3474 378 5 of of ADP dpc-3474 378 6 adjuvant adjuvant ADJ dpc-3474 378 7 treatment treatment NOUN dpc-3474 378 8 with with ADP dpc-3474 378 9 immune immune ADJ dpc-3474 378 10 checkpoint checkpoint NOUN dpc-3474 378 11 inhibitors inhibitor NOUN dpc-3474 378 12 and and CCONJ dpc-3474 378 13 targeted target VERB dpc-3474 378 14 therapies therapy NOUN dpc-3474 378 15 by by ADP dpc-3474 378 16 both both CCONJ dpc-3474 378 17 the the DET dpc-3474 378 18 us us PROPN dpc-3474 378 19 food food NOUN dpc-3474 378 20 and and CCONJ dpc-3474 378 21 drug drug PROPN dpc-3474 378 22 administration administration PROPN dpc-3474 378 23 ( ( PUNCT dpc-3474 378 24 fda fda PROPN dpc-3474 378 25 ) ) PUNCT dpc-3474 378 26 and and CCONJ dpc-3474 378 27 the the DET dpc-3474 378 28 european european PROPN dpc-3474 378 29 studies study NOUN dpc-3474 378 30 have have AUX dpc-3474 378 31 reported report VERB dpc-3474 378 32 the the DET dpc-3474 378 33 melanoma melanoma NOUN dpc-3474 378 34 recurrence recurrence NOUN dpc-3474 378 35 detection detection NOUN dpc-3474 378 36 modality modality NOUN dpc-3474 378 37 : : PUNCT dpc-3474 378 38 a a X dpc-3474 378 39 ) ) PUNCT dpc-3474 378 40 symptoms symptom NOUN dpc-3474 378 41 / / SYM dpc-3474 378 42 self self NOUN dpc-3474 378 43 - - PUNCT dpc-3474 378 44 reported report VERB dpc-3474 378 45 by by ADP dpc-3474 378 46 the the DET dpc-3474 378 47 patient patient NOUN dpc-3474 378 48 , , PUNCT dpc-3474 378 49 b b NOUN dpc-3474 378 50 ) ) PUNCT dpc-3474 378 51 by by ADP dpc-3474 378 52 physician physician NOUN dpc-3474 378 53 examination examination NOUN dpc-3474 378 54 ( ( PUNCT dpc-3474 378 55 i.e. i.e. X dpc-3474 378 56 physical physical ADJ dpc-3474 378 57 examination examination NOUN dpc-3474 378 58 ) ) PUNCT dpc-3474 378 59 , , PUNCT dpc-3474 378 60 or or CCONJ dpc-3474 378 61 c c X dpc-3474 378 62 ) ) PUNCT dpc-3474 378 63 by by ADP dpc-3474 378 64 imaging image VERB dpc-3474 378 65 ( ( PUNCT dpc-3474 378 66 e.g. e.g. ADV dpc-3474 378 67 ultrasound ultrasound NOUN dpc-3474 378 68 , , PUNCT dpc-3474 378 69 pet pet NOUN dpc-3474 378 70 - - PUNCT dpc-3474 378 71 ct ct PROPN dpc-3474 378 72 , , PUNCT dpc-3474 378 73 among among ADP dpc-3474 378 74 others other NOUN dpc-3474 378 75 ) ) PUNCT dpc-3474 378 76 . . PUNCT dpc-3474 379 1 the the DET dpc-3474 379 2 most most ADV dpc-3474 379 3 frequent frequent ADJ dpc-3474 379 4 modality modality NOUN dpc-3474 379 5 for for ADP dpc-3474 379 6 detection detection NOUN dpc-3474 379 7 of of ADP dpc-3474 379 8 recurrence recurrence NOUN dpc-3474 379 9 was be AUX dpc-3474 379 10 patient patient ADJ dpc-3474 379 11 self self NOUN dpc-3474 379 12 - - PUNCT dpc-3474 379 13 report report NOUN dpc-3474 379 14 across across ADP dpc-3474 379 15 most most ADJ dpc-3474 379 16 studies study NOUN dpc-3474 379 17 ( ( PUNCT dpc-3474 379 18 mainly mainly ADV dpc-3474 379 19 by by ADP dpc-3474 379 20 symptoms symptom NOUN dpc-3474 379 21 ) ) PUNCT dpc-3474 380 1 [ [ X dpc-3474 380 2 1,16,22,24 1,16,22,24 NUM dpc-3474 380 3 ] ] PUNCT dpc-3474 380 4 . . PUNCT dpc-3474 381 1 meyers meyer NOUN dpc-3474 381 2 et et PROPN dpc-3474 381 3 al al PROPN dpc-3474 381 4 study study PROPN dpc-3474 381 5 reported report VERB dpc-3474 381 6 that that SCONJ dpc-3474 381 7 melanoma melanoma NOUN dpc-3474 381 8 recurrence recurrence NOUN dpc-3474 381 9 detection detection NOUN dpc-3474 381 10 was be AUX dpc-3474 381 11 by by ADP dpc-3474 381 12 patient patient ADJ dpc-3474 381 13 self self NOUN dpc-3474 381 14 - - PUNCT dpc-3474 381 15 reports report NOUN dpc-3474 381 16 in in ADP dpc-3474 381 17 67 67 NUM dpc-3474 381 18 % % NOUN dpc-3474 381 19 , , PUNCT dpc-3474 381 20 by by ADP dpc-3474 381 21 clinical clinical ADJ dpc-3474 381 22 examination examination NOUN dpc-3474 381 23 in in ADP dpc-3474 381 24 26 26 NUM dpc-3474 381 25 % % NOUN dpc-3474 381 26 , , PUNCT dpc-3474 381 27 and and CCONJ dpc-3474 381 28 by by ADP dpc-3474 381 29 imaging image VERB dpc-3474 381 30 in in ADP dpc-3474 381 31 only only ADV dpc-3474 381 32 7 7 NUM dpc-3474 381 33 % % NOUN dpc-3474 381 34 of of ADP dpc-3474 381 35 cases case NOUN dpc-3474 381 36 [ [ X dpc-3474 381 37 16 16 NUM dpc-3474 381 38 ] ] PUNCT dpc-3474 381 39 . . PUNCT dpc-3474 382 1 in in ADP dpc-3474 382 2 lee lee PROPN dpc-3474 382 3 et et PROPN dpc-3474 382 4 al al PROPN dpc-3474 382 5 series series PROPN dpc-3474 382 6 , , PUNCT dpc-3474 382 7 59 59 NUM dpc-3474 382 8 % % NOUN dpc-3474 382 9 of of ADP dpc-3474 382 10 recurrences recurrence NOUN dpc-3474 382 11 were be AUX dpc-3474 382 12 detected detect VERB dpc-3474 382 13 by by ADP dpc-3474 382 14 patient patient ADJ dpc-3474 382 15 self self NOUN dpc-3474 382 16 - - PUNCT dpc-3474 382 17 report report NOUN dpc-3474 382 18 ( ( PUNCT dpc-3474 382 19 symptoms symptom NOUN dpc-3474 382 20 ) ) PUNCT dpc-3474 382 21 and and CCONJ dpc-3474 382 22 similarly similarly ADV dpc-3474 382 23 , , PUNCT dpc-3474 382 24 in in ADP dpc-3474 382 25 bleicher bleicher PROPN dpc-3474 382 26 et et PROPN dpc-3474 382 27 al al PROPN dpc-3474 382 28 series series PROPN dpc-3474 382 29 , , PUNCT dpc-3474 382 30 60 60 NUM dpc-3474 382 31 % % NOUN dpc-3474 382 32 of of ADP dpc-3474 382 33 recurrences recurrence NOUN dpc-3474 382 34 were be AUX dpc-3474 382 35 detected detect VERB dpc-3474 382 36 by by ADP dpc-3474 382 37 patient patient ADJ dpc-3474 382 38 self self NOUN dpc-3474 382 39 - - PUNCT dpc-3474 382 40 report report NOUN dpc-3474 382 41 [ [ X dpc-3474 382 42 22,24 22,24 NUM dpc-3474 382 43 ] ] X dpc-3474 382 44 . . PUNCT dpc-3474 383 1 based base VERB dpc-3474 383 2 on on ADP dpc-3474 383 3 this this DET dpc-3474 383 4 data data NOUN dpc-3474 383 5 , , PUNCT dpc-3474 383 6 it it PRON dpc-3474 383 7 appears appear VERB dpc-3474 383 8 to to PART dpc-3474 383 9 be be AUX dpc-3474 383 10 mandatory mandatory ADJ dpc-3474 383 11 to to PART dpc-3474 383 12 directly directly ADV dpc-3474 383 13 question question VERB dpc-3474 383 14 patients patient NOUN dpc-3474 383 15 for for ADP dpc-3474 383 16 specific specific ADJ dpc-3474 383 17 symptoms symptom NOUN dpc-3474 383 18 ( ( PUNCT dpc-3474 383 19 e.g. e.g. ADV dpc-3474 383 20 headache headache NOUN dpc-3474 383 21 , , PUNCT dpc-3474 383 22 dyspnea dyspnea NOUN dpc-3474 383 23 , , PUNCT dpc-3474 383 24 pain pain NOUN dpc-3474 383 25 , , PUNCT dpc-3474 383 26 bumps bump NOUN dpc-3474 383 27 , , PUNCT dpc-3474 383 28 or or CCONJ dpc-3474 383 29 asthenia asthenia PROPN dpc-3474 383 30 ) ) PUNCT dpc-3474 383 31 during during ADP dpc-3474 383 32 follow follow NOUN dpc-3474 383 33 - - PUNCT dpc-3474 383 34 up up NOUN dpc-3474 383 35 after after ADP dpc-3474 383 36 melanoma melanoma NOUN dpc-3474 383 37 treatment treatment NOUN dpc-3474 383 38 . . PUNCT dpc-3474 384 1 this this PRON dpc-3474 384 2 should should AUX dpc-3474 384 3 be be AUX dpc-3474 384 4 in in ADP dpc-3474 384 5 addition addition NOUN dpc-3474 384 6 to to ADP dpc-3474 384 7 melanoma melanoma PROPN dpc-3474 384 8 guidelines guideline NOUN dpc-3474 384 9 - - PUNCT dpc-3474 384 10 directed direct VERB dpc-3474 384 11 imaging imaging NOUN dpc-3474 384 12 and and CCONJ dpc-3474 384 13 other other ADJ dpc-3474 384 14 complementary complementary ADJ dpc-3474 384 15 testing testing NOUN dpc-3474 384 16 and and CCONJ dpc-3474 384 17 should should AUX dpc-3474 384 18 not not PART dpc-3474 384 19 be be AUX dpc-3474 384 20 overlooked overlook VERB dpc-3474 384 21 or or CCONJ dpc-3474 384 22 underestimated underestimate VERB dpc-3474 384 23 . . PUNCT dpc-3474 385 1 recurrence recurrence NOUN dpc-3474 385 2 predictors predictor NOUN dpc-3474 385 3 several several ADJ dpc-3474 385 4 risk risk NOUN dpc-3474 385 5 factors factor NOUN dpc-3474 385 6 are be AUX dpc-3474 385 7 associated associate VERB dpc-3474 385 8 with with ADP dpc-3474 385 9 or or CCONJ dpc-3474 385 10 predict predict VERB dpc-3474 385 11 the the DET dpc-3474 385 12 risk risk NOUN dpc-3474 385 13 of of ADP dpc-3474 385 14 melanoma melanoma NOUN dpc-3474 385 15 recurrence recurrence NOUN dpc-3474 385 16 . . PUNCT dpc-3474 386 1 the the DET dpc-3474 386 2 most most ADV dpc-3474 386 3 frequent frequent ADJ dpc-3474 386 4 predictors predictor NOUN dpc-3474 386 5 of of ADP dpc-3474 386 6 recurrence recurrence NOUN dpc-3474 386 7 were be AUX dpc-3474 386 8 breslow breslow ADJ dpc-3474 386 9 thickness thickness NOUN dpc-3474 386 10 and and CCONJ dpc-3474 386 11 male male ADJ dpc-3474 386 12 sex sex NOUN dpc-3474 386 13 [ [ X dpc-3474 386 14 1,3,6,22,42 1,3,6,22,42 NUM dpc-3474 386 15 ] ] PUNCT dpc-3474 386 16 . . PUNCT dpc-3474 387 1 meier meier PROPN dpc-3474 387 2 et et PROPN dpc-3474 387 3 al al PROPN dpc-3474 387 4 showed show VERB dpc-3474 387 5 that that SCONJ dpc-3474 387 6 the the DET dpc-3474 387 7 location location NOUN dpc-3474 387 8 of of ADP dpc-3474 387 9 the the DET dpc-3474 387 10 initial initial ADJ dpc-3474 387 11 tumor tumor NOUN dpc-3474 387 12 ( ( PUNCT dpc-3474 387 13 trunk trunk NOUN dpc-3474 387 14 in in ADP dpc-3474 387 15 men man NOUN dpc-3474 387 16 and and CCONJ dpc-3474 387 17 lower low ADJ dpc-3474 387 18 extremities extremity NOUN dpc-3474 387 19 in in ADP dpc-3474 387 20 women woman NOUN dpc-3474 387 21 ) ) PUNCT dpc-3474 387 22 and and CCONJ dpc-3474 387 23 breslow breslow ADJ dpc-3474 387 24 thickness thickness NOUN dpc-3474 387 25 were be AUX dpc-3474 387 26 the the DET dpc-3474 387 27 main main ADJ dpc-3474 387 28 predictors predictor NOUN dpc-3474 387 29 of of ADP dpc-3474 387 30 recurrence recurrence NOUN dpc-3474 387 31 [ [ X dpc-3474 387 32 6 6 NUM dpc-3474 387 33 ] ] PUNCT dpc-3474 387 34 . . PUNCT dpc-3474 388 1 o’connell o’connell INTJ dpc-3474 388 2 et et PROPN dpc-3474 388 3 al al PROPN dpc-3474 388 4 reported report VERB dpc-3474 388 5 that that SCONJ dpc-3474 388 6 recurrence recurrence NOUN dpc-3474 388 7 predictors predictor NOUN dpc-3474 388 8 were be AUX dpc-3474 388 9 nodular nodular ADJ dpc-3474 388 10 histologic histologic ADJ dpc-3474 388 11 subtype subtype NOUN dpc-3474 388 12 and and CCONJ dpc-3474 388 13 breslow breslow ADJ dpc-3474 388 14 thickness thickness NOUN dpc-3474 389 1 [ [ X dpc-3474 389 2 3 3 NUM dpc-3474 389 3 ] ] PUNCT dpc-3474 389 4 . . PUNCT dpc-3474 390 1 similarly similarly ADV dpc-3474 390 2 , , PUNCT dpc-3474 390 3 bleicher bleicher PROPN dpc-3474 390 4 et et PROPN dpc-3474 390 5 al al PROPN dpc-3474 390 6 showed show VERB dpc-3474 390 7 that that SCONJ dpc-3474 390 8 age age NOUN dpc-3474 390 9 , , PUNCT dpc-3474 390 10 male male ADJ dpc-3474 390 11 sex sex NOUN dpc-3474 390 12 , , PUNCT dpc-3474 390 13 stage stage NOUN dpc-3474 390 14 , , PUNCT dpc-3474 390 15 and and CCONJ dpc-3474 390 16 breslow breslow NOUN dpc-3474 390 17 thickness thickness NOUN dpc-3474 390 18 as as ADP dpc-3474 390 19 important important ADJ dpc-3474 390 20 recurrence recurrence NOUN dpc-3474 390 21 factors factor NOUN dpc-3474 390 22 [ [ X dpc-3474 390 23 22 22 NUM dpc-3474 390 24 ] ] PUNCT dpc-3474 390 25 . . PUNCT dpc-3474 391 1 berger berger PROPN dpc-3474 391 2 et et PROPN dpc-3474 391 3 al al PROPN dpc-3474 391 4 series series PROPN dpc-3474 391 5 included include VERB dpc-3474 391 6 recurrent recurrent ADJ dpc-3474 391 7 factors factor NOUN dpc-3474 391 8 : : PUNCT dpc-3474 391 9 male male ADJ dpc-3474 391 10 sex sex NOUN dpc-3474 391 11 , , PUNCT dpc-3474 391 12 tclassification tclassification NOUN dpc-3474 391 13 , , PUNCT dpc-3474 391 14 and and CCONJ dpc-3474 391 15 ulceration ulceration NOUN dpc-3474 391 16 as as ADP dpc-3474 391 17 predictors predictor NOUN dpc-3474 391 18 [ [ X dpc-3474 391 19 1 1 NUM dpc-3474 391 20 ] ] PUNCT dpc-3474 391 21 . . PUNCT dpc-3474 392 1 thomas thomas PROPN dpc-3474 392 2 et et PROPN dpc-3474 392 3 al al PROPN dpc-3474 392 4 series series PROPN dpc-3474 392 5 evaluated evaluate VERB dpc-3474 392 6 risk risk NOUN dpc-3474 392 7 factors factor NOUN dpc-3474 392 8 for for ADP dpc-3474 392 9 specific specific ADJ dpc-3474 392 10 recurrence recurrence NOUN dpc-3474 392 11 patterns pattern NOUN dpc-3474 392 12 . . PUNCT dpc-3474 393 1 for for ADP dpc-3474 393 2 lcit lcit ADJ dpc-3474 393 3 recurrence recurrence NOUN dpc-3474 393 4 : : PUNCT dpc-3474 393 5 age age NOUN dpc-3474 393 6 , , PUNCT dpc-3474 393 7 anatomic anatomic ADJ dpc-3474 393 8 location location NOUN dpc-3474 393 9 , , PUNCT dpc-3474 393 10 breslow breslow ADJ dpc-3474 393 11 thickness thickness NOUN dpc-3474 393 12 ; ; PUNCT dpc-3474 393 13 for for ADP dpc-3474 393 14 lymph lymph NOUN dpc-3474 393 15 node node NOUN dpc-3474 393 16 recurrence recurrence NOUN dpc-3474 393 17 : : PUNCT dpc-3474 393 18 age age NOUN dpc-3474 393 19 and and CCONJ dpc-3474 393 20 breslow breslow ADJ dpc-3474 393 21 thickness thickness NOUN dpc-3474 393 22 ; ; PUNCT dpc-3474 393 23 and and CCONJ dpc-3474 393 24 for for ADP dpc-3474 393 25 systemic systemic ADJ dpc-3474 393 26 recurrence recurrence NOUN dpc-3474 393 27 : : PUNCT dpc-3474 393 28 anatomic anatomic ADJ dpc-3474 393 29 location location NOUN dpc-3474 393 30 ( ( PUNCT dpc-3474 393 31 head head NOUN dpc-3474 393 32 and and CCONJ dpc-3474 393 33 neck neck NOUN dpc-3474 393 34 or or CCONJ dpc-3474 393 35 trunk trunk NOUN dpc-3474 393 36 ) ) PUNCT dpc-3474 393 37 , , PUNCT dpc-3474 393 38 breslow breslow ADJ dpc-3474 393 39 thickness thickness NOUN dpc-3474 393 40 , , PUNCT dpc-3474 393 41 ulceration ulceration NOUN dpc-3474 393 42 , , PUNCT dpc-3474 393 43 and and CCONJ dpc-3474 393 44 lymphovascular lymphovascular ADJ dpc-3474 393 45 invasion invasion NOUN dpc-3474 393 46 [ [ X dpc-3474 393 47 42 42 NUM dpc-3474 393 48 ] ] PUNCT dpc-3474 393 49 . . PUNCT dpc-3474 394 1 overall overall ADJ dpc-3474 394 2 survival survival NOUN dpc-3474 394 3 : : PUNCT dpc-3474 394 4 role role NOUN dpc-3474 394 5 of of ADP dpc-3474 394 6 recurrent recurrent ADJ dpc-3474 394 7 disease disease NOUN dpc-3474 394 8 the the DET dpc-3474 394 9 patterns pattern NOUN dpc-3474 394 10 of of ADP dpc-3474 394 11 recurrence recurrence NOUN dpc-3474 394 12 tend tend VERB dpc-3474 394 13 to to PART dpc-3474 394 14 impact impact VERB dpc-3474 394 15 melanoma melanoma NOUN dpc-3474 394 16 overall overall ADJ dpc-3474 394 17 survival survival NOUN dpc-3474 394 18 ( ( PUNCT dpc-3474 394 19 os os NOUN dpc-3474 394 20 ) ) PUNCT dpc-3474 394 21 ; ; PUNCT dpc-3474 394 22 therefore therefore ADV dpc-3474 394 23 , , PUNCT dpc-3474 394 24 careful careful ADJ dpc-3474 394 25 understanding understanding NOUN dpc-3474 394 26 of of ADP dpc-3474 394 27 recurrence recurrence NOUN dpc-3474 394 28 type type NOUN dpc-3474 394 29 can can AUX dpc-3474 394 30 help help VERB dpc-3474 394 31 with with ADP dpc-3474 394 32 patient patient ADJ dpc-3474 394 33 management management NOUN dpc-3474 394 34 and and CCONJ dpc-3474 394 35 counseling counseling NOUN dpc-3474 394 36 : : PUNCT dpc-3474 394 37 the the DET dpc-3474 394 38 sole sole ADJ dpc-3474 394 39 occurrence occurrence NOUN dpc-3474 394 40 of of ADP dpc-3474 394 41 recurrent recurrent ADJ dpc-3474 394 42 disease disease NOUN dpc-3474 394 43 ( ( PUNCT dpc-3474 394 44 irrespective irrespective ADV dpc-3474 394 45 of of ADP dpc-3474 394 46 type type NOUN dpc-3474 394 47 ) ) PUNCT dpc-3474 394 48 is be AUX dpc-3474 394 49 associated associate VERB dpc-3474 394 50 with with ADP dpc-3474 394 51 a a DET dpc-3474 394 52 worse bad ADJ dpc-3474 394 53 prognosis prognosis NOUN dpc-3474 394 54 . . PUNCT dpc-3474 395 1 meyers meyer NOUN dpc-3474 395 2 et et PROPN dpc-3474 395 3 al al PROPN dpc-3474 395 4 study study PROPN dpc-3474 395 5 showed show VERB dpc-3474 395 6 that that SCONJ dpc-3474 395 7 the the DET dpc-3474 395 8 median median ADJ dpc-3474 395 9 survival survival NOUN dpc-3474 395 10 was be AUX dpc-3474 395 11 22 22 NUM dpc-3474 395 12 months month NOUN dpc-3474 395 13 for for ADP dpc-3474 395 14 melanoma melanoma NOUN dpc-3474 395 15 recurrences recurrence NOUN dpc-3474 395 16 in in ADP dpc-3474 395 17 the the DET dpc-3474 395 18 lcit lcit NOUN dpc-3474 395 19 - - PUNCT dpc-3474 395 20 lymph lymph NOUN dpc-3474 395 21 node node NOUN dpc-3474 395 22 group group NOUN dpc-3474 395 23 and and CCONJ dpc-3474 395 24 7 7 NUM dpc-3474 395 25     SPACE dpc-3474 395 26 months month NOUN dpc-3474 395 27 for for ADP dpc-3474 395 28 the the DET dpc-3474 395 29 systemic systemic ADJ dpc-3474 395 30 recurrence recurrence NOUN dpc-3474 395 31 group group NOUN dpc-3474 396 1 [ [ X dpc-3474 396 2 16 16 NUM dpc-3474 396 3 ] ] PUNCT dpc-3474 396 4 . . PUNCT dpc-3474 397 1 leeneman leeneman PROPN dpc-3474 397 2 et et PROPN dpc-3474 397 3 al al PROPN dpc-3474 397 4 showed show VERB dpc-3474 397 5 a a DET dpc-3474 397 6 mean mean ADJ dpc-3474 397 7 os os NOUN dpc-3474 397 8 of of ADP dpc-3474 397 9 1.9 1.9 NUM dpc-3474 397 10 years year NOUN dpc-3474 397 11 ( ( PUNCT dpc-3474 397 12 95 95 NUM dpc-3474 397 13 % % NOUN dpc-3474 397 14 ci ci NOUN dpc-3474 397 15 : : PUNCT dpc-3474 397 16 0.83.2 0.83.2 NUM dpc-3474 397 17 ) ) PUNCT dpc-3474 397 18 for for ADP dpc-3474 397 19 patients patient NOUN dpc-3474 397 20 initially initially ADV dpc-3474 397 21 diagnosed diagnose VERB dpc-3474 397 22 with with ADP dpc-3474 397 23 stage stage NOUN dpc-3474 397 24 ib ib NOUN dpc-3474 397 25 , , PUNCT dpc-3474 397 26 1.5 1.5 NUM dpc-3474 397 27 years year NOUN dpc-3474 397 28 ( ( PUNCT dpc-3474 397 29 95 95 NUM dpc-3474 397 30 % % NOUN dpc-3474 397 31 ci ci NOUN dpc-3474 397 32 : : PUNCT dpc-3474 397 33 1.1 1.1 NUM dpc-3474 397 34 - - SYM dpc-3474 397 35 2.1 2.1 NUM dpc-3474 397 36 ) ) PUNCT dpc-3474 397 37 for for ADP dpc-3474 397 38 patients patient NOUN dpc-3474 397 39 initially initially ADV dpc-3474 397 40 diagnosed diagnose VERB dpc-3474 397 41 with with ADP dpc-3474 397 42 stage stage NOUN dpc-3474 397 43 ii ii PROPN dpc-3474 397 44 , , PUNCT dpc-3474 397 45 and and CCONJ dpc-3474 397 46 10 10 NUM dpc-3474 397 47 review review NOUN dpc-3474 397 48 | | ADV dpc-3474 397 49 dermatol dermatol ADJ dpc-3474 397 50 pract pract NOUN dpc-3474 397 51 concept concept NOUN dpc-3474 397 52 . . PUNCT dpc-3474 398 1 2023;13(4):e2023304 2023;13(4):e2023304 NUM dpc-3474 398 2 10 10 NUM dpc-3474 398 3 . . PUNCT dpc-3474 399 1 cohn cohn PROPN dpc-3474 399 2 - - PUNCT dpc-3474 399 3 cedermark cedermark PROPN dpc-3474 399 4 g g NOUN dpc-3474 399 5 , , PUNCT dpc-3474 399 6 månsson månsson NOUN dpc-3474 399 7 - - PUNCT dpc-3474 399 8 brahme brahme NOUN dpc-3474 399 9 e e NOUN dpc-3474 399 10 , , PUNCT dpc-3474 399 11 rutqvist rutqvist NOUN dpc-3474 399 12 le le PROPN dpc-3474 399 13 , , PUNCT dpc-3474 399 14 larsson larsson PROPN dpc-3474 399 15 o o PROPN dpc-3474 399 16 , , PUNCT dpc-3474 399 17 singnomklao singnomklao PROPN dpc-3474 399 18 t t PROPN dpc-3474 399 19 , , PUNCT dpc-3474 399 20 ringborg ringborg PROPN dpc-3474 399 21 u. u. PROPN dpc-3474 399 22 metastatic metastatic PROPN dpc-3474 399 23 patterns pattern NOUN dpc-3474 399 24 , , PUNCT dpc-3474 399 25 clinical clinical ADJ dpc-3474 399 26 outcome outcome NOUN dpc-3474 399 27 , , PUNCT dpc-3474 399 28 and and CCONJ dpc-3474 399 29 malignant malignant ADJ dpc-3474 399 30 phenotype phenotype NOUN dpc-3474 399 31 in in ADP dpc-3474 399 32 malignant malignant ADJ dpc-3474 399 33 cutaneous cutaneous ADJ dpc-3474 399 34 melanoma melanoma NOUN dpc-3474 399 35 . . PUNCT dpc-3474 400 1 acta acta PROPN dpc-3474 400 2 oncol oncol ADJ dpc-3474 400 3 stockh stockh NOUN dpc-3474 400 4 swed swe VERB dpc-3474 400 5 . . PUNCT dpc-3474 401 1 1999;38(5):549 1999;38(5):549 PROPN dpc-3474 401 2 - - PUNCT dpc-3474 401 3 57 57 NUM dpc-3474 401 4 . . PUNCT dpc-3474 402 1 doi doi NOUN dpc-3474 402 2 : : PUNCT dpc-3474 402 3 10.1080/028418699431122 10.1080/028418699431122 NUM dpc-3474 402 4 . . PUNCT dpc-3474 403 1 pmid pmid NOUN dpc-3474 403 2 : : PUNCT dpc-3474 403 3 10427942 10427942 NUM dpc-3474 403 4 . . PUNCT dpc-3474 404 1 11 11 NUM dpc-3474 404 2 . . X dpc-3474 405 1 cromwell cromwell PROPN dpc-3474 405 2 kd kd PROPN dpc-3474 405 3 , , PUNCT dpc-3474 405 4 ross ross PROPN dpc-3474 405 5 mi mi PROPN dpc-3474 405 6 , , PUNCT dpc-3474 405 7 xing xing PROPN dpc-3474 405 8 y y PROPN dpc-3474 405 9 , , PUNCT dpc-3474 405 10 et et PROPN dpc-3474 405 11     SPACE dpc-3474 405 12 al al PROPN dpc-3474 405 13 . . PUNCT dpc-3474 405 14 variability variability NOUN dpc-3474 405 15 in in ADP dpc-3474 405 16 melanoma melanoma PROPN dpc-3474 405 17 post post ADJ dpc-3474 405 18 - - ADJ dpc-3474 405 19 treatment treatment NOUN dpc-3474 405 20 surveillance surveillance NOUN dpc-3474 405 21 practices practice NOUN dpc-3474 405 22 by by ADP dpc-3474 405 23 country country NOUN dpc-3474 405 24 and and CCONJ dpc-3474 405 25 physician physician NOUN dpc-3474 405 26 specialty specialty NOUN dpc-3474 405 27 : : PUNCT dpc-3474 405 28 a a DET dpc-3474 405 29 systematic systematic ADJ dpc-3474 405 30 review review NOUN dpc-3474 405 31 . . PUNCT dpc-3474 406 1 melanoma melanoma NOUN dpc-3474 406 2 res re NOUN dpc-3474 406 3 . . PUNCT dpc-3474 407 1 2012;22(5):376 2012;22(5):376 NUM dpc-3474 407 2 - - PUNCT dpc-3474 407 3 85 85 NUM dpc-3474 407 4 . . PUNCT dpc-3474 408 1 doi doi NOUN dpc-3474 408 2 : : PUNCT dpc-3474 408 3 10.1097 10.1097 NUM dpc-3474 408 4 / / SYM dpc-3474 408 5 cmr.0b013e328357d796 cmr.0b013e328357d796 NOUN dpc-3474 408 6 . . PUNCT dpc-3474 409 1 pmid pmid NOUN dpc-3474 409 2 : : PUNCT dpc-3474 409 3 22914178 22914178 NUM dpc-3474 409 4 12 12 NUM dpc-3474 409 5 . . PUNCT dpc-3474 410 1 garbe garbe PROPN dpc-3474 410 2 c c PROPN dpc-3474 410 3 , , PUNCT dpc-3474 410 4 amaral amaral PROPN dpc-3474 410 5 t t PROPN dpc-3474 410 6 , , PUNCT dpc-3474 410 7 peris peris PROPN dpc-3474 410 8 k k PROPN dpc-3474 410 9 , , PUNCT dpc-3474 410 10 et et PROPN dpc-3474 410 11     SPACE dpc-3474 410 12 al al PROPN dpc-3474 410 13 . . PUNCT dpc-3474 411 1 european european PROPN dpc-3474 411 2 consensus consensus NOUN dpc-3474 411 3 - - PUNCT dpc-3474 411 4 based base VERB dpc-3474 411 5 interdisciplinary interdisciplinary ADJ dpc-3474 411 6 guideline guideline NOUN dpc-3474 411 7 for for ADP dpc-3474 411 8 melanoma melanoma NOUN dpc-3474 411 9 . . PUNCT dpc-3474 412 1 part part NOUN dpc-3474 412 2 2 2 NUM dpc-3474 412 3 : : PUNCT dpc-3474 412 4 treatment treatment NOUN dpc-3474 412 5 update update NOUN dpc-3474 412 6 2022 2022 NUM dpc-3474 412 7 . . PUNCT dpc-3474 413 1 eur eur PROPN dpc-3474 413 2 j j PROPN dpc-3474 413 3 cancer cancer NOUN dpc-3474 413 4 . . PUNCT dpc-3474 414 1 2022;170:256 2022;170:256 NUM dpc-3474 414 2 - - SYM dpc-3474 414 3 84 84 NUM dpc-3474 414 4 . . PUNCT dpc-3474 415 1 doi doi NOUN dpc-3474 415 2 : : PUNCT dpc-3474 415 3 10.1016 10.1016 NUM dpc-3474 415 4 / / SYM dpc-3474 415 5 j. j. PROPN dpc-3474 415 6 ejca.2022.04.018 ejca.2022.04.018 PROPN dpc-3474 415 7 . . PUNCT dpc-3474 416 1 pmid pmid NOUN dpc-3474 416 2 : : PUNCT dpc-3474 416 3 35623961 35623961 NUM dpc-3474 416 4 . . PUNCT dpc-3474 417 1 13 13 NUM dpc-3474 417 2 . . PUNCT dpc-3474 418 1 swetter swetter PROPN dpc-3474 418 2 sm sm PROPN dpc-3474 418 3 , , PUNCT dpc-3474 418 4 tsao tsao PROPN dpc-3474 418 5 h h NOUN dpc-3474 418 6 , , PUNCT dpc-3474 418 7 bichakjian bichakjian PROPN dpc-3474 418 8 ck ck PROPN dpc-3474 418 9 , , PUNCT dpc-3474 418 10 et et NOUN dpc-3474 418 11     SPACE dpc-3474 418 12 al al PROPN dpc-3474 418 13 . . PUNCT dpc-3474 418 14 guidelines guideline NOUN dpc-3474 418 15 of of ADP dpc-3474 418 16 care care NOUN dpc-3474 418 17 for for ADP dpc-3474 418 18 the the DET dpc-3474 418 19 management management NOUN dpc-3474 418 20 of of ADP dpc-3474 418 21 primary primary ADJ dpc-3474 418 22 cutaneous cutaneous ADJ dpc-3474 418 23 melanoma melanoma NOUN dpc-3474 418 24 . . PUNCT dpc-3474 419 1 j j PROPN dpc-3474 419 2 am be AUX dpc-3474 419 3 acad acad ADJ dpc-3474 419 4 dermatol dermatol NOUN dpc-3474 419 5 . . PUNCT dpc-3474 420 1 2019;80(1):208 2019;80(1):208 NUM dpc-3474 420 2 - - SYM dpc-3474 420 3 50 50 NUM dpc-3474 420 4 . . PUNCT dpc-3474 421 1 doi doi NOUN dpc-3474 421 2 : : PUNCT dpc-3474 421 3 10.1016 10.1016 NUM dpc-3474 421 4 / / SYM dpc-3474 421 5 j.jaad j.jaad PROPN dpc-3474 421 6 .2018.08.055 .2018.08.055 PROPN dpc-3474 421 7 . . PUNCT dpc-3474 422 1 pmid pmid NOUN dpc-3474 422 2 : : PUNCT dpc-3474 422 3 30392755 30392755 NUM dpc-3474 422 4 . . PUNCT dpc-3474 423 1 14 14 NUM dpc-3474 423 2 . . PUNCT dpc-3474 424 1 cancer cancer PROPN dpc-3474 424 2 council council PROPN dpc-3474 424 3 australia australia PROPN dpc-3474 424 4 melanoma melanoma PROPN dpc-3474 424 5 guidelines guideline NOUN dpc-3474 424 6 . . PUNCT dpc-3474 425 1 clinical clinical ADJ dpc-3474 425 2 practice practice NOUN dpc-3474 425 3 guidelines guideline NOUN dpc-3474 425 4 for for ADP dpc-3474 425 5 the the DET dpc-3474 425 6 diagnosis diagnosis NOUN dpc-3474 425 7 and and CCONJ dpc-3474 425 8 management management NOUN dpc-3474 425 9 of of ADP dpc-3474 425 10 melanoma melanoma NOUN dpc-3474 425 11 . . PUNCT dpc-3474 426 1 accessed access VERB dpc-3474 426 2 february february PROPN dpc-3474 426 3 7 7 NUM dpc-3474 426 4 , , PUNCT dpc-3474 426 5 2023 2023 NUM dpc-3474 426 6 . . PUNCT dpc-3474 427 1 https://wiki.cancer.org.au/australia https://wiki.cancer.org.au/australia PROPN dpc-3474 428 1 /guidelines /guideline NOUN dpc-3474 428 2 : : PUNCT dpc-3474 428 3 melanoma melanoma NOUN dpc-3474 428 4 15 15 NUM dpc-3474 428 5 . . PUNCT dpc-3474 429 1 svedman svedman NOUN dpc-3474 429 2 fc fc PROPN dpc-3474 429 3 , , PUNCT dpc-3474 429 4 pillas pillas NOUN dpc-3474 429 5 d d PROPN dpc-3474 429 6 , , PUNCT dpc-3474 429 7 taylor taylor PROPN dpc-3474 429 8 a a PROPN dpc-3474 429 9 , , PUNCT dpc-3474 429 10 kaur kaur PROPN dpc-3474 429 11 m m PROPN dpc-3474 429 12 , , PUNCT dpc-3474 429 13 linder linder PROPN dpc-3474 429 14 r r PROPN dpc-3474 429 15 , , PUNCT dpc-3474 429 16 hansson hansson PROPN dpc-3474 429 17 j. j. PROPN dpc-3474 429 18 stage stage PROPN dpc-3474 429 19 - - PUNCT dpc-3474 429 20 specific specific ADJ dpc-3474 429 21 survival survival NOUN dpc-3474 429 22 and and CCONJ dpc-3474 429 23 recurrence recurrence NOUN dpc-3474 429 24 in in ADP dpc-3474 429 25 patients patient NOUN dpc-3474 429 26 with with ADP dpc-3474 429 27 cutaneous cutaneous ADJ dpc-3474 429 28 malignant malignant ADJ dpc-3474 429 29 melanoma melanoma NOUN dpc-3474 429 30 in in ADP dpc-3474 429 31 europe europe PROPN dpc-3474 429 32 a a DET dpc-3474 429 33 systematic systematic ADJ dpc-3474 429 34 review review NOUN dpc-3474 429 35 of of ADP dpc-3474 429 36 the the DET dpc-3474 429 37 literature literature NOUN dpc-3474 429 38 . . PUNCT dpc-3474 430 1 clin clin PROPN dpc-3474 430 2 epidemiol epidemiol PROPN dpc-3474 430 3 . . PUNCT dpc-3474 431 1 2016;8:109 2016;8:109 NUM dpc-3474 431 2 - - SYM dpc-3474 431 3 22 22 NUM dpc-3474 431 4 . . PUNCT dpc-3474 432 1 doi doi NOUN dpc-3474 432 2 : : PUNCT dpc-3474 432 3 10.2147 10.2147 NUM dpc-3474 432 4 / / SYM dpc-3474 432 5 clep clep PROPN dpc-3474 432 6 .s99021 .s99021 PUNCT dpc-3474 432 7 . . PUNCT dpc-3474 433 1 pmid pmid NOUN dpc-3474 433 2 : : PUNCT dpc-3474 433 3 27307765 27307765 NUM dpc-3474 433 4 . . PUNCT dpc-3474 434 1 16 16 NUM dpc-3474 434 2 . . PUNCT dpc-3474 435 1 meyers meyers PROPN dpc-3474 435 2 mo mo PROPN dpc-3474 435 3 , , PUNCT dpc-3474 435 4 yeh yeh PROPN dpc-3474 435 5 jj jj PROPN dpc-3474 435 6 , , PUNCT dpc-3474 435 7 frank frank PROPN dpc-3474 435 8 j j PROPN dpc-3474 435 9 , , PUNCT dpc-3474 435 10 et et PROPN dpc-3474 435 11     SPACE dpc-3474 435 12 al al PROPN dpc-3474 435 13 . . PROPN dpc-3474 435 14 method method NOUN dpc-3474 435 15 of of ADP dpc-3474 435 16 detection detection NOUN dpc-3474 435 17 of of ADP dpc-3474 435 18 initial initial ADJ dpc-3474 435 19 recurrence recurrence NOUN dpc-3474 435 20 of of ADP dpc-3474 435 21 stage stage NOUN dpc-3474 435 22 ii ii PROPN dpc-3474 435 23 / / SYM dpc-3474 435 24 iii iii NUM dpc-3474 435 25 cutaneous cutaneous ADJ dpc-3474 435 26 melanoma melanoma NOUN dpc-3474 435 27 : : PUNCT dpc-3474 435 28 analysis analysis NOUN dpc-3474 435 29 of of ADP dpc-3474 435 30 the the DET dpc-3474 435 31 utility utility NOUN dpc-3474 435 32 of of ADP dpc-3474 435 33 follow follow NOUN dpc-3474 435 34 - - PUNCT dpc-3474 435 35 up up ADP dpc-3474 435 36 staging staging NOUN dpc-3474 435 37 . . PUNCT dpc-3474 436 1 ann ann PROPN dpc-3474 436 2 surg surg PROPN dpc-3474 436 3 oncol oncol PROPN dpc-3474 436 4 . . PUNCT dpc-3474 437 1 2009;16(4):941 2009;16(4):941 NUM dpc-3474 437 2 - - SYM dpc-3474 437 3 7 7 NUM dpc-3474 437 4 . . PUNCT dpc-3474 437 5 doi doi NOUN dpc-3474 437 6 : : PUNCT dpc-3474 437 7 10.1245 10.1245 NUM dpc-3474 437 8 / / SYM dpc-3474 437 9 s10434 s10434 PROPN dpc-3474 437 10 - - PUNCT dpc-3474 437 11 008 008 NUM dpc-3474 437 12 - - PUNCT dpc-3474 437 13 0238 0238 NUM dpc-3474 437 14 - - PUNCT dpc-3474 437 15 y. y. NOUN dpc-3474 437 16 pmid pmid PROPN dpc-3474 437 17 : : PUNCT dpc-3474 437 18 19101766 19101766 NUM dpc-3474 437 19 . . PUNCT dpc-3474 438 1 17 17 NUM dpc-3474 438 2 . . PUNCT dpc-3474 439 1 barbour barbour PROPN dpc-3474 439 2 s s PROPN dpc-3474 439 3 , , PUNCT dpc-3474 439 4 mark mark PROPN dpc-3474 439 5 smithers smithers PROPN dpc-3474 439 6 b b PROPN dpc-3474 439 7 , , PUNCT dpc-3474 439 8 allan allan PROPN dpc-3474 439 9 c c PROPN dpc-3474 439 10 , , PUNCT dpc-3474 439 11 et et PROPN dpc-3474 439 12     SPACE dpc-3474 439 13 al al PROPN dpc-3474 439 14 . . PUNCT dpc-3474 439 15 patterns pattern NOUN dpc-3474 439 16 of of ADP dpc-3474 439 17 recurrence recurrence NOUN dpc-3474 439 18 in in ADP dpc-3474 439 19 patients patient NOUN dpc-3474 439 20 with with ADP dpc-3474 439 21 stage stage NOUN dpc-3474 439 22 iiib iiib NOUN dpc-3474 439 23 / / SYM dpc-3474 439 24 c c X dpc-3474 439 25 cutaneous cutaneous ADJ dpc-3474 439 26 melanoma melanoma NOUN dpc-3474 439 27 of of ADP dpc-3474 439 28 the the DET dpc-3474 439 29 head head NOUN dpc-3474 439 30 and and CCONJ dpc-3474 439 31 neck neck NOUN dpc-3474 439 32 following follow VERB dpc-3474 439 33 surgery surgery NOUN dpc-3474 439 34 with with ADP dpc-3474 439 35 and and CCONJ dpc-3474 439 36 without without ADP dpc-3474 439 37 adjuvant adjuvant ADJ dpc-3474 439 38 radiation radiation NOUN dpc-3474 439 39 therapy therapy NOUN dpc-3474 439 40 : : PUNCT dpc-3474 439 41 is be AUX dpc-3474 439 42 isolated isolate VERB dpc-3474 439 43 regional regional ADJ dpc-3474 439 44 recurrence recurrence NOUN dpc-3474 439 45 salvageable salvageable ADJ dpc-3474 439 46 ? ? PUNCT dpc-3474 440 1 ann ann PROPN dpc-3474 440 2 surg surg PROPN dpc-3474 440 3 oncol oncol PROPN dpc-3474 440 4 . . PUNCT dpc-3474 441 1 2015;22(12):4052 2015;22(12):4052 NUM dpc-3474 441 2 - - SYM dpc-3474 441 3 9 9 NUM dpc-3474 441 4 . . PUNCT dpc-3474 441 5 doi doi NOUN dpc-3474 441 6 : : PUNCT dpc-3474 441 7 10.1245 10.1245 NUM dpc-3474 441 8 / / SYM dpc-3474 441 9 s10434 s10434 ADJ dpc-3474 441 10 -014 -014 NOUN dpc-3474 441 11 - - PUNCT dpc-3474 441 12 4356 4356 NUM dpc-3474 441 13 - - SYM dpc-3474 441 14 4 4 NUM dpc-3474 441 15 . . PUNCT dpc-3474 442 1 pmid pmid NOUN dpc-3474 442 2 : : PUNCT dpc-3474 442 3 25582744 25582744 NUM dpc-3474 442 4 . . PUNCT dpc-3474 443 1 18 18 NUM dpc-3474 443 2 . . PUNCT dpc-3474 443 3 turner turner PROPN dpc-3474 443 4 rm rm PROPN dpc-3474 443 5 , , PUNCT dpc-3474 443 6 bell bell PROPN dpc-3474 443 7 kjl kjl PROPN dpc-3474 443 8 , , PUNCT dpc-3474 443 9 morton morton PROPN dpc-3474 443 10 rl rl PROPN dpc-3474 443 11 , , PUNCT dpc-3474 443 12 et et PROPN dpc-3474 443 13     SPACE dpc-3474 443 14 al al PROPN dpc-3474 443 15 . . PROPN dpc-3474 443 16 optimizing optimize VERB dpc-3474 443 17 the the DET dpc-3474 443 18 frequency frequency NOUN dpc-3474 443 19 of of ADP dpc-3474 443 20 follow follow NOUN dpc-3474 443 21 - - PUNCT dpc-3474 443 22 up up ADP dpc-3474 443 23 visits visit NOUN dpc-3474 443 24 for for ADP dpc-3474 443 25 patients patient NOUN dpc-3474 443 26 treated treat VERB dpc-3474 443 27 for for ADP dpc-3474 443 28 localized localized ADJ dpc-3474 443 29 primary primary ADJ dpc-3474 443 30 cutaneous cutaneous ADJ dpc-3474 443 31 melanoma melanoma NOUN dpc-3474 443 32 . . PUNCT dpc-3474 444 1 j j PROPN dpc-3474 444 2 clin clin PROPN dpc-3474 444 3 oncol oncol PROPN dpc-3474 444 4 . . PUNCT dpc-3474 445 1 2011;29(35):4641 2011;29(35):4641 NUM dpc-3474 445 2 - - SYM dpc-3474 445 3 6 6 NUM dpc-3474 445 4 . . PUNCT dpc-3474 445 5 doi doi NOUN dpc-3474 445 6 : : PUNCT dpc-3474 445 7 10.1200 10.1200 NUM dpc-3474 445 8 / / SYM dpc-3474 445 9 jco.2010.34.2956 jco.2010.34.2956 PROPN dpc-3474 445 10 . . PUNCT dpc-3474 446 1 pmid pmid NOUN dpc-3474 446 2 : : PUNCT dpc-3474 446 3 22067399 22067399 NUM dpc-3474 446 4 . . PUNCT dpc-3474 447 1 19 19 NUM dpc-3474 447 2 . . X dpc-3474 447 3 damude damude PROPN dpc-3474 447 4 s s PROPN dpc-3474 447 5 , , PUNCT dpc-3474 447 6 hoekstra hoekstra PROPN dpc-3474 447 7 - - PUNCT dpc-3474 447 8 weebers weeber NOUN dpc-3474 447 9 jehm jehm NOUN dpc-3474 447 10 , , PUNCT dpc-3474 447 11 francken francken PROPN dpc-3474 447 12 ab ab PROPN dpc-3474 447 13 , , PUNCT dpc-3474 447 14 ter ter NOUN dpc-3474 447 15 meulen meulen NOUN dpc-3474 447 16 s s PROPN dpc-3474 447 17 , , PUNCT dpc-3474 447 18 bastiaannet bastiaannet NOUN dpc-3474 447 19 e e NOUN dpc-3474 447 20 , , PUNCT dpc-3474 447 21 hoekstra hoekstra PROPN dpc-3474 447 22 hj hj PROPN dpc-3474 447 23 . . PUNCT dpc-3474 448 1 the the DET dpc-3474 448 2 melfo melfo PROPN dpc-3474 448 3 - - PUNCT dpc-3474 448 4 study study NOUN dpc-3474 448 5 : : PUNCT dpc-3474 448 6 prospective prospective ADJ dpc-3474 448 7 , , PUNCT dpc-3474 448 8 randomized randomize VERB dpc-3474 448 9 , , PUNCT dpc-3474 448 10 clinical clinical ADJ dpc-3474 448 11 trial trial NOUN dpc-3474 448 12 for for ADP dpc-3474 448 13 the the DET dpc-3474 448 14 evaluation evaluation NOUN dpc-3474 448 15 of of ADP dpc-3474 448 16 a a DET dpc-3474 448 17 stageadjusted stageadjuste VERB dpc-3474 448 18 reduced reduce VERB dpc-3474 448 19 follow follow NOUN dpc-3474 448 20 - - PUNCT dpc-3474 448 21 up up ADP dpc-3474 448 22 schedule schedule NOUN dpc-3474 448 23 in in ADP dpc-3474 448 24 cutaneous cutaneous ADJ dpc-3474 448 25 melanoma melanoma NOUN dpc-3474 448 26 patients patient NOUN dpc-3474 448 27 - - PUNCT dpc-3474 448 28 results result NOUN dpc-3474 448 29 after after ADP dpc-3474 448 30 1 1 NUM dpc-3474 448 31 year year NOUN dpc-3474 448 32 . . PUNCT dpc-3474 449 1 ann ann PROPN dpc-3474 449 2 surg surg PROPN dpc-3474 449 3 oncol oncol PROPN dpc-3474 449 4 . . PUNCT dpc-3474 450 1 2016;23(9):2762 2016;23(9):2762 NUM dpc-3474 450 2 - - SYM dpc-3474 450 3 71 71 NUM dpc-3474 450 4 . . PUNCT dpc-3474 451 1 doi doi NOUN dpc-3474 451 2 : : PUNCT dpc-3474 451 3 10.1245 10.1245 NUM dpc-3474 451 4 / / SYM dpc-3474 451 5 s10434 s10434 PROPN dpc-3474 451 6 - - PUNCT dpc-3474 451 7 016 016 NUM dpc-3474 451 8 - - PUNCT dpc-3474 451 9 5263 5263 NUM dpc-3474 451 10 - - PUNCT dpc-3474 451 11 7 7 NUM dpc-3474 451 12 . . PUNCT dpc-3474 452 1 pmid pmid NOUN dpc-3474 452 2 : : PUNCT dpc-3474 452 3 27194552 27194552 NUM dpc-3474 452 4 . . PUNCT dpc-3474 453 1 20 20 NUM dpc-3474 453 2 . . X dpc-3474 453 3 romano romano NOUN dpc-3474 453 4 e e PROPN dpc-3474 453 5 , , PUNCT dpc-3474 453 6 scordo scordo PROPN dpc-3474 453 7 m m PROPN dpc-3474 453 8 , , PUNCT dpc-3474 453 9 dusza dusza PROPN dpc-3474 453 10 sw sw PROPN dpc-3474 453 11 , , PUNCT dpc-3474 453 12 coit coit PROPN dpc-3474 453 13 dg dg PROPN dpc-3474 453 14 , , PUNCT dpc-3474 453 15 chapman chapman NOUN dpc-3474 453 16 pb pb PROPN dpc-3474 453 17 . . PUNCT dpc-3474 453 18 site site NOUN dpc-3474 453 19 and and CCONJ dpc-3474 453 20 timing timing NOUN dpc-3474 453 21 of of ADP dpc-3474 453 22 first first ADJ dpc-3474 453 23 relapse relapse NOUN dpc-3474 453 24 in in ADP dpc-3474 453 25 stage stage NOUN dpc-3474 453 26 iii iii NUM dpc-3474 453 27 melanoma melanoma NOUN dpc-3474 453 28 patients patient NOUN dpc-3474 453 29 : : PUNCT dpc-3474 453 30 implications implication NOUN dpc-3474 453 31 for for ADP dpc-3474 453 32 follow follow VERB dpc-3474 453 33 - - PUNCT dpc-3474 453 34 up up ADP dpc-3474 453 35 guidelines guideline NOUN dpc-3474 453 36 . . PUNCT dpc-3474 454 1 j j PROPN dpc-3474 454 2 clin clin PROPN dpc-3474 454 3 oncol oncol PROPN dpc-3474 454 4 . . PUNCT dpc-3474 455 1 2010;28(18):3042 2010;28(18):3042 NUM dpc-3474 455 2 - - SYM dpc-3474 455 3 7 7 NUM dpc-3474 455 4 . . PUNCT dpc-3474 455 5 doi doi NOUN dpc-3474 455 6 : : PUNCT dpc-3474 455 7 10.1200 10.1200 NUM dpc-3474 455 8 / / SYM dpc-3474 455 9 jco.2009.26.2063 jco.2009.26.2063 PROPN dpc-3474 455 10 . . PUNCT dpc-3474 456 1 pmid pmid NOUN dpc-3474 456 2 : : PUNCT dpc-3474 456 3 20479405 20479405 NUM dpc-3474 456 4 . . PUNCT dpc-3474 457 1 21 21 NUM dpc-3474 457 2 . . PUNCT dpc-3474 458 1 koskivuo koskivuo PROPN dpc-3474 458 2 i i PROPN dpc-3474 458 3 , , PUNCT dpc-3474 458 4 kemppainen kemppainen PROPN dpc-3474 458 5 j j PROPN dpc-3474 458 6 , , PUNCT dpc-3474 458 7 giordano giordano PROPN dpc-3474 458 8 s s PROPN dpc-3474 458 9 , , PUNCT dpc-3474 458 10 al al PROPN dpc-3474 458 11 . . PROPN dpc-3474 458 12 whole whole ADJ dpc-3474 458 13 body body NOUN dpc-3474 458 14 pet/ pet/ NOUN dpc-3474 458 15 ct ct NUM dpc-3474 458 16 in in ADP dpc-3474 458 17 the the DET dpc-3474 458 18 follow follow NOUN dpc-3474 458 19 - - PUNCT dpc-3474 458 20 up up NOUN dpc-3474 458 21 of of ADP dpc-3474 458 22 asymptomatic asymptomatic ADJ dpc-3474 458 23 patients patient NOUN dpc-3474 458 24 with with ADP dpc-3474 458 25 stage stage NOUN dpc-3474 458 26 iib iib NOUN dpc-3474 458 27 - - PUNCT dpc-3474 458 28 iiib iiib ADJ dpc-3474 458 29 cutaneous cutaneous ADJ dpc-3474 458 30 melanoma melanoma NOUN dpc-3474 458 31 . . PUNCT dpc-3474 459 1 acta acta PROPN dpc-3474 459 2 oncol oncol ADJ dpc-3474 459 3 stockh stockh NOUN dpc-3474 459 4 swed swe VERB dpc-3474 459 5 . . PUNCT dpc-3474 460 1 2016;55(11):1355 2016;55(11):1355 NUM dpc-3474 460 2 - - SYM dpc-3474 460 3 9 9 NUM dpc-3474 460 4 . . PUNCT dpc-3474 460 5 doi doi NOUN dpc-3474 460 6 : : PUNCT dpc-3474 460 7 10.1080/0284186x.2016.1213879 10.1080/0284186x.2016.1213879 ADJ dpc-3474 460 8 . . PUNCT dpc-3474 461 1 pmid pmid NOUN dpc-3474 461 2 : : PUNCT dpc-3474 461 3 27553064 27553064 NUM dpc-3474 461 4 . . PUNCT dpc-3474 462 1 22 22 NUM dpc-3474 462 2 . . PUNCT dpc-3474 463 1 bleicher bleicher PROPN dpc-3474 463 2 j j PROPN dpc-3474 463 3 , , PUNCT dpc-3474 463 4 swords sword VERB dpc-3474 463 5 ds ds PROPN dpc-3474 463 6 , , PUNCT dpc-3474 463 7 mali mali VERB dpc-3474 463 8 me i PRON dpc-3474 463 9 , , PUNCT dpc-3474 463 10 et et NOUN dpc-3474 463 11     SPACE dpc-3474 463 12 al al PROPN dpc-3474 463 13 . . PROPN dpc-3474 463 14 recurrence recurrence NOUN dpc-3474 463 15 patterns pattern NOUN dpc-3474 463 16 in in ADP dpc-3474 463 17 patients patient NOUN dpc-3474 463 18 with with ADP dpc-3474 463 19 stage stage NOUN dpc-3474 463 20 ii ii NOUN dpc-3474 463 21 melanoma melanoma NOUN dpc-3474 463 22 : : PUNCT dpc-3474 463 23 the the DET dpc-3474 463 24 evolving evolve VERB dpc-3474 463 25 role role NOUN dpc-3474 463 26 of of ADP dpc-3474 463 27 routine routine ADJ dpc-3474 463 28 imaging imaging NOUN dpc-3474 463 29 for for ADP dpc-3474 463 30 surveillance surveillance NOUN dpc-3474 463 31 . . PUNCT dpc-3474 464 1 j j PROPN dpc-3474 464 2 surg surg PROPN dpc-3474 464 3 oncol oncol PROPN dpc-3474 464 4 . . PUNCT dpc-3474 465 1 2020;122(8):1770 2020;122(8):1770 NUM dpc-3474 465 2 - - SYM dpc-3474 465 3 7 7 NUM dpc-3474 465 4 . . PUNCT dpc-3474 465 5 doi:10.1002 doi:10.1002 NOUN dpc-3474 465 6 / / SYM dpc-3474 465 7 jso.26214 jso.26214 PROPN dpc-3474 465 8 . . PUNCT dpc-3474 466 1 pmid pmid NOUN dpc-3474 466 2 : : PUNCT dpc-3474 466 3 33098702 33098702 NUM dpc-3474 466 4 . . PUNCT dpc-3474 467 1 medicine medicine NOUN dpc-3474 467 2 agency agency PROPN dpc-3474 467 3 ( ( PUNCT dpc-3474 467 4 ema ema PROPN dpc-3474 467 5 ) ) PUNCT dpc-3474 467 6 have have AUX dpc-3474 467 7 significantly significantly ADV dpc-3474 467 8 changed change VERB dpc-3474 467 9 melanoma melanoma NOUN dpc-3474 467 10 management management NOUN dpc-3474 467 11 [ [ X dpc-3474 467 12 37 37 NUM dpc-3474 467 13 ] ] PUNCT dpc-3474 467 14 . . PUNCT dpc-3474 468 1 the the DET dpc-3474 468 2 projected project VERB dpc-3474 468 3 increase increase NOUN dpc-3474 468 4 in in ADP dpc-3474 468 5 the the DET dpc-3474 468 6 use use NOUN dpc-3474 468 7 of of ADP dpc-3474 468 8 adjuvant adjuvant ADJ dpc-3474 468 9 systemic systemic ADJ dpc-3474 468 10 therapy therapy NOUN dpc-3474 468 11 might might AUX dpc-3474 468 12 also also ADV dpc-3474 468 13 lead lead VERB dpc-3474 468 14 to to ADP dpc-3474 468 15 changes change NOUN dpc-3474 468 16 in in ADP dpc-3474 468 17 melanoma melanoma NOUN dpc-3474 468 18 recurrence recurrence NOUN dpc-3474 468 19 patterns pattern NOUN dpc-3474 468 20 among among ADP dpc-3474 468 21 treated treat VERB dpc-3474 468 22 patients patient NOUN dpc-3474 468 23 when when SCONJ dpc-3474 468 24 compared compare VERB dpc-3474 468 25 to to ADP dpc-3474 468 26 those those PRON dpc-3474 468 27 described describe VERB dpc-3474 468 28 in in ADP dpc-3474 468 29 this this DET dpc-3474 468 30 study study NOUN dpc-3474 468 31 . . PUNCT dpc-3474 469 1 strict strict ADJ dpc-3474 469 2 follow follow NOUN dpc-3474 469 3 - - PUNCT dpc-3474 469 4 up up NOUN dpc-3474 469 5 and and CCONJ dpc-3474 469 6 patient patient ADJ dpc-3474 469 7 education education NOUN dpc-3474 469 8 play play VERB dpc-3474 469 9 a a DET dpc-3474 469 10 critical critical ADJ dpc-3474 469 11 role role NOUN dpc-3474 469 12 in in ADP dpc-3474 469 13 detecting detect VERB dpc-3474 469 14 melanoma melanoma NOUN dpc-3474 469 15 recurrences recurrence NOUN dpc-3474 469 16 . . PUNCT dpc-3474 470 1 due due ADP dpc-3474 470 2 to to ADP dpc-3474 470 3 the the DET dpc-3474 470 4 higher high ADJ dpc-3474 470 5 prevalence prevalence NOUN dpc-3474 470 6 of of ADP dpc-3474 470 7 regional regional ADJ dpc-3474 470 8 lymph lymph NOUN dpc-3474 470 9 node node NOUN dpc-3474 470 10 recurrences recurrence NOUN dpc-3474 470 11 in in ADP dpc-3474 470 12 early early ADJ dpc-3474 470 13 - - PUNCT dpc-3474 470 14 stage stage NOUN dpc-3474 470 15 melanoma melanoma NOUN dpc-3474 470 16 , , PUNCT dpc-3474 470 17 ultrasound ultrasound NOUN dpc-3474 470 18 may may AUX dpc-3474 470 19 prove prove VERB dpc-3474 470 20 to to PART dpc-3474 470 21 be be AUX dpc-3474 470 22 a a DET dpc-3474 470 23 valuable valuable ADJ dpc-3474 470 24 and and CCONJ dpc-3474 470 25 cost cost NOUN dpc-3474 470 26 - - PUNCT dpc-3474 470 27 effective effective ADJ dpc-3474 470 28 strategy strategy NOUN dpc-3474 470 29 for for ADP dpc-3474 470 30 recurrence recurrence NOUN dpc-3474 470 31 detection detection NOUN dpc-3474 470 32 in in ADP dpc-3474 470 33 early early ADJ dpc-3474 470 34 - - PUNCT dpc-3474 470 35 stage stage NOUN dpc-3474 470 36 melanoma melanoma NOUN dpc-3474 471 1 [ [ X dpc-3474 471 2 1 1 NUM dpc-3474 471 3 ] ] PUNCT dpc-3474 471 4 . . PUNCT dpc-3474 472 1 conversely conversely ADV dpc-3474 472 2 , , PUNCT dpc-3474 472 3 for for ADP dpc-3474 472 4 patients patient NOUN dpc-3474 472 5 with with ADP dpc-3474 472 6 more more ADV dpc-3474 472 7 advanced advanced ADJ dpc-3474 472 8 disease disease NOUN dpc-3474 472 9 at at ADP dpc-3474 472 10 diagnosis diagnosis NOUN dpc-3474 472 11 , , PUNCT dpc-3474 472 12 cross cross ADJ dpc-3474 472 13 - - ADJ dpc-3474 472 14 sectional sectional ADJ dpc-3474 472 15 full full ADJ dpc-3474 472 16 - - PUNCT dpc-3474 472 17 body body NOUN dpc-3474 472 18 imaging imaging NOUN dpc-3474 472 19 ( ( PUNCT dpc-3474 472 20 e.g. e.g. ADV dpc-3474 472 21 pet pet NOUN dpc-3474 472 22 - - PUNCT dpc-3474 472 23 ct ct NOUN dpc-3474 472 24 ) ) PUNCT dpc-3474 472 25 might might AUX dpc-3474 472 26 be be AUX dpc-3474 472 27 of of ADP dpc-3474 472 28 benefit benefit NOUN dpc-3474 472 29 due due ADP dpc-3474 472 30 to to ADP dpc-3474 472 31 the the DET dpc-3474 472 32 more more ADV dpc-3474 472 33 frequent frequent ADJ dpc-3474 472 34 systemic systemic ADJ dpc-3474 472 35 metastasis metastasis NOUN dpc-3474 472 36 . . PUNCT dpc-3474 473 1 this this DET dpc-3474 473 2 knowledge knowledge NOUN dpc-3474 473 3 gap gap NOUN dpc-3474 473 4 needs need VERB dpc-3474 473 5 to to PART dpc-3474 473 6 be be AUX dpc-3474 473 7 addressed address VERB dpc-3474 473 8 in in ADP dpc-3474 473 9 order order NOUN dpc-3474 473 10 to to PART dpc-3474 473 11 better well ADV dpc-3474 473 12 identify identify VERB dpc-3474 473 13 patients patient NOUN dpc-3474 473 14 at at ADP dpc-3474 473 15 high high ADJ dpc-3474 473 16 risk risk NOUN dpc-3474 473 17 of of ADP dpc-3474 473 18 disease disease NOUN dpc-3474 473 19 recurrence recurrence NOUN dpc-3474 473 20 and and CCONJ dpc-3474 473 21 personalize personalize VERB dpc-3474 473 22 surveillance surveillance NOUN dpc-3474 473 23 strategies strategy NOUN dpc-3474 473 24 [ [ X dpc-3474 473 25 11,24,45 11,24,45 NUM dpc-3474 473 26 ] ] PUNCT dpc-3474 473 27 . . PUNCT dpc-3474 474 1 recognizing recognize VERB dpc-3474 474 2 melanoma melanoma NOUN dpc-3474 474 3 recurrence recurrence NOUN dpc-3474 474 4 patterns pattern NOUN dpc-3474 474 5 can can AUX dpc-3474 474 6 aid aid VERB dpc-3474 474 7 in in ADP dpc-3474 474 8 the the DET dpc-3474 474 9 design design NOUN dpc-3474 474 10 of of ADP dpc-3474 474 11 active active ADJ dpc-3474 474 12 surveillance surveillance NOUN dpc-3474 474 13 strategies strategy NOUN dpc-3474 474 14 that that PRON dpc-3474 474 15 have have VERB dpc-3474 474 16 the the DET dpc-3474 474 17 potential potential NOUN dpc-3474 474 18 to to PART dpc-3474 474 19 modify modify VERB dpc-3474 474 20 clinical clinical ADJ dpc-3474 474 21 follow follow NOUN dpc-3474 474 22 - - PUNCT dpc-3474 474 23 up up ADP dpc-3474 474 24 plans plan NOUN dpc-3474 474 25 . . PUNCT dpc-3474 475 1 references reference NOUN dpc-3474 475 2 1 1 NUM dpc-3474 475 3 . . PUNCT dpc-3474 475 4 berger berger PROPN dpc-3474 475 5 ac ac PROPN dpc-3474 475 6 , , PUNCT dpc-3474 475 7 ollila ollila PROPN dpc-3474 475 8 dw dw PROPN dpc-3474 475 9 , , PUNCT dpc-3474 475 10 christopher christopher PROPN dpc-3474 475 11 a a PROPN dpc-3474 475 12 , , PUNCT dpc-3474 476 1 et et PROPN dpc-3474 476 2     SPACE dpc-3474 476 3 al al PROPN dpc-3474 476 4 . . PROPN dpc-3474 476 5 patient patient ADJ dpc-3474 476 6 symptoms symptom NOUN dpc-3474 476 7 are be AUX dpc-3474 476 8 the the DET dpc-3474 476 9 most most ADV dpc-3474 476 10 frequent frequent ADJ dpc-3474 476 11 indicators indicator NOUN dpc-3474 476 12 of of ADP dpc-3474 476 13 recurrence recurrence NOUN dpc-3474 476 14 in in ADP dpc-3474 476 15 patients patient NOUN dpc-3474 476 16 with with ADP dpc-3474 476 17 american american PROPN dpc-3474 476 18 joint joint PROPN dpc-3474 476 19 committee committee PROPN dpc-3474 476 20 on on ADP dpc-3474 476 21 cancer cancer NOUN dpc-3474 476 22 stage stage NOUN dpc-3474 476 23 ii ii PROPN dpc-3474 476 24 melanoma melanoma NOUN dpc-3474 476 25 . . PUNCT dpc-3474 477 1 j j PROPN dpc-3474 477 2 am be AUX dpc-3474 477 3 coll coll PROPN dpc-3474 477 4 surg surg PROPN dpc-3474 477 5 . . PUNCT dpc-3474 478 1 2017;224(4):652 2017;224(4):652 NUM dpc-3474 478 2 - - SYM dpc-3474 478 3 9 9 NUM dpc-3474 478 4 . . PUNCT dpc-3474 478 5 doi doi NOUN dpc-3474 478 6 : : PUNCT dpc-3474 478 7 10.1016 10.1016 NUM dpc-3474 478 8 / / SYM dpc-3474 478 9 j j PROPN dpc-3474 478 10 .jamcollsurg.2016.12.038 .jamcollsurg.2016.12.038 NUM dpc-3474 478 11 . . PUNCT dpc-3474 479 1 pmid pmid NOUN dpc-3474 479 2 : : PUNCT dpc-3474 479 3 28189663 28189663 NUM dpc-3474 479 4 . . PUNCT dpc-3474 480 1 2 2 X dpc-3474 480 2 . . X dpc-3474 480 3 siegel siegel PROPN dpc-3474 480 4 rl rl PROPN dpc-3474 480 5 , , PUNCT dpc-3474 480 6 miller miller PROPN dpc-3474 480 7 kd kd PROPN dpc-3474 480 8 , , PUNCT dpc-3474 480 9 wagle wagle NOUN dpc-3474 480 10 ns ns ADJ dpc-3474 480 11 , , PUNCT dpc-3474 480 12 jemal jemal ADJ dpc-3474 480 13 a. a. NOUN dpc-3474 480 14 cancer cancer NOUN dpc-3474 480 15 statistics statistic NOUN dpc-3474 480 16 , , PUNCT dpc-3474 480 17 2023 2023 NUM dpc-3474 480 18 . . PUNCT dpc-3474 481 1 ca can AUX dpc-3474 481 2 cancer cancer PROPN dpc-3474 481 3 j j PROPN dpc-3474 481 4 clin clin PROPN dpc-3474 481 5 . . PUNCT dpc-3474 482 1 2023;73(1):17 2023;73(1):17 NUM dpc-3474 482 2 - - SYM dpc-3474 482 3 48 48 NUM dpc-3474 482 4 . . PUNCT dpc-3474 483 1 doi doi NOUN dpc-3474 483 2 : : PUNCT dpc-3474 483 3 10.3322 10.3322 NUM dpc-3474 483 4 / / SYM dpc-3474 483 5 caac.21763 caac.21763 PROPN dpc-3474 483 6 . . PUNCT dpc-3474 484 1 pmid pmid NOUN dpc-3474 484 2 : : PUNCT dpc-3474 484 3 36633525 36633525 NUM dpc-3474 484 4 . . PUNCT dpc-3474 485 1 3 3 X dpc-3474 485 2 . . X dpc-3474 485 3 o’connell o’connell PROPN dpc-3474 485 4 ep ep PROPN dpc-3474 485 5 , , PUNCT dpc-3474 485 6 o’leary o’leary ADJ dpc-3474 485 7 dp dp PROPN dpc-3474 485 8 , , PUNCT dpc-3474 485 9 fogarty fogarty PROPN dpc-3474 485 10 k k PROPN dpc-3474 485 11 , , PUNCT dpc-3474 485 12 khan khan PROPN dpc-3474 485 13 zj zj PROPN dpc-3474 485 14 , , PUNCT dpc-3474 485 15 redmond redmond PROPN dpc-3474 485 16 hp hp PROPN dpc-3474 485 17 . . PROPN dpc-3474 485 18 predictors predictor NOUN dpc-3474 485 19 and and CCONJ dpc-3474 485 20 patterns pattern NOUN dpc-3474 485 21 of of ADP dpc-3474 485 22 melanoma melanoma NOUN dpc-3474 485 23 recurrence recurrence NOUN dpc-3474 485 24 following follow VERB dpc-3474 485 25 a a DET dpc-3474 485 26 negative negative ADJ dpc-3474 485 27 sentinel sentinel NOUN dpc-3474 485 28 lymph lymph NOUN dpc-3474 485 29 node node NOUN dpc-3474 485 30 biopsy biopsy NOUN dpc-3474 485 31 . . PUNCT dpc-3474 486 1 melanoma melanoma NOUN dpc-3474 486 2 res re NOUN dpc-3474 486 3 . . PUNCT dpc-3474 487 1 2016;26(1):66 2016;26(1):66 NUM dpc-3474 487 2 - - SYM dpc-3474 487 3 70 70 NUM dpc-3474 487 4 . . PUNCT dpc-3474 488 1 doi doi NOUN dpc-3474 488 2 : : PUNCT dpc-3474 488 3 10.1097 10.1097 NUM dpc-3474 488 4 / / SYM dpc-3474 488 5 cmr.0000000000000211 cmr.0000000000000211 X dpc-3474 488 6 . . PUNCT dpc-3474 489 1 pmid pmid NOUN dpc-3474 489 2 : : PUNCT dpc-3474 489 3 26460498 26460498 NUM dpc-3474 489 4 . . PUNCT dpc-3474 490 1 4 4 X dpc-3474 490 2 . . X dpc-3474 490 3 surveillance surveillance NOUN dpc-3474 490 4 , , PUNCT dpc-3474 490 5 epidemiology epidemiology NOUN dpc-3474 490 6 , , PUNCT dpc-3474 490 7 and and CCONJ dpc-3474 490 8 end end VERB dpc-3474 490 9 results result NOUN dpc-3474 490 10 ( ( PUNCT dpc-3474 490 11 seer seer NOUN dpc-3474 490 12 ) ) PUNCT dpc-3474 490 13 program program NOUN dpc-3474 490 14     SPACE dpc-3474 490 15 . . PUNCT dpc-3474 491 1 cancer cancer NOUN dpc-3474 491 2 stat stat PROPN dpc-3474 491 3 facts fact VERB dpc-3474 491 4 : : PUNCT dpc-3474 491 5 melanoma melanoma NOUN dpc-3474 491 6 of of ADP dpc-3474 491 7 the the DET dpc-3474 491 8 skin skin NOUN dpc-3474 491 9 . . PUNCT dpc-3474 492 1 accessed access VERB dpc-3474 492 2 february february PROPN dpc-3474 492 3 7 7 NUM dpc-3474 492 4 , , PUNCT dpc-3474 492 5 2023 2023 NUM dpc-3474 492 6 . . PUNCT dpc-3474 493 1 https://seer.cancer.gov/statfacts/html/melan.html https://seer.cancer.gov/statfacts/html/melan.html PROPN dpc-3474 493 2 5 5 NUM dpc-3474 493 3 . . PUNCT dpc-3474 494 1 adler adler PROPN dpc-3474 494 2 nr nr PROPN dpc-3474 494 3 , , PUNCT dpc-3474 494 4 haydon haydon PROPN dpc-3474 494 5 a a PROPN dpc-3474 494 6 , , PUNCT dpc-3474 494 7 mclean mclean PROPN dpc-3474 494 8 ca ca PROPN dpc-3474 494 9 , , PUNCT dpc-3474 494 10 kelly kelly PROPN dpc-3474 494 11 jw jw PROPN dpc-3474 494 12 , , PUNCT dpc-3474 494 13 mar mar PROPN dpc-3474 494 14 vj vj PROPN dpc-3474 494 15 . . PUNCT dpc-3474 495 1 metastatic metastatic ADJ dpc-3474 495 2 pathways pathway NOUN dpc-3474 495 3 in in ADP dpc-3474 495 4 patients patient NOUN dpc-3474 495 5 with with ADP dpc-3474 495 6 cutaneous cutaneous ADJ dpc-3474 495 7 melanoma melanoma NOUN dpc-3474 495 8 . . PUNCT dpc-3474 496 1 pigment pigment ADJ dpc-3474 496 2 cell cell NOUN dpc-3474 496 3 melanoma melanoma NOUN dpc-3474 496 4 res re NOUN dpc-3474 496 5 . . PUNCT dpc-3474 497 1 2017;30(1):13 2017;30(1):13 NUM dpc-3474 497 2 - - SYM dpc-3474 497 3 27 27 NUM dpc-3474 497 4 . . PUNCT dpc-3474 498 1 doi doi NOUN dpc-3474 498 2 : : PUNCT dpc-3474 498 3 10.1111 10.1111 NUM dpc-3474 498 4 / / SYM dpc-3474 498 5 pcmr.12544 pcmr.12544 PROPN dpc-3474 498 6 . . PUNCT dpc-3474 499 1 epub epub PROPN dpc-3474 499 2 2016 2016 NUM dpc-3474 499 3 nov nov PROPN dpc-3474 499 4 30 30 NUM dpc-3474 499 5 . . PUNCT dpc-3474 500 1 pmid pmid NOUN dpc-3474 500 2 : : PUNCT dpc-3474 500 3 27900851 27900851 NUM dpc-3474 500 4 . . PUNCT dpc-3474 501 1 6 6 NUM dpc-3474 501 2 . . PUNCT dpc-3474 502 1 meier meier PROPN dpc-3474 502 2 f f PROPN dpc-3474 502 3 , , PUNCT dpc-3474 502 4 will will AUX dpc-3474 502 5 s s PROPN dpc-3474 502 6 , , PUNCT dpc-3474 502 7 ellwanger ellwanger NOUN dpc-3474 502 8 u u NOUN dpc-3474 502 9 , , PUNCT dpc-3474 502 10 et et PROPN dpc-3474 502 11     SPACE dpc-3474 502 12 al al PROPN dpc-3474 502 13 . . PUNCT dpc-3474 503 1 metastatic metastatic ADJ dpc-3474 503 2 pathways pathway NOUN dpc-3474 503 3 and and CCONJ dpc-3474 503 4 time time NOUN dpc-3474 503 5 courses course NOUN dpc-3474 503 6 in in ADP dpc-3474 503 7 the the DET dpc-3474 503 8 orderly orderly ADJ dpc-3474 503 9 progression progression NOUN dpc-3474 503 10 of of ADP dpc-3474 503 11 cutaneous cutaneous ADJ dpc-3474 503 12 melanoma melanoma NOUN dpc-3474 503 13 . . PUNCT dpc-3474 504 1 br br PROPN dpc-3474 504 2 j j PROPN dpc-3474 504 3 dermatol dermatol NOUN dpc-3474 504 4 . . PUNCT dpc-3474 505 1 2002;147(1):62 2002;147(1):62 NUM dpc-3474 505 2 - - SYM dpc-3474 505 3 70 70 NUM dpc-3474 505 4 . . PUNCT dpc-3474 506 1 doi doi NOUN dpc-3474 506 2 : : PUNCT dpc-3474 506 3 10.1046 10.1046 NUM dpc-3474 506 4 / / SYM dpc-3474 506 5 j.1365 j.1365 NOUN dpc-3474 506 6 - - PUNCT dpc-3474 506 7 2133 2133 NUM dpc-3474 506 8 .2002.04867.x .2002.04867.x NOUN dpc-3474 506 9 . . PUNCT dpc-3474 507 1 pmid pmid NOUN dpc-3474 507 2 : : PUNCT dpc-3474 507 3 12100186 12100186 NUM dpc-3474 507 4 . . PUNCT dpc-3474 508 1 7 7 X dpc-3474 508 2 . . X dpc-3474 508 3 leiter leiter PROPN dpc-3474 508 4 u u PROPN dpc-3474 508 5 , , PUNCT dpc-3474 508 6 meier meier PROPN dpc-3474 508 7 f f PROPN dpc-3474 508 8 , , PUNCT dpc-3474 508 9 schittek schittek PROPN dpc-3474 508 10 b b PROPN dpc-3474 508 11 , , PUNCT dpc-3474 508 12 garbe garbe PROPN dpc-3474 508 13 c. c. PROPN dpc-3474 508 14 the the DET dpc-3474 508 15 natural natural ADJ dpc-3474 508 16 course course NOUN dpc-3474 508 17 of of ADP dpc-3474 508 18 cutaneous cutaneous ADJ dpc-3474 508 19 melanoma melanoma NOUN dpc-3474 508 20 . . PUNCT dpc-3474 509 1 j j PROPN dpc-3474 509 2 surg surg PROPN dpc-3474 509 3 oncol oncol PROPN dpc-3474 509 4 . . PUNCT dpc-3474 510 1 2004;86(4):172 2004;86(4):172 NUM dpc-3474 510 2 - - PUNCT dpc-3474 510 3 8 8 NUM dpc-3474 510 4 . . PUNCT dpc-3474 511 1 doi doi NOUN dpc-3474 511 2 : : PUNCT dpc-3474 511 3 10.1002 10.1002 NUM dpc-3474 511 4 / / SYM dpc-3474 511 5 jso.20079 jso.20079 PROPN dpc-3474 511 6 . . PUNCT dpc-3474 512 1 pmid pmid NOUN dpc-3474 512 2 : : PUNCT dpc-3474 512 3 15221923 15221923 NUM dpc-3474 512 4 . . PUNCT dpc-3474 513 1 8 8 NUM dpc-3474 513 2 . . PUNCT dpc-3474 513 3 deschner deschner PROPN dpc-3474 513 4 b b PROPN dpc-3474 513 5 , , PUNCT dpc-3474 513 6 wayne wayne PROPN dpc-3474 513 7 jd jd PROPN dpc-3474 513 8 . . PUNCT dpc-3474 514 1 follow follow VERB dpc-3474 514 2 - - PUNCT dpc-3474 514 3 up up NOUN dpc-3474 514 4 of of ADP dpc-3474 514 5 the the DET dpc-3474 514 6 melanoma melanoma NOUN dpc-3474 514 7 patient patient NOUN dpc-3474 514 8 . . PUNCT dpc-3474 515 1 j j PROPN dpc-3474 515 2 surg surg PROPN dpc-3474 515 3 oncol oncol PROPN dpc-3474 515 4 . . PUNCT dpc-3474 516 1 2019;119(2):262 2019;119(2):262 NUM dpc-3474 516 2 - - SYM dpc-3474 516 3 8 8 NUM dpc-3474 516 4 . . PUNCT dpc-3474 516 5 doi doi NOUN dpc-3474 516 6 : : PUNCT dpc-3474 516 7 10.1002 10.1002 NUM dpc-3474 516 8 / / SYM dpc-3474 516 9 jso.25324 jso.25324 PROPN dpc-3474 516 10 . . PUNCT dpc-3474 517 1 pmid pmid NOUN dpc-3474 517 2 : : PUNCT dpc-3474 517 3 30548539 30548539 NUM dpc-3474 517 4 . . PUNCT dpc-3474 518 1 9 9 X dpc-3474 518 2 . . X dpc-3474 518 3 yee yee PROPN dpc-3474 518 4 vsk vsk PROPN dpc-3474 518 5 , , PUNCT dpc-3474 518 6 thompson thompson PROPN dpc-3474 518 7 jf jf PROPN dpc-3474 518 8 , , PUNCT dpc-3474 518 9 mckinnon mckinnon PROPN dpc-3474 518 10 jg jg PROPN dpc-3474 518 11 , , PUNCT dpc-3474 518 12 et et PROPN dpc-3474 518 13     SPACE dpc-3474 518 14 al al PROPN dpc-3474 518 15 . . PROPN dpc-3474 518 16 outcome outcome NOUN dpc-3474 518 17 in in ADP dpc-3474 518 18 846 846 NUM dpc-3474 518 19 cutaneous cutaneous ADJ dpc-3474 518 20 melanoma melanoma NOUN dpc-3474 518 21 patients patient NOUN dpc-3474 518 22 from from ADP dpc-3474 518 23 a a DET dpc-3474 518 24 single single ADJ dpc-3474 518 25 center center NOUN dpc-3474 518 26 after after ADP dpc-3474 518 27 a a DET dpc-3474 518 28 negative negative ADJ dpc-3474 518 29 sentinel sentinel ADJ dpc-3474 518 30 node node ADJ dpc-3474 518 31 biopsy biopsy NOUN dpc-3474 518 32 . . PUNCT dpc-3474 519 1 ann ann PROPN dpc-3474 519 2 surg surg PROPN dpc-3474 519 3 oncol oncol PROPN dpc-3474 519 4 . . PUNCT dpc-3474 520 1 junio junio PROPN dpc-3474 520 2 de de PROPN dpc-3474 520 3 2005;12(6):429 2005;12(6):429 PROPN dpc-3474 520 4 - - PUNCT dpc-3474 520 5 39 39 NUM dpc-3474 520 6 . . PUNCT dpc-3474 520 7 doi doi NOUN dpc-3474 520 8 : : PUNCT dpc-3474 520 9 10.1245 10.1245 NUM dpc-3474 520 10 / / SYM dpc-3474 520 11 aso.2005.03.074 aso.2005.03.074 PROPN dpc-3474 520 12 . . PUNCT dpc-3474 521 1 pmid pmid NOUN dpc-3474 521 2 : : PUNCT dpc-3474 521 3 15886905 15886905 NUM dpc-3474 521 4 . . PUNCT dpc-3474 522 1 review review VERB dpc-3474 522 2 | | ADV dpc-3474 522 3 dermatol dermatol ADJ dpc-3474 522 4 pract pract NOUN dpc-3474 522 5 concept concept NOUN dpc-3474 522 6 . . PUNCT dpc-3474 523 1 2023;13(4):e2023304 2023;13(4):e2023304 NUM dpc-3474 523 2 11 11 NUM dpc-3474 523 3 35 35 NUM dpc-3474 523 4 . . PUNCT dpc-3474 524 1 wan wan PROPN dpc-3474 524 2 g g PROPN dpc-3474 524 3 , , PUNCT dpc-3474 524 4 nguyen nguyen PROPN dpc-3474 524 5 n n CCONJ dpc-3474 524 6 , , PUNCT dpc-3474 524 7 liu liu PROPN dpc-3474 524 8 f f PROPN dpc-3474 524 9 , , PUNCT dpc-3474 524 10 desimone desimone PROPN dpc-3474 524 11 ms ms PROPN dpc-3474 524 12 , , PUNCT dpc-3474 524 13 leung leung PROPN dpc-3474 524 14 bw bw PROPN dpc-3474 524 15 , , PUNCT dpc-3474 524 16 rajeh rajeh NOUN dpc-3474 524 17 a a PRON dpc-3474 524 18 , , PUNCT dpc-3474 524 19 collier collier PROPN dpc-3474 524 20 mr mr PROPN dpc-3474 524 21 , , PUNCT dpc-3474 524 22 choi choi PROPN dpc-3474 524 23 ms ms PROPN dpc-3474 524 24 , , PUNCT dpc-3474 524 25 amadife amadife PROPN dpc-3474 524 26 m m PROPN dpc-3474 524 27 , , PUNCT dpc-3474 524 28 tang tang PROPN dpc-3474 524 29 k k PROPN dpc-3474 524 30 , , PUNCT dpc-3474 524 31 zhang zhang PROPN dpc-3474 524 32 s s PROPN dpc-3474 524 33 , , PUNCT dpc-3474 524 34 phillipps phillipps PROPN dpc-3474 524 35 js js PROPN dpc-3474 524 36 , , PUNCT dpc-3474 524 37 jairath jairath NOUN dpc-3474 524 38 r r NOUN dpc-3474 524 39 , , PUNCT dpc-3474 524 40 alexander alexander PROPN dpc-3474 524 41 na na PROPN dpc-3474 524 42 , , PUNCT dpc-3474 524 43 et et PROPN dpc-3474 524 44 al al PROPN dpc-3474 524 45 . . PROPN dpc-3474 524 46 prediction prediction NOUN dpc-3474 524 47 of of ADP dpc-3474 524 48 early early ADJ dpc-3474 524 49 - - PUNCT dpc-3474 524 50 stage stage NOUN dpc-3474 524 51 melanoma melanoma NOUN dpc-3474 524 52 recurrence recurrence NOUN dpc-3474 524 53 using use VERB dpc-3474 524 54 clinical clinical ADJ dpc-3474 524 55 and and CCONJ dpc-3474 524 56 histopathologic histopathologic NOUN dpc-3474 524 57 features feature NOUN dpc-3474 524 58 . . PUNCT dpc-3474 525 1 npj npj PROPN dpc-3474 525 2 precis precis PROPN dpc-3474 525 3 oncol oncol ADJ dpc-3474 525 4 . . PUNCT dpc-3474 526 1 2022 2022 NUM dpc-3474 526 2 oct oct PROPN dpc-3474 526 3 31;6(1):79 31;6(1):79 NUM dpc-3474 526 4 . . PUNCT dpc-3474 527 1 doi doi NOUN dpc-3474 527 2 : : PUNCT dpc-3474 527 3 10.1038 10.1038 NUM dpc-3474 527 4 /s41698 /s41698 NOUN dpc-3474 527 5 - - PUNCT dpc-3474 527 6 022 022 NUM dpc-3474 527 7 - - PUNCT dpc-3474 527 8 00321 00321 NUM dpc-3474 527 9 - - PUNCT dpc-3474 527 10 4 4 NUM dpc-3474 527 11 . . NUM dpc-3474 527 12 36 36 NUM dpc-3474 527 13 . . PUNCT dpc-3474 527 14 coit coit PROPN dpc-3474 527 15 dg dg PROPN dpc-3474 527 16 , , PUNCT dpc-3474 527 17 ariyan ariyan PROPN dpc-3474 527 18 ce ce PROPN dpc-3474 527 19 . . PROPN dpc-3474 528 1 fifty fifty NUM dpc-3474 528 2 years year NOUN dpc-3474 528 3 of of ADP dpc-3474 528 4 progress progress NOUN dpc-3474 528 5 in in ADP dpc-3474 528 6 surgical surgical ADJ dpc-3474 528 7 oncology oncology NOUN dpc-3474 528 8 : : PUNCT dpc-3474 528 9 melanoma melanoma NOUN dpc-3474 528 10 . . PUNCT dpc-3474 529 1 j j PROPN dpc-3474 529 2 surg surg PROPN dpc-3474 529 3 oncol oncol PROPN dpc-3474 529 4 . . PUNCT dpc-3474 530 1 2022;126(5):888 2022;126(5):888 NUM dpc-3474 530 2 - - SYM dpc-3474 530 3 95 95 NUM dpc-3474 530 4 . . PUNCT dpc-3474 531 1 doi doi NOUN dpc-3474 531 2 : : PUNCT dpc-3474 531 3 10.1002 10.1002 NUM dpc-3474 531 4 /jso.27081 /jso.27081 NOUN dpc-3474 531 5 . . PUNCT dpc-3474 532 1 pmid pmid NOUN dpc-3474 532 2 : : PUNCT dpc-3474 532 3 36087090 36087090 NUM dpc-3474 532 4 37 37 NUM dpc-3474 532 5 . . PUNCT dpc-3474 533 1 lao lao PROPN dpc-3474 533 2 cd cd PROPN dpc-3474 533 3 , , PUNCT dpc-3474 533 4 khushalani khushalani PROPN dpc-3474 533 5 ni ni PROPN dpc-3474 533 6 , , PUNCT dpc-3474 533 7 angeles angeles PROPN dpc-3474 533 8 c c NOUN dpc-3474 533 9 , , PUNCT dpc-3474 533 10 petrella petrella PROPN dpc-3474 533 11 tm tm PROPN dpc-3474 533 12 . . PROPN dpc-3474 533 13 current current ADJ dpc-3474 533 14 state state NOUN dpc-3474 533 15 of of ADP dpc-3474 533 16 adjuvant adjuvant ADJ dpc-3474 533 17 therapy therapy NOUN dpc-3474 533 18 for for ADP dpc-3474 533 19 melanoma melanoma NOUN dpc-3474 533 20 : : PUNCT dpc-3474 533 21 less less ADJ dpc-3474 533 22 is be AUX dpc-3474 533 23 more more ADJ dpc-3474 533 24 , , PUNCT dpc-3474 533 25 or or CCONJ dpc-3474 533 26 more more ADJ dpc-3474 533 27 is be AUX dpc-3474 533 28 better well ADJ dpc-3474 533 29 ? ? PUNCT dpc-3474 534 1 am be AUX dpc-3474 534 2 soc soc PROPN dpc-3474 534 3 clin clin PROPN dpc-3474 534 4 oncol oncol PROPN dpc-3474 534 5 educ educ PROPN dpc-3474 534 6 book book NOUN dpc-3474 534 7 . . PUNCT dpc-3474 535 1 2022;42:1 2022;42:1 NUM dpc-3474 535 2 - - SYM dpc-3474 535 3 7 7 NUM dpc-3474 535 4 . . PUNCT dpc-3474 535 5 doi doi NOUN dpc-3474 535 6 : : PUNCT dpc-3474 535 7 10.1200 10.1200 NUM dpc-3474 535 8 / / SYM dpc-3474 535 9 edbk_351153 edbk_351153 NOUN dpc-3474 535 10 . . PUNCT dpc-3474 536 1 pmid pmid NOUN dpc-3474 536 2 : : PUNCT dpc-3474 536 3 35658502 35658502 NUM dpc-3474 536 4 . . PUNCT dpc-3474 537 1 38 38 NUM dpc-3474 537 2 . . PUNCT dpc-3474 538 1 ascierto ascierto PROPN dpc-3474 538 2 pa pa PROPN dpc-3474 538 3 , , PUNCT dpc-3474 538 4 del del PROPN dpc-3474 538 5 vecchio vecchio PROPN dpc-3474 538 6 m m PROPN dpc-3474 538 7 , , PUNCT dpc-3474 538 8 mandalá mandalá PROPN dpc-3474 538 9 m m PROPN dpc-3474 538 10 , , PUNCT dpc-3474 538 11 et et PROPN dpc-3474 538 12     SPACE dpc-3474 538 13 al al PROPN dpc-3474 538 14 . . PROPN dpc-3474 539 1 adjuvant adjuvant PROPN dpc-3474 539 2 nivolumab nivolumab ADV dpc-3474 539 3 versus versus ADP dpc-3474 539 4 ipilimumab ipilimumab VERB dpc-3474 539 5 in in ADP dpc-3474 539 6 resected resect VERB dpc-3474 539 7 stage stage NOUN dpc-3474 539 8 iiib iiib NOUN dpc-3474 539 9 - - PUNCT dpc-3474 539 10 c c NOUN dpc-3474 539 11 and and CCONJ dpc-3474 539 12 stage stage NOUN dpc-3474 539 13 iv iv NUM dpc-3474 539 14 melanoma melanoma NOUN dpc-3474 539 15 ( ( PUNCT dpc-3474 539 16 checkmate checkmate NOUN dpc-3474 539 17 238 238 NUM dpc-3474 539 18 ): ): PUNCT dpc-3474 539 19 4 4 NUM dpc-3474 539 20 - - PUNCT dpc-3474 539 21 year year NOUN dpc-3474 539 22 results result NOUN dpc-3474 539 23 from from ADP dpc-3474 539 24 a a DET dpc-3474 539 25 multicentre multicentre NOUN dpc-3474 539 26 , , PUNCT dpc-3474 539 27 double double ADJ dpc-3474 539 28 - - PUNCT dpc-3474 539 29 blind blind ADJ dpc-3474 539 30 , , PUNCT dpc-3474 539 31 randomised randomise VERB dpc-3474 539 32 , , PUNCT dpc-3474 539 33 controlled control VERB dpc-3474 539 34 , , PUNCT dpc-3474 539 35 phase phase NOUN dpc-3474 539 36 3 3 NUM dpc-3474 539 37 trial trial NOUN dpc-3474 539 38 . . PUNCT dpc-3474 540 1 lancet lancet PROPN dpc-3474 540 2 oncol oncol PROPN dpc-3474 540 3 . . PUNCT dpc-3474 541 1 2020;21(11):1465 2020;21(11):1465 NUM dpc-3474 541 2 - - SYM dpc-3474 541 3 77 77 NUM dpc-3474 541 4 . . PUNCT dpc-3474 542 1 doi doi NOUN dpc-3474 542 2 : : PUNCT dpc-3474 542 3 10.1016 10.1016 NUM dpc-3474 542 4 / / SYM dpc-3474 542 5 s1470 s1470 PROPN dpc-3474 542 6 -2045(20)30494 -2045(20)30494 NOUN dpc-3474 542 7 - - PUNCT dpc-3474 542 8 0 0 NUM dpc-3474 542 9 . . PUNCT dpc-3474 543 1 pmid pmid NOUN dpc-3474 543 2 : : PUNCT dpc-3474 543 3 32961119 32961119 NUM dpc-3474 543 4 . . PUNCT dpc-3474 544 1 39 39 NUM dpc-3474 544 2 . . PUNCT dpc-3474 545 1 gershenwald gershenwald PROPN dpc-3474 545 2 je je PROPN dpc-3474 545 3 , , PUNCT dpc-3474 545 4 scolyer scolyer PROPN dpc-3474 545 5 ra ra PROPN dpc-3474 545 6 , , PUNCT dpc-3474 545 7 hess hess PROPN dpc-3474 545 8 kr kr PROPN dpc-3474 545 9 , , PUNCT dpc-3474 545 10 et et PROPN dpc-3474 545 11     SPACE dpc-3474 546 1 al al PROPN dpc-3474 546 2 . . PROPN dpc-3474 546 3 melanoma melanoma PROPN dpc-3474 546 4 staging staging NOUN dpc-3474 546 5 : : PUNCT dpc-3474 546 6 evidence evidence NOUN dpc-3474 546 7 - - PUNCT dpc-3474 546 8 based base VERB dpc-3474 546 9 changes change NOUN dpc-3474 546 10 in in ADP dpc-3474 546 11 the the DET dpc-3474 546 12 american american PROPN dpc-3474 546 13 joint joint PROPN dpc-3474 546 14 committee committee PROPN dpc-3474 546 15 on on ADP dpc-3474 546 16 cancer cancer NOUN dpc-3474 546 17 eighth eighth PROPN dpc-3474 546 18 edition edition NOUN dpc-3474 546 19 cancer cancer NOUN dpc-3474 546 20 staging staging NOUN dpc-3474 546 21 manual manual NOUN dpc-3474 546 22 . . PUNCT dpc-3474 547 1 ca can AUX dpc-3474 547 2 cancer cancer PROPN dpc-3474 547 3 j j PROPN dpc-3474 547 4 clin clin PROPN dpc-3474 547 5 . . PUNCT dpc-3474 548 1 2017;67(6):472 2017;67(6):472 NUM dpc-3474 548 2 - - SYM dpc-3474 548 3 92 92 NUM dpc-3474 548 4 . . PUNCT dpc-3474 549 1 doi doi NOUN dpc-3474 549 2 : : PUNCT dpc-3474 549 3 10.3322 10.3322 NUM dpc-3474 549 4 / / SYM dpc-3474 549 5 caac.21409 caac.21409 PROPN dpc-3474 549 6 . . PUNCT dpc-3474 550 1 pmid pmid NOUN dpc-3474 550 2 : : PUNCT dpc-3474 550 3 29028110 29028110 NUM dpc-3474 550 4 . . PUNCT dpc-3474 551 1 40 40 NUM dpc-3474 551 2 . . PUNCT dpc-3474 552 1 park park NOUN dpc-3474 552 2 ts ts PROPN dpc-3474 552 3 , , PUNCT dpc-3474 552 4 phan phan PROPN dpc-3474 552 5 gq gq PROPN dpc-3474 552 6 , , PUNCT dpc-3474 552 7 yang yang PROPN dpc-3474 552 8 jc jc PROPN dpc-3474 552 9 , , PUNCT dpc-3474 552 10 et et PROPN dpc-3474 552 11     SPACE dpc-3474 552 12 al al PROPN dpc-3474 552 13 . . PROPN dpc-3474 552 14 routine routine ADJ dpc-3474 552 15 computer computer NOUN dpc-3474 552 16 tomography tomography NOUN dpc-3474 552 17 imaging imaging NOUN dpc-3474 552 18 for for ADP dpc-3474 552 19 the the DET dpc-3474 552 20 detection detection NOUN dpc-3474 552 21 of of ADP dpc-3474 552 22 recurrences recurrence NOUN dpc-3474 552 23 in in ADP dpc-3474 552 24 high high ADJ dpc-3474 552 25 - - PUNCT dpc-3474 552 26 risk risk NOUN dpc-3474 552 27 melanoma melanoma NOUN dpc-3474 552 28 patients patient NOUN dpc-3474 552 29 . . PUNCT dpc-3474 553 1 ann ann PROPN dpc-3474 553 2 surg surg PROPN dpc-3474 553 3 oncol oncol PROPN dpc-3474 553 4 . . PUNCT dpc-3474 554 1 2017;24(4):947 2017;24(4):947 NUM dpc-3474 554 2 - - SYM dpc-3474 554 3 51 51 NUM dpc-3474 554 4 . . PUNCT dpc-3474 555 1 doi doi NOUN dpc-3474 555 2 : : PUNCT dpc-3474 555 3 10.1245 10.1245 NUM dpc-3474 555 4 / / SYM dpc-3474 555 5 s10434 s10434 PROPN dpc-3474 555 6 - - PUNCT dpc-3474 555 7 017 017 NUM dpc-3474 555 8 - - PUNCT dpc-3474 555 9 5768 5768 NUM dpc-3474 555 10 - - SYM dpc-3474 555 11 8 8 NUM dpc-3474 555 12 . . PUNCT dpc-3474 556 1 pmid pmid NOUN dpc-3474 556 2 : : PUNCT dpc-3474 556 3 28144760 28144760 NUM dpc-3474 556 4 . . PUNCT dpc-3474 557 1 41 41 NUM dpc-3474 557 2 . . PUNCT dpc-3474 557 3 eggermont eggermont PROPN dpc-3474 557 4 amm amm PROPN dpc-3474 557 5 , , PUNCT dpc-3474 557 6 chiarion chiarion NOUN dpc-3474 557 7 - - PUNCT dpc-3474 557 8 sileni sileni NOUN dpc-3474 557 9 v v NOUN dpc-3474 557 10 , , PUNCT dpc-3474 557 11 grob grob PROPN dpc-3474 557 12 jj jj PROPN dpc-3474 557 13 , , PUNCT dpc-3474 557 14 et et PROPN dpc-3474 557 15     SPACE dpc-3474 557 16 al al PROPN dpc-3474 557 17 . . PROPN dpc-3474 557 18 adjuvant adjuvant PROPN dpc-3474 557 19 ipilimumab ipilimumab PROPN dpc-3474 557 20 versus versus ADP dpc-3474 557 21 placebo placebo NOUN dpc-3474 557 22 after after ADP dpc-3474 557 23 complete complete ADJ dpc-3474 557 24 resection resection NOUN dpc-3474 557 25 of of ADP dpc-3474 557 26 high high ADJ dpc-3474 557 27 - - PUNCT dpc-3474 557 28 risk risk NOUN dpc-3474 557 29 stage stage NOUN dpc-3474 557 30 iii iii X dpc-3474 557 31 melanoma melanoma NOUN dpc-3474 557 32 ( ( PUNCT dpc-3474 557 33 eortc eortc NOUN dpc-3474 557 34 18071 18071 NUM dpc-3474 557 35 ): ): PUNCT dpc-3474 557 36 a a DET dpc-3474 557 37 randomised randomised ADJ dpc-3474 557 38 , , PUNCT dpc-3474 557 39 double double ADJ dpc-3474 557 40 - - PUNCT dpc-3474 557 41 blind blind ADJ dpc-3474 557 42 , , PUNCT dpc-3474 557 43 phase phase NOUN dpc-3474 557 44 3 3 NUM dpc-3474 557 45 trial trial NOUN dpc-3474 557 46 . . PUNCT dpc-3474 558 1 lancet lancet PROPN dpc-3474 558 2 oncol oncol PROPN dpc-3474 558 3 . . PUNCT dpc-3474 559 1 2015;16(5):522 2015;16(5):522 NUM dpc-3474 559 2 - - PUNCT dpc-3474 559 3 30 30 NUM dpc-3474 559 4 . . PUNCT dpc-3474 560 1 doi doi NOUN dpc-3474 560 2 : : PUNCT dpc-3474 560 3 10.1016 10.1016 NUM dpc-3474 560 4 / / SYM dpc-3474 560 5 s1470 s1470 PROPN dpc-3474 560 6 - - PUNCT dpc-3474 560 7 2045(15)70122 2045(15)70122 NOUN dpc-3474 560 8 - - PUNCT dpc-3474 560 9 1 1 NUM dpc-3474 560 10 . . PUNCT dpc-3474 561 1 pmid pmid NOUN dpc-3474 561 2 : : PUNCT dpc-3474 561 3 25840693 25840693 NUM dpc-3474 561 4 . . PUNCT dpc-3474 562 1 42 42 NUM dpc-3474 562 2 . . PUNCT dpc-3474 563 1 thomas thomas PROPN dpc-3474 563 2 dc dc PROPN dpc-3474 563 3 , , PUNCT dpc-3474 563 4 han han PROPN dpc-3474 563 5 g g PROPN dpc-3474 563 6 , , PUNCT dpc-3474 563 7 leong leong PROPN dpc-3474 563 8 sp sp PROPN dpc-3474 563 9 , , PUNCT dpc-3474 563 10 et et PROPN dpc-3474 563 11     SPACE dpc-3474 563 12 al al PROPN dpc-3474 563 13 . . PROPN dpc-3474 563 14 recurrence recurrence NOUN dpc-3474 563 15 of of ADP dpc-3474 563 16 melanoma melanoma NOUN dpc-3474 563 17 after after ADP dpc-3474 563 18 a a DET dpc-3474 563 19 negative negative ADJ dpc-3474 563 20 sentinel sentinel ADJ dpc-3474 563 21 node node ADJ dpc-3474 563 22 biopsy biopsy NOUN dpc-3474 563 23 : : PUNCT dpc-3474 563 24 predictors predictor NOUN dpc-3474 563 25 and and CCONJ dpc-3474 563 26 impact impact NOUN dpc-3474 563 27 of of ADP dpc-3474 563 28 recurrence recurrence NOUN dpc-3474 563 29 site site NOUN dpc-3474 563 30 on on ADP dpc-3474 563 31 survival survival NOUN dpc-3474 563 32 . . PUNCT dpc-3474 564 1 ann ann PROPN dpc-3474 564 2 surg surg PROPN dpc-3474 564 3 oncol oncol PROPN dpc-3474 564 4 . . PUNCT dpc-3474 565 1 2019;26(7):2254 2019;26(7):2254 NUM dpc-3474 565 2 - - SYM dpc-3474 565 3 62 62 NUM dpc-3474 565 4 . . PUNCT dpc-3474 566 1 doi doi NOUN dpc-3474 566 2 : : PUNCT dpc-3474 566 3 10.1245 10.1245 NUM dpc-3474 566 4 / / SYM dpc-3474 566 5 s10434 s10434 PROPN dpc-3474 566 6 - - PUNCT dpc-3474 566 7 019 019 NUM dpc-3474 566 8 - - PUNCT dpc-3474 566 9 07369 07369 NUM dpc-3474 566 10 - - PUNCT dpc-3474 566 11 w. w. NOUN dpc-3474 566 12 pmid pmid PROPN dpc-3474 566 13 : : PUNCT dpc-3474 566 14 31011906 31011906 NUM dpc-3474 566 15 . . PUNCT dpc-3474 567 1 43 43 NUM dpc-3474 567 2 . . PUNCT dpc-3474 568 1 garbe garbe PROPN dpc-3474 568 2 c c PROPN dpc-3474 568 3 , , PUNCT dpc-3474 568 4 amaral amaral PROPN dpc-3474 568 5 t t PROPN dpc-3474 568 6 , , PUNCT dpc-3474 568 7 peris peris PROPN dpc-3474 568 8 k k PROPN dpc-3474 568 9 , , PUNCT dpc-3474 568 10 et et PROPN dpc-3474 568 11 al al PROPN dpc-3474 568 12 . . PUNCT dpc-3474 569 1 european european PROPN dpc-3474 569 2 consensus consensus NOUN dpc-3474 569 3 - - PUNCT dpc-3474 569 4 based base VERB dpc-3474 569 5 interdisciplinary interdisciplinary ADJ dpc-3474 569 6 guideline guideline NOUN dpc-3474 569 7 for for ADP dpc-3474 569 8 melanoma melanoma NOUN dpc-3474 569 9 . . PUNCT dpc-3474 570 1 part part NOUN dpc-3474 570 2 1 1 NUM dpc-3474 570 3 : : PUNCT dpc-3474 570 4 diagnostics diagnostic NOUN dpc-3474 570 5 : : PUNCT dpc-3474 570 6 update update NOUN dpc-3474 570 7 2022 2022 NUM dpc-3474 570 8 . . PUNCT dpc-3474 571 1 eur eur PROPN dpc-3474 571 2 j j PROPN dpc-3474 571 3 cancer cancer NOUN dpc-3474 571 4 . . PUNCT dpc-3474 572 1 2022;170:236 2022;170:236 NUM dpc-3474 572 2 - - SYM dpc-3474 572 3 255 255 NUM dpc-3474 572 4 . . PUNCT dpc-3474 573 1 doi doi NOUN dpc-3474 573 2 : : PUNCT dpc-3474 573 3 10.1016 10.1016 NUM dpc-3474 573 4 / / SYM dpc-3474 573 5 j j PROPN dpc-3474 573 6 .ejca.2022.03.008 .ejca.2022.03.008 X dpc-3474 573 7 . . PUNCT dpc-3474 574 1 pmid pmid NOUN dpc-3474 574 2 : : PUNCT dpc-3474 574 3 35570085 35570085 NUM dpc-3474 574 4 . . PUNCT dpc-3474 575 1 44 44 NUM dpc-3474 575 2 . . PUNCT dpc-3474 576 1 national national ADJ dpc-3474 576 2 comprehensive comprehensive ADJ dpc-3474 576 3 cancer cancer NOUN dpc-3474 576 4 network network NOUN dpc-3474 576 5 clinical clinical ADJ dpc-3474 576 6 practice practice NOUN dpc-3474 576 7 guidelines guideline NOUN dpc-3474 576 8 in in ADP dpc-3474 576 9 oncology oncology NOUN dpc-3474 576 10 . . PUNCT dpc-3474 577 1 melanoma melanoma NOUN dpc-3474 577 2 : : PUNCT dpc-3474 577 3 cutaneous cutaneous ADJ dpc-3474 577 4 . . PUNCT dpc-3474 578 1 updated update VERB dpc-3474 578 2 march march PROPN dpc-3474 578 3 2023 2023 NUM dpc-3474 578 4 . . PUNCT dpc-3474 579 1 accessed access VERB dpc-3474 579 2 september september PROPN dpc-3474 579 3 22 22 NUM dpc-3474 579 4 , , PUNCT dpc-3474 579 5 2023 2023 NUM dpc-3474 579 6 . . PUNCT dpc-3474 580 1 https://www.nccn.org https://www.nccn.org PUNCT dpc-3474 580 2 /professionals /professional NOUN dpc-3474 580 3 / / SYM dpc-3474 580 4 physician_gls physician_gls NOUN dpc-3474 580 5 / / SYM dpc-3474 580 6 pdf pdf NOUN dpc-3474 580 7 / / SYM dpc-3474 580 8 cutaneous_melanoma.pdf cutaneous_melanoma.pdf NOUN dpc-3474 580 9 45 45 NUM dpc-3474 580 10 . . PUNCT dpc-3474 581 1 rueth rueth PROPN dpc-3474 581 2 nm nm PROPN dpc-3474 581 3 , , PUNCT dpc-3474 581 4 cromwell cromwell PROPN dpc-3474 581 5 kd kd PROPN dpc-3474 581 6 , , PUNCT dpc-3474 581 7 cormier cormier PROPN dpc-3474 581 8 jn jn PROPN dpc-3474 581 9 . . PROPN dpc-3474 582 1 long long ADJ dpc-3474 582 2 - - PUNCT dpc-3474 582 3 term term NOUN dpc-3474 582 4 follow follow NOUN dpc-3474 582 5 - - PUNCT dpc-3474 582 6 up up NOUN dpc-3474 582 7 for for ADP dpc-3474 582 8 melanoma melanoma NOUN dpc-3474 582 9 patients patient NOUN dpc-3474 582 10 : : PUNCT dpc-3474 582 11 is be AUX dpc-3474 582 12 there there PRON dpc-3474 582 13 any any DET dpc-3474 582 14 evidence evidence NOUN dpc-3474 582 15 of of ADP dpc-3474 582 16 a a DET dpc-3474 582 17 benefit benefit NOUN dpc-3474 582 18 ? ? PUNCT dpc-3474 583 1 surg surg PROPN dpc-3474 583 2 oncol oncol PROPN dpc-3474 583 3 clin clin PROPN dpc-3474 583 4 n n PRON dpc-3474 583 5 am be AUX dpc-3474 583 6 . . PUNCT dpc-3474 584 1 2015;24(2):359 2015;24(2):359 X dpc-3474 584 2 - - SYM dpc-3474 584 3 77 77 NUM dpc-3474 584 4 . . PUNCT dpc-3474 585 1 doi doi NOUN dpc-3474 585 2 : : PUNCT dpc-3474 585 3 10.1016 10.1016 NUM dpc-3474 585 4 / / SYM dpc-3474 585 5 j j PROPN dpc-3474 585 6 .soc.2014.12.012 .soc.2014.12.012 PROPN dpc-3474 585 7 . . PUNCT dpc-3474 586 1 pmid pmid NOUN dpc-3474 586 2 : : PUNCT dpc-3474 586 3 25769718 25769718 NUM dpc-3474 586 4 . . PUNCT dpc-3474 587 1 23 23 NUM dpc-3474 587 2 . . PUNCT dpc-3474 588 1 hayes hayes PROPN dpc-3474 588 2 aj aj PROPN dpc-3474 588 3 , , PUNCT dpc-3474 588 4 moskovic moskovic ADJ dpc-3474 588 5 e e NOUN dpc-3474 588 6 , , PUNCT dpc-3474 588 7 o’meara o’meara X dpc-3474 588 8 k k NOUN dpc-3474 588 9 , , PUNCT dpc-3474 588 10 et et PROPN dpc-3474 588 11     SPACE dpc-3474 588 12 al al PROPN dpc-3474 588 13 . . PROPN dpc-3474 588 14 prospective prospective ADJ dpc-3474 588 15 cohort cohort NOUN dpc-3474 588 16 study study NOUN dpc-3474 588 17 of of ADP dpc-3474 588 18 ultrasound ultrasound ADJ dpc-3474 588 19 surveillance surveillance NOUN dpc-3474 588 20 of of ADP dpc-3474 588 21 regional regional ADJ dpc-3474 588 22 lymph lymph NOUN dpc-3474 588 23 nodes node NOUN dpc-3474 588 24 in in ADP dpc-3474 588 25 patients patient NOUN dpc-3474 588 26 with with ADP dpc-3474 588 27 intermediate intermediate ADJ dpc-3474 588 28 - - PUNCT dpc-3474 588 29 risk risk NOUN dpc-3474 588 30 cutaneous cutaneous ADJ dpc-3474 588 31 melanoma melanoma NOUN dpc-3474 588 32 . . PUNCT dpc-3474 589 1 br br PROPN dpc-3474 589 2 j j PROPN dpc-3474 589 3 surg surg PROPN dpc-3474 589 4 . . PUNCT dpc-3474 590 1 2019;106(6):729 2019;106(6):729 NUM dpc-3474 590 2 - - SYM dpc-3474 590 3 34 34 NUM dpc-3474 590 4 . . PUNCT dpc-3474 590 5 doi doi NOUN dpc-3474 590 6 : : PUNCT dpc-3474 590 7 10.1002 10.1002 NUM dpc-3474 590 8 / / SYM dpc-3474 590 9 bjs.11112 bjs.11112 PROPN dpc-3474 590 10 . . PUNCT dpc-3474 591 1 pmid pmid NOUN dpc-3474 591 2 : : PUNCT dpc-3474 591 3 30816996 30816996 NUM dpc-3474 591 4 . . PUNCT dpc-3474 592 1 24 24 NUM dpc-3474 592 2 . . PUNCT dpc-3474 593 1 lee lee PROPN dpc-3474 593 2 ay ay PROPN dpc-3474 593 3 , , PUNCT dpc-3474 593 4 droppelmann droppelmann PROPN dpc-3474 593 5 n n PRON dpc-3474 593 6 , , PUNCT dpc-3474 593 7 panageas panageas PROPN dpc-3474 593 8 ks ks PROPN dpc-3474 593 9 , , PUNCT dpc-3474 593 10 et et PROPN dpc-3474 593 11     SPACE dpc-3474 593 12 al al PROPN dpc-3474 593 13 . . PROPN dpc-3474 593 14 patterns pattern NOUN dpc-3474 593 15 and and CCONJ dpc-3474 593 16 timing timing NOUN dpc-3474 593 17 of of ADP dpc-3474 593 18 initial initial ADJ dpc-3474 593 19 relapse relapse NOUN dpc-3474 593 20 in in ADP dpc-3474 593 21 pathologic pathologic ADJ dpc-3474 593 22 stage stage NOUN dpc-3474 593 23 ii ii PROPN dpc-3474 593 24 melanoma melanoma NOUN dpc-3474 593 25 patients patient NOUN dpc-3474 593 26 . . PUNCT dpc-3474 594 1 ann ann PROPN dpc-3474 594 2 surg surg PROPN dpc-3474 594 3 oncol oncol PROPN dpc-3474 594 4 . . PUNCT dpc-3474 595 1 2017;24(4):939 2017;24(4):939 NUM dpc-3474 595 2 - - SYM dpc-3474 595 3 46 46 NUM dpc-3474 595 4 . . PUNCT dpc-3474 596 1 doi doi NOUN dpc-3474 596 2 : : PUNCT dpc-3474 596 3 10.1245 10.1245 NUM dpc-3474 596 4 / / SYM dpc-3474 596 5 s10434 s10434 PROPN dpc-3474 596 6 - - PUNCT dpc-3474 596 7 0165642 0165642 NUM dpc-3474 596 8 - - PUNCT dpc-3474 596 9 0 0 NUM dpc-3474 596 10 . . PUNCT dpc-3474 597 1 pmid pmid NOUN dpc-3474 597 2 : : PUNCT dpc-3474 597 3 27804026 27804026 NUM dpc-3474 597 4 . . PUNCT dpc-3474 598 1 25 25 NUM dpc-3474 598 2 . . PUNCT dpc-3474 599 1 livingstone livingstone PROPN dpc-3474 599 2 e e PROPN dpc-3474 599 3 , , PUNCT dpc-3474 599 4 eigentler eigentler NOUN dpc-3474 599 5 tk tk PROPN dpc-3474 599 6 , , PUNCT dpc-3474 599 7 windemuth windemuth NOUN dpc-3474 599 8 - - PUNCT dpc-3474 599 9 kieselbach kieselbach NOUN dpc-3474 599 10 c c NOUN dpc-3474 599 11 , , PUNCT dpc-3474 599 12 et et PROPN dpc-3474 599 13     SPACE dpc-3474 599 14 al al PROPN dpc-3474 599 15 . . PUNCT dpc-3474 599 16 actual actual ADJ dpc-3474 599 17 practice practice NOUN dpc-3474 599 18 of of ADP dpc-3474 599 19 melanoma melanoma NOUN dpc-3474 599 20 follow follow NOUN dpc-3474 599 21 - - PUNCT dpc-3474 599 22 up up NOUN dpc-3474 599 23 and and CCONJ dpc-3474 599 24 treatment treatment NOUN dpc-3474 599 25 in in ADP dpc-3474 599 26 germany germany PROPN dpc-3474 599 27 : : PUNCT dpc-3474 599 28 results result NOUN dpc-3474 599 29 of of ADP dpc-3474 599 30 a a DET dpc-3474 599 31 prospective prospective ADJ dpc-3474 599 32 , , PUNCT dpc-3474 599 33 longitudinal longitudinal ADJ dpc-3474 599 34 cohort cohort NOUN dpc-3474 599 35 study study NOUN dpc-3474 599 36 . . PUNCT dpc-3474 600 1 br br PROPN dpc-3474 600 2 j j PROPN dpc-3474 600 3 dermatol dermatol NOUN dpc-3474 600 4 . . PUNCT dpc-3474 601 1 2015;172(6):1646 2015;172(6):1646 NUM dpc-3474 601 2 - - SYM dpc-3474 601 3 50 50 NUM dpc-3474 601 4 . . PUNCT dpc-3474 602 1 doi doi NOUN dpc-3474 602 2 : : PUNCT dpc-3474 602 3 10.1111 10.1111 NUM dpc-3474 602 4 / / SYM dpc-3474 602 5 bjd.13612 bjd.13612 NOUN dpc-3474 602 6 . . PUNCT dpc-3474 603 1 pmid pmid NOUN dpc-3474 603 2 : : PUNCT dpc-3474 603 3 25495472 25495472 NUM dpc-3474 603 4 . . PUNCT dpc-3474 604 1 26 26 NUM dpc-3474 604 2 . . PUNCT dpc-3474 605 1 dicker dicker PROPN dpc-3474 605 2 tj tj PROPN dpc-3474 605 3 , , PUNCT dpc-3474 605 4 kavanagh kavanagh PROPN dpc-3474 605 5 gm gm PROPN dpc-3474 605 6 , , PUNCT dpc-3474 605 7 herd herd NOUN dpc-3474 605 8 rm rm PROPN dpc-3474 605 9 , , PUNCT dpc-3474 605 10 et et PROPN dpc-3474 605 11     SPACE dpc-3474 605 12 al al PROPN dpc-3474 605 13 . . PROPN dpc-3474 606 1 a a DET dpc-3474 606 2 rational rational ADJ dpc-3474 606 3 approach approach NOUN dpc-3474 606 4 to to ADP dpc-3474 606 5 melanoma melanoma NOUN dpc-3474 606 6 follow follow VERB dpc-3474 606 7 - - PUNCT dpc-3474 606 8 up up NOUN dpc-3474 606 9 in in ADP dpc-3474 606 10 patients patient NOUN dpc-3474 606 11 with with ADP dpc-3474 606 12 primary primary ADJ dpc-3474 606 13 cutaneous cutaneous ADJ dpc-3474 606 14 melanoma melanoma NOUN dpc-3474 606 15 . . PUNCT dpc-3474 607 1 scottish scottish ADJ dpc-3474 607 2 melanoma melanoma PROPN dpc-3474 607 3 group group NOUN dpc-3474 607 4 . . PUNCT dpc-3474 608 1 br br PROPN dpc-3474 608 2 j j PROPN dpc-3474 608 3 dermatol dermatol NOUN dpc-3474 608 4 . . PUNCT dpc-3474 609 1 1999;140(2):249 1999;140(2):249 NUM dpc-3474 609 2 - - SYM dpc-3474 609 3 54 54 NUM dpc-3474 609 4 . . PUNCT dpc-3474 610 1 doi doi NOUN dpc-3474 610 2 : : PUNCT dpc-3474 610 3 10.1046 10.1046 NUM dpc-3474 610 4 / / SYM dpc-3474 610 5 j.1365 j.1365 NOUN dpc-3474 610 6 - - PUNCT dpc-3474 610 7 2133.1999.02657.x 2133.1999.02657.x NOUN dpc-3474 610 8 . . PUNCT dpc-3474 611 1 pmid pmid NOUN dpc-3474 611 2 : : PUNCT dpc-3474 611 3 10233217 10233217 NUM dpc-3474 611 4 . . PUNCT dpc-3474 612 1 27 27 NUM dpc-3474 612 2 . . PUNCT dpc-3474 612 3 sparks spark VERB dpc-3474 612 4 ds ds PROPN dpc-3474 612 5 , , PUNCT dpc-3474 612 6 read read VERB dpc-3474 612 7 t t PROPN dpc-3474 612 8 , , PUNCT dpc-3474 612 9 lonne lonne PROPN dpc-3474 612 10 m m PROPN dpc-3474 612 11 , , PUNCT dpc-3474 612 12 et et PROPN dpc-3474 612 13     SPACE dpc-3474 612 14 al al PROPN dpc-3474 612 15 . . PROPN dpc-3474 612 16 primary primary ADJ dpc-3474 612 17 cutaneous cutaneous ADJ dpc-3474 612 18 melanoma melanoma NOUN dpc-3474 612 19 of of ADP dpc-3474 612 20 the the DET dpc-3474 612 21 scalp scalp NOUN dpc-3474 612 22 : : PUNCT dpc-3474 612 23 patterns pattern NOUN dpc-3474 612 24 of of ADP dpc-3474 612 25 recurrence recurrence NOUN dpc-3474 612 26 . . PUNCT dpc-3474 613 1 j j PROPN dpc-3474 613 2 surg surg PROPN dpc-3474 613 3 oncol oncol PROPN dpc-3474 613 4 . . PUNCT dpc-3474 614 1 2017;115(4 2017;115(4 NUM dpc-3474 614 2 ): ): PUNCT dpc-3474 614 3 449 449 NUM dpc-3474 614 4 - - SYM dpc-3474 614 5 54 54 NUM dpc-3474 614 6 . . PUNCT dpc-3474 615 1 doi doi NOUN dpc-3474 615 2 : : PUNCT dpc-3474 615 3 10.1002 10.1002 NUM dpc-3474 615 4 / / SYM dpc-3474 615 5 jso.24535 jso.24535 PROPN dpc-3474 615 6 . . PUNCT dpc-3474 616 1 pmid pmid NOUN dpc-3474 616 2 : : PUNCT dpc-3474 616 3 28035664 28035664 NUM dpc-3474 616 4 . . PUNCT dpc-3474 617 1 28 28 NUM dpc-3474 617 2 . . PUNCT dpc-3474 618 1 oh oh INTJ dpc-3474 618 2 y y NOUN dpc-3474 618 3 , , PUNCT dpc-3474 618 4 choi choi NOUN dpc-3474 618 5 s s PART dpc-3474 618 6 , , PUNCT dpc-3474 618 7 cho cho VERB dpc-3474 618 8 my my PRON dpc-3474 618 9 , , PUNCT dpc-3474 618 10 et et PROPN dpc-3474 618 11     SPACE dpc-3474 618 12 al al PROPN dpc-3474 618 13 . . PUNCT dpc-3474 618 14 male male ADJ dpc-3474 618 15 sex sex NOUN dpc-3474 618 16 and and CCONJ dpc-3474 618 17 breslow breslow ADJ dpc-3474 618 18 thickness thickness NOUN dpc-3474 618 19 are be AUX dpc-3474 618 20 important important ADJ dpc-3474 618 21 risk risk NOUN dpc-3474 618 22 factors factor NOUN dpc-3474 618 23 for for ADP dpc-3474 618 24 recurrence recurrence NOUN dpc-3474 618 25 of of ADP dpc-3474 618 26 localized localized ADJ dpc-3474 618 27 melanoma melanoma NOUN dpc-3474 618 28 in in ADP dpc-3474 618 29 korean korean ADJ dpc-3474 618 30 populations population NOUN dpc-3474 618 31 . . PUNCT dpc-3474 619 1 j j PROPN dpc-3474 619 2 am be AUX dpc-3474 619 3 acad acad ADJ dpc-3474 619 4 dermatol dermatol NOUN dpc-3474 619 5 . . PUNCT dpc-3474 620 1 2020;83(4):1071 2020;83(4):1071 NUM dpc-3474 620 2 - - SYM dpc-3474 620 3 9 9 NUM dpc-3474 620 4 . . PUNCT dpc-3474 620 5 doi doi NOUN dpc-3474 620 6 : : PUNCT dpc-3474 620 7 10.1016 10.1016 NUM dpc-3474 620 8 / / SYM dpc-3474 620 9 j.jaad.2019.09.029 j.jaad.2019.09.029 PROPN dpc-3474 620 10 . . PUNCT dpc-3474 621 1 pmid pmid PROPN dpc-3474 621 2 : : PUNCT dpc-3474 621 3 31562946 31562946 NUM dpc-3474 621 4 . . PUNCT dpc-3474 622 1 29 29 NUM dpc-3474 622 2 . . PUNCT dpc-3474 622 3 leeneman leeneman PROPN dpc-3474 622 4 b b PROPN dpc-3474 622 5 , , PUNCT dpc-3474 622 6 franken franken PROPN dpc-3474 622 7 mg mg PROPN dpc-3474 622 8 , , PUNCT dpc-3474 622 9 coupé coupé ADJ dpc-3474 622 10 vmh vmh PROPN dpc-3474 622 11 , , PUNCT dpc-3474 622 12 et et PROPN dpc-3474 622 13     SPACE dpc-3474 622 14 al al PROPN dpc-3474 622 15 . . PROPN dpc-3474 622 16 stage stage NOUN dpc-3474 622 17 - - PUNCT dpc-3474 622 18 specific specific ADJ dpc-3474 622 19 disease disease NOUN dpc-3474 622 20 recurrence recurrence NOUN dpc-3474 622 21 and and CCONJ dpc-3474 622 22 survival survival NOUN dpc-3474 622 23 in in ADP dpc-3474 622 24 localized localized ADJ dpc-3474 622 25 and and CCONJ dpc-3474 622 26 regionally regionally ADV dpc-3474 622 27 advanced advanced ADJ dpc-3474 622 28 cutaneous cutaneous ADJ dpc-3474 622 29 melanoma melanoma NOUN dpc-3474 622 30 . . PUNCT dpc-3474 623 1 eur eur PROPN dpc-3474 623 2 j j PROPN dpc-3474 623 3 surg surg PROPN dpc-3474 623 4 oncol oncol PROPN dpc-3474 623 5 . . PUNCT dpc-3474 624 1 2019;45(5):825 2019;45(5):825 PROPN dpc-3474 624 2 - - PUNCT dpc-3474 624 3 31 31 NUM dpc-3474 624 4 . . PUNCT dpc-3474 625 1 doi doi NOUN dpc-3474 625 2 : : PUNCT dpc-3474 625 3 10.1016 10.1016 NUM dpc-3474 625 4 / / SYM dpc-3474 625 5 j.ejso.2019.01.225 j.ejso.2019.01.225 PROPN dpc-3474 625 6 . . PUNCT dpc-3474 626 1 pmid pmid NOUN dpc-3474 626 2 : : PUNCT dpc-3474 626 3 30765270 30765270 NUM dpc-3474 626 4 . . PUNCT dpc-3474 627 1 30 30 NUM dpc-3474 627 2 . . PUNCT dpc-3474 628 1 bartlett bartlett PROPN dpc-3474 628 2 ek ek PROPN dpc-3474 628 3 , , PUNCT dpc-3474 628 4 lee lee PROPN dpc-3474 628 5 ay ay PROPN dpc-3474 628 6 , , PUNCT dpc-3474 628 7 spanheimer spanheimer NOUN dpc-3474 628 8 pm pm NOUN dpc-3474 628 9 , , PUNCT dpc-3474 628 10 et et PROPN dpc-3474 628 11     SPACE dpc-3474 628 12 al al PROPN dpc-3474 628 13 . . PROPN dpc-3474 628 14 nodal nodal NOUN dpc-3474 628 15 and and CCONJ dpc-3474 628 16 systemic systemic ADJ dpc-3474 628 17 recurrence recurrence NOUN dpc-3474 628 18 following follow VERB dpc-3474 628 19 observation observation NOUN dpc-3474 628 20 of of ADP dpc-3474 628 21 a a DET dpc-3474 628 22 positive positive ADJ dpc-3474 628 23 sentinel sentinel NOUN dpc-3474 628 24 lymph lymph NOUN dpc-3474 628 25 node node NOUN dpc-3474 628 26 in in ADP dpc-3474 628 27 melanoma melanoma NOUN dpc-3474 628 28 . . PUNCT dpc-3474 629 1 br br PROPN dpc-3474 629 2 j j PROPN dpc-3474 629 3 surg surg PROPN dpc-3474 629 4 . . PUNCT dpc-3474 630 1 2020;107(11):1480 2020;107(11):1480 NUM dpc-3474 630 2 - - SYM dpc-3474 630 3 8 8 NUM dpc-3474 630 4 . . PUNCT dpc-3474 630 5 doi doi NOUN dpc-3474 630 6 : : PUNCT dpc-3474 630 7 10.1002 10.1002 NUM dpc-3474 630 8 / / SYM dpc-3474 630 9 bjs.11621 bjs.11621 PROPN dpc-3474 630 10 . . PUNCT dpc-3474 631 1 pmid pmid NOUN dpc-3474 631 2 : : PUNCT dpc-3474 631 3 32484242 32484242 NUM dpc-3474 631 4 . . PUNCT dpc-3474 632 1 31 31 NUM dpc-3474 632 2 . . PUNCT dpc-3474 633 1 namin namin PROPN dpc-3474 633 2 aw aw INTJ dpc-3474 633 3 , , PUNCT dpc-3474 633 4 cornell cornell PROPN dpc-3474 633 5 ge ge PROPN dpc-3474 633 6 , , PUNCT dpc-3474 633 7 thombs thomb VERB dpc-3474 633 8 la la PROPN dpc-3474 633 9 , , PUNCT dpc-3474 633 10 zitsch zitsch PROPN dpc-3474 633 11 rp rp NOUN dpc-3474 633 12 . . PUNCT dpc-3474 633 13 patterns pattern NOUN dpc-3474 633 14 of of ADP dpc-3474 633 15 recurrence recurrence NOUN dpc-3474 633 16 and and CCONJ dpc-3474 633 17 retreatment retreatment ADJ dpc-3474 633 18 outcomes outcome NOUN dpc-3474 633 19 among among ADP dpc-3474 633 20 clinical clinical ADJ dpc-3474 633 21 stage stage NOUN dpc-3474 633 22 i i PRON dpc-3474 633 23 and and CCONJ dpc-3474 633 24 ii ii PROPN dpc-3474 633 25 head head NOUN dpc-3474 633 26 and and CCONJ dpc-3474 633 27 neck neck NOUN dpc-3474 633 28 melanoma melanoma NOUN dpc-3474 633 29 patients patient NOUN dpc-3474 633 30 . . PUNCT dpc-3474 634 1 head head NOUN dpc-3474 634 2 neck neck NOUN dpc-3474 634 3 . . PUNCT dpc-3474 635 1 2019;41(5):1304 2019;41(5):1304 NUM dpc-3474 635 2 - - SYM dpc-3474 635 3 11 11 NUM dpc-3474 635 4 . . PUNCT dpc-3474 636 1 doi doi NOUN dpc-3474 636 2 : : PUNCT dpc-3474 636 3 10.1002 10.1002 NUM dpc-3474 636 4 / / SYM dpc-3474 636 5 hed.25562 hed.25562 NOUN dpc-3474 636 6 . . PUNCT dpc-3474 637 1 pmid pmid NOUN dpc-3474 637 2 : : PUNCT dpc-3474 637 3 30629324 30629324 NUM dpc-3474 637 4 . . PUNCT dpc-3474 638 1 32 32 NUM dpc-3474 638 2 . . PUNCT dpc-3474 638 3 ertekin ertekin PROPN dpc-3474 638 4 ss ss PROPN dpc-3474 638 5 , , PUNCT dpc-3474 638 6 podlipnik podlipnik X dpc-3474 638 7 s s PROPN dpc-3474 638 8 , , PUNCT dpc-3474 638 9 riquelme riquelme PROPN dpc-3474 638 10 - - PUNCT dpc-3474 638 11 mc mc PROPN dpc-3474 638 12 loughlin loughlin PROPN dpc-3474 638 13 c c PROPN dpc-3474 638 14 , , PUNCT dpc-3474 638 15 et et PROPN dpc-3474 638 16     SPACE dpc-3474 638 17 al al PROPN dpc-3474 638 18 . . PROPN dpc-3474 638 19 initial initial ADJ dpc-3474 638 20 stage stage NOUN dpc-3474 638 21 of of ADP dpc-3474 638 22 cutaneous cutaneous ADJ dpc-3474 638 23 primary primary ADJ dpc-3474 638 24 melanoma melanoma NOUN dpc-3474 638 25 plays play VERB dpc-3474 638 26 a a DET dpc-3474 638 27 key key ADJ dpc-3474 638 28 role role NOUN dpc-3474 638 29 in in ADP dpc-3474 638 30 the the DET dpc-3474 638 31 pattern pattern NOUN dpc-3474 638 32 and and CCONJ dpc-3474 638 33 timing timing NOUN dpc-3474 638 34 of of ADP dpc-3474 638 35 disease disease NOUN dpc-3474 638 36 recurrence recurrence NOUN dpc-3474 638 37 . . PUNCT dpc-3474 639 1 acta acta PROPN dpc-3474 639 2 derm derm PROPN dpc-3474 639 3 venereol venereol NOUN dpc-3474 639 4 . . PUNCT dpc-3474 640 1 2021;101(7):adv00502 2021;101(7):adv00502 X dpc-3474 640 2 . . PUNCT dpc-3474 641 1 doi doi NOUN dpc-3474 641 2 : : PUNCT dpc-3474 641 3 10.2340/00015555 10.2340/00015555 NUM dpc-3474 641 4 - - SYM dpc-3474 641 5 3832 3832 NUM dpc-3474 641 6 . . PUNCT dpc-3474 642 1 pmid pmid NOUN dpc-3474 642 2 : : PUNCT dpc-3474 642 3 34003298 34003298 NUM dpc-3474 642 4 . . PUNCT dpc-3474 643 1 33 33 NUM dpc-3474 643 2 . . PUNCT dpc-3474 644 1 fusi fusi PROPN dpc-3474 644 2 s s PROPN dpc-3474 644 3 , , PUNCT dpc-3474 644 4 ariyan ariyan PROPN dpc-3474 644 5 s s PROPN dpc-3474 644 6 , , PUNCT dpc-3474 644 7 sternlicht sternlicht PROPN dpc-3474 644 8 a. a. NOUN dpc-3474 644 9 data datum NOUN dpc-3474 644 10 on on ADP dpc-3474 644 11 first first ADJ dpc-3474 644 12 recurrence recurrence NOUN dpc-3474 644 13 after after ADP dpc-3474 644 14 treatment treatment NOUN dpc-3474 644 15 for for ADP dpc-3474 644 16 malignant malignant ADJ dpc-3474 644 17 melanoma melanoma NOUN dpc-3474 644 18 in in ADP dpc-3474 644 19 a a DET dpc-3474 644 20 large large ADJ dpc-3474 644 21 patient patient ADJ dpc-3474 644 22 population population NOUN dpc-3474 644 23 . . PUNCT dpc-3474 645 1 plast plast PROPN dpc-3474 645 2 reconstr reconstr PROPN dpc-3474 645 3 surg surg PROPN dpc-3474 645 4 . . PUNCT dpc-3474 646 1 1993;91(1):94 1993;91(1):94 NUM dpc-3474 646 2 - - SYM dpc-3474 646 3 8 8 NUM dpc-3474 646 4 . . PUNCT dpc-3474 646 5 doi doi NOUN dpc-3474 646 6 : : PUNCT dpc-3474 646 7 10.1097/00006534 10.1097/00006534 NUM dpc-3474 646 8 -199301000 -199301000 PROPN dpc-3474 646 9 - - PUNCT dpc-3474 646 10 00014 00014 NUM dpc-3474 646 11 . . PUNCT dpc-3474 647 1 pmid pmid NOUN dpc-3474 647 2 : : PUNCT dpc-3474 647 3 8416544 8416544 NUM dpc-3474 647 4 . . PUNCT dpc-3474 648 1 34 34 NUM dpc-3474 648 2 . . PUNCT dpc-3474 649 1 bhave bhave PROPN dpc-3474 649 2 p p X dpc-3474 649 3 , , PUNCT dpc-3474 649 4 pallan pallan PROPN dpc-3474 649 5 l l NOUN dpc-3474 649 6 , , PUNCT dpc-3474 649 7 long long ADV dpc-3474 649 8 gv gv ADP dpc-3474 649 9 , , PUNCT dpc-3474 649 10 menzies menzie NOUN dpc-3474 649 11 am be AUX dpc-3474 649 12 , , PUNCT dpc-3474 649 13 atkinson atkinson PROPN dpc-3474 649 14 v v PROPN dpc-3474 649 15 , , PUNCT dpc-3474 649 16 cohen cohen PROPN dpc-3474 649 17 jv jv PROPN dpc-3474 649 18 , , PUNCT dpc-3474 649 19 et et PROPN dpc-3474 649 20     SPACE dpc-3474 650 1 al al PROPN dpc-3474 650 2 . . PUNCT dpc-3474 650 3 melanoma melanoma PROPN dpc-3474 650 4 recurrence recurrence NOUN dpc-3474 650 5 patterns pattern NOUN dpc-3474 650 6 and and CCONJ dpc-3474 650 7 management management NOUN dpc-3474 650 8 after after ADP dpc-3474 650 9 adjuvant adjuvant ADJ dpc-3474 650 10 targeted target VERB dpc-3474 650 11 therapy therapy NOUN dpc-3474 650 12 : : PUNCT dpc-3474 650 13 a a DET dpc-3474 650 14 multicentre multicentre NOUN dpc-3474 650 15 analysis analysis NOUN dpc-3474 650 16 . . PUNCT dpc-3474 651 1 br br PROPN dpc-3474 651 2 j j PROPN dpc-3474 651 3 cancer cancer NOUN dpc-3474 651 4 . . PUNCT dpc-3474 652 1 febrero febrero PROPN dpc-3474 652 2 de de PROPN dpc-3474 652 3 2021;124(3):574 2021;124(3):574 PROPN dpc-3474 652 4 - - SYM dpc-3474 652 5 80 80 NUM dpc-3474 652 6 . . PUNCT